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Thermodynamic and kinetic analysis of the ligand substitution reactions of different 
heterometallic Ru(II)-Pt(II) complexes with a series of bio-relevant thiourea nucleophiles 
of different steric demands and ionic nucleophiles have been investigated as a function of 
concentration and temperature using UV/visible and stopped-flow spectrophotometric 
techniques. To achieve this, five different sets of complexes involving mono di and 
multinuclear homo and heterometallic complexes with tridentate N-donor ligands of 
different linker ligands were synthesized and characterized by various spectroscopic 
methods. The substitution reactions of the chloride complexes were studied in methanol 
in the presence of 0.02 M LiCf3SO3 adjusted with LiCl to prevent possible solvolysis. The 
aqua complexes were studied in acidic aqueous medium at pH 2.0. All reactions were 
investigated under pseudo first-order conditions. Density functional theory (DFT) 
calculations were used to aid further interpretations and understandings of the 
experimental results.  
 
Substitution reactivity of heterometallic Ru(II)-Pt(II) and Co(II)-Pt(II) complexes bridged 
by tetra-2-pyridyl-1,4-pyrazine (tppz) ligand was investigated for the first time. The 
reactions proceeded via two steps. The pseudo first-order rate constants, kobs(1st, 2nd) for 
the substitution of the chloride ligand(s) from the Pt(II) complexes and subsequent 
displacement of the linker. The dechelation step was confirmed by 1H NMR and           
195Pt NMR studies. Incorporation of Ru(tppz) moiety increases the substitution reactivity 
and is ascribed to the increased π-back donation from the tppz ligand which increases 
the electrophilicity of the metal centre, overall charge and the global electrophilicity index 
of the complex. However, when changed the second metal centre from a Ru(II) to a 
Co(II), the rate of substitution decreased by  a factor of four due to the weaker π-
backbonding from Co(II). 
 
The substitution reactivity of another set of heterometallic Ru(II)-Pt(II) complexes with 
a semi-rigid linker, 4’-pyridyl-2,2’:6’,2”-terpyridine (qpy) showed that replacing the cis 
pyridyl group by a (tpy)Ru(qpy) moiety lowers the energy of anti-bonding LUMO (π*) 
orbitals and increases the metal-metal interactions and electronic transition within the 
complex whereby enhancing the reactivity of Pt(II) centre. However, when two Pt(II) 
moieties are linked to a (qpy)Ru(qpy), the orthogonal geometry at the Ru(II) metal 
centre prevents the extended π-electron density to flow through the three metal centres. 
The kinetic results obtained were supported by pKa and 195Pt NMR studies.  
ii 
 
Substitution reactions of the mononuclear Pt(II) complexes revealed that the 
polyethylene glycoxy pendent units act as a σ-donors including the lone pair electrons on 
the first oxygen atom thereby decreasing the reactivity of the parent Pt(II) terpyridine 
complex. However, this σ-donation towards the terpyridine moiety was found to be 
effective only up to one unit of the ethylene glycoxy pendant, beyond which the 
reactivity was sterically controlled. The dinuclear Pt(II) complexes bridged by 
polyehtyleneglycol ether units show that the reactivity of the complexes depend on the 
Pt···Pt distance and the steric hindrance at the Pt(II) centre. The substitution reactivity 
of heterometallic Ru(II)-Pt(II) complexes bridged by the same polyehtyleneglycol ether 
units indicate that the presence of Ru(tpy)2 moiety influences the structural geometry of 
the complex system which in turn controls the reactivity of the Pt(II) centre. This is 
further driven by the entrapment effect of the nucleophile due to the V-shape geometry 
adopted by the heterometallic complexes. In all cases the reactivity was also controlled by 
steric and electronic effects. However, when two metal centres are bridged by a flexible 
non-aromatic linker, the electronic transitions and the metal-metal interactions were 
found to be minor, especially for the longer linkers.  
 
The 1H and 195Pt NMR spectroscopic techniques were used to further understand the 
observed substitution kinetics and to confirm the degradation of the bridging ligand 
from the metal centre(s). In all cases, the negative activation entropies obtained support 
the associative mode of substitution. This investigation reveals that the length and the 
nature of the bridging linker plays an important role in controlling the reactivity of the 
heterometallic complexes. It is envisaged that the findings of this project would offer a 
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Role of Platinum and Ruthenium Complexes as Anticancer 
Agents 
1.1 Introduction 
Cancer is one of the most deadly diseases in the world that is caused mainly by 
abnormalities in the genetic material of cell transformation.1 Such abnormalities are 
caused due to the effect of environmental factors such as exposure to carcinogens; 
chemicals, certain type of radiation, tobacco smoke. Depending on the type and 
location, this disease is treated by surgery, chemotherapy, radiation and 
immunotherapy.2 However, to date, effective treatment of cancer has become one of the 
challenging tasks since certain cancer cell-lines are resistant to the available anticancer 
treatments.3 Therefore, current anticancer research focuses on synthesizing new drugs 
which are of improved cytotoxicity.4  
Even though metals are considered toxic for human body, many precious metal ions 
still play a vital role in many biological processes.5 The positively charged metal centers 
interact with the negatively charged groups of proteins and nucleic acids. The number 
of metal based anticancer drugs which are in current clinical use is still low. The 
majority of the drugs are platinum compounds. Examples include; cisplatin (cis-
diamminedichloridoplatinum(II)) (1), carboplatin (cis-diammine(1,1-
cyclobutanedicarboxylato) platinum(II)), and oxaliplatin (Figure 1.1).6 However, due 
to the severe side effects and acquired resistance to certain cancer cells, a large number 
of other metal complexes have been synthesized and screened for anticancer activity.5 
Amongst them, ruthenium complexes are the most well documented. The two most 
promising ruthenium based anticancer compounds known to date are NAMI-A7 and 
KP1019.8 They have shown unique antimestatic activity. The complexes were found to 
be active against most cisplatin- resistant tumour cells. This chapter reviews the 
chemistry of Pt(II) and Ru(II) and their compounds as metalotheraputic agents in the 
medicinal chemistry.  
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1.2 The General Chemistry of Platinum(II) Complexes 
Platinum is one of the most well studied transition metals due to its biological activity.9 
The most well known oxidation states are 0, +2, +4.10 The +2 and +4 states are the most 
important because they comprise the majority of the platinum complexes.  These 
complexes are kinetically and thermodynamically stable. Research on biological 
applications of Pt(II) complexes started in the 1950s with the systematic investigations 
of inorganic reaction mechanisms. Of all the oxidation states of platinum, the +2 species 
is the most versatile and well studied in the reaction mechanisms due its moderately 
slow reactivity and high redox stability.10b,11 Moreover other distictive features of Pt(II) 
species include the presence of a vacant pz orbital for nucleophilic attack, formation of σ 
and π-bonds with complexes and the ability to undergo oxidative addition and 
reductive elimination.10b  
Since Pt(II) is a soft acid, it prefers to bind with soft bases. Pt(II) forms a range of stable 
mono and multinuclear complexes with neutral ligands such as C2H4, CO, tertiary 
phosphines  and anionic monodentate ligands such as halides, sulphides and 
nitrites.10b,12 With tridentate N―N―N donor ligands such as 2,2´:6´,2˝-terpyridine (tpy), 
four-coordinate mononuclear complexes are more common. Furthermore, apart from 
mono and multinuclear complexes, with bidentate ligands such as N―N, P―P, S―S, 
N―O, N―P and N―S, Pt(II) often forms bridged dinuclear chelated complexes.13  
 
Compared to other square planar complexes of platinum group elements, Pt(II) 
complexes are relatively inert. This kinetic property of Pt(II) complexes is thought to be 
the key to the activity of most Pt(II) coordinated compounds. It is also often used for 
studying the mechanism of their reactions. In the past, several studies13-14 have been 
reported on understanding the substitution and kinetic behaviour of Pt(II) complexes. 
Data from these studies resulted in the development of the trans effect.15 
 
Apart from medicinal applications, other major applications of platinum compounds 
include catalysis, electrical and electronic applications, photoluminescence, usage in 
high sensitive optical sensors.16 However, the greatest accomplishment of platinum 
chemistry was the discovery of the biologically active platinum antitumour complex, 
cisplatin.9  
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1.3 Development of Platinum-based Anticancer Drugs and Structure 
Activity Relationship 
The antitumour activity of cisplatin, first synthesized by Peyrone in 1845 was 
serendipitously discovered in 1969 by Barnett Rosenberg9,17 during an investigation of 
the effects of electric field on Escherichia coli (E. coli) bacteria growth in ammonium 
chloride solution using a platinum electrode.18 The drug was first approved for clinical 
uses in 1978.19 Cisplatin forms DNA adducts and intereferes with DNA transcription 
and replication, causing cell apotosis.20  
 
Following the success of cisplatin, a number of platinum based compounds were 
synthesized and tested for anticancer activity. Based on the results obtained by 
screening a large number of cisplatin related complexes, Cleare and Hoeschele, 
proposed some early structural-activity relationships, (SAR), governing the activity.21  
They proposed that:21-22  
 the platinum complexes must have anionic leaving groups with moderate 
binding strength to platinum and should possess a weak trans effect to avoid 
labilisation of the amine moiety. 
 the platinum complexes must have a cis geometry. The cis geometry is 
preferred because the complexes of trans geometry were found to be inactive.  
 the amine group(s) must possess at least one N—H group, which is thought to 
play a role in the hydrogen bond formation with the DNA.22a  
 the complex must be neutral.23 It was thought that neutral complexes would 
lead higher activity through and facilitate the entry of the drug through the cell 
membrane.  




































Cisplatin   (1)
 
Figure 1.1 Platinum complexes in worldwide clinical use and as well as those with regionally 
limited approval: nedaplatin, lobaplatin.6 
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1.3.1 Cisplatin  
Despite its simplicity in structure, cisplatin is one of the most potent anticancer drugs 
developed for chemotherapy in the last three decades.17c,23,25 Since the beginning of its 
clinical trials in 1971,9,26 the drug has been used as an effective treatment against a 
wide range of cancerous cells such as cancers of the bladder, head, testicular, neck and 
ovarian.9,17c,27 However, due to the severe side effects, such as vomiting/nausea,28 
nephrotoxicity and neurotoxicity,6b,29 frequent development of drug resistance in 
certain tumour cells29j,30 and limited water solubility,17c the effectiveness of the drug is 
limited. Even though, the actual cell distribution of cisplatin and its mechanism of 
action with cellular material are not fully understood,31 a large body of research in the 
past three decades have revealed considerable information about how the drug kills 
certain tumour cells and becomes resistant to others.32 
 
1.3.1.1 Mechanism of Action of Cisplatin 
Further studies on cisplatin unravelled the mechanism of Pt(II) compounds and how it 
destroys cancer cells in the human body. It is widely accepted that the main binding 
target of cisplatin is DNA.17c,33 In the blood plasma the chloride concentration is high 
enough (~100 mM) to suppress  the hydrolysis of the complex thus, most of it remains 
unchanged.22a,27d The neutral compound enters into the cell either by passive diffusion 
or active uptake which have been now reported to involve copper transporter proteins 
so-called constitutive triple response 1 (CTR1) sites.34 However, on crossing the cell 
membrane, the neutral cisplatin molecule undergoes hydrolysis of one or both the 
chloride ligands producing charged species (Figure 1.2).17c,18,22a The first aquation 
process is rapid due to the low chloride concentration inside the cell (ca. 2 - 4 mM)35 
onto which the rate of reaction of cisplatin with DNA depends on.36 Since water is a 
better leaving group than chloride, the resulting charged species are more reactive 
towards biomolecules.37 The antitumour activity of cisplatin is intervened  by 
recognition of platinated DNA adducts17c by the protiens (for example high-mobility 
group proteins (HMG)) which prevent cisplatin adducts from interfearing with DNA 
transcription (Figure 1.2). Inside the cell some of the drug may interact with sulfur 
donors in the blood since they have a high affinity for platinum centres,38 yielding to 
stable or kinetically inert39 Pt―S bonded products. Accumulation of coordinated sulfur 
containing proteins and amino acids40 to the platinum drug may lead to potential 
deactivation of the drug and some toxic side effects41,37 which affects the 
biodistribution of the drug and its pharmacokinetics. This reduces the formation of the 
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required Pt—DNA adducts and drug accumulation.40a,42 Due to the  trans influence of 
certain sulfur containing compounds of thioethers40a or methionine derivatives43 to the 
Pt(II) centre results in the removal of the  trans amine ligand by the incoming sulfur 
ligand before DNA binds with the drug40a,43 thereby hindering the actual mechanism of 
the action of the drug and its cytotoxicity.40a 
 
 
Figure 1.2 Suggested reaction pathway for cisplatin in the cell and binding to DNA. Extracted 
from references.17c,18,24,38 
 
1.3.1.2 Reactivity of Cisplatin with DNA 
Due to poor solubility, cisplatin is administered into the human body intravenously as a 
sterile saline solution at a dose of about 50 - 120 mg/m2 (m2 = body surface area) per 
course over 0.5 to 2 hours9,27d for five consecutive days in every 21 days. To minimise 
the side effetcs, the drug is often given in combination therapy with other antitumour 
adjuvants such as bleomycin,44 arabinofurasylcytosine,45 5-fluorouracil46 and 
paclitaxel.44 Once it is entered into the cell, the hydrolysed form of cisplatin lowers the 
pKa of the complex. However, under physiological pH,47 some of the aqua drug 
complexes may get changed to hydroxo species. The hydrated species may bind to DNA 
in multiple steps (Scheme 1.1), which include:48 
a. Aquation: Binding of cisplatin to DNA proceeds via formation of the mono 
aquated species which follows a first-order kinetics and is thought to be the rate 
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determining step.42,49 This step also depends on the nature of the trans amine 
group.50  
b. Preassociation: This involves formation of hydrogen bonding and insertion by 
intercalation with DNA.   
c. Monofunctional adduct formation: Approximately 90% of the Pt-DNA adducts 
formed here are  mainly between 1,2 adjacent N7 guanine sites (60-65%)36 
which causes the double strand DNA to form a kink51 of 45° - 70° at the 
platinations site, resulting in partial unwinding and loss of helical stability while 
the cross-links between adjacent N7 adenine- N7 guanine are 20 - 25%52 which 
unwinds DNA by 13° at the platination site. 
d. Second aquation: Hydrolysis of the second chloride ligand produces diaqua 
species which are twice reactive towards DNA compared to the monoaqua 
species.  
e. Ring closure and formation of bifuntional adduct: Formation of interstrand 
or intrastrand bifunctional adduct is thought to be essential for effective 
anticancer activity. However, it is not yet known whether the bifuntional adduct 
is formed directly from the monochloro complex or whether it is via aquation.  
f. DNA distortion : DNA gets distorted by various proteins. 
 
 
Scheme 1.1 The sequence of cisplatin binding to DNA and the structurally different adducts 
formed.48 The k values and t1/2 values were obtained from a kinetic study of 
hydrolysis of cisplatin by short lengths of single- or double-strand DNA containing 
adjacent guanosines using 15N NMR at pH 7.1 in water containing 10 mol dm-3  
sodium phosphate.22a 
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Even though, inside the cell cisplatin can also react with many other cellular 
components, a number of reasearch has shown that the major bindings involve the 
coordination of cisplatin with the DNA bases viz. adenine (A), cytosine (C), guanine (G) 
and thymine (T) especially, the N7-position of guanine.9,18,22a,26,40a,52-53 The possible 
modes of cisplatin binding to DNA are shown in Figure 1.3. The monofunctional adducts 
often form either interstrand or intrastrand adducts which can then stop DNA 
multiplication.54 However, the major contributor to the cisplatin anticancer activity are 





































Figure 1.3 Some possible cisplatin-DNA binding modes.22a,55 
 
The binding of cisplatin to DNA alters the DNA conformation and brings distortion to 
the structure. This results in DNA unwinding, bending56 and flattening of the minor 
grooves in the DNA helix.9,53d These changes result in the inhibition of DNA 
transcription which is an important step for protein synthesis and cell division. The 
target of cisplatin inside the DNA is the telomeric regions of chromosomes27d,57 which 
protect the ends of chromosomes from degradation during cell division.27d,58 
Degradation of the telomeric regions in the chromosomes by cisplatin suppresses cell 
division causing significant damages in the DNA and DNA replication leading to 
apoptosis.27d,59 
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1.3.1.3 Cisplatin Resistance 
Resistance of certain tumour cells to cisplatin is due to failure of cancerous cells to 
respond to the inhibitory effects of the drug. Experimental evidence suggests that the 
development of resistance to cisplatin is thought to be due to a number of reasons. Any 
or all of the following factors may play a role in resistance of the drug to the tumour 
cells:22a,27d,52,60 
 low intracellular accumulation due to either by decreased influx (intake) or 
enhanced efflux (expelling) in the plasma membrane, 
 Increased detoxification by binding with S-donor molecules such as glutathione 
and methallothioneins.  
 Increased tolerance to Pt-DNA adducts, 
 Increased nucleotide excision repair (NER) mechanism which confer the 
resistance on the cell line. To circumvent this problem, various agents are given 
in conjunction with cisplatin. 
 
1.3.2 Develoment of Second Generation Cisplatin Analogues 
Since cisplatin’s therapeutic efficacy is limitted due to its severe side effects and 
resistnce to certain tumour cells, a number of  Pt(II) complexes have been developed in 
order to improve the clinical limitations with less tumour resistance and toxicity.9,29a-
c,30g,61 Out of a large pool of platinum complexes that have been synthesised and 
clinically screened for anticancer activity, only a few are currently registered for clinical 
administration. These include; carboplatin, [cis-diamine(1,1-
cyclobutanedicarboxylato)platinum(II)] (2), trans-L-1,2-diaminocyclohexaneoxalato 
platinum(II) oxaliplatin (3), cis-diammineglycolatoplatinum(II), nedaplatin (4), [cis-
diammineglycolatoplatinum(II)] and lobaplatin (5)17c,52,61 (Figure 1.1).6 
 
Of the five platinum complexes in Figure 1.1; carboplatin was reported to be less 
toxic9,17c,62 and hence, the drug is administered at higher doses (2000 mg/dose)63 than 
standard regimens (900 mg/m2)9,64 due to its slower aquation62,65 owing the less labile  
cyclobutanedicarboxylato ligand42,53f compared to the chloride ligands in cisplatin.9,17c,42 
The drug is now widely used for the treatment of ovarian cancer66 and is remarkably 
less toxic towards kidney and nervous sytem. This led to the synthesis of 1,2-
diaminocyclohexaneplatinum(II), oxaliplatin which contains a bidentate leaving 
group22a with enhanced water solubility and slower hydrolysis process resulting in a 
high cellular uptake.67 The drug was effective for treatment of colorectal cancer, a type 
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of cancer which is resistant to cisplatin and carboplatin.9,17c,68  It is currently approved 
for clinical use in France27c Europe, China and United States.17c,69 The carboplatin 
analogue, nedaplatin, is registered in Japan for the treatment of head, neck, lung and 
oesophageal cancer27c while lobaplatin has been clinically approved in China.27c 
However, these complexes which are structural analogues of cisplatin, suffer from a 
similar kind of cross-resistance.30f,70 and hence the search for effective anticancer drugs 
is ongoing.  
1.4 Current  Findings on Anticancer Platinum(II) Drugs 
Current research on anticancer drugs focuses on the synthesis of structurally different 
complexes of cisplatin which can exhibit effective antitumour activity with less side 
effects and tumour resistance. Thus, a number of active mono- and multi-nuclear Pt(II) 
and other transition metal complexes have been discovered with various structural 
modifications. This includes complexes with trans configuration, non- H-amine neutral 
ligands of homometallic and heterometallic supramolecular complexes.23 However, 
focus here will be only on multinuclear platinum complexes. 
 
1.4.1 Multinuclear Platinum(II) Complexes 
Multinuclear platinum complexes contain two or more platinum atoms linked together 
by a bridging linker. The new approach of designing Pt(II) anticancer drugs allowed the 
synthesis of various multinuclear Pt(II) compounds having different binding modes 
with DNA. The complexes vary from cis to trans and from bifunctional to polyfunctional, 
with varying flexible linkers71 as well as rigid bridges72 (Figure 1.4). Mechanistically, 
these complexes are expected to interact with DNA in a unique way. Results obtained 
showed some of these complexes display a very good antitumour activity where some 
complexes overcome the cisplatin resistance.  
 
1.4.2 Polynuclear Platinum(II) Complexes with Flexible Linkers 
The first reported multinuclear platinum complexes were based on cisplatin like (2,2-
cis,cis) (6)73 and transplatin like (2,2-trans,trans) (7)73 terminal structures linked by 
flexible alkyldiamine bridging groups of variable lengths.73-74 The complexes were 
bifunctional at each metal centre. The complexes were found to cross-link with DNA 
upon reacting. When tested for anticancer activity, the 2,2-cis,cis complex  was reported 
to be active in cells resistant to cisplatin. Furthermore, DNA binding functions of their 
monofunctional complexes showed that DNA 1,1/t,t complex cross-links with DNA 
more efficiently than 2,2/cis,cis complex.75 Furthermore, for the straight chain enjoined 
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complexes, it was reported that 1,6-hexanediamine (n = 6 CH2) was ideal for their 
optimum activity.73-74,76  
 
However, the most promising within this new class of anticancer compounds is the 
trinuclear complex, [{trans-PtCl(NH3)2}2{μ-trans-Pt(NH3)2(H2N(CH2)6NH2)2}]4+ 
(1,0,1/t,t,t), or BBR3464. This complex was found to exhibit cytotoxicity at ten to 
thousand times lower doze limits77 than cisplatin and has successfully passed through 
the phase II clinical trials and is currently undergoing some other clinical trials.78 The 
complex was found to be a very potent cytotoxic agent and is effective against 
melanoma, pancreatic cancer, lung cancer27c,72,75 and has less neuro and nephro toxicity 
and less side effects such as nausea and vomiting. This compound can monofunctionally 
bind to DNA to form long-range interstrand and intrastrand DNA cross-links.72,79 It has 
a higher cellular uptake due to its high effective positive charge and no cross-resistance 
to cisplatin resistance cells.27c The cationic inert tetraamine platinum linker enhances 
water solubility and high DNA affinity. 
 
Meanwhile, a number of other linking ligands have also been used to develop related 
dinuclear platinum complexes.80 The dinuclear Pt(II) complex, (11)  ([ClPt(dtdeg)PtCl] 
(where dtdeg = bis[4’-(2,2’:6’,2”-tpyridyl)]-diethyleneglycolether)), was synthesized 
and characterized.81 DNA interaction study using calf thymas (CT) DNA as a substrate 
showed a very high activity against all the cancer cell-lines tested, in some cases with a 
better activity than the well know anticancer drug, cisplatin.81 







































































Figure 1.4 Some polynuclear Pt(II) complexes which have shown potential anticancer 
activity.75,78-79,81-82 
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1.4.3 Polynuclear Platinum(II) Complexes with Rigid Linkers 
A number of other multinuclear platinum complexes, with rigid bridging linkers which 
include; 4,4’-dipyridyl(sulfide or selenide),83 4,4’-dipyrazolylmethane,84 mesitylene,85 
phenyldiamine, azines,14a,25a azoles29b,86 and hydrazines87 have been synthesized and 
tested for cytotoxicity. 
 
A rigid bridged dinuclear platinum complexe (12) (Figure 1.5) with square planar 
geometries has been reported by linking two cisplatin like platinum centres through 
4,4’-dipyrazolylmethane (dpzm) ligand.84b,c Another dinuclear transplatin like platinum 
complex, [{trans-Pt(NH3)2Cl}2(μ-dpzm)]Cl2 (13) along with complex (12) were found to 
have high levels of DNA intrastand cross-linking which was thought to be due to the 
rigidity of the linker especially, the bifunctional complex, (13) was found to bind 
preferentially with adenine residues.88 Furthermore, since selenium and sulphur 
compounds are known to have chemoprotective activity, the dinuclear complexes 
bridged by either 4,4’-dipyridylselenide or sulfur89 (14a) and (14b) were found to 
diminish the known toxic side effects of anticancer drugs.90 
  
A series of short pyrazole and hydroxo bridged dinuclear platinum complexes (Figure 
1.5) were syntheszed (15a) and (15b) and expected to form 1,2-intrastand adducts 
without major distortions of the DNA.29b In these complexes the hydroxo group was 
incorporated both as a linker as well as a leaving group. From the crystal structure 
obtained for [{cis-Pt(9-EtG2}2(µ-OH)(µ-pyrazolate)](NO3)2, (where EtG = 9-
ethylguinine which is a model nucleobase)86a it was reported that the average distance 
between the platinum atoms is comparable with the distance separating a normal 
sequential nucleobase in a B- type DNA strand to form stable DNA adducts. The rate of 
reaction of these complexes with DNA was found to be relatively slower for the first 
step.91 However, the rate of second step, once the five membered ring is opened, was 
found to be faster.91  
 
In a related effort, Wheat et al.84a reported an extension of the work on complex (12) to 
yield a trinuclear Pt(II) complex (19). The dpzm moiety offers moderate rigidity due to 
the incorporation of the CH2 spacers in the linker. The complex shows anticancer 
activity in the murine leukaemia cell line L1210.84a This complex is a structural 
analogue of the well known trinuclear anticancer complex, BBR3464. 
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An interesting design of another trinuclear Pt(II) complex with moderate rigidity comes 
from the mesitylene ligand with three terminus Pt(II) centres linked by three N,N′-
bis(2-pyridylmethyl)amine (20).85 This complex shows promising cytotoxicity in 
human and mouse tumour cells including those which are cisplatin resistant.92 
Molecular pharmacology studies on the underlying mechanisms of its antitumour 
effects revealed that the complex has a unique DNA binding mode thereby forming 
trifunctional intrastrand DNA adducts.93 All three Pt(II) centres of the complex were 



































































(13) X = Se    (14b)
X = S       (14a)




































Figure 1.5 Multinuclear platinum (II) complexes with rigid linkers which have shown 
anticancer activity.25a,84a,85,93-94 
 
Often, azine bridged dinuclear complexes (Figure 1.6), (21), (22), (23), (24), (25) and 
(26) compared to cisplatin, were found to show lower cytotoxicity in several human 
cell-lines. However, their activity (as chloride complexes) against mouse leukemia cells, 
which is cisplatin resistant, was found to be comparably higher.25a Furthermore, the 
complexes undergo substitution reactions with thiourea and biologically active 
nucleophiles. Another group of polynuclear complexes bridged by phenyldiamine and 
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cyclohexanediamine rigid linkers ( 27), (28), (29), (30) and (31) have been reported 
in a kinetic and mechanistic study by Jaganyi et al.14a,14d,14f and van Rudi et al.95 












































R1, R2, R3 = H   (21)
R1, R2 = CH3   R3 = H   (22)
R1, R3 = CH3   R2 H   (23)
R1, R2, R3 = H   (20)
R1 = CH3   R2, R3 = H   (24)
R1, R2 = CH3   R3 H   (25)





























Figure 1.6 Multinuclear Pt(II) complexes with rigid linkers which are used for kinetic and 
mechanistic study.14a,14d 
 
1.5 Platinum(II) Polypyridyl Complexes 
Platinum complexes of 2,2´:6´,2˝-terpyridine (tpy) have the basic form [Pt(Ytpy)X]n+, 
where Y is the substituent on the terpyridine ligand and X is the ligand in the fourth 
coordination site.17d Pt(II) terpyridine chromophores are known as potential anticancer 
agents due to their tendency to selectively bind to DNA.59b,96 Cationic, Pt(II) terpyridine 
and its derivatives have been proven to inhibit the telomerase activity by binding with 
the G-quadruplex of DNA.59b Polypyridyl complexes with extended π-conjugated ligand 
systems enhance the strength of σ-bonding framework within  the ligand system and 
the π-stacking with DNA.97 They can interact with DNA either by covalent binding or by 
intercalating with the base pairs .17d,96c  
 
1.5.1 DNA Intercalation 
DNA intercalation is a non-covalent association between DNA base pairs and platinum 
molecules.17d,98 Intercalation of Pt(II) terpyridine with DNA was reported in 1974 by 
Lippard and co workers96a during an investigation of [Pt(tpy)(HET)]+ (HET = 2-
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hydroxyethanethiol) and CT DNA, which showed interactions of the compound with 
DNA with a binding constant of 1.2 ± 0.2 x 106 M-1 at a pH of 6.8 in 0.003 M sodium 
chloride solution.17d The complex was shown to add between the DNA base pairs where 
it is bound to every other base-pair space in DNA.99  
 
Lippard and co-workers17d,96a further investigated the intercalative property of a 
variety of Pt(II) terpyridine complexes of the type [Pt(tpy)X]n+ (for n = 1, X = HOˉ, Cl , 
HET, Cysteine (Cys) and n = 2, X = aminoethanethiol (AET)). Each of these complexes 
was found to unwind circular DNA. The observed high binding  constant for the AET 
complex was believed to be due to its high charge (Table 1.1).17d Further investigations 
reported100 for two complexes, [Pt(tpy)(2-CH3py)]2+ (py = pyridine) and [Pt(tpy)(py)]2+ 
with similar aromatic surfaces when subjected to DNA binding, showed a higher 
binding constant for the latter complex. The methyl group on the second position of 
[Pt(tpy)(2-CH3py)]2+ reduces the stacking surface which causes more destabilization of 
the resulting complex thereby reducing the binding constant. Thus, it has been 
established17d structural features such as, the planarity and size of the molecule, 
aromaticity and surface extension of the π system, the charge and the ability of the 
group on the fourth coordination centre to form hydrogen bonding with DNA base 
pairs17d,100 influences the DNA binding ability. 
 
Table 1.1 Binding constants of Pt(II) terpyridine complexes reported.17d,101, 102, 103 
Complex       DNA medium Binding constant, K (M-1) 
[Pt(tpy)Cl]+ ct-DNA; Tris buffer 3.9 x 105 
[Pt(tpy)(HET)]+ ct-DNA; pH 7.5, 0.2 M NaCl 1.2 x 105 
[Py(tpy)(AET)]2+ ct-DNA; pH 7.5, 0.2 M NaCl 4.3 x 105 
[Pt(tpy)Cys]+ ct-DNA; pH 7.5, 0.2 M NaCl 1.0 x 105 
[Pt(tpy)(OH)]+ st-DNA; pH 9.0, 0.5 M EPSS buffer 7 x 104 
 
 
1.5.2 Substitution of Platinum(II) terpyridine Complexes with 
Biologically Active Nucleophiles 
Apart from non-covalent binding, [Pt(Ytpy)X]n+ (where X = a labile group such as 
chloride, hydroxide, water or pyridine derivatives and Y = H, Cl, OCH3, CH3 and 2-
C5H5N), is also capable of undergoing ligand substitution reactions with biological 
molecules.17d,104 An example of such a reaction is shown in Scheme 1.2 for the reaction of 
terpyridine with guanosine. Information obtained from such kinetic studies is 
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important for  understanding the mechanism of action of platinum anticancer drugs 
with DNA. (Scheme 1.2).  
 
An equilibrium kinetic study reported by Bugarčić et al.14j,105  on [Pt(tpy)Cl]+  at pH 6, 
and van Eldik and co-workers14j on [Pt(tpy)(OH2)]2+ at pH of 2.5, with some biologically 
active nucleophiles, glutathione (GSH), inosine (INO), inosine-5´-monophosphate (5´-
IMP) and guanisine-5´-monophosphate(5´-GMP) has shown a high reactivity towards 
all the selected nucleophiles, particularly 5´-GMP and GSH.105,14j In addition, reactions of 
Pt(II)terpyridine complexes with other DNA bases such as adenosine and 1-
methylcytosine (Hmcyt) were found to form di- and tri-cationic complexes depending 
on the reaction stoichiometry.17d Further kinetic studies of [Pt(tpy)Cl]+ with other 
bionucleophiles, viz. histidine (His) and cysteine (Cys) at pH 3 under pseudo first-order 
conditions  showed a higher reactivity for Cys (kobs = 1.3 x 10-2 s-1) compared to His 
((kobs = 8.5 x 10-5 s-1),106 which was attributed to the stability of the [Pt(tpy)(His)]+ 
cation in aqueous medium compared to the Cys coordinated cation.17d  
 
The driving force for such reactions depends on both thermodynamic factors such as 
the stability of the Pt―N bond formed relative to the Pt―X bond, and kinetic factors 
such as the rate of replacement of X by the incoming ligand.17d In such instances, 
investigating the reactions under pseudo conditions can force the reaction to go to 
completion. Studies reported by Lowe et al.104 support the binding of Pt(II) (tpy) to N7 

































Scheme 1.2  Reaction of Pt(II) (tpy) with guanosine (1:1) showing the N7 binding of guanosine 
with Pt(II) (tpy) (32).17d,104  
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1.5.3 Previous Kinetics and Mechanistic Studies on Platinum(II) 
 terpyridine  Complexes with Thiourea and Ionic nucleophiles 
Pt(II) terpyridine and its analogues are good anticancer probes and have gained a 
conciderable research interest in the past few decades. To design more effective 
anticancer Pt(II) drugs, a clear understanding of kinetic and mechanistic substitution 
behaviour of such complexes is important in order to elucidate the mechanism of action 
of the drug in the body.107  
 
van Eldik et al.14k investigated the effect of increasing the π-acceptor of pyridine ligands 
on the substitution kinetics of aqua Pt(II) with tri(N-donor) non-leaving ligands viz. 
[Pt(diethylenetriamine)OH2]2+ (aaa), [Pt(2,6-bis-aminomethylpyridine)OH2]2+ (apa), 
[Pt(N-(pyridyl-2-methyl)-1,2diamino-ethane)OH2]2+ (aap), [Pt(bis(2-
pyridylmethyl)amine) OH2]2+ (pap), [Pt(2,2´-bipyridine)(NH3)(OH2)]2+ (app) and 
[Pt(tpy)OH2]2+ (ppp) (Figure 1.7) with thiourea (TU), dimethylthiourea (DMTU), 
trimethylthiourea (TMTU). The rate of substitution reactions showed a general 
increase by a factor of four orders of magnitude simply by adding pyridine rings within 
the non-leaving chelate ligand of the complexes. The aqua ligands were substituted in 
the order aaa < apa < aap < pap < app < ppp. The increase in reactivity was attributed 
to an increased electronic communication within the chelate ligand due to the increase 
in the π-acceptance of the pyridine rings.14k It is known that increasing the π-
backbonding ability of the ligand system around the platinum centre helps to stabilise 
the five coordinate transition state through back donation of the electron density onto 
the aromatic system resulting in an increase in the substitution reaction.14k 
 
Jaganyi et al.14b further extended the investigation to include an understanding of how 
groups that are attached to the terpyridine ligand (ancilary group) affects its capacity 
to receive electron density from the platinum metal centre and ultimately the reactivity 
of the metal centre.107-108 For example, when the ancilliary substituent at the 4’-position 
is an ortho substituted phenyl ring (39), the reactivity of the complexs depended on the 
electron donating or electron withdrawing capacity of the substituent groups.108 When 
electron donating groups (as in 39) are attached, the reactivity is smaller than that of 
Pttpy and vice versa when electron accepting groups (Cl, CF3 as in 40) are attached. 
Furthermore, when the ancilliary is a phenyl ring, extension of π-backbonding towards 
the ancilliary ring is absent.14b They also studied the cis σ-effect108 by replacing one of 
the cis pyridine ring on the terpyridine with a phenyl ring. Results obtained further 
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Figure 1.7 Pt(II) complexes studied by van Eldik et al.14k (33-38). Pt(II)terpyridine 
complexes studied by Jaganyi et al. (38,39) and (40).86-87,90-91 
Additionally, the type of substituents on the ortho position of the ancilliary phenyl ring 
influences the reactivity either by enhancing or reducing the π-backbonding ability of 
the terpyridine moiety. The presence of electron withdrawing groups such as CF3 group 
on the 4’-position of terpyridine (40, when R = CF3), the substitution reactivity was 
moderately enhanced due to the electron withdrawal property of terpyridine which 
increases the π-backbonding ability of the chelated terpyridine ring. The opposite was 
observed for the electron donating CH3 group present on the ortho position of the 4’-
phenyl ring, which reduces the π-backbonding ability of the terpyridine system.  
 
1.6 Therapeutic Ruthenium Complexes: A Possible Alternative to 
Platinum  
To widen the search of clinically improved anticancer drugs, with broader spectrum of 
activity, other metals such as ruthenium34b,111 and cobalt112 have to be considered. Such 
metal complexes are expected to have the same or different mechanism of action but 
certainly different biodistribution and toxicity profiles to that of Pt(II) 
compounds.111g,113 Of the metal complexes studied so far, Ru(II) complexes offer the 
most potential alternatives to cisplatin resistant tumour cells with reduced toxicity.5,113 
This section will focus mainly on terpyridine and polypyridine type Ru(II) complexes. 
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Applications of ruthenium complexes are wide. The complexes are used as 
immunosuppressants, antimicrobial agents, antibiotics, radiophysical therapeutic 
agents and antimicrobial agents. For example, ruthenium compounds such as 
[Ru(II)Cl2(chloroquine)2] is active against malaria vectors and other antibiotics such as 
Ru(III) derivatives of thiosemicarbazone are active against salmonella typhi.7 Properties 
of ruthenium complexes or compounds which make them suitable in various 
applications include their low redox potential, greater potential to transfer of electrons, 
coordination ability to heteroatoms, their Lewis acid property and their unique 
reactivity towards metallic species.114 Ruthenium is also important due to its excellent 
catalytic properties.114-115 Compounds such as [RuH2(PPh3)2(PPh2)C6H4F] (where PPh3 
= triphenylphosphine) are used in the catalytic hydrogenation of anthracene.116  
 
1.6.1 The General Chemistry of Ruthenium(II) Complexes 
Ruthenium was discovered in 1844 in Russia by Karl Klaus from Ruthenia ores, the 
Latin name for Russia.117 It is a silvery metal which crystallizes in hexagonal close 
packing arrangement and have a high melting point of 2334 °C.118 Ruthenium belongs 
to group 8 in the periodic table and has a [Kr] 4d7 5s1 elecronic configuration. 
Properties of ruthenium are more similar to osmium than iron.119 Ruthenium forms 
various compounds in different ligand systems containing carbon, nitrogen, oxygen and 
sulfur donors. It also forms bridged binuclear, trinuclear and poly nuclear complexes 
with different oxidation states.120 Of the most common oxidation states,  Ru(III) and 
Ru(II) are the most inert, the latter is much less inert.11b This inertness of oxidation 
states is a great advantage for the study of substitution reactions of ruthenium 
complexes. Some examples of common ruthenium complexes include [RuHCl(PPh3)2], 
[Ru(NH3)5H2O]2+ and [Ru(tpy)Cl3].119  
 
In solution, Ru(II) and Ru(III) complexes form very stable complexes specially with 
nitrogen donor ligands.121 Due to the stability of ruthenium complexes bearing nitrogen 
donor ligands, coordination chemistry of ruthenium with ligands such as terpyridine 
and bipyridine have gained a considerable research interest.120,122 Complexes formed 
with those ligands are often used in photochemistry,123 pharmaceutical applications 
and in electrochemistry.124 Ruthenium compounds of terpyridine and bipyridine show 
strong metal to ligand charge transfer (MLCT) absorptions.124b,125 As a result, they are 
often used in photophysical applications.125 
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1.6.2 The Biological Importance of Ruthenium(II) Complexes 
The exploration of ruthenium complexes as potential anticancer agents dates back to 
the 1970’s when Clarke et al.126 reported the anticancer activity of 
pentaammine(purine)ruthenium(III) complexes capable of inhibiting DNA and protein 
synthesis.5 Complexes of cis-[Ru(III)(NH3)4Cl2]+ and fac-[Ru(III)(NH3)3Cl3] also 
exhibited a very promising cytotoxicity. However, due to the low water solubility of 
most of the complexes, further clinical trials were hindered. At a later time, Mestroni et 
al.127 reported cis and trans- RuCl2(dimethylsulfoxide)4 complexes (41)  (Figure 1.8) 
which bind to DNA and exhibit anticancer activity. The complexes had better aqueous 
solubility. The complexes were found to bind at the N7 position of guanine residues and 
have less severe side effects. They also prolongs host survival.128 Interestingly, the trans 
compound was found to show a better antimetastatic activity. This compound may be a 
possible replacement for cisplatin therapy which could exhibit a different 
mechanism.113,129  
 
Apart from the ruthenium ammine-chloro derivatives, ruthenium complexes with 
dimethylsulfoxide (dmso) ligands have been reported. Of the ruthenium heterocyclic 
compounds known, the complexes reported by Keppler et al.,5 showed the best 
anticancer activity. They possess the formula trans-[RuCl4(L)2]ˉ, where L is imidazole 
(KP418) or indazole (KP1019 (42).5 More improved compounds of dmso of the form 
Na{trans-[Ru(III)Cl4(dmso)(Him)]}, (Him = imidazole), nicknamed NAMI (43) , and 
[H2Im][trans-Ru(III)Cl4(dmso)(HIm)], also known as NAMI-A (44) were later 
synthesized. The compounds were found to bind DNA via the sulfur atoms on the 
compound.113,130 The most promising ruthenium complexes to enter clinical trials are, 
NAMI-A7 and KP1019, developed by Keppler et al.8 NAMI-A and KP1019 were found to 
be less toxic with mild side effects.131 They were found to be effective on solid 
tumours.132 These complexes are thought to be more effective against metastatic 
cancers since the mechanism of action of these complexes is expected to be via 
tranferrin-mediated transport to the cells.131 
 
Recent studies have explored potential Ru(II) antitomour complexes of the form [(η6-
arene)Ru(XY)(Z)] where XY is a chelating ligand and Z is monoanionic.133 The arene 
ligand binds as a 16-electron donor and a π-acceptor. It is thought to stabilize the +2 
oxidation state. The XY chelate ligand provides additional stability to the whole 
structure.133 The anionic ligand, Z, is a leaving group and if it is a labile group such as 
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halide, that can provide a coordination site for the biomolecules. Small variations of the 
ligands possibly can fine-tune their pharmacological properties.133  
 
Another group of ruthenium compounds which exhibits antitomour activity are Ru(II) 
polypyridyl complexes. Complexes such as [Ru(tpy)Cl3] (45) were found to have strong 
cytotoxicity and antitomour activity which are expected to be due to the binding of two 
guanines of DNA.134 Some of these complexes exist as enantiomers, hence are able to 
enantioselectively recognize DNA.113 For example, the cis-[Ru(bpy)2]2+ fragment was 
found to bind with DNA135 while cis-[Ru(bpy)2Cl2] (46) was found to be inactive. 
Polypyridyl ruthenium complexes are also found to be useful probes for DNA cleavage 
and DNA conformation.111g,136 Ru(II) polypyridyl complexes can interact with DNA 
through noncovalent interactions such as groove binding, electrostatic binding137 and 









































































































(47) (48) (49)  
Figure 1.8 Structure of some of the ruthenium complexes which were found to have 
antitomour activity.5,8 
Chapter 1                                                         
21 
 
In vitro studies for complexes (48) showed cytotoxicity against certain cancer cell-lines 
and the effect was dependent on the concentration of ruthenium complex. This 
behaviour was reported to be fairly comparable to that of NAMI-A.139 Another related 
mononuclear Ru(II) complex, cis-[Ru(azpy)2Cl2] (49) where azpy = 2-
phenylazopyridine was found to show high cytotoxicity against some fast growing cell-
lines.140 The higher reactivity of this compound was assumed to be due to the flexibility 
of the azpy ligands which enhances the substitution of the chloride ligands thereby 
allowing it to bind with two DNA bases.5 
 
Thorp and co-workers141 have reported the DNA cleavage due to Ru(II) complex of the 
form [Ru(tpy)(L)OH2]2+ (where L = bpy, phen (1,10-phenanthroline) and tmen 
(N,N,N′,N′-tetramethylethylenediamine)) by cyclic voltammetry. The aqua complexes 
were first converted to oxo form by electrolysis at pH 7. Addition of these complexes to 
DNA solution was found to decrease the current, which indicates the binding of the 
charged complexes to DNA. Apart from the direct addition of the oxo activated 
complexes, the authors also reported that the DNA cleavage reactions can also be 
performed via electrolysis at a specific potential and pH. The electrochemical process 











Scheme 1.3 Schematic representation of catalytic electrolysis reaction for the cleavage of DNA 
by [Ru(tpy)(bpy)O]2+.141 
 
1.6.3 Ruthenium Complexes as Biological Probes 
After the success of cisplatin and its related complexes as anticancer agents, the search 
for other active metal based anticancer complexes has been extended.142 Since Ru(II) 
and Ru(III) complexes have similar ligand exchange kinetics as Pt(II) complexes, this 
property of ruthenium gained reseach interest in the search for the development of 
better anticancer drugs.133,142c,143 Of the number of complexes synthesized, only very 
few metal based drugs reach the biological target without the molecule being modified. 
In a biological environment such as the human body, most metal based drugs interact 
with macromolecules, proteins, as well as some sulfur and  oxygen donor compounds, 
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some of which are vital for the desired therapeutic properties.5,7 Abilitty to have 
variable coordinating sites, oxidation states, alterations to ligand affinity and 
substitution kinetics and photodynamic property makes ruthenium a suitable metal for 
synthesizing future therapeutic agents.113,122 
 
There are three main properties of ruthenium complexes which makes them suitable 
for therapeutic applications:7-8,113 
 rate of ligand exchange 
Many ruthenium complexes have been clinically tested especially for treating 
cancer since Ru(II) and Ru(III) complexes exhibit similar kinetic ligand 
exchange behaviour to those of Pt(II) complexes.72 Their ligand exchange 
reactions are kinetically stable and this prevents them from rapid 
equilibrations.144  Their ligand exchange reactions are moderate enough to be 
monitored. For example, the time frame that Pt(II), Ru(II), Ru(III) and Co(III) 
along with some other few metals take for ligand exchange reactions is within 
the time scale for many cell division processes.145  
 
 variable oxidation states 
Availability of Ru(II), Ru(III) and Ru(IV) under physiological conditions makes 
ruthenium unique among the platinum group. Ru(II) and Ru(IV) complexes are 
more biologically active than Ru(III) complexes. In biological systems, single 
electron transfer proteins reduce Ru(III) and Ru(IV) while molecular oxygen 
and cytochrome oxidase oxidizes Ru(II). This redox property of ruthenium 
increases the effectiveness of ruthenium drugs in biological environments.8 For 
example, the drug can be administered into the body as an inert Ru(III) 
complex, which then gets activated in the diseased tissues. Compared to 
healthy tissues, most cancer cells have high concentration of glutathione and 
low pH, which creates a reducing environment. In this environment, Ru(II) 
complexes can get oxidized to Ru(III) by biological oxidants.146  
 
 the ability of ruthenium to mimic iron when binding to certain biological 
molecules 
The low toxicity of ruthenium drugs make it suitable for ruthenium to mimic 
iron147 in many biological molecules including serum transferrin and albumin 
which are used to solubilise and transport iron in mamals.148 Since rapidly 
dividing cancer cells have a greater necessity for iron, it increases the number 
Chapter 1                                                         
23 
 
of transferrin receptors on the surface of the cell whereby increasing the radio-
labelled ruthenium compounds in cancer cells from 2 - 12 fold compared to the 
healthy cells.149 
 
 The above mentioned properties along with the unique DNA binding pattern of 
ruthenium due to its different geometries compared to platinum, offer ruthenium a 
relatively low resistance amongst its active compounds. Since ruthenium selectively 
accumulate in cancer cell,149 its toxicity is expected to be reduced. Additionally, 
ruthenium is transported into the cells by tranfering dependent and transfering 
independent mechanisms; transfering mediated uptake is assumed to be more efficient. 
The pharmacological target and the underlying molecular mechanism of anticancer 
activity of ruthenium complexes has not yet been clearly understood. However, it was 
found that the cytotoxicity of ruthenium complex is due to their ability to bind with 
DNA helix.113 
 
1.6.4 Intercalation of Ruthenium Complexes in Two DNA Bases 
Polypyridyl complexes of Ru(II) can interact with DNA by intercalation.150 This involves 
DNA mediated electron transfer interactions which play an important role in 
understanding the mechanism of action of anticancer ruthenium drugs. Complexes such 
as [Ru(phen)3]2+, [Ru(bpy)3]2+ [Ru(phen)2PMIP]2+, PMIP = 2-(4-
methylphenyl)imidazo[4,5-f]1,10-phenanthroline, [Ru(dmp)2PMIP]2+[57f]  where dmp = 
2,9-dimethyl-1,10-phenanthroline and isomers of ,,-[Ru(azpy)2Cl2] were found to be 
useful probes.113,151  Those complexes were found to have very high cytotoxicity as 
well.113 The complex -[Ru(azpy)2Cl2] was found to have even higher cytotoxicity than 
cisplatin and  possess more orientations to interact with DNA.152 The complexes were 
found to bind with DNA by surface interactions as well as by DNA intercalations. When 
human lung tumour cells, A549 were treated with [Ru(dmp)2PMIP]2+ at IC50 
concentration (80 μM), an increase in apoptotic cells of 11.8% was reported.111e This 
compound was found to bind to DNA enantiospecifically. From this study, it was found 
that the Ru(II) polypyridyl complexes showed a significant dose dependent cytotoxicity 
towards human lung cancer cells, A549. Further flow cytometry experiments showed 
that the polypyridyl complexes strongly intercalate with CT DNA with a binding 
constant of 106 M-1, suggesting that the antitumour activity of Ru(II) complexes may be 
due to their ability to intercalate with DNA.111e Another study by Zhang et al.111f 
reported that Ru(II)-arene complexes induced significant apoptosis in human lung 
cancer HCC827 cell-line at the concentration range of 5 – 100 μM with IC50 values 
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ranging from 19.6 ± 5.3 μM. Ru(II) complex wth planar aromatic ligands such as 
terpyridine and phenanthroline have advantages over the other ruthenium complexes. 
Some of these advantages include:
122
 
 the ease of controlling the metalation and substitution reactions 
 strong absorption due to MLCT 
 strong luminescent characteristics 
 lengthening of DNA double helix on binding to DNA 
 aromaticity of the ligand moiety which allows overlapping of the π system with 
DNA base pairs 
 
A study on the effect of leaving group and the internal functional groups of Ru(II) 
polypyridyl complexes on the cytotoxicity was reported by Corral et al.111g No 
correlation was found between the lability of the leaving group and the cytotoxicity. 
However, the complexes were found to be cytotoxic against certain cancer cell-lines 
(Table 1.2)111g and bind with DNA in a non-cisplatin mode.111g  
 
Table 1.2 Concentration that inhibits 50% growth inhibition  of cells (μM) of mononuclear 
ruthenium complexes and the dinuclear ruthenium complex, [Ru(apy)(tpy)]2[μ-
H2N(CH2)6NH2](ClO4)4 after 48 hours treatment in some selected cell-lines.111g 
Compound tested A2780 A2780R L1210/0 L1212/2 
[Ru(apy)(tpy)Cl](ClO4) 23 25 100 56 
[Ru(apy)(tpy)(H2O)](ClO4)2·2H2O 11 30 80 97 
[Ru(apy)(tpy)(CH3CN)](ClO4)2 31 28 70 40 
[Ru(azpy)(tpy)Cl]Cl·5H2O 19 42 42 26 
[Ru(impy)(tpy)Cl](ClO4) >100 62 >100 >100 
[Ru(apy)(tpy)]2[μ-
H2N(CH2)6NH2](ClO4)4 
33 28 >100 >100 
x-[Ru(azpy)2Cl2] 0.1 0.2 0.1 0.2 
cisplatin 6 25 2 24 
x-[Ru(azpy)2Cl2] and cisplatin are included as references,  apy= 2,2'-azobispyridine, azpy= 2-
phenylazopyridine or 2-phenylpyridinylmethylene amine, impy= 2-phenylpyridinylmethylene amine. 
  
Most mononuclear polypyridyl complexes of Ru(II) complexes that bind with DNA non-
intercalatively were found in the minor grooves of DNA with particular preference for 
A/T  (adenine/ thymine) centres153 mainly due to electrostatic interaction and van der 
Waals forces.154 The 1H NMR study on DNA binding of Ru(II) complexes, ∆∆-
[{Ru(Me2bpy)2}2(μ-bpm)]4+ and ∆∆-[{Ru(Me2bpy)2}2(μ-bpm)]4+ with free 
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d(CAATCGCGATTG)2 where Me2bpy = 4,4’-dimethyl-2,2’-bipyridine; bpm = 2,2’-
bipyrimidine, were found to be of ca. 1 × 104 M-1.154 This binding was further enhanced 
by the van der Waal forces and hydrogen bonding. Dinuclear ruthenium complexes 
were found to have advantages over other platinum complexes due to their 
photochemical and steriochemical activities with the nucleic acids such as variations in 
their size and shapes.154 
 
1.6.5 Photodynamic Therapy 
Photodynamic therapy (PDT) is a technique that uses a photosensitizer drug, and a 
light of particular wavelength to kill the cells.118 In this technique, the photosensitizing 
agent is injected into the bloodstream, which is then absorbed by the cells in the 
body.118 Some agents get retained with the cancer cells and during which the drug is 
photoactivated by the light.155 The use of ruthenium complexes as PDT agents is 
promising as they are expected to react with double stranded DNA  either from their 
excited state or via the formation of free radicals such as OH•.156 Complexes such as 
[Ru(bpy)3]2+ and Ru(phen)3]2+ have intense absorption in the visible region due to 
MLCT transitions. Generally, Ru(II) polypyridyl and related complexes have intense 
MLCT and exhibit long-lived triplet 3MLCT excited states due to absorption of photons, 
to transfer energy to another molecule either by electron transfer to energy 
transfer.118,157  
 
1.6.6 Postulated Mechanisms of Action of Anticancer Ruthenium 
Complexes 
Anticancer therapy of ruthenium is generally based on the ability of ruthenium to 
coordinate to DNA base pairs via the nitrogen atoms of the nucleic bases, in particular 
N7 of guanine. The interactions of ruthenium complexes with DNA is thought to be 
enhanced by non-covalent interactions such as H-bonding interactions with the DNA 
base pairs.158 However, these drugs are thought to be inactive until Ru(III) gets reduced 
in the cell.159  
 
The mechanism of action of ruthenium anticancer compounds with DNA is hardly 
known.34b In biological environments, ruthenium mimics iron when binding with 
certain proteins such as transferrins and albumins.7 The serum transferrins recognize 
Fe(III) not Fe(II). Transferrin bound to Fe(III) bind strongly to its receptor thereby 
internalizing into the cells. Low pH induces the release of Fe(III) from transferrin. Since 
many solid tumour cells express higher level of transferrin receptors, this transport 
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mechanism is thought to be useful for cancer therapy. Apart from the redox 
transformations, interaction of the ruthenium complexes with different biomolecules 
such as serum transport proteins160 and DNA nucleotides161 is expected to play an 
important role in the compounds’ mode of action.162 NMR studies reported for the well-
known two ruthenium complexes, KP1019163 and NAMI-A132a shows that in the 
presence of certain biological reducing agents such as ascorbic acid and glutathione, the 
Ru(III) centres in those molecules are likely to undergo reduction162 which then can 




Scheme 1.4 Schematic representation of suggested mode of action of ruthenium based 
anticancer drugs.162 
 
Insertion to DNA is also achieved when the intercalating polypyridyl ligands are 
coordinated or attached on the non-leaving group to the ruthenium complex.5 
Furthermore, presence of polypyridyl ligands enhance their photoluminescence 
property as well as the stability of ruthenium complexes.164 In addition, it was found 
that the presence of large aromatic ring systems, promoted binding of the complex with 
DNA by hydrophobic arene-purine base π-π stacking interactions.5,165 
 
1.6.7 Substitution Reactions of Ruthenium(II) Complexes 
Substitution kinetics of Ru(II) complexes have not been extensively studied. Most 
substitution reactions of ruthenium involve complexes of Ru(III) and Ru(II), in 
particular Ru(II).154,166 Substitution reactions of Ru(II) complexes are generally slow 
and follow a dissociative167 or dissociative interchange168 mechanism whereas Ru(III) 
complexes have shown some associative mechanism.167a,169 Most reported substitution 
kinetics of Ru(II) complexes are in the form [Ru(NH3)5X]2+ where X is a halide or water. 
The specific rates of substitution of [Ru(NH3)5H2O]2+ form at 25 °C with neutral ligands 
vary in the range 0.02 - 0.3 M-1 s-l.170 The activation parameter for the reaction over the 
range of temperature from 15 to 35 °C were ∆H (+22.9 ± 1 kcal) and ∆S (-2.5 ± 3 cal 
mol-1 K-1), which are within the range of an interchange dissociative mechanism.170  
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Creutz et al.171 reported hydride substitution from Ru(II) complexes viz., 
Ru(tpy)(bpy)H+ and Ru(tpy)(dmb)H+ (dmb = 4,4´- dimethyl-2,2´-bipyridine) in aqueous 
media at 25 °C using CO2, CO, CH2O, and H3O+. The substitution of Ru(tpy)(dmb)H+ with 
CO was about 105 times lower than that of Ru(tpy)(bpy)H+ using CH2O nucleophile. 
However, in the case of Ru(tpy)(bpy)H+, the protonation step was very fast, and only 
the formation of the product Ru(tpy)(bpy)(H2O)2+ was observed. Substitution kinetics 
of another ruthenium complex of terpyridine, [Ru(tpy)(tmen)O]2+  with (CH3)3CHOH at 
25 °C gave the second order rate constant, (4.3 ± 0.4) M-1 s-l.172  
 
In a different study based on investigation of substitution kinetics of 
[Ru(tpy)(bpy)(OH2)]2+ and [Ru(tpy)(tmen)(OH2)]2+ with thiourea and acetonitrile 
nucleophiles,173 the reactions pathway was reported to follow the first order kinetics. 
The substitution rate of the cis coordinated bidentate ligands was found to depend on 
the steric and the electronic properties of the bidentate ligand. The meridionally 
coordinated terpyridine ligand was found to ratify the stereoelectronic rigidity on 
metal centre. The rate of substitution was found to be in the order of 10-4 M-1 s-1. 
 
1.6.8 Polynuclear Ruthenium Complexes 
A number of polynuclear ruthenium complexes have been synthesized and tested for 
DNA interactions since ruthenium complexes are considered as anticipated probes for 
DNA conformation174 or cleavage agents.136 Some of these complexes exhibit chirality 
and thus, are capable of enantioselectively bind to DNA.161 The interactions of these 
complexes with DNA are expected to be unique and would involve long range 
intrastrand cross-links.5 The bulkiness, charge and the variability in geometry of 
multinuclear Ru(II) complexes is expected to increase their DNA binding affinity, which 
can be useful in the development of new photoprobes in the nucleic acid.111d  
 
Dinuclear Ru(II) complexes of [Ru(bpy)3]2+ and [Ru(phen)3]2+ moieties bridged by 
flexible alkanes have been synthesized and studies on their DNA binding affinity have 
shown promising electrostatic interactions with DNA and photocleavage activity.175 In 
those complexes, the length and the nature of the bridging linker play a crucial role on 
the binding efficacy.120 A dinuclear Ru(II) complex [Ru(dpq)2(phen)]2+ (dpq = 
dipyrido[3,2-d:2’,3’-f]-quinoxaline) (50) (Figure 1.9) was found to have a high affinity 
for DNA intercalation.176 The long flexible mercaptoethyl ether linker was found to 
influence DNA binding size. Another dinuclear Ru(II) complex,  
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[Cl(bpy)Ru(dtdeg)Ru(bpy)Cl]Cl2 (51) was synthesized and its interaction with a 
guanine derivative, EtG was found to exhibit good cytotoxic activity.120  
 
The dinuclear Ru(II) complex, ([{Ru(apy)(tpy)}2{μ-H2N(CH2)6NH2}]4+ (52) has no labile 
leaving group attached to the metal centre for coordination. However, when cytotoxic 
tests were carried out using different cancerous cell-lines, the coordinative mechanism 
was found to be comparable to that of cisplatin.5 Furthermore, the results suggest that 
the mechanism of action is different from that of cisplatin. Cytotoxicity occurs 
presumably via electrostatic and groove binding.5 A similar dinuclear Ru(II) complex, 
[{Ru(tpy)Cl}2(μ-paa)](BF4)2 (where paa = 2-pyridinealdazine) (53), possessing two 
chloride leaving groups was found to coordinatively interact with DNA by forming intra 
and interstrand DNA adducts.5 Two structurally similar multinuclear ruthenium 
complexes formed by a pyrazine (pz) (54) and 4,4’-bipyridine (55) have been shown to 
modify human and murine carcinoma cells.139  
 
Variations of the linker or the terminal ligand significantly influences the cytotoxicity of 
the complex. Semi-rigid dinuclear complex, (56) was found to show even higher DNA 
affinity177 compared to its related complex (57). It was found that the increase in 
planarity of the bridging ligand increases the hydrophobicity, resulting in a stronger 
binding to DNA.178 The rigid dinuclear phenanthroline complex, bridged by a rigid 
ligand HAT (HAT = 1,4,5,8,9,12 -hezaazatriphenylene) ligand has shown to bind DNA 
weakly compared to (56).179  



































































































































Figure 1.9 Some dinuclear cationic Ru(II) complexes linked by flexible and rigid linkers.5,120 
 
1.7 Heteronuclear Ruthenium(II)-Platinum(II)  Polypyridyl Complexes 
The continuous search for better anticancer drugs has gained interest in 
heteropolynuclear platinum and ruthenium complexes.34b,180 Since the mechanisms of 
action of ruthenium and platinum aniticancer complexes are different, it was thought 
that the combination of the two metals may result into anticancer drugs of improved 
efficacy. To date, only few heteropolynuclear ruthenium-platinum complexes have been 
synthesised and reported as potential anticancer agents.113,120,180-181 
 
The first heteronuclear ruthenium-platinum complex reported was [{cis-
RuCl2(dmso)3}(H2N(CH2)4NH2){cis-PtCl2(NH3)}] (58) (Figure 1.10) where the two metal 
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centres were linked by a long flexible ,-diaminoalkane group.180,182 The compound 
was found to bind with DNA probably by forming DNA-DNA interstrand cross-link 
where each metal centre binds to one strand of DNA helix. Another heterometallic 
Ru(II)-Pt(II) complex having a flexible linker of the form 
[Cl(tpy)Ru(dtdeg)Ru(tpy)Cl]Cl3 (59) has been reported.120 Reactivity of this complex 
with DNA using EtG was studied using NMR study. The complex was found to 
coordinate with EtG via its N7 position.120 
  
Heterometallic Ru(II)-Pt(II) complexes with a short semi-rigid linker, 4’-pyridyl-
2,2’:6’,2”-terpyridine (qpy) has been synthesized and characterized.120 The qpy linking 
ligand possess two different coordination sites; a tridentate coordination site at the 
parent terpyridine moiety as well as a monodentate coordination site at the pyridine 
which is appended at the 4’-position of the terpyridine backbone. Multinuclear Ru(II)-
Pt(II) complexes of qpy, [(tpy)Ru(qpy)Pt(en)Cl](NO3)3 (60) and 
[Cl(en)Pt(qpy)Ru(qpy)Pt(en)Cl](NO3)4 (61) (en = 1,2-ethylenediamine) have been 
reported. The complexes possess a bis(terpyridyl)-Ru(II) moiety and one or two 
ethylenediamine centres coordinated to a Pt(II) centre. The complexes were found to 
react with DNA model base, EtG via the platinum unit which substitutes the labile 
ligands on the terminal Pt(II) centre(s). Presence of ruthenium was found to increase 
the water solubility and electrostatic interactions with the DNA base by its high 
charge.120 
 
Another heterometallic Ru(II)-Pt(II) complex, [(bpy)2Ru(dpb)PtCl2]Cl2 (62) was found 
to react with DNA at its platinum centre as well as via its planar ligands on the Ru(II) 
centre.183 Cross- linking interactions of the complex with DNA were found to be higher 
than that of cisplatin.183 The compounds were also found to have DNA intercalation 
when different bridging ligands such as 2,3-bis(2-pyridyl)pyrazine and 2,2’-















































































































Figure 1.10 The Ru(II)-Pt(II) with a long and flexible linkers (58) and (59) along with  the 
heterodinuclear Ru(II)-Pt(II) complexes with different linkers.5,113,120,180,172181b 
Anions omitted for simplicity. 
 
DNA intercalation of Ru(II)-Pt(II) complexes bridged by back to back planar tridentate 
ligands such as [(tpy)Ru(tppz)PtPtCl](PF6)3 (63) and [ClPt(tppz)Ru(tppz)PtPtCl](PF6)4 
(64) where tppz = 2,3,5,6-tetrakis(2-pyridyl)pyrazine have been reported by Prussin et  
al.184 The metal complexes (63) and (64) when incubated at different ratios of DNA 
base pair to metal concentrations at room temperature, results obtained show binding 
of the complexes to DNA base pairs  and the effect was reported to be even greater than 
the well-known Pt(II) anticancer drug, cisplatin.184 The binding of the complexes with 
DNA base pairs was also found to be temperature dependent and different from that of 
cisplatin. This was assumed to be due to the high molecular mass of the complexes and 
the formal charge of the complexes compared to that of cisplatin.184 Furthermore, 
photochemical analysis of the complexes showed strong MLCT.185 The planar ligands 
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were found to be excellent bridges which enhance the electronic communication 
between the hetero metal centres.124b,185a Since the complexes are currently under 
further studies of mechanism of action with DNA184, investigation of their substitution 
kinetics would bring useful data towards the development of these promising 
complexes as anticancer drugs. 
 
In the mentioned heterometallic complexes, ruthenium was chosen as the second 
element180  firstly, due to its antitumour activity186 and secondly,  because the 
octahedral Ru(II) coordination sphere is more sterically demanding compared to that 
of square planar Pt(II). These properties are thought to improve the kinetic control and 
the sequence specificity of the types of DNA adducts formed.180 Furthermore, attaching 
a platinum ion can be useful for imparting the reactivity at the less reactive ruthenium 
centre in order to facilitate unique cross-linking with specific DNA sequences.180  
 
Heterometallic Ru(II)-Pt(II) complexes are important models for introducing 
photoinduction of  Pt(II) centres with DNA.111g,187 In such complexes, photo reactive 
light absorbing ruthenium unit is linked with a reactive platinum centre. The molecule 
can be photoactivated by the light absorbing ruthenium unit which will improve the 
reactivity of the platinum centre which then coordinates to DNA.120  The positively 
charged ruthenium centre is thought to increase the solubility of the complexes as well 
as electrostatic interactions with DNA.120 
 
1.8 Aims of this Study 
Multinuclear platinum complexes have been found to exhibit remarkable anticancer 
activity towards many different cancer cell-lines. Some multinuclear complexes are 
endowed with superior cytotoxicity compared to clinical Pt(II) based drugs. The search 
for finding other effective anticancer drugs is ongoing. One attractive route is the 
development of heterometallic complexes where a Pt(II) moiety is combined with 
another metal possess cytotoxicity. One area of such complexes include heterometallic 
Ru(II)-Pt(II) complexes. The anticancer activity of heterometallic Ru(II)-Pt(II) 
complexes have not yet been studied extensively. An important aspect to the success of 
this approach is to investigate the mechanistic and kinetic substitution behaviour of 
such complexes.   
 
Therefore, the main aim of this study is to investigate the ligand substitution kinetics of 
heterometallic Ru(II)-Pt(II) complexes. In this study mononuclear and dinuclear Pt(II) 
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complexes alongside heterometallic complexes were investigated with neutral thiourea 
ligands: thiourea, 1-methyl-2-thiourea, 1,3-dimethyl-2-thiourea, 1,1,3,3-tetramethyl-2-
thiourea and/or anions, iodide and/or thiocyanate. The chosen thiourea nucleophiles 
vary according to their steric size. Sulfur donor thiourea nucleophiles are good models 
to represent the reaction of the sulphur containing biomolecules in the body with 
platinum based drugs. In order to understand how the structural arrangement of the 
complex influences the kinetic behaviour of the molecules, quantum calculations were 
performed at the B3LYP/LACVP level of theory using density functional theory 
technique.  
 
The work reported in this thesis is based on an investigation of kinetics and 
thermodynamic properties of five different sets of complexes, three of which are 
designed to deliver an in-depth understanding of the role of flexible 
polyethyleneglycolether linker on the reactivity of mononuclear, dinuclear platinum 
complexes and heterometallic Ru(II)-Pt(II) complexes.  
 
The specific objectives of this work were: 
1. To investigate the kinetic and mechanistic behaviour of mixed-metal Ru(II)-
Pt(II) and Co(II)-Pt(II) complexes of the form [(tpy)Ru(tppz)PtCl](PF6)3, 
[ClPt(tppz)Ru(tppz)PtCl](PF6)4  and [ClPtRu2(tppz)3PtCl](PF6)6 (where tppz =  
tetra-2-pyridyl-1,4-pyrazine). In this section a cobalt complex, 
[(tpy)Co(tppz)PtCl](PF6)3 is used to understand the effect of the Ru(II) on the 
reactivity of the complexes. This is presented in Chapter 3. 
 
2. To investigate the substitution kinetics of heterometallic Ru(II)-Pt(II) 
complexes, where the two metal centers are linked by a short semi- rigid linker, 
qpy. The ligand, qpy binds to Ru(II) tridentately via its terpyridine ligand 
backbone while the pyridine group on the 4’-position monodentately binds to 
the second metal center, Pt(II). This ligand has very versatile coordination 
chemistry; forming mononuclear compounds with pendant groups, metal 
coordinated polygons and polymers. This is presented in Chapter 4. 
 
3. To gain an understanding on the effect of increasing the length of the flexible 
polyethylene glycoxy pendant on the rate of substitution kinetics of parent 
Pttpy moiety. This work is covered in Chapter 5. 
 
Chapter 1                                                         
34 
 
4. To gain further understanding of the role of flexible polyethyleneglycolether 
linkers on the reactivity of the dinuclear Pt(II) terpyridine complexes when a 
second Pt(II) terpyridine group is coupled through the polyethyleneglycoxy 
linker whose kinetics will be reported in Chapter 6. 
 
5. To understand the role of Ru(tpy)2 moiety on the substitution kinetics of 
heterometallic Ru(II)-Pt(II) complexes bridged by flexible polyethyleneglycol 
ether linkers of different chain lengths. This gives further understanding on the 
role of polyethyleneglycol ether linkers have on the reactivity of the mixed-
metal Ru(II)-Pt(II) complexes, when one end of the ligand is capped with Ru(II) 
terpyridine. No kinetic data has been reported on multinuclear complexes 
linked by flexible linkers with mixed-metal complexes. In this study, different 
chain lengths of polyethyleneglycol ether ligand system is used for synthesis of 
heterometallic Ru(II)-Pt(II) polypyridyl complexes. The complexes consist of 
substitutionally inert Ru(II) terpyridine capped moieties linked with 
polyethyleneglycoly ether linkers which are coordinated to a Pt(II) centre. This 
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Substitution Reaction Kinetics  
2.1 General Considerations 
A substitution reaction occurs when a ligand in a coordination sphere of a reactive 
centre is replaced by another molecule or an ion,1 causing a temporary change in 
coordination number due to breaking of bonds and formation of new bonds with the 
incoming species.2 Two important aspects need to be considered when describing 
substitution reactions. The first is based on the changes in the electron distribution that 
takes place during bond breaking and new bond making while the second aspect 
addresses the timing of the bond breaking and making processes.1 
 
In the decisive work reported by Ingold and Hughes3 the modes of bond breaking in a 
substitution reaction at a carbon centre were classified either as homolytic or 
heterolytic, depending  on the type of bond breaking.1 Homolytic bond breaking 
involves dividing the bonding electron pair evenly between the products such that each 
species gets an electron. Hetrolytic reactions can be further subdivided into 
electrophilic or nucleophilic reactions. When the electron pair departs with the leaving 
group, it is classified as nucleophilic heterolysis. In electrophilic heterolysis, the 
electron pair remains in the reactive centre when the leaving group departs.1 These 
reactions can be represented as:1-2      
M : X                   M  + X         homolysis                                                                      (2.1) 
M : X                   M⁺  + :X⁻          nucleophilic heterolysis                                            (2.2) 
  M : X                   M:⁻  + X⁺         electrophilic heterolysis                                           (2.3) 
Although the method is adequate for describing substitutions on carbon centres, it can 
not meet most of the classification criteria for inorganic reaction mechanisms.2 
Inorganic reactions can be divided into electrophilic substitution (SE) or nucleophilic 
substitutions (SN), and the latter could be represented by SN1 or  SN2 depending on the 
molecularity of the rate determining step of the mechanism.1,4 Often most substitution 
reaction pathways are based on  SN1 or  SN2 mechanisms.4  
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2.2 Mechanistic Classification of Inorganic Substitution Reactions 
A reaction mechanism illustrates the progress of different steps by which a chemical 
transformation occurs which culminates in the observed overall reaction.5 Langford 
and Gray6 used an operational way to classify inorganic reactions based on the 
concepts of stoichiometric mechanism and intimate mechanisms.2 The stoichiometric 
mechanism can be determined from the kinetic behaviour and classified in one of the 
three forms.2,7 
a. Limiting associative (A)- a mechanism having an intermediate with 
higher coordination number. The ‘A’ term replaces the older SN2 term. 
b. Limiting dissociative (D)- a mechanism having an intermediate with 
lower coordination number. The ‘D’ term replaces the older SN1 term. 
c. Interchange (I)- a mechanism in which the bond breaking and bond 
forming take place in a pre-formed aggregate. No observable 
intermediate forms for this pathway. 
The stoichiometric interchange mechanism is further classified based on intimacy:1-2    
a. Associatively activated (IA) – an intimate mechanism which has a 
transition state which involve the bonding between the incoming group 
and the reactive centre. 
b. Dissociatively activated (ID) – an intimate mechanism where no direct 
interaction between the reactive centre and the entering group in the 
transition state, i.e. the reaction centre is more sensitive to changes in 
the leaving group, 
 
For the intimate mechanism, the incoming group, Y, and the leaving group, X, are 
interchanged in the inner coordination sphere of the metal centre. Therefore, the rate is 
independent of the incoming nucleophile and the relative reaction coordinates from 
associative to dissociative can be represented as in Figure 2.1.8  
 
 




Figure 2.1 Reaction profiles for (a) associative A, (b) associative interchange, Ia, (c)  
  dissociative interchange Id and (d) dissociative D.8 
 
2.2.1 Limiting Associative Mechanism 
In this mechanism, the intermediate is formed via two transition states in which bond 
formation is more dominant than bond breaking (Scheme 2.1). Here, the rate 
determining step is one which involves formation of a bond between the metal centre 
and the incoming nucleophile. When the entering group, Y, and the leaving group, X, are 
chemically identical, the bond making and the bond breaking transition states have the 
same energy. In a non-coordinating medium and in the presence of an excess of Y, the 
substitution is strongly dependent on the nature of the incoming nucleophile. Y 
participates in the early stages of the transition state and at the end stereochemistry of 
the complex is retained.9  
In an associative mechanism, all the species involved such as the incoming group, the 
leaving group and the chelate ligand can influence the stability and the activation 
energy of the reaction. Thus, all the groups will influence the rate of substitution 
reaction of the complex. For this reason many ligand substitution reactions are 
performed by varying the character of the ligands.10 
















Incoming group can attach from
 top  or bottom
L
Y





 are the chelate ligands
 
Scheme 2.1 Associative mode of substitution at the metal centre.11 
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It has been reported12 that Pt(II) complexes containing strong cis Pt―C bonds result in 
the mechanistic changeover in Pt(II) complexes of the form cis-[Pt(L)2R2] (where L2 = 
Me, Ph and R2 = thioethers or DMSO). The trans effect due to the strong σ-donor 
increases the electron density at the Pt(II) centre and weakens the Pt―S bond length in 
case of DMSO. The fourteen-electron transition state intermediate is stabilized by the 
strong σ-donor carbine ligands. However, when one of the thioethers were replaced by 
a strong π-acceptor ligand such as CO or CNˉ, an associative mechanism was favoured 
for the Pt(II) complexes. The stronger π-accepting ligands remove the electron density 
from the metal centre thereby increasing the electrophilicity of the Pt(II) centre. This 
enhances the acceptance of the electron density from the incoming nucleophile and 
removing the added electron density from the metal centre in a five-coordinate 
transition state. Thus, the type of the reaction mechanism depends on the nature of the 
chelate ligand at the Pt(II) centre.  
 
2.2.2 Dissociative Mechanism 
Depending on the electronic and the steric effects, a dissociative pathway may be 
favoured by weakening of the metal-leaving group bond. In dissociative (D) 
mechanism, the bond between the leaving group and the metal breaks completely 
before incoming group attaches to the metal centre resulting in an intermediate with 
lower coordination number. This allows the intermediate to discriminate the potential 
ligands in the surrounding medium before it reacts with the entering group.9a The rate 
of reaction with the entering group depends on the nature of the leaving group and is 
independent of the concentration and the nature of the incoming group. The leaving 
group moves from the coordination shell, which favours the solvent attack as the 
solvent is present in large access. Therefore, the formation of the product will occur 
while the leaving group is still in close proximity.  
 
One of the important aspects of dissociative mechanism in square planar Pt(II) 
complexes is the non-stereo specific products formed. During dissociation mechanism, 
the complex forms a T-shaped three coordinate intermediate, which undergoes 
intermolecular rearrangements of   ‘cis-like’ configuration to a ‘trans-like’ configuration. 
The mechanism is rare for square planar Pt(II) complexes because increase of electron 
density at the Pt(II) centre hinders the approach of the nucleophiles and stabilization of 
the coordinatively unsaturated 14-eletron intermediate.12d 
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2.2.3 Interchange Mechanism 
In between the limiting associative and limiting dissociative mechanisms, there exists a 
set of mechanisms which involves a single activated complex in which bond formation 
between the metal centre and the incoming nucleophile and bond breaking between 
the metal and the leaving group are concurrent. These mechanisms are considered as 
interchange mechanisms. They are: 
i. Associatively Activated Interchange Mechanism: In this mechanism, the rate of 
reaction dependents on the nature of the incoming species since the rate 
limiting step involves bond formation between the entering group and the 
reactive centre in the transition state. The bond breaking is less important even 
though the two steps co-exist leading to a single activated complex.13          
 
ii.  Dissociatively Activated Interchange Mechanism: In a dissociatively activated 
mechanism, the leaving group starts to break away from the inner coordination 
sphere to the outer coordination sphere at the same time while the entering 
group moves from the outer coordination sphere to the inner coordination 
sphere. In this mechanism, if there is a reagent whose concentration is much 
less than that of the solvent which is already in the inner coordination sphere 
when the dissociation takes place, then the probability of the solvent attaching 
to the reactive metal centre is higher. Thus, the discrimination between the 
entering group and the solvent molecules is minimized. 
                                                                                                                                                                                                                                                                                                                 
2.3 Substitution Reactions of Square Planar Platinum(II) Complexes 
A full understanding of four coordinate substitution reactions dates back to 1920s.13 
Square planar complexes  often contain d8, low-spin, 2+ oxidation state metal centres.9 
Common examples of square planar complexes include coordinated complexes 
commonly formed by Ni(II), Pd(II), Au(III), Rh(I) and Pt(II).9b Of these, substitution 
reactions of platinum are the most well studied and understood in inorganic reaction 
mechanisms due to its redox stability and moderately slow reactivity.14 This allows the 
synthesis of specifically designed platinum complexes and investigation of their kinetic 
behaviour.2,9b,13,14b To date, appreciable amount of research has been reported on the 
kinetic and the mechanistic behaviour of substitution reactions of Pt(II) 
complexes.6,7b,13,14b Since the mechanism of substitution behaviour of Pt(II) is similar to 
other square planar d8-metal complexes, the information collected on Pt(II) complexes 
can therefore be useful to the other d8-metal complexes. For example, substitution 
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reactions of Pd(II) complexes are very similar to Pt(II)’s. However, Pd(II) complexes are 
often five order of magnitude faster than the Pt(II) analogues.15   
 
During substitution, the coordinatively unsaturated square planar d8 Pt(II) metal 
complexes often undergo an associative mechanism which proceeds via a five 
coordinate, trigonal bipyramidal transition state having eighteen electrons in the 
valence shell.16 Pt(II) d8 complexes have vacant 6pz orbitals which can easily 
accommodate the extra electrons from the incoming nucleophile.2,9b,14b Moreover, 
square planar complexes being four coordinate, are not sterically hindered. Thus, the 
incoming ligand can approach the metal centre both from above and below the plane, 
retaining the stereochemistry of the complex as shown in Figure 2.2(e).7b  
 
 
Figure 2.2 Schematic representation of the energy profile and possible steric changes during 
  an associative substitution of leaving group, X by the entering group, Y of a square 
  planar complex: energies at 2, 4, 6, and 8 represent the transition states and the 
  reaction intermediates would have energies shown at 3, 5 and 7.7b,17 
 
Therefore, the incoming ligand binds to the metal centre before the leaving group 
leaves, resulting in a trigonal bipyramidal complex7b,9b,13 (Figure 2.2, c). Although an 
associative mechanism is more common for square planar complexes, recently, some 
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2.3.1 Kinetics and Mechanism of Substitution Reactions 
The nature of the reactants and the solvent play an important role during the 
substitution reactions of Pt(II) complexes. The substitution kinetics of square planar 
complexes may take place in any one of the three pathways shown in Figure 2.3.2 This 
involves an associative pathway either by direct attack of the nucleophile or the solvent 
and a dissociative pathway which involves a three coordinate intermediate.2 
 
 
Figure 2.3 Schematic representation for substitution in d8 four coordinate square planar  
  complexes showing the alternative D and A or Ia solvolysis.2 
 
2.4 Determining the Rates of Ligand Substitution Reactions 
2.4.1 Reversible Second-Order Reactions 
Second-order reactions may not always go to completion but rather may attain 
equilibrium as represented below 









ML3Y   +     XML3X    +  Y
                          (2.4) 
 where, A = metal complex (ML3X), X is the leaving group 
               B = incoming nucleophile, Y 
              k2 = second-order rate constant 
             k-2 = observed first-order rate constant for the reverse reaction 
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The reaction involves a mixed-order behaviour where the forward reaction is second-
order and the reverse reaction is first-order. Therefore, to resolve the complexity, 
pseudo first-order conditions is applied for the forward reaction where [B]0 ≫ [A]0. 
Thus, the equation can then be simplified to reversible first-order reaction. 










22                                                    (2.5) 
Taking the stoichiometric ratio of the reaction as 1:1:, the mass balances at any time, t 
can be written as 
    tt CAA ][][][ 0   
and tt CBB ][][][ 0                                                              (2.6) 
At equilibrium the mass balance becomes: 
eqmeqm CAA ][][][  0  
and eqmeqm CBB ][][][  0                                                 (2.7) 
Also at equilibrium the two opposing reactions take place at the same rate. That is, 





22                                                                    (2.8) 
hence, 
eqmeqmeqm CkBAk ][][][ 22                                                                                                              (2.9) 
Using Equation 2.7 and Equation 2.9, the following equation can be obtained 
])][]([][][ 022 eqmeqmeqm AAkBAk                                                                                          (2.10) 
Thus, rearranging Equation 2.10  leads to 
             eqmeqmeqm
AkBAkAk ][][][][ 2202                                                                            (2.11) 
Substituting Equation 2.6 for [C]t, and substituting into Equation 2.5 gives 






                             
             ttt
AkAkBAk ][][][][ 2022                                                                      (2.12) 
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Combining Equations 2.11 and Equation 2.12 gives: 






2222                          (2.13) 
Substitution of [B]t and [B]eqm according to Equations 2.6 and 2.7 and approximating 




2 eqmt AkAk ][][   leads to 






220202                                     
                    
)][])([][( eqmt AAkBk  202                                                                (2.14) 





































                   
                    
tkobs                                                                                                           (2.15) 
              where 202 ][  kBkkobs  
             kobs   = observed first-order or observed pseudo first-order rate constant  
             [B]0  = is the initial concentration of the nucleophile. 
 
Thus, plotting kobs against [B]0 gives a straight line with a slope of k2 and an intercept of 
k-2. The ratio of k2/k-2 gives the equilibrium constant, K, which is a measure of the 
thermodynamic equilibrium position of the reaction.19 Figure 2.4 shows an example of 
such plots obtained for the substitution reaction of Pttpytteg with different 
nucleophiles (where tpy is 2,2':6',2''-terpyridine and tteg is tetraethylene glycoxy 
ether).  
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Figure 2.4 Dependence of the pseudo first-order rate constant (kobs) on the concentration of 
  the nucleophiles for the chloride substitution from Pttpytteg in methanol solution 
  (I = 0.02 M LiCF3SO3, adjusted with LiCl) at 298 K. 
 
From Figure 2.4, it can be seen that k2 is sensitive to the nature of the entering 
nucleophile as this is a nucleophile dependent path.14a A plot which passes though zero 
implies that the forward reaction is irreversible and goes to completion. Noteworthy is 
that a positive intercept may also be attributed to the reverse reaction or a parallel 
solvolysis.20 Some kinetic studies are carried out in coordinating solvents2,15 such as 
water and methanol which are present in large excess. In cases where the contribution 
from the reverse reaction is negligible, then k-2 term can be ascribed as a measure of the 
solvolysis pathway.9b,13,14b This solvent associated pathway has been reported21 for the 
substitution kinetics of several square planar complexes.  
 
As mentioned earlier, associative substitution reactions of square planar Pt(II) 
complexes are just order with respect to both the metal complex and the nucleophile. 
However, in order to simplify the kinetics of substitution of Pt(II) complexes, pseudo 
first-order conditions are adopted by keeping the concentration of the nucleophile at 
least 10 fold greater than that of the metal complex in order to force the reaction to go 
to completion. This simplifies the concentration dependence of rate to first order.  
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2.4.2 Activation Parameters 
The temperature dependence of a rate constant is often studied to determine the 
reaction’s activation parameters.4,7c,9b In inorganic reactions, this is important in 
assigning the mechanism that the reaction undergoes. The enthalpy of activation 
( H ) and entropy of activation (
S ) are determined as stipulated in the Transition 
State Theory.4,9b Practically, to measure H  and 
S , the observed second-order rate 
constant is measured at various temperatures. The third activation parameter, volume 
of activation, V  is measured by varying the pressure of the reaction medium. The 
activation parameters along with the second-order rate constants obtained can 
therefore be used to postulate the reaction mechanism of the system. 
 
2.4.2.1 Measurement of enthalpy of activation ( HΔ ) and entropy of 




According to the Transition State Theory many reactions occur via a formation of a pre-
equilibrium between the reactants and the activated transition state complex which is 
in equilibrium with the reactants and can be described as follows7b,c,22  
       
B   A
*





                  







Ad b                                                                                                               
               
]][[ BAK
h
Tkb                                                                                               (2.17) 
where kb = Boltzmann constant (1.38 x 10-23 J K-1) and h = Planck’s constant (6.62 x 10-34 J s-1). 
The experimental second-order rate constant, k2 can be written as  




k b2                                                                                                              (2.18) 
The Gibbs free energy of activation, 
G , is expressed as 
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  KRTG ln     STH                                                                           
(2.19) 
Substituting Equation 2.19 into Equation 2.18 gives 








































                                                               (2.20) 
Rearranging and taking logarithm results in 





























k blnln 2                                                                             (2.21) 
Subsequent linearization affords 

























ln 2                                                                             (2.22) 
 
Equation 2.22 is in the form y =  mx  + c. A plot of ln(k2/T) against 1/T is linear with a 
slope from which the enthalpy of activation, H  can be calculated. The entropy of 
activation, 
S  can be determined from the y-intercept. This plot is generally known 
as Eyring plot.7b,9b,23 The magnitude of the two activation parameters can be used to 
assign the reaction mechanism. In an associatively activated mechanism, the value of 
H  tend to be relatively small while 
S  are normally negative compared to a 
dissociatively activated mechanism where the H is large and 
S is positive.2 If the 
mechanism of the reaction is assigned solely based on the activation parameters, it is 
necessary to draw such a conclusion from kinetic data taken from several nucleophiles. 
A drawback is that 
S  is obtained from the intercept by extrapolating the graph to 
infinite temperatures. The error associated with its determination is usually three 
times higher than that of H .24 Thus, a more reliable parameter in assigning a 
reaction mechanism is the volume of activation, ( V ) which can be determined by 
the measurements of the bimolecular rate constants, k2 when the pressure of the 
medium is varied.25 However, to make a meaningful assignment on the mode of 
activation, the sign and the magnitude of the two activation parameters, i.e. H  
and
S , are crucial.  
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2.4.2.2   Volume of Activation ( VΔ ) 
The volume of activation is an important parameter for elucidating the underlying 
reaction mechanisms. The volume of activation represents the change in partial volume 
on moving from reactants  to the transition state of the reaction, in such a way that the 
volume profile of the reaction can be analysed in terms of the changes in volume of the 
reactant.26 If the reaction mechanism is associative, this change in volume is greater 
than one. The activation volume is determined from a series of observed rate constants, 
kobs, obtained at different applied pressures.2,24 It is a useful supplement to the 
activation parameters ( S and H ).  
The thermodynamic equation: 
               VdPSdTdG                                                                                            (2.23) 
the partial derivatives can be written as: 













                                                                                                           (2.24) 
where V° is the difference in partial molar volume between products and reactants. 
Since  




































                                                                            
(2.25) 
Since the equilibrium constant, K = k2/k-2, the expression can be written as: 






                                                                                                          
(2.26) 
where V is the volume of activation for the forward reaction and it the difference in 
the molar volumes of the activated complex and the reactant under the experimental 
conditions. Integrating both sides within an applied pressure range of P = 0 to P = P, k2 
= (k2)₀ to k2 gives 
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 022 )ln(ln  and is in the form mxcy 
                         
(2.27) 
where (k2)₀ is the rate constant at zero pressure (coefficient compressibility of the 
solvent). 
 
A plot of ln k2 verses P gives a straight line with a slope of .
RT
V 
  The value of V is 
a combination of both an intrinsic contribution (  intV ) due to changes in internuclear 
distances within the reactants in forming the transition state and an electrostrictive 
contribution (  elecV ).
27 Ligand substitution reactions involving charged species,  elecV  
may be dominated by changes in charge occurring during the reaction. For the solvent 
exchange interpretations the  elecV  
term is absent and V  is due to the activation 
step for bond making.27 A positive value of V  indicates a dissociative mechanism 
while a negative value means the mechanism is associative. The errors associated with 
volume of activation are relatively small compared to S
 
since the activation volumes 
are determined from the slope of the graph. Thus, to have an appreciable effect on the 
rate of reaction, a high pressure (100 - 200 MPa) is required. Recently, Jaganyi et al.28 
and van Eldik et al.29 reported V
 
for mechanistic investigations of ligand 
substitution reactions. 
 
2.4.3 Instrumental Techniques Used in Chemical Kinetics 
Kinetic investigations are normally performed by monitoring the dependence of a 
physical variable such as pressure, pH, conductivity, absorbance and density30 which is 
proportional to the concentration of the products or the reactants as a function of time. 
The data is then analyzed by fitting to an appropriate model to determine the rate 
constant.9b A number of different techniques such as nuclear magnetic resonance 
(NMR), UV/visible spectrophotometry and pulsed methods are used to study the rate of 
reactions.23 However, the choice of technique used to follow the kinetics depends on 
the nature and rapidity of the reaction.31 Regardless of the technique employed, the 
physical property measured must be proportional to concentration as a function of 
time after mixing. The reactants must be mixed in the shortest time possible within the 
time scale of the reaction. The physical conditions such as temperature and pressure 
must be controlled accurately. 
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A chemical reaction is generally considered as fast if 50% of the reaction completes in 
10 seconds or less.31 Kinetic studies of very fast reactions such as reactions involving 
proton transfer, enzymes and non-covalent complex formation,23 that lie outside the 
time frame of the normal laboratory operations are studied using specialised 
techniques and instruments. Normally, for fast reactions, the time varies from 1 minute 
to 10-14 seconds.24 One approach of analysing fast reactions is to bring their rates into 
the conventional time range by changing the conditions such as temperature, 
concentration or the solvent which is reliable only if the half-life is greater than 1 
hour.32 The two main methods often used to study fast reactions include flow methods 
and pulse methods.23 
Sufficiently slow reactions are often studied using conventional methods such as 
UV/visible spectrophotometry which involve first mixing of the reagents and then 
determining the decrease in the concentration of the reactant(s) or the increase in the 
concentration of the product(s) with respect to time. Thus, the time taken to mix the 
reagents and take the necessary measurements should be short enough so that it does 
not interfere with the actual rate of the reaction. Despite the number of methods 
available,23 only the techniques of UV/visible absorption spectrophotometry and the 
stopped-flow method would be highlighted in this thesis. 
 
2.4.3.1   UV/visible Spectrophotometry 
A substitution reaction which is slow (a reaction which generally takes longer than 16 
minutes) are monitored using UV/visible spectrophotometer. UV/visible 
spectrophotometry is a sensitive technique14b which can detect the sample 
concentrations ranging from 10-4 to 10-6 mol dm-3.32 The instrument comprises of two 
light sources, one in the visible (tungsten lamp, 800 to 400 nm) and the other in ultra-
violet (deuterium lam, 400 - 200 nm), monochromator, reference and sample 
compartment, temperature control unit, detector, the data processer and the output-
readout system.31  The commonly used detector is a photomultiplier tube. In a 
UV/visible spectrophotometer, radiation from the light sources is passed through a 
monochromator. The light gets dispersed by the grating prisms and the 
monochromator allows a particular wavelength to pass through. The light of the single 
wavelength with intensity, 0I , passes through the sample cell called a cuvette of length, 
l where the sample absorbs some light. Modern spectrophotometers are based on a 
double-beam design where it manages the light alternatively to pass through the 
sample cell and the reference cell using a chopper which is a motor that rotates a 
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mirror  into and out of the light path.31,33 The basic set-up of the UV/visible 




Figure 2.5 Schematic diagram of a UV/visible spectrophotometry setup.34  
 




Figure 2.6 Photograph of a double-beam-in-space Varian Cary 100 Bio UV/visible 
spectrophotometer used by the University of KwaZulu Natal, Pietermaritzburg 
campus kinetics research group. 
 
The spectrophotometer measures the transmitted light (T) from the sample which can 
be represented as  
           I
I
T 0                                                                                                                      (2.28) 
where 0I  
is  the intensity of the incident light and I  is the intensity of the transmitted light. 
The transmittance is converted into absorbance by use of Equation 2.29 and is 
displayed on the screen.     
           TA log                                                                                                             (2.29) 
In Beer’s law (Equation 2.30), concentration of the sample is directly proportional to 
the absorbance and thus, can be determined from its absorbance.31 
          clA                                                                                                                       (2.30) 
where A is the absorbance, ε is the molar absorptivity in mol-1 dm3 cm-1, c  is the concentration in 
mol dm-3 and l is the path length in cm (1 cm). 
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For a simple first-order reaction, 
                                              X Y
k1
                                                (2.31)   
The absorption at any time t, (At) is  
       
][][ YXA YXt                                                                                                  (2.32) 
   where  YX  , = molar absorptivity of  X and Y  respectively 
Upon completion of the reaction, the absorption is given by 
      00
][][ YXA YX                                                                                              (2.33) 
        where  A  absorbance at infinity 
0][X  and 0][Y  initial concentration of X and Y respectively  
For the kinetic analysis, absorbance can be obtained from the following equation  























                                                                                          (2.34)    
The observed rate constant for the reaction can be obtained by a least squares fit of the 
observed absorbance versus time trace at a specific wavelength. The second-order rate 
constant for the reaction is obtained by monitoring the reaction at different 
concentrations. The reactions can also be performed at different temperatures to 
determine the activation parameters. 
Figure 2.7 shows the reaction profile obtained for the substitution of 
[ClPt(tppz)Ru(tppz)PtCl](PF6)4 (where tppz = tetra-2-pyridyl-1,4-pyrazine) with 
thiourea. The kinetics for the reaction was studied at 383 nm and the kinetic trace 
obtained for the reaction at 298 K is shown as an inset in Figure 2.7. The rate constant 
for the reaction was obtained by fitting first-order exponential decay function using 
Origin 7.5®.35 
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Figure 2.7 Spectrum obtained from Cary UV/visible spectrophotometer for the substitution 
of  Clˉ from [ClPt(tppz)Ru(tppz)PtCl](PF6)4 (2.0 x 10-5 M) by thiourea (0.0004 M) in 
methanol solution (I = 0.02 M (adjusted with LiCF3SO3 and LiCl) at 383 nm and 
298 K. 
 
Apart from its use in the direct monitoring of conventionally slow kinetics of ligand 
substitution reactions, UV/visible spectroscopy is also used to perform UV/visible 
spectroscopic titrations to determine the pKa values of the coordinated protic ligands 
such as aqua ligands. In such titrations, the aqua complex is titrated against a suitable 
strong base and the resulting change in the absorbance is spectroscopically monitored. 
By analysing the data obtained at a specific wavelength, the pKa values for the complex 
are obtained. Such thermodynamic pKa values of the coordinated aqua ligands are 
important for probing the electrophilicity of the metal complexes as reported by 
Jaganyi et al.36 and van Eldik et al.29,36a,b,37 An example of a spectroscopic titration 
spectrum is given in Chapter 4, Figure 4.2. 
 
2.4.4 Flow methods 
Chemical reactions which are too fast to study using absorption spectrophotometry are 
analysed using flow methods pioneered by Hartridge and Roughton.9b The mixing time 
of flow methods varies approximately from 1 ms to 10 seconds. Fast reactions with 
half- lives of about 10-2 seconds are normally followed by flow methods.31 In flow 
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methods two reactant solutions are rapidly mixed under pressure in a reaction mixing 
chamber. Concentrations of the reactants or products are then measured at various 
time intervals at different positions of the tube. The most common types of flow 
methods are continuous flow method and stopped-flow method. 
 
2.4.4.1   Continuous flow method 
This technique is used to study rapid reactions (which take less than one second) in 
solution.30 This method works on the idea where the two reacting solution (A and B, 
Figure 2.8) are forced into the mixing chamber by the pistons and the resulting solution 
then flows through the observation tube, where it gets spectroscopically detected at a 
specific distance (d) from the mixer where a steady state is attained. This method 
requires a larger amount of solutions. The use of stopped-flow reaction technique is an 
alternative to overcome this problem.30  
 
Figure 2.8 Diagrammatic representation of a continuous flow kinetic system. The letter d 
  represents the distance from the mixture to the point of observation.38 
 
2.4.4.2   Sopped-Flow Technique 
The stopped-flow technique is the most popular for studying reactions which are very 
fast and having a half-life rage of about 100 to 103 seconds.31 A schematic diagram of the 
stopped-flow technique is shown in Figure 2.9 and a photograph of SX 20 stopped-flow 
spectrophotometer is shown in Figure 2.10.  




Figure 2.9 Diagrammatic representation of stopped-flow apparatus.23 
 
The apparatus is designed to study a reaction between two substances in solution 
where one of the reactant is placed in drive syringe A and the other in syringe B and 
equilibrated at the desired temperature. The reactants are then charged into the mixing 
chamber by a compressed gas-driven piston (800 kPa) where they get mixed rapidly in 
about 0.001 seconds.31 The reaction solution then goes into the stop syringe, causing 
the plunger to strike the stop block which ceases the flow of solution thereby leaving 
the solution of the reaction mixture in the observation cell.14b,23,31 UV/visible 
spectrophotometry is the most commonly used detector for the reaction analyzer. The 
amount of light transmitted through the observation chamber in a given wavelength is 
measured as the reaction goes to completion. The transmitted light is converted into 
electric current by the photomultiplier. The computer computes and interprets the data 
as a kinetic trace of absorbance verses time.14b,23,31   
Some advantages of stopped-flow technique includes its capacity to measure very fast 
reactions constants and the analysis require only a very small amount of sample           
(≈ 0.2 mL).14b 




Figure 2.10 Photograph of the Applied Photophysics SX 20 stopped-flow system coupled to an 
  online data acquisition system setup used by the University of KwaZulu Natal,  
  Pietermaritzburg campus kinetics research group. 
 
2.5 Factors Influencing the Reactivity of Square Planar Platinum(II) 
Complexes 
The magnitude of rate constants of square planar Pt(II) complexes depend on a number 
of factors. Some of these factors will be discussed here in detail.  
 
2.5.1 Effect of the Entering Group 
It is well understood that in an associative substitution reaction mechanism, the second 
order rate constant, k2 is dependent on the nucleophilicity of the entering group. 
Nucleophilicity is a measure of how readily a nucleophile can attack an electron 
deficient centre such as Pt(II). Thus, the stronger the nucleophile, the faster the rate at 
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The nucleophilicity of the ligand is often influenced by several factors:7b 
(a) Polarisability: Polarisability is an important aspect for the rates than for 
equilibria14a which is often explained by using Peasons’s 
“Hard Soft Acid Base” †(HSAB) theory.7b,39 Increasing 
polarisability of the metal centre increases the 
effectiveness of the incoming nucleophile. 
 
(b) Basicity: The basicity of a nucleophile depends on its pKa which 
often correlates with the nucleophilicity of the entering 
nucleophile towards the metal centre. The relationship 
between the logk2 and the basicity of the entering 
nucleophiles for the substitution reaction of Pt(II) 
terpyridine type complexes with azole nucleophiles has 
been reported recently.21a 
 
(c) Oxidability: Ligands which are easily oxidised are considered as good 
nucleophiles (strong reducing agents) and their strength 
can be identified based on their electrode reduction 
potential. 
 
(d) Metal Centre: The nature of the reaction centre affects the rate of 
substitution of square planar complexes. Thus, the nature 
of metal centre limits the applicability of nucleophilicity 
scales in inorganic chemistry since reactions show 
dependence on the nature of the metal centre. Heavier 
elements are better polarised in the transition state 
following the order: Ni(II) > Pd(II) > Pt(II). 
 
(e) Solvation Energy: Ligands which are easily solvated are weak nucleophiles 
because energy is required to remove the solvent shell 
before it gets coordinated with the metal centre. 
 
                                                          
†
Hard acids (metal ions) are small and highly charged (eg: Li+ and Mg2+) and thieir valence electron shell is 
not easily distorted while soft acids (metal ions) are large and possess low charge having an easily distortable 
or removable valence electron shell. Polarisability refers to the “softness” of the nucleophile, i.e. “Hard” 
nucleophiles  prefers “hard” metal centres and “soft” nucleophiles prefers  “soft” substrates or metal centres. 
Pt(II) being a soft  metal centre is more effective towards large and soft donors.  
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Studies reported on Pt(II) complexes show that the nucleophilic reactivity order for 
commonly used nucleophiles follow the order:14a,14c,40 
R3P > Tu > 
I  > 
SCN  > 3N  > 

2NO  > 
Br  > py  > aniline ~ NH3 ~
Cl  > H2O >
OH     
 
It is also important to note that the nucleophilicity of the reagents is independent of 
their base strength. Based on earlier studies,14c,40 the most detailed study on 
nucleophilicity was reported by Bellucco41 for trans-Pt(py)2Cl2 in methanol at 30 °C 




pypy +        Y
n









By using trans-Pt(py)2Cl2 as the standard, the nucleophilic reactivity constants, Ptn  was 
defined as:9b  









n                                                                                                             (2.36) 
 where  kY = the measured second order rate constant for the entering nucleophile  
          
o
sk = the second order rate constant for the attack of solvent in an associative 
mechanism and is equal to  ks / [Methanol] 
              kS = the observed rate constant for solvent attack (methanol) on the   complex. 
 
            
 
Plots of log kY for different Pt(II) complexes with various number of nucleophiles 
yielded linear free energy relationship (LFER).42 Such a linear free energy relationship 
is given by:9b,14a 
                   log kY  = Ptsn   + log kS 
                                    or 
                   log k2  = Ptsn   + log k-2                                                                                                (2.37) 
 
where the slope, s depends on the complex and is called the nucleophilic discrimination 
factor, a measure of the sensitivity of the metal centre to the nucleophilicity of the 
incoming ligand.14a A larger value of s means that the reaction is very sensitive to the 
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changes in nucleophilicity of the substituting ligands. Ligands that are capable of  
forming dative π-bonding with Pt(II) centre in the transition state have larger values of 
s (smaller kS)14a which enhances the addition of the electrons from the nucleophile. 
Generally, Pt(II) complexes with softer ligands have larger s values. The intercept log ks 
is the intrinsic reactivity. A smaller value of intrinsic reactivity is accompanied with 
very fast reactions and hence, a greater nucleophilic discrimination factor. Thus, the 
nucleophilic reactivity constant is a measure of the reactivity of a nucleophile towards a 
Pt(II) metal centre. 
 
After a number of investigations, it was also reported that the nucleophilicity of the 
incoming ligand also depends on other properties14a such as biphilicity of the ligand 
and the charge effect14c,43 while steric hindrance plays a minor role.44 Some of the 
experimental results obtained are presented in Table 2.1. For many nucleophiles, a plot 
of kY against Ptn  is a straight line as represented in Figure 2.11. 
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Figure 2.11 Correlation of the rates of reaction of Pt(II) complexes with the standard trans-
  Pt(py)2Cl2 for different nucleophiles: •, trans-Pt(PEt3)2Cl2 in methanol at 30 °C; ∎, 
  Pt(en)Cl2 in water at 35 °C, produced from references.14a,41,46 
 
In a study van Eldik et al.47 reported the nucleophilic discrimination ability of Pt(II) 
complexes of [Pt(N-N-C)Cl] (N-N-CH = 6-phenyl-2,2'-bipyridine), [Pt(N-C-N)Cl] (N-CH-
N = 1,3-di(2-pyridyl)benzene), and [Pt(N-N-N)Cl]Cl (N-N-N = 2,2':6',2''-terpyridine) 
where the rate constants for the substitution of Cl⁻ by MeOH, Br⁻ and I⁻ were measured 
as well as the corresponding logk2 verse nPt. In that study, it was found that due to the 
biphilic nature of thiourea, its nucleophilic discriminating factor was misleading from 
plot. The resulting values for s were reported to be 0.61 ± 0.04 (NCN), 0.9 ± 0.1 (NNC), 
1.39 ± 0.02 (NNN) respectively. 
 
2.5.2 The Effect of Leaving Group 
Since square planar Pt(II) complexes mainly follow associative mode of substitution 
reactions, the effect of the leaving group is less important on the rate of substitution 
compared to the incoming group. However, some substitution reactions have shown a 
dependence on the nature of the leaving group.  
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For this purpose, Pt(dien)X⁺ systems (Equation 2.38) has been studied extensively. Data 
obtained is represented in Table 2.2. 
Pt(dien)X + py                                   2Pt(dien)py  +  X                        (2.38) 
 
Table 2.2 Effects of leaving group on the rates of reaction of Pt(dien) complexes in water at 
25 °C.48 
Ligand, X 106 kobs, s-1 

3NO  very fast 
H2O 1900 
Cl  35 
Br  23 
I  10 

3N  0.83 
SCN  0.3 

2NO  0.05 
CN  0.017 
 
The decrease in the rate of substitution of X from the substitution by pyridine ligand 
follows the order:  

3NO > OH2  > 





2NO  > 
CN  
 
In general, it is easier to substitute ligands which are less nucleophilic than those which 
are more nucleophilic. For example, the rate of substitution in the Pt(dien) is reduced 
by  a factor of 2000 when the cyano is replaced by a chloride as a leaving group while 
replacement of Cl⁻ by CN⁻ is 104 times greater than that of Cl⁻.41,48a Thus, for a square 
planar complex, it is clear that even though the reactivity of a complex strongly 
depends on the nature of the incoming group, is also dependent on the leaving 
group.2,14b Pitteri et al.49 had reported the effect of displacement of halides from several 
square planar Pt(II) complexes with different nucleophiles depend on the nature of the 
leaving groups. 
 
2.5.3 Effect of Steric Hindrance 
Associative mode of mechanisms involves an increase in the steric hindrance in the 
transition state.  Therefore, for a sterically hindered complex, the rate is expected to be 
slower due to the transition state destabilization. The influence to the rate of reaction 
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could be either due to the steric bulk in the spectator ligand or in the incoming 
nucleophile. 
 
It is rationalized that increasing the steric bulk of the spectator ligands usually decrease 
the rate of substitution. Studies have reported that steric hindrance due to methyl and 
ethyl substituents on the tridentate (Rndien) ligands slows down the substitution rate 
of [Pt(Rndien)Cl]+ complexes on increasing the size of the substituent, R, by five orders 
of magnitude compared to the unhindered molecule (Table 2.3). The corresponding 
Pt(II) complexes, even though not yet been studied extensively, based on the available 
data a similar trend is expected to be followed for Pt(II) complexes. 
 
Table 2.3 Rate constants and activation parameters for the substitution of Clˉ by Iˉ in 
[Pd(Rndien)Cl]⁺ (n = 0, 3-5) in aqueous solution at 25 °C.50   
Rndien k1 s-1 
HΔ kJ mol-1 SΔ J K-1 mol-1 VΔ cm3 mol-1 
dien 44 43 -69 -10.0 
1,4,7-Et3dien 10 41 -86 -10.8 
1,1,7,7-Et4dien 2.2 x 10-3 66 -74 -14.9 
1,1,4,7,7-Me5dien 0.28 50 -88 -10.9 
1,1,4,7,7-Et5dien 7.2 x 10-4 59 -106 -12.8 
 
The steric effect of the spectator ligand might influence differently for cis and the trans 
positions. This steric effect, using cis and trans isomers was reported by using cis/ 
trans-[Pt(PEt3)2LX] (L= phenyl, o-tolyl, mesityl, X = MeOH, Clˉ and Brˉ).7c,9b,51 The 
substitution of chloro ligand in trans -[Pt(PEt3)2LX] complex by thiourea showed that 
by having one or two ortho-methyl groups on the phenyl rings decelerated the 
reactivity by a factor of only 130 : 10 : 1 respectively for R = phenyl, o-tolyl and 
mesityl.51b The decrease in reactivity was reported to be even greater for the cis 
complex, cis -[Pt(PEt3)2LBr] ( 32000 : 110 : 1), with the same modification on the 
phenyl ring.51c 
 
The larger decrease in the rates observed for cis complex can be explained in terms of 
transition state complex of the cis isomer where the leaving group and the entering 
group are in equatorial positions (Figure 2.12). In the case of the cis isomer, in the 
transition state, the group L occupies the axial position thus, L interacts with the 
leaving group at 90° which causes more steric repulsion between the ortho-methylene 
substituents and the entering and the leaving group. For the trans isomer, L occupies an 
equatorial position in the transition state, which lies at 120° to the incoming group 
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which is further apart.7c Also in the trigonal bipyramidal intermediate the cis isomer 
offers more shielding than the trans isomer. Recently Jaganyi et al.36f reported 
mechanistic elucidation of substitution reactions of Pt(II) dinuclear complexes bridged 
by pyrazine units where the rate of substitution was found to be controlled by the 



























P = PEt3 Y = Py
L = phenyl, o-tolyl, mesityl  
Figure 2.12 The steric effect of the aryl square planar complex showing the steric bulk for the 
  cis isomer blocking the attacking site.7c 
 
2.5.4 Effect of Solvent 
Since the solvent is the reaction medium in which the reaction takes place, it can 
rapidly substitutes the labile group rendering the rate to be independent of the 
entering nucleophile and has been reported21 for substitution reactions of Pt(II) 
complexes proceeding via the solvent pathway. This contribution of the solvent to the 
overall rate of reaction depends on the coordination ability of the solvent.2,14a The effect 
was experimentally investigated for the chloride exchange reaction for trans-Pt(py)2Cl2 
(Table 2.4, Equation 2.39).9b 
       trans- Pt(py)2Cl2  + 
Cl36                             trans- Pt(py)2Cl( Cl
36
 )    + 
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Table 2.4 Effect of solvent on the chloride exchange reaction (Equation 2.39) at 25 °C.52 
Coordinating  k-2 / (10-5 s-1) Weakly  coordinating  k2/ M-1 s-1 
DMSO 380 CCl4 104 
H2O 3.5 C6H6 102 
EtOH 1.4 i-BuOH 10-1 




Results obtained show that for the strongly coordinating solvents, the reaction 
preceded via a solvolytic pathway which is independent of the concentration of the 
chloride while the opposite is true for the weakly or non-coordinating solvents. For 
coordinating solvents such as DMSO, the rates of the reaction showed a direct 
dependence on the nucleophilicity of the solvent, (kS >> kCl[
Cl ]). This is also because 
the soft Pt(II) metal centre prefers to bond with larger S in DMSO. For poorly 
coordinating (or non-coordinating) solvents such as CCl4, larger rates of reaction have 
been reported where the chloride acts as a nucleophile (kCl[
Cl ] > kS).14a Romeo et al.53 
have reported similar effects. Linear free energy relationships between several 
parameters that are commonly used to describe the Lewis acidity of the solvent and 
reactivity were found to depend strongly on the salvation of the incoming nucleophile. 
 
2.5.5 Non-Participating Ligand 
Substitution reactions of square planar Pt(II) complexes are influenced to a great extent 
by the nature of the spectator ligand. A number of research studies has been reported 
on the effect of reactivity on changing the properties such as the π- and σ-bond 
strengths and the steric factors of the spectator ligands which are trans and cis to the 
leaving group.36b,54 It is known that the influence on the reactivity due to the trans 
ligand is much stronger than the two cis ligands.14d 
  
2.5.5.1   The trans Effect 
The trans effect is the influence exerted by a non-labile ligand in a square planar 
complex on the rate of replacement of a labile ligand trans to it.4 This concept of trans 
influence was  first observed by Werner  in the early 20th century.9b,55 By 1926 
Chernyaev used the concept of trans effect to synthesize isomeric square planar Pt(II) 
complexes.14a The trans ligand (L) labilize the ligand trans to it (X). In this case the 
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spectator ligands (A2) facilitate the replacement by the incoming nucleophile Y.14b 
(Equation 2.40).   
 
M XL Y M YL X (2.40)
  A   A
  A  A
 
 
In an associative mechanism, a greater trans effect increases the rate of substitution for 
square planar complexes. Using a standard complex, studies have established the 
general order of labilization by trans-directing ligands to be:2,9b,14a,b  
CN , C2H4, CO, NO > R3P ≈ 
H ≈ SC(NH2)2 > 

3CH  > 

56HC  > 
SCN  > 

2NO  >                                                 
I > Br  > Cl  > NH3 > 
OH  > H2O 
A ligand high up in the trans effect series would have a greater trans effect.                                                            
Kinetically, the trans effect can be large, hence, with a good trans labilizing ligand the 
effect may increase up to 106 or more.14a Since trans effect is a kinetic phenomenon, in 
order to understand it better, its effect at the ground state and the transition state 
should be considered. For example, a stabilization of the transition state and 
destabilization of the ground state leads to a reaction coordinates marked by smaller 
energy barrier leading to a higher reactivity.  
At this point it is important for one to differentiate the two closely related but 
characteristically distinct concepts, trans effect and trans influence. The trans effect 
provides information about the trans ligand on ground state as well as the transition 
state, while trans influence is a ground state phenomenon which involves the ground 
state effects such as ground state bond length.7c,9b,46 To understand the trans effect 
better, it is important to know both σ-and π-bonding effects. These effects involve the 
ground state orbitals shared by the metal M,  the leaving group X and the trans ligand 
L7c (Equation 2.40).  
In a square planar Pt(II) complex, a good π-accepting trans ligand can stabilise the five 
coordinate transition state intermediate by accepting the electron density from metal 
centre.14a The π-orbital in the metal centre is a filled dxy, dzy or dyz orbital and the 
electrons are transferred from these orbital to the empty p orbitals on the trans ligand, 
L.14a This makes the metal centre highly electrophilic. Thus, the increase in the electron 
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density due to the five coordinate transition state on the metal centre is reduced. 
Hence, the activation energy is reduced and thus, the rate of substitution increases.  
In the transition state, the leaving group and the trans ligand do not directly share the 
same p orbital. Thus, such a ligand has a greater σ-donacity in the ground state and is 
the dominant contributor for the ground state trans influence. Of the studies conducted 
to explain trans effect,56 the π-bonding theory and the polarisation theory are the two 
very common theories.4 Trans effect due to an appended alkyldiammine pendent 
groups have been recently reported by Jaganyi et al.28,36c for the substitution kinetics of 
mono and dinuclear Pt(II) complexes with thiourea nucleophiles.  
 
The π-back bonding effect in a metal complexes was first introduced by Pauling57 to 
account for the short Ni―C bond distances in Ni(CO)4. The π-bonding theory states that 
ligands with π-bonds, such as C2H4, PR3 and CO have stronger π-acceptor abilities thus, 
stabilise the transition state and therefore appear higher in the trans-effect series.14a,46 
A pair of electrons is donated from the ligand to platinum centre to form the σ-bond 
while the π-bond is formed by the overlap of electrons from the filled d orbital (either 
dxz or dyz) of platinum with the vacant orbital of the ligand.14a,46  
 
In general, removal of electron density from the platinum centre to the empty orbitals 
of the ligand weakens the M―X bond in the ground state.14a Chatt et al.58 and Orgel59 
independently proposed a π-bonding stabilization of the trigonal bipyramidal 
intermediate complex for the reaction of trans-PtA2LX with Y to form trans-PtA2LY 
where Y is the entering group, X is the leaving group and L is the trans ligand         
(Figure 2.13).  
 
 
Figure 2.13 π-back donation of the electrons from the filled d orbital to the vacant orbitals of 
  the trans ligand in PtA2LXY.14a,46         
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Chatt et al., stated that strong trans directing ligands enhance the substitution reactions 
by removing the electron density from the metal centre to the π-backbonding ligand.58 
One of the hybrid orbitals, either dxz or pz overlaps with the empty orbital on the trans 
ligand.46 Thus, the other two orbitals readily accept the electron density from the 
incoming ligand thereby favouring a rapid reaction.2,14a Orgel59 also supported this 
theory indicating that the presence of the π-acceptor ligand in the five coordinate 
transition state lowers the energy of the intermediate because the electron density on 
the Pt(II) is reduced along the Pt―X and Pt―Y directions, thereby retaining the original 
configuration.14a  
 
Polarization theory, reported by Meerwein,60 is based on weakening of the Pt―X bond 
due to the strong trans effect caused by the trans ligand in PtA2LX.14a The charge on the 
Pt(II) induces a dipole in L, which in turn induces a dipole in the platinum metal which 
repels the negative charge in X14a resulting in a weakening of the Pt―X bond. A 
diagrammatic representation of charge induced dipoles in L―Pt―X is shown in Figure 
2.14. However, there are some contradictions to this theory. Thus, the effect of covalent 
bonding in such systems needs to be considered. Ligands of high polarisability are 
expected to form the strongest bonds with Pt(II).  
 
 
Figure 2.14 Distribution of Charge induced dipoles in the L―Pt―X coordinate of trans- 
  PtA2LX.14a 
 
The σ- and π-trans effect is best described in the molecular orbital theory (MO 
theory).14a  
 
i   σ-trans effect                                                         
A simplified MO diagram for
2
4PtCl is given in Figure 2.15. The most stable σ-orbitals 
tailed by the π-bonding orbitals are located mostly on the chloride groups followed by 
the anti-bonding orbitals of the σ and π-orbitals.46 These orbitals are derived from the 
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5d orbitals of Pt(II) and have four probable MO of which the *xy  is the most stable and 
the *22 yx 
 is relatively the least stable MO.14a,46 The higher energy pz valence orbitals 
are not involved in the σ-bond formation and the higher energy anti-bonding σ orbitals; 
σs*, σx* and σy* are relatively the least stable from all.14a  
 




In a square planar complexes, 22 yx
d

, s, xp , yp and 25 zd metal valence orbitals are used 
for the σ-bond formation.46 However, only the two p orbitals have the right geometry 
for the trans directing properties. Therefore, in trans-PtA2LX, the leaving group, X and 
the trans ligand, L must share the same dsp2 orbital in the ground state.14a It is known 
that trans effect causes destabilization of the σ-trans ligand by elongation of the Pt―L 
bond via σ-donation. This in turn weakens the Pt―X bond due to the smaller share of 
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the electrons available for the bonding,14a thus, increases the rate of substitution of X 
(Figure 2.16). If the trans ligand is a stronger σ-donor, then the Pt―L shortens as a 
result of less electron density available for this bond and the Pt―X bond lengthens as 
reported by Jaganyi et al.36c 
 
L Pt XL Pt X
(a) (b)  
Figure 2.16 Representation of L― Pt―X bonding using σx MO (a) The σ-bond strength of L and 
  X are almost equal. (b) Strong σ-donor ligand L, the σ-bond strength of L is much 
  greater than that of X.9b,14a 
Langford and Gray6 used the σ-donation to explain the increase in the stabilization of 
the trigonal bipyramidal intermediate. In a ground state square planar complex, the 
same xp orbital is used to form the L―Pt―X bonds.14a Addition of  the incoming ligand, 
Y from above the xy plane shifts X out of plane resulting in two suitable p orbitals 
( xp and zp ) increasing the number of orbitals available for formation of bonds (Figure 
2.17).14a As a result, good σ-bonding ligands such as H and CH3 which can donate to the 
extra p orbital can stabilize the σ structure in the trigonal bipyramidal intermediate 
through trans effect.14a Jaganyi et al.36c recently reported the trans effect due to the σ-
donation  of the alkyl pendent chains on the substitution kinetics of Pt(II) complexes by 
thiourea nucleophiles. It was reported that the alkyl chain on the trans N-donor atom of 
the chelate head group increases the rate of substitution of the aqua leaving groups due 












  A  A
  A
 
Figure 2.17 The σ-trans effect due to the stabilization of the trigonal bipyramidal 
intermediate. (a) Only one p orbital is available for σ-bond formation of L and X. 
(b) Two p orbitals are available for the σ-bonding of L, X and Y.14a 
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ii   π-trans effect  
Good trans directing groups such as CO abd C2H4 stabilize the complex by  strong π-
back donation from the filled Pt(II) 5dxz or 5dyz to the empty π* (px or py) orbital of the 
ligand.14a In the trigonal plane, the four orbitals are shared in π-bonding with the three 
ligands, L, X and Y. This stabilises the trigonal bipyramidal transition state if trans 
ligand, L, can form bonds with the π* orbitals which results in the transfer of electron 
density from the platinum centre to the π-acceptor ligands thereby lowering the energy 
of the system.14a Thus, a good trans ligand lowers the activation energy of the 
reaction.9b,14a This theory rates the trans ligands according to the following orders:14a,17 
                             C2H4 ,  CO > CNˉ  > SCNˉ >  Iˉ > Brˉ > Clˉ > NH3 > OHˉ                     
Recent studies reported36a,b that trans π-accepting ligands can cause an increase in the 
substitution reaction of Pt(II) complexes by increasing the electrophilicity of the Pt(II) 
centre.  
 
2.5.5.2   Cis- Effect 
For square planar Pt(II) complexes, even though, the cis effect has not been studied 
detail, it is generally assumed that the cis effect is smaller than the trans effect. The 
reactivity of Pt(II) complexes are less  sensitive towards the properties of cis ligands 
compared to trans. However, the cis effect becomes important if the cis ligands are 
bulky as cis position can impose greater steric influence.2 It is known that good trans 
directing ligands have  poor cis effects.61 For example, experimental results obtained for 
cis-Pt(PEt3)2LCl (where L = Clˉ, C6H6 and CH3ˉ) with pyridine (Equation 2.47) have 
shown the same trend for the corresponding trans-Pt(PEt3)2LCl with pyridine with the 
change of the trans ligand, L in the order of CH3 (6.0 x 102 s-1) > C6H5 (3.8 x 102 s-1) > 
Cl (1.7 x 102 s-1).51a  
cis-Pt(PEt3)2LCl  + py                            cis-Pt(PEt3)2L(py)   + 
Cl                            (2.41) 
 
van Eldik et al.47 reported that the cis effect on the substitution kinetics of Pt(II) 
complexes viz; [Pt(1,3-di(2-pyridyl)benzene)Cl] (NCN), [Pt(6-phenyl-2,2'-bipy)Cl] 
(NNC) and [Pt(terpy)Cl] (NNN) using thiourea nucleophiles was much slower than the 
Pt(II) (NNN) complex. Pt(II) (NNC) where the Pt―C bond is on the cis position. The 
reactivity was much faster when the Pt―C bond was on the trans position due to 
stronger trans effect. The deceleration of the rate of substitution of Pt(II) (NNC) 
complex as compared to (NNN) was attributed to the reduced nucleophilic 
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discrimination of the (NNC) complex since the cis σ-donor lowers the electrophilicity of 
the Pt(II) metal centre due to their electron donating effect.47 
 
Additionally, Jaganyi et al.62 also reported the Pt―C cis σ-donor effect on the 
substitution reaction of Pt(II) terpyridine type complexes by thiourea nucleophiles. The 
authors reported a decrease in the reactivity due to the accumulation of electron 
density at the Pt(II) metal centre of a Pt(II) (NNC) thereby decreasing its 
electrophilicity. This further prevents the approach of the nucleophiles due to a 
destabilization of the transition state. Furthermore, in different studies Jaganyi et 
al.21a,63 reported the σ-donor ability of an isoquinoline ligand which is cis to the leaving 
group effectively decreases the electrophilicity of the Pt(II) metal centre thereby 
decreasing the substitution reactivity.  
So far the factors that control the reactivity are studied mostly for mononuclear 
complexes with square planar Pt(II) geometry. However, not much studies have been 
reported for multinuclear and heterometallic square planar complexes with bridging 
linkers. Nevertheless, it is known from literature28,36d that the bridging linker confers 
special structural properties such as flexibility and rigidity which then influences the 
substitution reactivity of the complex. Thus, an understanding of how the subtle 
changes in the structural feature of the complex affects the substitution reactivity at the 
Pt(II) centre is important. In the following chapters, the influence of some of these 
factors on the rate of substitution kinetics of square planar Pt(II) complexes will be 
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Mixed-metal Ruthenium(II)-Platinum(II) and Cobalt(II)-
Platinum(II) Complexes of Tetra-2-pyridyl-1,4-pyrazine 
Bridging Ligand. A Kinetic, Mechanistic and Computational 
Investigation 
3.0 Abstract 
The substitution kinetics of monometallic [Pt(tpy)Cl]Cl (Pttpy) and  mixed- metal 
Ru(II)-Pt(II) and Co(II)-Pt(II) complexes of the form [(tpy)Ru(tppz)PtCl](PF6)3 (RuPt), 
[ClPt(tppz)Ru(tppz)PtCl](PF6)4 (PtRuPt), [ClPtRu2(tppz)3PtCl](PF6)6 (PtRuRuPt) and 
[(tpy)Co(tppz)PtCl](PF6)3 (CoPt) ( where tpy = 2,2’:6’,2”-terpyridine and tppz = tetra-2-
pyridyl-1,4-pyrazine) with thiourea nucleophiles and ionic nucleophiles viz; thiourea 
(TU), 1-methythiourea (MTU), 1,3-dimethyl-2-thiourea (DMTU), 1,1,3,3-tetramethyl-2-
thiourea (TMTU) and an ionic nucleophile, iodide (Iˉ) and thiocynide (SCNˉ) were 
investigated under pseudo first-order conditions as a function of concentration and 
temperature by using UV/visible spectrophotometer and stopped-flow reaction 
analyzer. The reactions proceeded in two steps. The pseudo first-order rate constants, 
kobs(1st, 2nd) for the substitution of the chloride ligand(s) from the Pt(II) complexes and 
subsequent displacement of the octahedrally coordinated Co(II)/Ru(II) linker. 
Incorporation of Ru(tppz) increases the reactivity due to the increased overall charge 
of the molecule and π-back donation by the tppz ligand which increases the 
electrophilicity of the Pt(II) metal centre. The increase in the number of tppz ligands 
further stabilises the LUMO (π*). Presence of two Ru(II) metal centres increase the 
intermetallic electronic communication within the molecule. Changing the metal centre 
from Ru(II) to Co(II), decreases the reactivity due to the weaker π-back donation. In all 
cases, the reactivity decrease with increase in the steric hindrance of the nucleophiles. 
The dechelation process is enhanced by the ligand field strength imposed by the 
addition of thiourea nucleophiles at the Pt(II) metal centre. The observed relatively low 
enthalpy of activation, H  and the negative entropy of activation, S  support an 
associative mode of activation for the steps. The observed kinetic results were 
supported by density functional theory (DFT) studies. 
  





The success of cisplatin as an anticancer drug prompted interest in platinum based 
drugs.1 However, due to the drawbacks of cisplatin such as nephrotoxicity and 
neurotoxicity,2 limited water solubility3 and resistance in certain tumour cells,2e,4 
chemists were provoked to synthesize a variety of analogues, of which, only few have 
shown potential for clinical application.5 Thus, research has given a particular interest 
on development of effective anticancer agents with fine-tuned performance. In this 
regard, particular focus is given on the development of combination therapy, consisting 
of multiple bioactive sites6 and  structurally different complexes of cisplatin derivatives 
with altered pharmacokinetic and pharmacodynamic properties which can exhibit 
effective antitumour activity with less side effects and tumour resistance. As such, 
mixed-metal supramolecular7 complexes of transition metals such as ruthenium, cobalt 
and platinum complexes have provided fertile grounds in  modern chemistry due to 
their increased potency as anticancer agents.6,8 Today, a number of supramolecular 
systems with various applications are known. These complexes are expected to disclose 
improved new chemical, physiological and biological activities.7a,9 
 
Special attention has been given to such complexes possessing polypyridyl ligands.8c,10 
Polypyridyl ligands form stable complexes with transition metals of different oxidation 
states.11 Such polypyridyl complexes consisting of polyazine bridging ligands between 
the two metal centres have shown enhanced electrostatic interactions with target 
nucleophiles.8b,11-12 Focus is given to multinuclear polyazine complexes of ruthenium 
due to their rich photophysical, redox properties,6a,13 their metal to ligand charge 
transitions (MLCT)8a,14 and biological activities such as cleaving DNA in the presence of 
oxygen.15 These MLCT states undergo intermolecular electron transfers with easily 
tunable ground state and excited state redox properties.8a 
 
In multinuclear complexes, the design of bridging ligand is important given that 
electron transfer between the metal centres depend on the type and nature of the 
bridging ligand.8c,16 In this regard, the ligand, tetra-2-pyridyl-1,4-pyrazine (tppz), is one 
of the known polyazine bridging ligand which is capable of forming monomeric and 
back-to-back8b,17 polymeric transition metal complexes.11,14 Homo and heterodimetalic 
analogues of tppz with ruthenium,6a,8a,17-18 osmium,8a cobalt,19 palladium20 and 
platinum6a have been recently reported.6a,11,14,21  
 




Mixed-metal supramolecular bioactive complexes of ruthenium of the form 
[(tpy)RuCl(BL)PtCl2](PF6) and [(bpy)2Ru(dpp)PtCl2]2+ (BL = dpp, dpq (dpq = 3 bis-(2-
pyridyl)benzoquinoxaline), dpb (dpb = 2,3- bispyridyl)benzoquinoxaline) and (bpy ) 
2,2’-bipyridine)) coupled with a cis-Pt(II)Cl2 moiety via a  bridging ligand have been 
investigated recently6a,22 and the latter complex was found to photo-cleave DNA 
through ruthenium chromophore.9 Recently, Higgins et al.22b,23 reported DNA 
interaction with mixed-metal Ru(II)-Pt(II) complexes of the form 
[(Ph2phen)2Ru(BL)PtCl2]2+ where Ph2phen = 4,7-diphenyl-1,10-phenanthroline. These 
complexes were reported to modify DNA by a new mechanism of photobinding that 
involves metal to ligand charge transfer (MLCT) excitations using visible light.22b 
Furthermore, the spectroscopic properties of Ru(II) chromophore are imparted onto 
the Pt(II) bioactive site demonstrating the significance of supramolecular 
architecture22b thus, enhancing the antitumour activity of the complex. 
 
Another aspect of mixed-metal interest is complexes consisting of cobalt, due to its 
usefulness as bimetallic catalysis, 24 electrochemistry25 luminescent properties26  and 
interaction with biological systems.27 The biological role of cobalt has shown 
antitumour, antiproliferative,27b antimicrobial,28 antifungal,29 antiviral30 and 
antioxidant activities.27a Apart from direct covalent coordination with DNA, cobalt 
complexes show noncovalent bindings such as hydrogen bonding and electrostatic 
groove bindings. Additionally, coupled with planar aromatic ligands, cobalt complexes 
undergo intercalation with DNA.27a,31  
 
DNA intercalation and binding activity of Co(II) phenanthroline, terpyridine and 
dipyrido complexes have been reported.27a,31e-g The Co(II) complexes, 
[Co(abz)Cl2(H2O)]·3H2O where azb = albendazole reported by Lopez-Sandoval et al.27b 
showed stronger anticancer activity towards human cancer cell lines than cisplatin. 
However, there is no literature available on ligand substitution reactions of mixed-
metal Co(II) complexes32 with a few reported on cobalt by van Rudi and co- workers.33  
 
Recently, Ru(II)-Pt(II) mixed-metal complexes of [(tpy)Ru(tppz)PtCl](PF6)3 and 
[ClPt(tppz)Ru(tppz)PtCl](PF6)4 where a ruthenium light absorber is coupled with a 
platinum bioactive site through the bridging ligand tppz were synthesized by Zhao et 
al.6a The bioactive site, Pt(II) tpy moiety, in these complexes, has been reported  to 
intercalate with the DNA double strands,8b thus, labilizing the Pt―Cl bond.6a 
Modification of DNA by these complexes was found to be more intense than by the well-




known anticancer drug, cisplatin.8b The mode of interaction of the complexes with DNA 
was found to be different from cisplatin. Coupling with light absorbing ruthenium 
improves solubility due to the high overall charge. Furthermore, interaction of these 
complexes with DNA was found to exhibit strong charge transitions from Ru(II) to anti-
bonding orbitals (π*) of tppz  
 
Since these complexes are potential anticancer agents, understanding the mechanism 
of action of these complexes with human cells is important. Thus, this work reports for 
the first time the kinetic and mechanistic study of mixed-metal Ru(II)-Pt(II) and Co(II)-
Pt(II)  complexes of the form [(tpy)Ru(tppz)PtCl](PF6)3, [ClPt(tppz)Ru(tppz)PtCl](PF6)4  
[ClPtRu2(tppz)3PtCl](PF6)6 and [(tpy)Co(tppz)PtCl](PF6)3 with biorelavant thiourea 
nucleophiles viz; TU, MTU, DMTU, TMTU and ionic nucleophiles, Iˉ and SCNˉ. For 
comparisons, data from literature was used for the well-known Pt(II) complex, Pttpy.  
The two complexes,  [(tpy)Ru(tppz)PtCl](PF6)3 and [ClPt(tppz)Ru(tppz)PtCl](PF6)4 
were the first Ru(II)-Pt(II) rigid tridentate bridged mixed-metal complexes shown to 
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Scheme 3.1 Structural formulae of investigated complexes. The numbering schemes used for 











Potassium tetrachloroplatinate (K2PtCl4, 99.99%), ruthenium(III) chloride trihydrate 
(98%), 1,5-cyclooctadiene (99%) and silver tetrafluroborate (AgBF4, 98%) were 
purchased from Aldrich and stored in a dessicator prior to use. Methanol (Merck, South 
Africa) was distilled over magnesium34 prior to use in kinetic analysis. Ammonim 
hexafluorophosphate (98%) was purchased from Fluka. Acetonitrile (BDH, ≥ 99.5%), 
dimethylsulfoxide (99.9%) were purchased from Aldrich and used as supplied. The 
ligand, tetra-2-pyridyl-1,4-pyrazine (97%) was bought from Aldrich. All other 
chemicals were purchased from Sigma Aldrich and used as received. 
 
3.2.2 Characterizations and Instrumentations 
1H NMR were recorded on either a Bruker Avance 400 or 500 MHz spectrometer, at 
303 K using tetramethylsilane, Si(CH3)4 as the reference for the chemical shifts. 195Pt 
NMR were studied on a 500 MHz spectrometer (195Pt, 107.5 MHz) chemical shifts 
externally referenced to K2PtCl6. Both 1H and 195Pt NMR spectroscopy are useful 
techniques to determine the coordination behaviour of the metal centres since their 
chemical shifts are influenced by the coordinating atoms, solvent and the 
temperature.35 Mass spectra were obtained on a Hewlett Packard HP5988A GC-MS 
using electron impact (IE) negative ionisation mode. Elemental analyses were 
performed by a Thermal Scientific Flash 2000. Kinetic analyses were studied either on 
Varian Cary 100 Bio UV/visible spectrophotometer with an attached Varian Peltier 
temperature-controller an online kinetic applications or on an Applier Photophysics   
SX 20 stopped-flow reaction analyser coupled with an online data acquisition. The 
temperature of the instrument was controlled within ± 0.1 °C.  
 
3.2.3 Synthesis of Ruthenium Precursors and Intermediate Complexes 
The [Ru(tpy)CI3],36 precursor and the intermediate complexes, viz;  
[(tpy)Ru(tppz)](PF6)2,11  [Ru(tppz)2](PF6)2,11 and [Ru2(tppz)3](PF6)411 were 
synthesized according to the literature procedures. Details of experimental procedures 
are given under Supporting Information.  
 
The purity of the intermediate complexes was confirmed by using 1H NMR and mass 
spectroscopy. The mass spectra obtained for the all complexes show characteristic 
peaks due to different species. Due to the poor solubility37 and the paramagnetic 
nature, the Ru(tpy)Cl3 precursor was used as synthesized.36 





Yield: 191 mg, 433 mmol, (76%), brown precipitate. 
 
[(tpy)Ru(tppz)](PF6)2,11 Yield: 70 mg, (60%), brown powder 1HNMR(400 MHz, 
CH3CN) (ppm)‡: 8.77 (2H, ds, J = 8.5 Hz), 8.50 (1H, t), 8.54 (2H, s), 7.99 (2H, t, J =  8.05, 
7.63, 1.2 Hz), 7.25 (2H, t , J = 7.5, 6.0, 1.0 Hz),  7.58 (2H, t, J =  6.0, 1.0 Hz), 8.37 (2H, t, J = 
7.5, 1.8 Hz), 8.24 (2H, t, J = 8.0, 6.5, 1.7 Hz), 7.75 (2H, d, J = 7.8, 6.8, 1.7 Hz), 8.75 (2H, d, J 
=  5.0, 2.0 Hz), 7.55 (2H, t, J = 8.0, 6.0, 1.8 Hz), 7.61 (2H, t, J = 8.0, 6.0, 1.8 Hz), 7.15(2H, t, 
J = 7.8, 6.2, 1.5 Hz), 7.41 (2H, d, J = 5.4, 1.6 Hz). TOF MS-ES+, m/z: 361.5719 (M2+). 
 
[Ru(tppz)2](PF6)2,11 Yield: 98 mg, (39%), brown powder 1HNMR(400 MHz, CH3CN)
(ppm): 8.38 (4H, d, J = 8.0 Hz), 8.26 (4H, t, J = 8.3, 7.8, 1.4 Hz), 7.78 (4H, dd, J = 7.8, 2.1 
Hz) 8.77 (4H, d, J = 5.0 Hz), 7.64 (4H, d, J = 7.4 Hz), 7.66 (4H, d, J = 8.0 Hz), 7.22 (4H, dt, 
6.9, 6.3, 1.2 Hz), 7.67 (4H, d, 5.1 J = Hz). TOF MS-ES+, m/z: 439.0962, (M2+ + 1). 
 
[Ru2(tppz)3](PF6)4,11 Yield: 50 mg, (12%), dark purple powder 1HNMR(400 MHz, 
CH3CN) (ppm): 9.06 (4H, d, J = 8.7, 1.2 Hz), 8.78 (4H, d, J = 4.8 Hz), 8.54 (4H, d, J = 8.1 
Hz), 8.33 (4H, dt, J = 8.1, 7.5, 1.7 Hz), 8.03 (4H, br), 8.01 (4H, br), 7.84 (4H, br), 7.81 (4H, 
br), 7.77 (4H, dd, J = 7.5, 1,3 Hz), 7.73 (4H, br), 7.54 (4H, dt, J = 7.1, 7.0, 1.2 Hz), 7.31 
(4H, dt, J = 7.1, 6.7, 1.6 Hz). TOF MS-ES+, m/z: 342.0604, (M4+).    
 
3.2.4 Synthesis of Platinum(II) Complexes 
The Pt(II) complexes, [Pt(DMSO)2Cl2]38 and [Pt(tpy)Cl]Cl.H2O (Pttpy)39 were 
synthesized as in literature. The heterometallic complexes, [(tpy)Ru(tppz)PtCl](PF6)3 
(RuPt),8b and the analogous complex [(tpy)Ru(tppz)PtCl](PF6)3 (CoPt),8b 
[ClPt(tppz)Ru(tppz)PtCl](PF6)4 (PtRuPt),8b and 
[PtCl(tppz)Ru(tppz)Ru(tppz)PtCl](PF6)6 (PtRuRuPt) 8b were synthesized following the 
literature method reported by Zhao et al.8b Details of experimental procedures and 





                                                          
‡
 ppm, s = singlet,  quat = quaternary, m = multiplet, dd = doublet of doublet, dt = doublet of 
triplets 




The identity and the purity of the complexes were confirmed by using 1H NMR, 195Pt 
NMR, elemental analyses and mass spectroscopy. The 1H NMR spectra obtained show 
the symmetric nature of the heterometallic complexes. The 195Pt NMR of all the 
complexes exhibited a characteristic signal between -2500 to -2600 ppm which 
confirms the coordination of platinum to the Ru(II) moieties. Due to the high charge 
and complexity of the molecules, the mass spectra obtained show characteristic 
fragmentation of the molecules. 
 
[PtCl2(DMSO)2]38 
Yield: 1.25 g, 65%, fine yellow crystals. Anal. Calc. for C4H12Cl2O2PtS2: C 11.38, H 2.86. 
Found: C 11.67, H 3.10. 
 
[Pt(tpy)Cl]Cl·H2O (Pttpy)39 Yield: 0.64 g, 1.19 mmol (89%), Orange crystalline 
powder. Anal. Calc. for C15H13N3Cl2OPt: C 34.83, H 2.53, N 8.12. Found: C 34.92, H 2.98, N 
7.75. 
 
[(tpy)Ru(tppz)PtCl](PF6)3 (RuPt) The complex was synthesized by modification of 
the literature method reported by Zhao et al.8b To a refluxing solution of [Pt(DMSO)2Cl2] 
(80 mg, 0.38 mmol) in acetonitrile (10 mL), a solution of  [(tpy)Ru(tppz)](PF6)2 (48 mg, 
48 mmol) in acetonitrile (10 mL) was added drop wise under nitrogen. The reaction 
mixture was refluxed for 6 hours. After cooling to room temperature, the mixture was 
filtered and the filtrate was added to an aqueous solution of ammonium hexafluoro 
phosphate (50 mL, 3 M). The purple precipitate formed was vacuum filtered, washed 
with ethanol (5 mL), distilled water (20 mL) and copious amount of diethyl ether. Yield: 
50 mg, 36 mmol, (76%), very dark purple powder. 1HNMR(500 MHz, CH3CN) (ppm): 
9.45 (2H, dd, J = 5.6, 1.3 Hz), 8.89 (2H, d, J = 8.2 Hz), 8.87 (2H, d, J = 8.5, 1.0 Hz), 8.75 
(2H, d, J = 8.7, 1.1 Hz), 8.63 (1H, t, J = 16.7, 8.3 Hz), 8.56 (2H, d, J = 7.7 Hz), 8.45 (dt, 2H, J 
= 8.0, 7.8, 1.6 Hz), 8.12 (2H, dt, J = 6.9, 6.7, 1.2 Hz), 8.02 (2H, t, J = 8.0, 7.9, 1.4 Hz), 7.99 
(2H, t, J = 7.8, 6.3, 1.5 hz), 7.69 (2H, d, J = 6.3, 1.1 Hz), 7.49 (2H, d, J = 6.2, 1.0 Hz), 7.45 
(2H, d, J = 7.8, 6.8, 1.5 Hz), 7.18 (2H, t, J = 7.8, 6.3, 1.5 Hz), 195Pt NMR  (CH3CN) δ/ ppm: -
2593. TOF MS-ES+, m/z: 318.0260, (M3+). Anal. Calc. for C39H27ClF18N9P3PtRu·5H2O: C 








[ClPt(tppz)Ru(tppz)PtCl](PF6)4 (PtRuPt)8b This compound was synthesized by a 
similar approach as [(tpy)Ru(tppz)PtCl](PF6)3. Yield: 62 mg, 32 mmol (77%), very dark 
purple powder. 1HNMR (500 MHz, CH3CN) (ppm): 9.51 (4H, dd, J = 5.5 Hz), 8.91 (4H, 
d, J = 8.4 Hz), 8.77 (4H, d, J = 8.5, 1.0 Hz), 8.51 (4H, dt, J = 8.2, 7.9, 1.3 Hz), 8.19 (4H, dt, J 
= 6.6, 7.1, 1.0 Hz), 8.09 (4H, t, J = 8.1, 8.01.0 Hz), 7.89 (4H, br, ), 7.50 (4H, br), 195Pt NMR  
(CH3CN) δ/ ppm: -2568. TOF MS-ES+, m/z: calculated: 318.0258, experimental: 
318.0260 ± 0.6). Anal. Calc. for C48H32Cl2F24N12P4Pt2Ru·H2O: C 29.77, N 8.68, H 1.77. 
Found: C 29.35, N 8.28, H 2.24.   
 
[ClPt(tppz)Ru(tppz)Ru(tppz)PtCl](PF6)4 (PtRuRuPt)8b The compound was 
synthesized by using an approach similar to [ClPt(tppz)Ru(tppz)PtCl](PF6)4. Yield: 
0.0201 g, (75%), dark purple powder. 1H NMR (500 MHz, CH3CN), (ppm): 9.56 (4H, 
dd, J = 6.2, 1.1 Hz), 9.07 (4H, d, J = 8.0 Hz), 9.01 (4H, d, J = 8.0 Hz), 8.91 (4H, d, J = 7.9 
Hz), 8.55 (4H, dt, J = 8.2, 8.0, 1.3 Hz), 8.23 (4H, dt, J = 7.2, 7.0, 1.1 Hz), 8.17 (4H, br), 8.11 
(4H, br), 8.08 (4H, br), 7.97 (4H, d, J = 6.2 Hz), 7.64 (4H, t, J = 7.7.2, 7.0 Hz), 7.52 (4H, t, J 
= 7.8 Hz), 195Pt NMR  (CH3CN) δ/ ppm: -2574. TOF MS-ES+, m/z: 342.0879, (M6+ -6H, 
where one chloride ligand is substituted by a DMSO molecule). Anal. Calc. for 
C72H48Cl2F36N18P6Pt2Ru2·5H2O: C 31.01, N 9.08, H 2.10. Found: C 31.45, N 8.74, H 1.82. 
   
[(tpy)Co(tppz)PtCl](PF6)3 (CoPt)8b This complex was synthesized following the 
method used for [(tpy)Ru(tppz)PtCl](PF6)3. Yield: 20 mg, (58%), dark brown powder. 
TOF MS-ES+, m/z: 625.1257, (C34H23CoN8 species)+. Anal. Calc. for C39H27ClF18N9P3PtCo: 
C 34.80, N 9.37, H 2.02. Found: C 34.82, N 8.96, H 2.18. 
 
3.2.5 Preparation of Nucleophile Solutions for Kinetic Measurements 
The solutions of nucleophiles, viz. TU, MTU, DMTU, TMTU, Iˉ and SCNˉ were prepared by 
dissolving the required amount of the nucleophile in methanol solution of fixed ionic 
strength of 0.02 M (adjusted with LiCF3SO3 and LiCl) to afford a concentration of 
approximately equal to 50 times greater than that of the metal complex for mono 
chloro compounds and approximately 100 times greater for dichloro compounds. The 
other nucleophile solutions were prepared by subsequent dilutions of the same stock 
solution to afford a series of standards of 10, 20, 30 and 40 (for mono chloro 
compounds) or 20, 40, 60 and 80 (for dichloro compounds) times that of the platinum 
complex. The concentration of the nucleophiles were kept pseudo first-order conditions 
to push the substitution reactions to completion.40 
 




3.2.6 Kinetic Measurements 
To establish a wavelength to perform the kinetic measurements, the spectral changes 
resulting in from mixing the metal complexes with the ligand solutions were 
predetermined on a UV/visible spectrophotometer over the wavelength range of 200 – 
800 mn. The wavelengths are summarised in Table S3.1 (Supporting Information). The 
fast substitution reactions were studied on an Applied Photophysics SX 20 stopped-
flow system which is coupled with an online data acquisition system. The substitution 
kinetics of the slower reactions were purposely analysed on UV/visible 
spectrophotometer. A typical kinetic trace obtained from the stopped-flow 
spectrophotometry for the reaction of CoPt with TU at 298 K is shown in Figure 3.4 and 
Figure S3.1 (Supporting Information). Temperature dependence studies were 
performed within the range of 15 – 40 C. All data were mathematically analysed using 
Origin 7.5®.41 Representative graphs are given in Figures 3.5, 3.6, and Figure S3.2 to 
Figure S3.9.  
 
3.2.7 Computational Modelling 
Computational calculations for the complexes Pttpy, RuPt, PtRuPt, PtRuRuPt, and 
CoPt were performed in gas phase as cations for the chloro complexes, using the 
software package Spartan® ’04 for Windows®.42 using the B3LYP43, density functional 
method (DFT)44 and the LACVP+** (Los Alamos Core Valence Potentials)45 pseudo 
potential basis set. The LACVP basis set employs effective core potentials for K-Cu, Pb-
Ag, Cs-La and Hf-Au.46 Data obtained are summarized in Tables 3.1, 3.2 and Tables S3.2 














Table 3.1  Selected bond lengths (Å), bond angles (°), natural bond orbital (NBO) charges, 
HOMO and LUMO energies and other computational data obtained for the 
complexes Pttpy, RuPt, PtRuPt, PtRuRuPt and CoPt obtained from the 
computational studies. Data for Pttpy is included for reference. 
 Pttpy RuPt PtRuPt PtRuRuPt CoPt 
Bond lengths (Å)      
Pt―N (trans) 1.966 1.972 1.969 1.967 1.961 
Pt―Cl 2.347 2.320 2.313 2.303 2.317 
N―N(pyrzine)  2.657 2.646 2.662 2.660 
Ru―Pt  6.624 6.651 6.663  
Co―Pt     6.649 
Pt―Pt   13.30 24.61  
N-N(pyridine)  2.657 2.646  2.662 2.660 
Ru-N(pyrzine cis)  2.020  2.036  2.058 2.028 
Torsion Angles(°)      
C-C-C- C of tppz 
central/terminal  
 10.39 24.15 11.10 25.00 
N7C2C3N6(with Pt)  0.44 11.62 0.03 13.02 
NBO charges      
Pt1/2   1.227   1.255   1.266   1.283   1.263 
Ntrans -0.565 -0.567 -0.560 -0.565 -0.547 
Cl -0.637 -0.565 -0.541 -0.504 -0.562 
Ru/Co    0.997  0.989   1.000  1.319 
N1  -0.502      - -0.496 -0.546 
N2  -0.498      - -0.494 -0.546 
N3  -0.492      - -0.474 -0.533 
N4  -0.489 -0.496 -0.500 -0.547 
N5  -0.491 -0.495 -0.502 -0.547 
N9  -0.471 -0.474 -0.484 -0.554 
HOMO/eV -9.45 -13.22 -14.76 -16.76 -13.42 
LUMO/eV -6.16 -10.75 -12.52 -15.09 -10.81 
∆E/eV   3.29   2.47   2.24   1.67   2.61 
η/eV  1.65   1.24   1.12   0.84   1.31 
μ/eV -7.81 -11.99 -13.64 -15.93  -12.12 
ω/eV  18.46   57.92   83.06   150.96    56.02 
η = chemical hardness, μ = chemical potential and ω = global electrophilicity index.47 NBO = natural bond 
orbital.




Table 3.2 Density functional theoretical (DFT) calculated minimum energy structures, HOMO and LUMO frontier molecular orbitals for the complexes 
investigated. The planarity of the molecules is viewed along the propagation axis showing the different planes. 
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3.3 Results and Discussion 
3.3.1 Synthesis and Characterization 
In this study, one mono nuclear Pttpy and four heterometallic Ru(II)/Co(II)-Pt(II) 
complexes were synthesized. The data obtained is in good agreement with the 
literature8b and the chemical structures. Details of the characterisation are given under 
experimental section. Exemplary spectra are presented under Supporting Information 
(Figures S3.10 to S3.23). 
 
The Ru(III) metal centre gets reduced to Ru(II) during refluxing in ethanol water 
mixture. The paramagnetic nature of CoPt complex hindered the characterization using 
normal 1H NMR studies due to broadening of signals.8c Thus, the complex was 
characterized using micro analysis and mass spectroscopy. The novel heterometallic 
complex, PtRuRuPt was synthesized and characterized using 1H NMR, 195Pt NMR, mass 
spectroscopy and micro analysis. In the 1H NMR (Figures S3.12 and S3.15), only twelve 
signals were seen in the aromatic region, a clear indication that the complexes are 
symmetric. The 195Pt NMR for all the complexes appeared around -2500 to -2700 ppm, 
typical of NNN coordinated Pt(II) centre.48 For all the complexes, the mass spectra show 
great fragmentations. 
 
3.3.2 Computation Calculations 
 In order to understand the structural and electronic properties of the complexes 
studied, computational calculations were performed at density functional theory (DFT) 
level. The geometry at the Ru(II) centres is distorted octahedral6a,49 while the Pt(II) 
centres exhibit a distorted square planar, typical for Pt(II) centres.50,46 The capping tpy 
ligand in RuPt and CoPt is coordinated to the Ru(II) metal centre meridonally along the 
equatorial plane. This mer-tpy chelating ligand exerts steric repulsion from its 
extended electron cloud towards the coordinated tppz ligand maintaining some degree 
of stereogenic rigidity.  
 
The optimized geometrical structures show that in all the heterometallic complexes the 
Co/Ru―N pyrazine bond orients along the z axis51  and hence the Co/Ru―N pyrazine 
bond length is shorter than the Co/Ru―N pyridine which reflects the steric constrains 
due to the tridentate coordination and the strong back donation facilitated by the 
bridge-mediated intermetallic electronic interactions.17 The capping pyridine groups 
are tilted from the central pyrazine group as can be seen in Figure 3.1.17,51 The 
intermetallic Ru―Pt distances increases with increase in the number of tppz ligands in 




the complex suggesting that the rigid tppz ligand controls the steric influences of the 
complexes throughout the series.51 DFT calculations for paramagnetic CoPt were 












Figure 3.1 Optimized molecular structure of CoPt, showing the torsion angles of the pyridyl 
groups. 
 
The DFT calculated frontier orbitals show the electron density of highest occupied 
molecular orbital (HOMO) orbitals are predominantly located on the Pt(II) and the 
chloride ligands while the lowest unoccupied molecular orbital (LUMO) electron 
density predominantly lies on the bridging tppz ligand, an indication of the 
contribution from the metal centres due the strong π-accepting ability53 which 
develops a high density condition in both the unoccupied and occupied orbitals,18a and 
hence the ΔE(gap) decreases with the number of tppz units.  
  
3.3.3 Kinetic Analyses 
The substitution reactions of the heterometallic complexes with thiourea nucleophiles 
viz; TU, MTU, DMTU, TMTU and ionic nucleophiles, Iˉ and SCNˉ were carried out in 
methanol. Representative data are given in Table 3.3 and Table S3.4 to Table S3.20 
(Supporting Information).The substitution reactions occurred via two separated steps 
i.e. substitution of the coordinated chloride ligand(s) followed by the release of the 




coordinated linker as comprehended from NMR study (Figures 3.2, 3.4, S3.24 and 
S3.25).  
 
This conclusion was drawn after monitoring the reaction between PtRuPt with TU (6 
eqv) and RuPt with TU (3 equivalence, eqv) as a nucleophile by 1H NMR and 195Pt NMR 
spectroscopy in acetonitrile. To rule out solvolysis, a freshly prepared solution of 
PtRuPt in acetonitrile (0.02 mM) was monitored under UV/visible spectrophometer 
over 12 hours and change in absorbance was observed (Figure S3.26). Arrays of the 1H 
NMR and 195Pt NMR spectra recorded for PtRuPt with 6 eqv of TU and RuPt with 3 eqv 
TU are given in Figures 3.2 and 3.3 respectively. Representative 195Pt NMR spectra for 
PtRuPt with TU (6 eqv) is depicted in Figure S3.25. As seen in Figure 3.2 a new set of 1H 
NMR signals, slightly upfield were observed after mixing PtRuPt with TU. The intensity 
of the distinctive signals of the coordinated complex, 6D (9.52 ppm) and 5C (7.49 ppm) 
decreased during the reaction. The two signals nearly disappeared after 240 minutes of 
the reaction and new signals at 8.78 ppm (doublet) and 7.23 ppm (triplet) were well 
formed. The spectrum obtained after twelve hours with 6 equivalence of TU produced a 
spectrum same as that of the linking Ru(II) complex, (Ru(tppz)2), indicating complete 
dechelation of the terminal Pt(II) centre. Furthermore, the 1H NMR spectrum obtained 
after 48 hours is similar to the spectrum obtained after twelve hours, hence re-
chelation of the (Ru(tppz)2) ligand with platinum is ruled out. Since the first step of the 
reaction is fast and takes less than 5 seconds to complete, this substitution step cannot 
be followed by the NMR technique.50 Thus, it can be concluded that the subsequent 
changes with the addition of TU in the spectra are due to the dechelation of the 











Figure 3.2 1H NMR spectra of PtRuPt (6.48 mM) with TU in acetonitrile at 298 K showing the 
dechelation of the coordinated platinum complex to form the (Ru(tppz)2) unit. 
The spetra also indicates the formation of other intermediate products, in which 
some of their chemical shifts merges making it difficult to assign them exactly. 
The numbering system used to monitor the reaction progress is shown on the 
structure of PtRuPt (inset). 
 
This was further confirmed by the 195Pt NMR spectra obtained for RuPt and PtRuPt 
(Figures 3.3, S3.24 and S3.25) after addition of 3 and 6 equivalence of TU respectively. 
By looking at Figure 3.3, at t = 0, the signal due to starting complex, RuPt, was observed 
at -2590 ppm. To elucidate the substitution reaction pathway with the nucleophiles, we 
first added two equivalence (eqv) of TU. The 195Pt NMR obtained after this addition 
shows complete disappearance of PtN3Cl signal at -2590 ppm. The 1H NMR and 195Pt 
NMR spectra show the formation of intermediate species. After 6 hours, two species, 
labelled as B (-3410 ppm) and C (-3950 ppm) are formed which is typical of PtN2S2 and 
Pt(TU)4]2+54 respectively.35a,48b,54 After 12 hours, there exists uncoordinated ligand in 
solution as indicated by a strong doublet at 8.77 ppm (6C, Figure 3.2). Furthermore, the 
singlet at -3950 ppm due to the Pt(TU)4 as the end product when the linking Ru(II) 
complex is released by TU, support the observed substitution kinetics. Additionally, 
when RuPt and PtRuPt were reacted with a large excess of TU (10 eqv) and (6 eqv) 
respectively, the 195Pt NMR spectra obtained for RuPt after 4 - 6 hours (Figure S3.24) 
7.07.58.08.59.09.5 ppm
complex t = 0
t = 120 mins





















































and the 195Pt NMR spectra obtained for PtRuPt after 10 - 30 hours (Figure S3.25) shows 
no peak corresponding to any intermediate products. In both the cases only one peak 
corresponding to the final product, [Pt(TU)4]2+ at around -4000 ppm was observed. 
This indicates that under pseudo first-order conditions the dechelation step is not 
stepwise and hence occurs simultaneously releasing the terminal Pt(II) centre, further 




Figure 3.3 195Pt NMR spectra for the reaction of RuPt (6.28 mM) with TU, showing the 
changes in the chemical shift of the Pt before adding the TU nucleophile and the 
degradation after addition of TU for the new complex [Pt(TU)4]2+.  
 
Based on NMR studies one can infer that the coordination of strong thiourea 
nucleophiles at terminal Pt(II) centre enhances simultaneous dissociation of the linker. 
Dechelation is in accord with recent reports by Jaganyi et al.35a,50 for substitution 
reactions of thiourea with Pt(II) dinuclear complexes bridged by rigid pyrazine and 
flexible diammine linkers and van Eldik and co-workers48b,50 for ring opening of bis-(2-
pyridylmethyl)amine chelate groups by strong labilizing thiourea nucleophiles. It is 
also noted that in this study dechelation of terpyridine type chelated Pt(II) complexes is 
observed for the first time. Noteworthy here is that for the weaker ionic nucleophiles, Iˉ 
and SCNˉ, only one step taken as the substitution of the chloride ligand was observed.  
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If all the facts are put together, it clearly shows that the substitution of the chloride 
ligand(s) occurred simultaneously from the diPt(II) complexes irrespective of the 
number of metal centres or the number of linking tppz groups. The second step is 
due to the displacement of the ligand35a caused by labilizing thiourea nucleophiles. 
Further support for this comes from the second substitution step, which occurs at least 
2400 times slower compared to the first step in RuPt, PtRuPt and PtRuRuPt while it is 
1400 times slower in CoPt. Thus, the rate of dechelation depends on the type of metal 
centres and irrespective of the electronic properties of the linker, ring opening is 
pervasive for Pt(NNN) coordinated complexes with strong labilizing thiourea 
nucleophiles.50 Hence, the overall substitution reaction can be represented by the 
mechanism given in Scheme 3.2.  
 
Cl Pt1 L1 L2 L3 Pt2M1 M2 Cl
Nu Pt1 L1 L2 L3 Pt2M1 M2 Nu









M1 = Ru(II) in RuPt, PtRuPt and PtRuRuPt, Co in CoPt
M2 = Ru(II) in PtRuRuPt
L2 = tpy in RuPt and CoPt, tppz in PtRuPt and 
L3 = tppz in PtRuRuPt
L1 = tpt in Pttpy, tppz  in  RuPt, PtRuPt, PtRuRuPt  








Scheme 3.2 Proposed reaction mechanism for the reactions between the complexes, RuPt, 
PtRuPt, PtRuRuPt and CoPt with thiourea nucleophiles. The full reaction 
mechanism holds for RuPt, PtRuPt, PtRuRuPt and CoPt with thiourea nucleophiles 
only. For the ionic nucleophiles studied, Iˉ and SCNˉ, the reaction mechanism holds 
only for the first step. The charges on the complexes are omitted for clarity. 
 
In all cases, the first step was fast and was studied on stopped-flow method while the 
subsequent slower step was studied by UV/visible spectrophotometer. An example of 
the combined time resolved kinetic trace obtained from the stopped-flow 
spectrophotometer showing the two substitution steps recorded at 298 K and 382 nm 
using RuPt (2.00 x 10-5 M) with TU (6.00 x 10-4 M) is given in Figure 3. 4. Included in 
this Figure is a typical kinetic trace obtained from a UV/visible spectrophotometer for 
the reaction between RuPt (2.00 x 10-5 M) with TU (6.00 x 10-4 M) for the second step 
in methanol solution (I = 0.02 M) at 330 nm at 298 K. Even though, stopped-flow 




analyzer could also be used to study the slower second step, the reaction was slow 
enough to be analyzed using UV/visible spectrophotometer, and hence, the kinetics of 
this step was followed under UV/visible spectrophotometer. 
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Figure 3.4 (a) Typical two well-resolved kinetic traces at 382 nm for the two-steps reaction 
between RuPt (2.0 x 10-5 M) by TU (6.00 x 10-4 M) followed on stopped-flow 
spectrophotometer at 298 K. (b) A typical plot showing the changes in absorbance 
between 250 – 750 nm wavelength range for the degradation of the chelate ligand 
in RuPt (2.00 x 10 -5 M) by TU (6.00 x 10-4 M) at 298 K. Inset is the kinetic trace 
followed at 382 nm.  I = 0.02 M (adjusted with LiCF3SO3 and LiCl). 
 
λ = 382 nm 




Both substitution steps fitted well to a single exponential model to obtain the observed 
first-order rate constant, kobs(1 st/2nd). The observed pseudo first-order rate constants    
kobs(1st) and kobs(2nd) were plotted against the concentration of the nucleophiles. Absence 
of non-zero intercepts indicated that the reactions were irreversible in nature and that 
they do not follow the solvotic pathway and hence, the rate law can be written as 
shown in Equation 3.1.55 The second-order rate constants, k2(1st/2nd) were obtained from 
the slopes of the plots. Representative plots for PtRuPt are shown in Figure 3.5. The 
data obtained is summarized in Table 3.3. Included in Table 3.3 is the literature kinetic 
data for Pttpy56 for comparison purposes except Pttpy with MTU which is new data.  
                                            ][)2/1(2)2/(1 Nukk ndstndstobs                                                (3.1) 
where k2 is the second-order rate constant for the forward reaction. 
  
























































Figure 3.5 Dependence of the pseudo first-order rate constants (kobs) on the concentrations 
of the nucleophiles (a) for the simultaneous displacement of chloride ligands in  
kobs.(1st), s-1, (b) for the dechelation of the ligands in kobs.(2nd), s-1,  from PtRuPt in 
methanol solution at 298 K and I = 0.02 M (adjusted with LiCF3SO3 and LiCl). 
 




The temperature dependence studies were performed between 15 - 40 °C in 5 °C 
intervals. Activation parameters, entropy of activation ( S ) and enthalpy of 
activation ( H ) for both the substitution of the chloride ligand and the subsequent 
dechelation step were calculated from the slopes and the intercepts of the Eyring 
plots.55 Representative plots are presented in Figure 3.6 and respective activation 
parameters are in Table 3.3. 
  



















































Figure 3.6 Eyring plots obtained for (a) RuPt with the nucleophiles for the substitution of 
chloride ligand, (b) Plots of ln(k-2/T) against 1/T for the reactions of  RuPt with 
the nucleophiles for the dechelation of the linker at various temperatures in the 
range 15 - 35 °C. 
  




Table 3.3  Summary of the rate constants and activation parameters for the displacement of the 
chloride ligand(s) by the nucleophiles studied and the kinetic data for the dechelation 
of the tppz units by thiourea nucleophiles. Data for Pttpy except with MTU is obtained 
from references56 and is included for comparisons. 
Complex Nu Second-order rate 
constant/ M-1 s-1 
Enthalpy of activation 
/ kJ mol-1 
Entropy of activation 
/ J K-1 mol-1 
k2 /1st k2 /2nd ∆H1≠ ∆H2≠ ∆S1≠ ∆S2≠ 
Pttpy TU 1494 ± 10          29 ± 2      -88 ± 5  
MTU  1306 ± 19       38 ± 0. 3    -68 ± 0.9  
DMTU     448 ± 10  36 ± 1       -73 ± 4  
TMTU     82 ± 4  35 ± 2       -91 ± 8  
Iˉ    243 ± 4  47 ± 3       -42 ± 11  
SCNˉ        17 ± 0.2  48 ± 2       -61 ± 1  
RuPt TU    8921 ± 100 3.0 ± 0.03 27 ± 2   43 ± 1    -78  ± 6     -93 ± 3 
MTU     8359 ± 155 2.5 ± 0.06 32 ± 3  56  ± 1       -61 ± 9  -50 ± 4 
DMTU    5395 ± 113 1.4 ± 0.04 38 ± 2  58  ± 3     -46 ± 6  -47 ± 9  
TMTU  288 ± 2     17 ± 0.6    -146 ± 2  
Iˉ   5443 ± 73         34 ±1   -60 ± 3  
SCNˉ  4334 ± 78         38 ± 1   -49 ± 3  
PtRuPt TU   9141 ± 260 3.7 ± 0.06        46 ± 0.4   35 ± 1 -17± 1  -118 ± 2  
MTU    8630 ± 157 2.1  ± 0.06    40 ± 0.2   41 ± 1   -34  ± 0.7 -101 ± 3 
DMTU     5684 ± 89 1.9 ± 0.05        41 ± 2  46  ± 2      -37 ± 7    -85 ± 7  
TMTU     690 ± 12         51 ± 3       -20 ± 9   
Iˉ       5541 ± 73        32  ± 2      -67 ± 6   
SCNˉ      4405 ± 92    45 ± 0.3    -35  ± 0.9   
PtRuRuPt TU  10035± 100 3.2  ± 0.08        33 ± 2   36 ± 2     -57  ± 6   -115 ± 8 
MTU     8860 ± 198 2.8  ± 0.06 45 ± 2    32 ± 2      -18 ± 7  -128  ± 7 
DMTU  6659 ± 139 1.5 ± 0.02 39 ± 2    45 ± 2 -41 ± 7     - 93 ± 5 
TMTU    4159 ± 72  52 ± 3       -7  ± 11   
Iˉ      6962 ± 74     22 ± 0.4   -96 ± 1   
SCNˉ     4536 ± 75         28 ± 1  -87 ± 3  
CoPt TU    2090 ± 31   1.5  ±  0.02 37 ± 1    37 ± 2 -56 ± 4 -118 ± 5 
MTU     2043 ± 38 1.4  ± 0.02 45 ± 2   38 ± 3 -33 ± 6  -116 ± 8 
DMTU     1707 ± 7 0.5 ± 0.01 47 ± 3    53 ± 2      -27 ± 9    -74 ± 7 
TMTU   989 ± 16         46 ± 2  -33 ± 6   
Iˉ      1813 ± 39  49 ± 4   -38 ± 7   
SCNˉ      994  ± 16   45 ± 2  -19 ± 2  




Data in Table 3.3 show the results obtained for the displacement of the chloro ligand(s) 
for the complexes and subsequent dechelation of the coordinated ligand. By using 
Pttpy’s rate constant as a standard value, the ratio of the rate of substitution of chloride 
ligand(s) by TU is 1 : 6.0 : 6.1 : 6.7 : 1.4 respectively for Pttpy : RuPt : PtRuPt : 
PtRuRuPt : CoPt. Thus, the order of reactivity of displacement of chloride ligand(s) by 
the nucleophiles studied follows the order PtRuRuPt > PtRuPt > RuPt > CoPt > Pttpy. 
The difference in reactivity can be attributed to the electronic effects of the linking 
complex unit(s) and the number and type of metal centres.  
 
The reactivity increases at least six folds from Pttpy to RuPt, by incorporation of the 
Ru(tppz) moiety. This could be attributed to the increased π-back donation along with 
the increased overall charge of the complex48b,57 and hence the electrophilicity of the 
Pt(II) centre56a,58 as supported by the DFT calculated higher NBO charge on the Pt(II) 
centre of RuPt (1.255) to that of Pttpy (1.227). The back donation from the tppz ligand 
is greater than the tpy ligand which makes the Pt(II) centre in RuPt more electrophilic 
than that of Pttpy. The crystal structure reported59 for Cu(tppz)(SCN)2 shows that the 
dihedral angles between the pyridyl rings are fairly small. Thus, supports the greater π-
back donation in RuPt due to its extended π conjugation. Since in a chemical reaction, 
the interactions occur only between the frontier molecular orbitals,60 the considerable 
decrease in the LUMO energy of RuPt along with the decrease in the frontier orbital 
gap makes it easier for the transfer of electrons into the anti-bonding π* LUMO orbital, 
thereby stabilizing the transition state. This destabilizes the ground state of RuPt as 
supported by the smaller chemical hardness, η (= (εLUMO - εHOMO)/2)47a value of RuPt. As 
expected, this significantly increases the global electrophilicity index, ω (= µ2/2η)47b,c 
obtained for RuPt and hence, the reactivity of RuPt is remarkably higher than that of 
Pttpy. 
  
Similarly, when compared the reactivity of Pttpy with CoPt, the increase is only by 1.4 
times. This increase in reactivity of CoPt can be attributed to the increase in the overall 
charge48b,58 along with the increased electrophilicity of the Pt(II) metal centre57a,59 due 
to the π-back donation from the tppz ligand. As expected, this decreases the anti-
bonding π* LUMO energy level and thus, the chemical hardness of CoPt. However, the 
increased overall charge from Pttpy to CoPt (from +1 to +3) and the increased global 
electrophilicity index of CoPt (56.02 eV), despite significant, do not reflect on the 
observed reactivity for CoPt to that of Pttpy as in the case of RuPt. Therefore, the 








By keeping the overall charge and the ligand system constant, when the metal centre is 
changed from Ru(II) (RuPt) to a Co(II) (CoPt), the substitution rates of displacement of 
chloride ligand decreases by more than 4 times while the dechelation was 2 times 
slower. A glance at the Ntrans atom to Pt(II) centre (N8), one notices that the nitrogen 
atom in RuPt (-0.567) is more negative than that of CoPt (-0.547). However, the NBO 
charges on the N atoms around Ru(II) metal centre are less negative in RuPt (Table 3.1) 
than that of the corresponding N atoms around Co(II) in CoPt. Conversely, the NBO 
charge on the Ru(II) metal centre of RuPt (0.997) is less positive compared to the 
Co(II) centre (1.319). This difference in the DFT calculated NBO charges indicate that 
Ru(II) enhances π-back donation in RuPt by accommodating the electron density at the 
Ru(II) metal centre, while in CoPt, the Co(II) metal centre donates the electron density 
into the capped tpy ligand and the linking tppz ligand as can be seen from the NBO 
charges on the N atoms. Thus, replacing the Ru(II) metal centre for a Co(II) changes the 
electron accepting property of the ligand system. Further support is the electron donor 
property of Co(bpy)32+ reported by Song et al.61 based on photophysical investigations 
performed on ruthenium and cobalt heterometallic complexes. This electron donation 
lowers the π-acceptability of the tppz ligand in CoPt as supported by the smaller NBO 
charge on the N8. Furthermore, the tilt angle, C C C C (Figure 3.1), in CoPt is 25.00 ° 
while it is 10.39 ° in RuPt. This tilt angle between the subunits of the bridging linker is 
critical for aromatic linkers containing π systems.62 This may have significant 
influences on the degree of metal-metal interactions.62a  
 
The weaker π-back donation in CoPt is also supported by the nearly absent 
(Co(dπ)→tppz(π*)) transitions at 500 to 590 nm as reported for Co(II)(tpy)2 complex63 
and the observed weaker (Pt(dπ)→tppz(π*)64 between 370 to 400 nm (Figure 3.7a) 
indicating the weak π-back donation and metal-metal electronic transitions.62a This is 
further backed by the DFT calculated smaller HOMO-LUMO energy gap. The slightly 
higher HOMO-LUMO gap in CoPt indicates that the compound is thermodynamically 
more stable65 and is supported by the calculated greater chemical hardness value47b for 
CoPt, which is an indication of its ground state stability to that of RuPt. Additionally, 
the higher electrongetivity of Ru (2.2 eV)66 compared to Co (1.9 eV)66 along with the 




global electrophilicity index, ω of RuPt, despite small, indicates the greater propensity 
of the molecule to accept electrons from the incoming nucleophiles.47c,d  
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Figure 3.7 (a) UV/visible spectra of Pttpy, RuPt, PtRuPt, PtRuRuPt and CoPt in methanol 
(0.01 mM). (b) Energy of highest absorption wavelength peak of band against the 
number of tppz units in the complexes. CoPt deviates from the straight line. 





The difference in reactivity might also be due to the spacial arrangement of the tppz 
ligand in both the complexes as can be seen from the DFT calculated minimum energy 
structures (See Table 3.2) which may influence the electronic properties of π* orbitals 
of the bridging tppz ligand.11 Since cobalt is a first row transition metal, the radial 
extension of its 3d orbital is smaller than 4d orbital in ruthenium. Thus, the π→π* 
transitions are stronger for 4d because of its stronger orbital diffuse compared to a 3d 
which is reflected on the observed much smaller absorption coefficient for CoPt       
(ɛ557 = 4769 M-1 cm-1, Figure S3.25) compared to its analogous complex, RuPt. This 
might be the controlling factor for the observed slower reactivity of CoPt to that of 
RuPt. 
 
Furthermore, to understand the spacial conjugation in the π-conjugated systems, we 
determined the effective conjugation length (ECL),51,67 reported by Osuka et al.68 Thus, a 
plot of absorption maxima, (∆Emax) (Equation 3.2)69 obtained from the UV/visible 
spectra (Figure 3.7a) against the number of tppz units (Figure 3.7b),51,70 the resultant 
slope indicates the extent of delocalization,18a which is observed to be greater for RuPt 
than that of CoPt with the other complexes, further supporting the greater π-
conjugation in RuPt (also see Figures S3.27 to S3.29).69a,18a,71 
 
                         
hc
Emax                                                                               (3.2) 
where h = is planks constant, c is the speed of light.  
 
The reactivity of a metal complex is influenced by the number of valence electronic 
configuration of the metal. In d7octahedral symmetry, the Co(II) coordinated system, 
even though it enormously favours high spin (HS) state,52,72 might undergo spin-
crossover transitions between low spin  and high spin  state.52,73 
These transitions between the two states can significantly affect the thermodynamic 
and the kinetic processes of the complex.52,61 The electron transfer from a nonbonding 
t2g to anti-bonding eg orbitals might result in concurrent loss of π-backbonding in 
CoPt,73a as a consequence affects the ligand field strength which in turn impacts on the 
strength of MLCT charge transfer transitions as can be seen in Figure 3.7a and from the 
DFT calculated NBO charges. For high spin state Co(II) complexes, the metal-ligand 
bond length is longer and hence the longer bond length does not allow a better 
overlapping of the orbitals.73a Moreover, the octahedral d7 Co(II) undergoes distinct 




Jahn-Teller distortions,63,74 which might result in a large first-order splitting of the  
level73a that can change the electronic property of the bridging ligand system, hence 
influence the reactivity of Pt(II) centre. This is accounted for by the slightly bigger 
HOMO-LUMO gap for CoPt (2.61 eV) compared to RuPt (2.47 eV).  
 
When a second platinum centre is introduced, the results obtained show a slight 
increase in lability of the chloride ligands in PtRuPt compared to RuPt when two tppz 
ligands are orthogonally bonded to the Ru(II) metal centre. The slightly higher 
reactivity of PtRuPt can be ascribed to the increased cationic charge and the higher π-
backbonding from the two tppz ligands in PtRuPt6a thereby decreasing the LUMO, π* 
energy (Table 3.1), resulting in a more electrophilic metal centre in PtRuPt as can be 
seen from the DFT calculated greater NBO charge on the Pt(II) metal centre. 
Consequently, the positive charge on the Ru(II) centre in PtRuPt decreases slightly. 
This observation is in line with the observed smaller HOMO-LUMO gap obtained for 
PtRuPt and is supported by the less negative tppz based reduction (tppz0/− couple)  for 
RuPt (-0.16 V) than PtRuPt (-0.03 V), reported by Zhao et al.8b This was explained as a 
result of the extra stability gained by the π* orbitals of tppz, by increasing the π-
accepting ability and the intermetal electronic transitions via electron exchange 
pathway within the complex,8b,17,51,75 on increasing the number of tppz ligands. This 
intermetal communications take place among the contiguous metal centres since the 
bridging tppz ligands are orthogonal to each other as a result of the octahedral 
geometry imposed by the Ru(II) metal centre.51 Coordination of this ligand to the Pt(II) 
metal centres76 pulls the electron density from the Pt(II) metal centres whereby making 
them more electrophilic. This makes the ground state PtRuPt complex more unstable 
as can be seen from the smaller chemical harness value of PtRuPt and hence, more 
reactive.47d This explanation is in line with the observed kinetic behaviour. A similar 
behaviour in reactivity was reported for the two complexes when incubated with DNA 
on agarose gel, where modification of DNA structures was higher for PtRuPt than that 
of RuPt.6a  
 
By keeping in mind that increasing the number of tppz ligands in the complex enhances 
the π-accepting ability, a second Ru(II) and a tppz ligand was then introduced into 
PtRuPt. As expected, this has increased the overall π-backbonding (Figure 3.7b) at the 
Pt(II) metal centre and the intermetallic communication within the molecule53a,77 as can 
be seen from the very low LUMO energy level of PtRuRuPt, enhancing the transfer of 
electrons from the 18 electron five coordinate intermediate, hence the DFT calculated 




positive NBO charge on the Pt(II) centre of PtRuRuPt increases. This is further 
supported by the DFT calculated smallest ∆Egap in PtRuRuPt as a result of the                
π-backbonding interactions between the t2g orbitals of the two Ru(II) centres and the p 
orbitals of the nitrogen atoms of pyrazine in the central tppz ligand which increases the 
stability of the tppz based (π*) LUMO electrons51 and decreases the stability of the 
Ru(dπ) HOMO electrons11,18a and is well supported by the very small chemical hardness 
value78 of PtRuRuPt. The destabilization of the HOMO electrons arises due to the 
repulsion between the charges among the metal centres51,79 together with the π−π* 
ligand transitions  move to lower energy levels because the anti-bonding π* orbitals of 
the bridging tppz ligand51  which gets stabilized on adding the second Ru(II) metal 
centre.18a Thus, the lower ΔE(gap) is due to the intermetal communication between 
Ru1 Ru2 in PtRuRuPt through the central tppz ligand51 which stabilizes the LUMO 
orbital18a as supported by Arana et al.11 for the two electron reduction observed      
(+1.53 V and +0.99 V) for [Ru2(tppz)3]4+ synthon, despite its symmetrical structure. 
Thus, this intermetal electronic communication between Ru1 Ru2 metals ions might 
be the main reason for the slightly higher reactivity of PtRuRuPt compared to RuPt 
and PtRuPt.  
 
If one considers the two diPt(II) complexes, PtRuPt and PtRuRuPt, it is noticeable that 
due to the orthogonal geometry at the Ru(II) metal centres, orbital overlapping 
between the tppz ligands is absent. Due to this geometry along with the symmetrical 
nature of the two complexes, the two Pt(II) centres are kinetically indistinguishable and 
hence, react independently. As a result, the two Pt(II) metal centres cannot be 
discriminated by the incoming nucleophile which results in a simultaneous 
displacement of the chloride ligands80 as reported previously for dinuclear Pt(II) 
complexes.81,82 If there was any orbital overlapping between the tppz ligands, one 
would expect a considerable increase in the reactivity as anticipated from the 
significant change in the DFT calculated global electrophilicity index, ω, on moving 
from RuPt to PtRuPt to PtRuRuPt. However, the increased global electrophilicity 
index is as a result of the increased aromatic systems in the complexes. In each 
complex, the electronic environment around the reactive Pt(II) metal centre varies only 
slightly and hence their substitution reactivity. The slight differences in reactivity 
observed is due to the increased intermetal communication on increasing the number 
of metal centres and the improved π-acceptor effect facilitated by the tppz ligands 
which stabilises the energy of anti-bonding LUMO orbitals as explained earlier.51  
 





The reaction rates for the second step are much slower by a factor of at least 2400 for 
RuPt, PtRuPt and PtRuRuPt while it is about 1400 times slower for CoPt. Binding the 
nucleophile to the Pt(II) centre increases the steric effect on the Pt(II) centre.35a This in 
turn blocks the approach of the nucleophile from above and below the Pt(II) centre, 
hence, the observed second step is slower.35a Furthermore, the results show that the 
rate of dissociation of the chelate ligand is less sensitive to the structural and electronic 
nature of the chelate ligand moiety as previously reported by Jaganyi et al.35a,83 and van 
Eldik et al.48b and explained this dechelation arising most likely due to the increased 
constraints perched on the incoming nucleophiles as the Pt(II) centre in the transition 
state is already hindered.48b,83-84 Once strong donor thiourea coordinates the Pt(II) 
centre, the electronegativity of the metal centre increases thereby enhancing the direct 
attack of the incoming nucleophile.85 This weakens the Pt―Ntppz bonds, thereby 
enhancing further substitution of thiourea ligands, resulting in the simultaneous 
release of the linker and formation of [Pt(TU)4]2+ in the case of TU.35a Furthermore, the 
increased steric distortions, along with the higher ligand field strength around the 
Pt(II) centre enhances the dechelation process as thiourea attacks to an already 
thiourea substituted Pt(II) centre.35a Dechelation of the coordinated ligands from 
square planar transition metal complexes such as  Pt(II),86  Au(III)84,87 and 
Pt(II)35a,40b,83,88 metal centres by sulphur donor have been reported previously. Pt(II) 
being a soft metal centre has more tendency to form bonds with sulphur donour than 
hard nitrogen donor atoms83 in the tppz ligand.  
 
In all cases, the substitution reactivity of the chloride(s) by the ionic nucleophiles was 
less than the strong donor TU and MTU. The reactivity of Iˉ was comparable to DMTU. 
The reactivity with the ionic nucleophiles were greater for Iˉ than SCNˉ  due to the 
higher polarisability of the Iˉ along with its  stronger electrostatic attraction towards 
the softer cationic Pt(II) metal centre.39  
 
In terms of steric effects, the complexes investigated are sensitive towards the steric 
hindrance of the incoming nucleophiles studied where the fastest rate of chloride 
substitution was observed for TU in all cases. Thus, the reactivity of the nucleophiles 
followed the order, TU > MTU > DMTU, Iˉ > SCNˉ > TMTU. For all the complexes studied, 
TMTU was the slowest due to the presence of methyl groups which hinder the 
approach of the nucleophile thereby decreasing its reactivity.40b,56a,83,88-89   
 




The results obtained for enthalpy for activation ( H ) and entropy of activation            
( S ) support an associative mode of activation typical for square planar Pt(II) 
complexes as a result of bond formation in the transition state.80,89a,90 Some of the 
activation entropies for the first step are small and negative. This may be because the 
substitution steps are accompanied by charge neutralization by the solvent molecules. 
The release of the electrostatically attracted solvent molecules results in an increase in 
entropy and counterweigh the negative intrinsic contributions due to the bond 




Incorporation of Ru(tppz) in RuPt increases the reactivity almost six times compared 
to the monometallic Pttpy. The significant increase in reactivity is ascribed mainly to 
the increased π-back donation from the tppz ligand which increases the electrophilicity 
of the metal centre,56a,58a,58c,91 along with the increased overall charge and the global 
electrophilicity index of the complex. On adding the second tppz ligand further 
stabilises the LUMO (π*) thereby enhancing π-back donation of the molecule. The 
intermetal communication between the two Ru(II) metal centres via the bridging tppz 
linker even stabilises the LUMO orbitals. Thus, the overall reactivity is driven by the 
increased π-backbonding and the overall electrophilicity of the molecules along with 
the decrease in the HOMO-LUMO gap obtained on adding more metal centres and tppz 
ligands to the complex. Thus, the reactivity followed the order PtRuRuPt > PtRuPt > 
RuPt > CoPt > Pttpy.  
 
Changing the metal centre from Ru(II) to Co(II) decreases the substitution reactivity of 
CoPt by four times that of RuPt. UV/visible spectrophotometric analysis along with the 
DFT calculations show that for CoPt electronic transitions from (Pt(dπ)→tppz(π*)) are 
very weak which is an indication of weak π-backbonding from the Pt(II) d orbitals to 
the tppz ligand. Based on the facts discussed, we conclude that the Ru(II) is better at 
accepting the electron density than Co(II) from the Pt(II) centre through the bridging 
tppz ligand.   
 
1H NMR and 195Pt NMR spectroscopic data confirms the observed dechelation of the 
coordinated ligand from the Pt(II) centre which was enhanced by the ligand field 
strength imposed by the addition of thiourea nucleophiles at the Pt(II) metal centre. 




The substitution reactions were sensitive towards the steric hindrance of the incoming 
nucleophiles. The observed enthalpy of activation, H  and the entropy of activation, 
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3.6 Supporting Information  
A summary of the wavelengths used for kinetic studies; representative DFT calculated 
structures of the complexes; representative mass spectra, NMR spectra, exemplary 
spectra for microanalysis, exemplary tables of kinetic data and the respective plots and 
graphs on concentration and temperature dependence studies for the complexes 
studied are given as supporting information. 
Table S 3.1  Summary of selected wavelengths (nm) used for the kinetic investigations for the 
heterometalic Ru(II)-Pt(II) and Co(II)-Pt(II) complexes of pyrazine, 2,3,5,6-tetra-
2-pyridyl with thiourea and the ionic nucleophiles. 
Complex Nu 
Wavelength (λ), nm 
step 1 (Stopped-flow) 
Step 2 
(UV/visible) 
Pttpy mtu 333 - 
RuPt TU 382 382 
 MTU 382 382 
 DMTU 380 382 
 TMTU 382 - 
 Iˉ 382 - 
 SCNˉ 382 - 
PtRuPt TU 383 383 
 MTU 383 382 
 DMTU 382 383 
 TMTU 383 - 
 Iˉ 383 - 
 SCNˉ 383 - 
PtRuRuPt TU 390 390 
 MTU 385 385 
 DMTU 384 384 
 TMTU 385 - 
 Iˉ 303 - 
 SCNˉ 382 - 
CoPt TU 292 270 
 MTU 377 280 
 DMTU 377 370 
 TMTU 405 - 
 Iˉ 370 - 
 SCNˉ 410 - 
 







































Figure S 3.1 Kinetic trace obtained at 292 nm for CoPt (4.0 x 10-5 M) with TU (6.0 x 10-4 M) on 
stopped flow at 298 K, I = 0.02 M LiCF3SO3, adjusted with LiCl. Inset is the kinetic 
trace obtained at 382 nm for RuPt (2.0 x 10-5 M) with TU (3.0 x 10-5 M) at 298 K, I = 














Table S 3.2  Geometry-optimised structures of the platinum complexes investigated 
and distribution of the electron density on the platinum complexes and 
the planarity of the molecules investigated. The blue area indicates the 
most electropositive areas and the red region indicates the most 
electronegative areas.  
















Table S 3.3  Selected bond lengths (Å), bond angles (°), NBO charges, HOMO and LUMO 
energies and other computational data obtained for the complexes Pttpy, RuPt, 
PtRuPt, PtRuRuPt and CoPt obtained from the computational studies and the X-
ray crystal structures. The values in brackets are obtained from the X-ray 
crystallographic structure. 
 Pttpy RuPt PtRuPt PtRuRuPt CoPt 
Bond lengths (Å)      






























Pt-Pt   13.302 
(17.622) 
24.613  
Ru-Ru    6.759  





Ru-N(cis Py terminal)  2.123 2.130 2.140 2.252 
Ru-N(cis Py central) - - - 2.128 - 
Ru-N(tpy trans)  2.036   1.902 
Ru-N(tpy cis)  2.141   2.031 
Pt – N(Py cis)      
Bond Angles(°)      

























N1-Co-N2  155.88   162.00 










h/i  78.01  78.40  78.40 81.00 
NBO charges      
N6 -0.599 -0.601 -0.599 -0.601 -0.601 
N7 -0.599 -0.601 -0.599 -0.601 -0.601 
 
 




……….Continuation of Table S 3.3     
Torsion Angles(°)      
























N7-Pt-Ru-N(1 of RuPt 
and CoPt) 
 85.28   69.67 
NCCN(central Pyrazine)    6.67  
N-C-C-N(with Pt)  0.44 11.62 0.03 13.02 
Dipole  0.01 16.47 0.13 0.00 18.33 
  Pz = pyrazine, py = pyridyl 
  
Table S 3.4  Average observed rate constants, kobs (1st), s-1  at 298.15 K for  Pttpy with MTU at 
various concentrations and temperature dependence of k2 M-1s-1, for the 
replacement of chloride ligand  in Pttpy by MTU at 30-fold excess over [Pttpy],. I = 
0.02 M (adjusted with LiCF3SO3 and LiCl). 
Conc., mM kobs,  s-1 1/T, K-1 In(k2/T) 
0.100 0.10967 0.00347 0.2399 
0.200 0.24957 0.00341 0.51451 
0.300 0.38307 0.00335 0.76144 
0.400 0.52425 0.0033 1.0077 













Table S 3.5  Average observed rate constants, kobs (1st), s-1  at 298.15 K for the replacement of chloride ligand in RuPt (3.0 x 10-5 M)  with the nucleophiles at 
various concentrations. I = 0.02 M (adjusted with LiCF3SO3 and LiCl). 
 
 
Table S 3.6  Average observed rate constants, kobs (2nd), s-1  at 298.15 K for the dechelation of the pyridyl units in RuPt (3 x 10-5 M) with the nucleophiles at 
various concentrations. I = 0.02 M (adjusted with LiCF3SO3 and LiCl). 
TU MTU DMTU 
 Conc., M kobs,  s-1  Conc., M kobs,  s-1  Conc., M kobs,  s-1 
0.00015 2.76 x 10-4 0.00015 2.87 x 10-4 0.00015 1.61 x 10-4 
0.0003 6.17 x 10-4 0.0003 4.36 x 10-4 0.0003 2.99 x 10-4 
0.00045 9.37 x 10-4 0.00045 7.28 x 10-4 0.00045 4.34 x 10-4 
0.0006 0.00119 0.0006 0.001 0.0006 5.52E-04 




TU MTU DMTU TMTU I- SCN- 
 Conc., M kobs,  s-1  Conc., M kobs,  s-1  Conc., M kobs,  s-1  Conc., M kobs,  s-1  Conc., M kobs,  s-1  Conc., M kobs,  s-1 
0.00015 1.6266  0.0003 2.74185 0.00015 0.98054 0.00020 0.057864 0.00015 0.9077 0.00015 0.7221 
0.00029 2.96973 0.00037 3.2127 0.0003 1.6780 0.00025 0.07023 0.0003 1.6629 0.0003 1.3888 
0.00045 4.02429 0.00045 3.89585 0.00045 2.5553 0.00029 0.085163 0.00045 2.5523 0.00045 2.0500 
0.0006 5.20728 0.0006 4.8251 0.0006 3.1224 0.00040 0.116908 0.0006 3.2482 0.0006 2.5441 
0.00075 6.62738 0.00075 6.18877 0.00075 4.0031 0.00050 0.144108 0.00075 4.0017 0.00075 3.1855 




Table S 3.7  Average observed rate constants, kobs (1st), s-1 at 298.15 K for the replacement of chloride ligand in PtRuPt (2.0 x 10-5 M) with the nucleophiles 
at various concentrations. I = 0.02 M (adjusted with LiCF3SO3 and LiCl). 
TU MTU DMTU TMTU Iˉ SCNˉ 
Conc., M kobs,  s-1 Conc., M kobs,  s-1 Conc., M kobs,  s-1 Conc., M kobs,  s-1 Conc., M kobs,  s-1 Conc., M kobs,  s-1 
0.0002 2.0542 0.0002 2.01688 0.0002 1.2045 0.0002 0.14769 0.0002 1.0192 0.0002 1.0166 
0.0004 3.6365 0.0004 3.23528 0.0004 2.08718 0.0004 0.28915 0.0004 2.3226 0.0004 1.7023 
    0.0005 2.64321       
0.0006 4.93334 0.0006 5.17973 0.0006 -- 0.0006 0.43196 0.0006 3.08438 0.0006 2.5216 
0.0008 7.11465 0.0008 6.6906 0.0008 4.6178 0.0008 0.56124 0.0008 4.5658 0.0008 3.7033 
0.001 9.59337 0.001 8.8281 0.001 5.68903 0.001 0.6656 0.001 5.55345 0.001 4.3316 
 
  
Table S 3.8  Average observed rate constants, kobs (2nd), s-1  at 298.15 K for the dechelation of the pyridyl units in PtRuPt (2.0 x 10-5 M) with the 
nucleophiles at various concentrations. I = 0.02 M (adjusted with LiCF3SO3 and LiCl). 
TU MTU DMTU 
Conc., M kobs,  s-1 Conc., M kobs,  s-1 Conc., M kobs,  s-1 
0.0002 6.62 x 10-4 0.0002 4.63 x 10-4 0.0002 3.98 x 10-4 
0.0004 0.00142 0.0004 7.98 x 10-4 0.0004 6.95 x 10-4 
0.0006 0.00217 0.0006 0.00132 0.0006 0.00123 
0.0008 0.00309 0.0008 0.00159 0.0008 0.00146 








Table S 3.9  Average observed rate constants, kobs (1st), s-1  at 298.15 K for the replacement of chloride ligand in PtRuRuPt (1.0 x 10-5 M) with the 
nucleophiles at various concentrations. I = 0.02 M (adjusted with LiCF3SO3 and LiCl). 
TU MTU DMTU TMTU Iˉ SCNˉ 
Conc., M kobs,  s-1 Conc., M kobs,  s-1 Conc., M kobs,  s-1 Conc., M kobs,  s-1 Conc., M kobs,  s-1 Conc., M kobs,  s-1 
0.0001 
 
0.0001 0.97715 0.0001 0.8144 0.0001 0.4852 0.0001 0.6521 0.0001 0.4925 
0.0002 2.0800 0.0002 1.76353 0.0002 1.426 0.0002 0.871 0.0002 1.47213 0.0002 0.9835 
0.0003 3.08633 0.0003 2.422 0.0003 1.97418 0.0003 1.2996 0.0003 2.03665 0.0003 1.3011 
0.0004 3.94305 0.0004 3.5174 0.0004 2.714 0.0004 1.6482 0.0004 2.81407 0.0004 1.783 
0.0005 5.0000 0.0005 4.5784 0.0005 3.2362 0.0005 2.0312 0.0005 3.46587 0.0005 2.2901 
 
 
Table S 3.10  Average observed rate constants, kobs (2nd), s-1 at 298.15 K for the dechelation of the coordinated ligand in PtRuRuPt with the nucleophiles at 
various concentrations. I = 0.02 M (adjusted with LiCF3SO3 and LiCl). 
TU MTU DMTU 
 Conc., M kobs,  s-1  Conc., M kobs,  s-1  Conc., M kobs,  s-1 
0.0001 3.92 x 10-4 0.0001 2.82 x 10-4 0.0001 1.51 x 10-4 
0.0002 6.40 x 10-4 0.0002 6.06 x 10-4 0.0002 3.06 x 10-4 
0.0003 9.35 x 10-4 0.0003 8.67 x 10-4 0.0003 4.30 x 10-4 
0.0004 0.00129 0.0004 0.00109 0.0004 6.13 x 10-4 
0.0005 0.0016 0.0005 
 










Table S 3.11  Average observed rate constants, kobs (1st), s-1  at 298.15 K for the replacement of chloride ligand in CoPt (4.0 x 10-5 M) with the nucleophiles at 
various concentrations. I = 0.02 M (adjusted with LiCF3SO3 and LiCl). 
TU MTU DMTU TMTU I- SCN- 
Conc., M kobs,  s-1 Conc., M kobs,  s-1 Conc., M kobs,  s-1 Conc., M kobs,  s-1 Conc., M kobs,  s-1 Conc., M kobs,  s-1 
0.0002 0.496 0.0002 0.4631 0.0002 0.3269 0.0002 0.2129 0.0002 0.290433 0.0002 0.2447 
0.0004 0.842667 0.0004 0.83014 0.0004 0.6915 0.0004 0.4171 0.0004 0.68285 0.0004 0.3696 
0.0006 1.28935 0.0006 1.21424 0.0006 1.0338 0.0006 0.6195 0.0006 1.025714 0.0006 0.6215 
0.0008 1.66195 0.0008 1.553 0.0008 1.3575 0.0008 0.796 0.0008 1.47965 0.0008 0.7579 
0.001 2.05865 0.001 2.0986 0.001 1.7079 0.001 0.9592 0.001 1.8585 0.001 1.010 
 
Table S 3.12  Average observed rate constants, kobs (2nd), s-1  at 298.15 K for the dechelation of the pyridyl units in CoPt (4.0 x 10-5 M) with the nucleophiles at 
various concentrations. I = 0.02 M (adjusted with LiCF3SO3 and LiCl). 
TU MTU DMTU 
Conc., M kobs,  s-1 Conc., M kobs,  s-1 Conc., M kobs,  s-1 
0.0002 0.000297 0.0002 0.000239 0.0002 9.71 x 10-5 
0.0004 0.000571 0.0004 0.000556 0.0004 0.000191 
0.0006 0.000924 0.0006 0.000864 0.0006 0.000261 
0.0008 0.001197 0.0008 0.001107 0.0008 0.000355 
0.001 0.001531 0.001 0.00146 0.001 0.000448 






















Figure S 3.2 Dependence of the pseudo first-order rate constants (kobs) on the concentrations 
of MTU for the displacement of chloride ligand in from Pttpy in methanol solution 
at 298 K and I = 0.02 M (adjusted with LiCF3SO3 and LiCl). 
 





















































Figure S 3.3 Dependence of the pseudo first-order rate constants (kobs) on the concentrations 
of the nucleophiles (a) for the displacement of chloride ligands in kobs1st, s-1  (b) for 
the dechelation of the ligands in kobs2nd, s-1, from RuPt in methanol solution at 298 
K and I = 0.02 M (adjusted with LiCF3SO3 and LiCl). 



































Figure S 3.4 Dependence of the pseudo first-order rate constants (kobs) on the concentrations 
of the nucleophiles (a) for the simultaneous displacement of the chloride ligands, 
kobs1st, s-1 (b) for the dechelation of the ligands, kobs2nd, s-1, from PtRuRuPt in 
methanol solution at 298 K and I = 0.02 M (adjusted with LiCF3SO3 and LiCl). 

























































Figure S 3.5 Dependence of the pseudo first-order rate constants (kobs) on the concentrations 
of the nucleophiles (a) for the displacement of the chloride ligand, kobs1st, s-1 (b) 
for the dechelation of the ligand, kobs2nd, s-1 from CoPt in methanol solution at 298 
K and I = 0.02 M (adjusted with LiCF3SO3 and LiCl). 





Table S 3.13  Temperature dependence of k2 M-1s-1, for the displacement of the aqua ligand in RuPt by nucleophiles at 30-fold excess over [RuPt], I = 0.02 M 
(adjusted with LiCF3SO3 and LiCl). 
TU MTU DMTU TMTU Iˉ SCNˉ 
1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 
0.00347 3.11454 0.00347 3.02634 0.00347 2.51549 0.00347 -0.94815 0.00347 2.50021 0.00347 2.15772 
0.00341 3.29369 0.00341 3.2077 0.00341 2.7604 0.003411 -0.90704 0.00341 2.76462 0.00341 2.46757 
0.00335 3.47705 0.00335 3.36858 0.00335 2.9768 0.003354 -0.74221 0.00335 2.94567 0.00335 2.72646 
0.0033 3.61121 0.0033 3.6287 0.0033 3.29297 0.003299 -0.5863 0.0033 3.19257 0.0033 2.94714 
0.00325 3.87124 0.00325 3.91634 0.00325 3.53436 0.003245   0.00325 3.43044 0.00325 3.19083 
 
 
Table S 3.14  Temperature dependence of k2 M-1s-1, for the dechelation of the pyridyl units in RuPt by thiourea nucleophiles at 30-fold excess over [RuPt], I 
= 0.02 M (adjusted with LiCF3SO3 and LiCl). 
TU MTU DMTU 
1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 
0.00347 -5.15171 0.00347 -5.65839 0.00347 -6.1472 
0.00341 -4.81778 0.00341 -5.29034 0.00341 -5.62497 
0.00335 -4.55839 0.00335 -4.87543 0.00335 -5.32898 
0.0033 -4.25257 0.0033 -4.5053 0.0033 -4.95961 












Table S 3.15  Temperature dependence of k2 M-1s-1, for the displacement of the aqua ligand in PtRuPt by nucleophiles at 60-fold excess over [PtRuPt],             
I = 0.02 M (adjusted with LiCF3SO3 and LiCl). 
TU MTU DMTU TMTU Iˉ SCNˉ 
1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 
0.00347 2.63302 0.00347 2.85908 0.00347 2.16223 0.00347 0.23565 0.00347 2.33553 0.00347 2.14869 
0.003411 2.87183 0.003411 3.165 0.003411 2.49082 0.003411 0.63654 0.003411 2.5531 0.003411 2.34985 
0.003354 3.317 0.003354 3.36574 0.003354 2.80685 0.003354 0.88157 0.003354 2.84733 0.003354 2.64588 
0.003299 3.48409 0.003299 3.68863 0.003299 2.97359 0.003299 1.35142 0.003299 2.99342 0.003299 2.98392 
0.003245 3.88284 0.003245 3.96378 0.003245 3.31565 0.003245 1.5959 0.003245 3.19942 0.003245 3.24761 
 
 
Table S 3.16  Temperature dependence of k2 M-1s-1, for the dechelation of the pyridyl units in PtRuPt by thiourea nucleophiles at 60-fold excess over 
[PtRuPt], I = 0.02 M (adjusted with LiCF3SO3 and LiCl). 
TU MTU DMTU 
1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 
0.00347   0.00347 -5.43628 0.00347 -5.67936 
0.00341 -4.63896 0.00341 -5.14642 0.00341 -5.25566 
0.00335 -4.41349 0.00335 -4.88489 0.00335 -5.0225 
0.0033 -4.17073 0.0033 -4.60967 0.0033 -4.69338 












Table S 3.17  Temperature dependence of k2 M-1s-1, for the displacement of the aqua ligand in PtRuRuPt by nucleophiles at 60-fold excess over [PtRuRuPt], 




Table S 3.18  Temperature dependence of k2 M-1s-1, for the dechelation of the pyridyl units in PtRuRuPt by thiourea nucleophiles at 60-fold excess over 
[PtRuRuPt], I = 0.02 M (adjusted with LiCF3SO3 and LiCl). 
TU MTU DMTU 
1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 
0.00347 -5.1066 0.00347 -5.1674 0.00347 -6.02278 
0.00341 -4.73573 0.00341 -4.90997 0.00341 -5.67055 
0.00335 -4.56057 0.00335 -4.62736 0.00335 -5.33713 
0.0033 -4.31535 0.0033 -4.50979 0.0033 -5.05952 





TU MTU DMTU TMTU Iˉ SCNˉ 
1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 
0.00347 2.95076 0.00347 2.74097 0.00347 2.4655 0.00347 1.43943 0.00347 2.97357 0.00347 1.61336 
0.003411 3.17488 0.003411 3.10021 0.003411 2.8066 0.003411 1.87015 0.003411 3.14176 0.003411 1.80233 
0.003354 3.42384 0.003354 3.29873 0.003354 3.09428 0.003354 2.09131 0.003354 3.27928 0.003354 1.98302 
0.003299 3.57999 0.003299 3.67861 0.003299 3.34262 0.003299 2.44511 0.003299 3.44608 0.003299 2.16699 
0.003245 3.86461 0.003245 3.98884 0.003245 3.52507 0.003245 2.89783 0.003245 3.57409 0.003245 2.38369 





Table S 3.19  Temperature dependence of k2 M-1s-1, for the displacement of the aqua ligand in CoPt by nucleophiles at 30-fold excess over [CoPt], I = 0.02 M 
(adjusted with LiCF3SO3 and LiCl). 
TU MTU DMTU TMTU Iˉ SCNˉ 
1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 
0.00347 1.4983994 0.00347 1.20850 0.00347 0.9611372 0.00347 0.5454441 0.00347 0.51538 0.00347 1.17197 
0.00341 1.7305361 0.00341 1.58010 0.00341 1.3452242 0.00341 0.904107 0.00341 0.88256 0.00341 1.49729 
0.00335 1.9751224 0.00335 1.915102 0.00335 1.7542578 0.00335 1.2421416 0.00335 1.24528 0.00335 1.74637 
0.00329 2.2394616 0.00329 2.166765 0.00329 2.0009207 0.00329 1.5665842 0.00329 1.47286 0.00329 2.14308 
0.00325 2.5117602 0.00325 2.417184 0.00325 2.2072244 0.00325 1.7787942 0.00325 1.72404 0.00325 2.51055 
 
 
Table S 3.20  Temperature dependence of k2 M-1s-1, for the dechelation of the pyridyl units in CoPt by thiourea nucleophiles at 30-fold excess over [CoPt], I = 
0.02 M (adjusted with LiCF3SO3 and LiCl). 
TU MTU DMTU 
1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 
0.003470415 -5.71353 0.00347 -5.87206 0.00347 -7.08116 
0.003411223 -5.47388 0.003411 -5.49783 0.003411 -6.76303 
0.003354016 -5.26543 0.003354 -5.33283 0.003354 -6.35325 
0.003298697 -4.94821 0.003299 -5.09471 0.003299 -6.07875 
0.003245173 -4.7254 0.003245 -4.80536 0.003245 -5.63694 






















Figure S 3.6 Eyring plot obtained for the substitution of chloride ligand in Pttpy, with MTU 
nucleophile at various temperatures in the range 15 - 40 °C 
 































(b)   
 
Figure S 3.7 Eyring plots obtained, as ln(k-2/T) against 1/T (a) for the reactions of  PtRuPt with 
the nucleophiles for the substitution of chloride ligands (b) for the dechelation of 
the linker at various at various temperatures in the range 15 - 40 °C 
 
 





































































Figure S 3.8 Eyring plots obtained, as ln(k-2/T) against 1/T (a) for the reactions of  PtRuRuPt 
with the nucleophiles for the substitution of chloride ligands (b) for the 
dechelation of the linker at various temperatures in the range 15 - 40 °C 
 
 



















































Figure S 3.9 Eyring plots obtained, as ln(k-2/T) against 1/T (a) for the reactions of  CoPt with 
the nucleophiles for the substitution of chloride ligands (b) for the dechelation of 





































































































































































































Figure S 3.13 1HNMR spectrum of [(tpy)Ru(tppz)PtCl](PF6)3. Spectrum zoomed in to show the signals due to the protons in the aromatic rings. Inset is the 











































































-2500 -2550 -2600 -2650 -2700 -2750 ppm
Pt





Figure S 3.14 1HNMR spectrum of [ClPt(tppz)Ru(tppz)PtCl](PF6)4. Spectrum zoomed in to show the signals due to the protons in the aromatic rings. Inset is 
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Figure S 3.15 1HNMR spectrum of [[ClPtRu2(tppz)3PtCl](PF6)6. Spectrum zoomed in to show the signals due to the protons on the aromatic rings. Inset is the 
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Figure S 3.16 Exemplary elemental analysis spectrum for CoPt. 
 






Figure S 3.17 Low resolution ESI mass spectrum of (tpy)Ru(tppz)(PF6)2. 
 





Figure S 3.18 Low resolution ESI mass spectrum of Ru(tppz)2(PF6)2. 
 





Figure S 3.19  Low resolution ESI mass spectrum of Ru2(tppz)3(PF6)4. 






Figure S 3.20 Low resolution ESI mass spectrum of RuPt. 






Figure S 3.21 Low resolution ESI mass spectrum of PtRuPt. 
 






Figure S 3.22 Low resolution ESI mass spectrum of PtRuRuPt 
 





Figure S 3.23 Low resolution ESI mass spectrum of CoPt 





Figure S 3.24 195Pt NMR spectra for the reaction of RuPt (6.28 mM) with TU, showing the changes in the chemical shift of the Pt before adding the TU 
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Figure S 3.25 Kinetic 195Pt NMR spectra in CD3CN for the reaction of PtRuPt (0.02 mM) with TU at 298 K. The bottom spectrum is obtained for the pure 
complex and the top spectrum is obtained by addition of six equivalence of TU after 12 hours. Inset is the trace obtained at 386 nm. 
 
 



















t = 10 hours
t = 26 hours
t = 30 hours























Figure S 3.26  A typical UV/visible plot showing the changes in absorbance between 250 t0 800 nm wavelength range for PtRuPt in acetonitrile (0.02 
mM) at 298 K over a period of 12 hours.  
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Figure S 3.27  (a)Computed HOMO energy against inverse number of metal centres. (b) Computed LUMO energy against inverse number of metal centres. 
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Figure S 3.28 Graph of DFT calculated HOMO-LUMO energy gap against inverse number of metal centres. CoPt deviates from the trend. 
























Figure S 3.29 Electronic absorption for the complexes investigated using 0.01 mM concentration for all the complexes measured in methanol at 298 K.






Equal amounts of RuCl3· 3H20 (~150 mg) and tpy were refluxed in absolute EtOH (125 
mL) for 3 hours. The resulting reaction mixture was cooled to room temperature and 
the precipitate was filtered, washed with cold absolute EtOH (10 mL) followed by 
copious amount of diethyl ether and dried under vacuo. 
[(tpy)Ru(tppz)](PF6)2, 
To a stirred solution of Ru(tpy)Cl3 (50.7 mg, 0.115 mmol) in an ethanol/ water mixture 
(1: 1) was added the ligand tppz (45 mg, 0.115 mmol).  The reaction mixture was 
flushed with nitrogen for 15 minutes and then refluxed for 12 hours.  The resulting 
reaction mixture was cooled and filtered in order to remove any unreacted tppz. The 
filtrate was added to an aqueous solution of ammonium hexafluoro phosphate. The 
resulting black precipitate was filtered and this product was chromatographed on 
neutral aluminium oxide using acetonitrile and toluene (1: 1) as an eluent. The first 
main orange band was isolated and solvent removed under vacuo and dried under 
vacuum to yield the desired product. 
[Ru(tppz)2](PF6)2, 
The ruthenium complexes; [Ru(tppz)2 (PF6)2] and [Ru2(tppz)3(PF6)4] were synthesized 
as from literature. To a stirred solution of Ru(III)Cl3·3H2O (58.5 mg, 0.22 mmol) in 
ethanol/ water (1: 1), was added the ligand, tppz (300 mg, 0.77 mmol).  The solution 
was flushed with nitrogen for 15 minutes and then heated to reflux for 48 hours. The 
purple reaction mixture was allowed to cool and filtered to remove any unreacted tppz. 
The filtrate was treated with aqueous ammonium hexafluro phosphate and the black 
precipitate formed was filtered and chromatographed on neutral alumina using 
acetonitrile/toluene (1 : 1) as an eluant.  The first orange band was collected and 
solvent removed and dried under vacuo to yield the monomeric product, 
Ru(tppz)(PF6)2. The homodimetalic complex, [Ru2(tppz)3(PF6)4] was obtained as a 
byproduct which was eluted as a purple band after the orange fraction.  This product 
was obtained after removing the solvent and drying it under vacuo.   
 
PtCl2(DMSO)2]  
Dimethyl sulphoxide (0.64 mL, 0.009 mol) was added to a solution of (10 mL) K2PtCl4 
(1.87 g, 0.0045 mol) at room temperature . The solution was left to stand until the 
yellow crystals were formed. The crystals were filtered, washed with water and diethyl 
ether and dried under vacuo. 




 [Pt(tpy)Cl]Cl·H2O (Pttpy)  
To a stirred solution of [Pt(COD)Cl2] (500 mg, 1.34 mmol) in water (30 mL), 2,2´:6´,2˝-
terpyridine (313 mg, 1.34 mmol) was added. The mixture was stirred and warmed to 
between 45-50 oC for 15 minutes. The clear orange-red solution obtained was cooled to 
room temperature and filtered to remove any unreacted [Pt(COD)Cl2]. Removal of 
solvent under reduced pressure gave an orange-red solid, [Pt(terpy)Cl]Cl·2H2O, 
(Pttpy). The product was collected, washed thoroughly with diethyl ether and air dried. 
Recrystallization of the dried solid in a hot methanol/water mixture (50: 50) gave 
orange needle like crystals of the titled compound. The crystals were filtered using 0.45 
μm nylon filter membrane on millipore filtration unit, washed with diethyl ether and 
air dried.  
 
[ClPt(tppz)Ru(tppz)PtCl](PF6)4 (PtRuPt)  
This compound was synthesized by a similar approach as [(tpy)Ru(tppz)PtCl](PF6)3. 
[ClPt(tppz)Ru(tppz)PtCl](PF6)4 was synthesized by dropwise addition of Ru(tppz)2 (50 
mg, 43 mmol) in acetonitrile (10 mL) to a refluxing solution of [Pt(DMSO)2Cl2] (38 mg, 
90 mmol) in acetonitrile (15 mL). The reaction mixture was refluxed for 6 hours under 
nitrogen and then cooled to room temperature and filtered. The filtrate was added to 
an aqueous solution of ammonium hexafluoro phosphate. The dark purple precipitate 
formed was filtered, washed with ethanol (5 mL), distilled water (20 mL) and copious 
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The Effect of Ruthenium(II) Terpyridine Fragment on the 
Reactivity of Platinum(II) centre. A Kinetic and Computational 
Approach 
4.0 Abstract 
The rate of substitution of a series of heterometallic Ru(II)-Pt(II) complexes; cis-
[Pt(en)(py)H2O](CF3SO3)2, Pt1, cis-[(tpy)Ru(qpy)Pt(en)H2O](CF3SO3)4, Pt2  and cis-
[H2Ol(en)Pt(qpy)Ru(qpy)Pt(en)H2O](CF3SO3)6, Pt3 (en = 1,2-ethylenediamine, py = 
pyridine, tpy = 2,2’:6’,2”-terpyridine and qpy 4’-pyridyl-2,2’:6’,2”-terpyridine), with 
thiourea nucleophiles, viz. thiourea (TU), 1,3-dimethylthiourea (DMTU) and 1,1,3,3-
tetramethylthiourea (TMTU) were studied under pseudo first-order conditions as a 
function of concentration and temperature by using UV/visible spectrophotometer and 
stopped-flow analyzer. The reactions proceeded via a single step, following first-order 
kinetics. The observed pseudo first-order rate constants, kobs followed the rate law:     
kobs = k2[Nu]. The observed reactivity trend, Pt3 ≈ Pt2 > Pt1 is in line with the observed 
pKa1 trend for the complexes investigated. The substitution reactivities of the 
heterometallic complexes are enhanced as a result of the increased overall charge and 
the electrophilicity of the complexes. Replacing the cis pyridyl group by a (tpy)Ru(qpy) 
moiety lowers the energy of anti-bonding LUMO (π*) orbitals and increases the metal-
metal interactions and electronic transition within the complex whereby enhancing the 
reactivity of Pt(II) centre. Incorporation of Ru(qpy)2 in Pt3 did not double the reactivity 
to that of Pt2 due to the orthogonal geometry of the coordinated qpy ligands at the 
Ru(II) metal centre. The rate of the reactivity of the nucleophiles is depended on the 
steric hindrance, where the reactivity followed the order: TU > DMTU > TMTU. The 
observed relatively low enthalpy of activation, H  and the negative entropy of 
activation, S  support an associative mode of activation for the displacement of the 
aqua ligand(s). Experimental data were supported by density functional theory (DFT) 
calculations. 
 





Development of new effective anticancer drugs has focused on designing new drugs 
with lesser side effects and drawbacks.1 In the past, a number of different mono- and 
multinuclear complexes with potential anticancer activity have been developed.1c,2 The 
architecture of the most well-known multinuclear Pt(II) complexes has platinum 
centres structurally joined by linkers with terminal platinum centres containing labile 
ligand(s) such as chloro or aqua.1b,3 These structural linkers are thought to play an 
important role in influencing the mode of interaction when binding with DNA base 
pairs. Reaction of such complexes with DNA oligomers have shown different adducts to 
that formed by cisplatin and its analogues.1a For example, multinuclear anticancer Pt(II) 
complexes linked by 4,4’-dipyrazolylmethane4 and pyrazole ligands which have one 
labile group were expected to exhibit different modes of actions with DNA than that of 
cisplatin.5  
 
Recent kinetic studies reported by van Eldik et al.6 and Jaganyi et al.7 for dinuclear 
Pt(II) complexes with flexible alkyldiamine linkers show that the reactivity depends on 
the distance between the two Pt(II) centres, their electrostatic interactions and the 
charge density around the metal centre.6,7b Of note, are multinuclear Pt(II) complexes 
bridged by flexible alkyldiamines,8 first synthesized by Farrell et al.9 Two good 







and its analogue (BBR3610).9 Both comprise of two or three Pt(II) centres linked via 
flexible alkyldiamine bridges. These compounds have shown strong clinical potential 
but are limited by in vitro degradation to release the linker in the presence of strong S-
containing biomolecules.9 However, it is difficult to generalize on how the factors 
control the kinetic and thermodynamic behaviour due to structural complexity of 
multinuclear complexes such as the flexibility1b,6c,d,7,10 (e.g., aliphatic diamine linkers) or 
the rigidity5,11 (e.g., azoles, azines and polypyridines) of the linkers.  
 
Out of the different metal complexes synthesized and tested for biological activity,12 Ru 
is of great interest.13 From the many Ru(II) complexes tested for biological activity, the 
compound [ImH][trans-RuCl4(DMSO-S)Im] (Im = imidazole), NAMI-A and its 
derivatives are the most studied.14 Interaction of other Ru complexes such as 
{[(NH3)4Ru]2(dpb)}4+ (dpb= 2,3-bis(2-pyridyl)benzoquinoxaline) with DNA has also 
been reported.15  
 




Furthermore, synthesis of heterometallic Ru(II)-Pt(II) complexes16 of the form, 
[(bpy)2M(dpb)PtCl2]Cl2 (M = Ru(II), Os(II); bpy = 2,2’-bipyridine; dpb = 2,3-bis(2-
pyridyl)benzoquinoxaline containing short heterocyclic rigid linkers have been 
reported.16 The presence of non-binding metal centres in the complexes increase the 
overall cationic charge thereby enhancing their water solubility.16-17 The complexes 
were also reported to photoreact with DNA through the light absorbing ruthenium 
metal centre,18,19,20 which transfers the energy into the platinum metal centres thereby 
enhancing its reactivity.16 This property can be a useful switch for kinetic and 
thermodynamic control of the platinum complexes in their substitution reactions. 
However, ligand substitution behaviour of heterometallic Pt(II)-Ru(II) complexes have 
not been studied kinetically to a great extent. 
 
Therefore, it is the aim of this work to investigate the substitution reactions of 
heterometallic Ru(II)-Pt(II) complexes, where the two metal centres are linked by a 4’-
pyridyl-2,2’:6’,2”-terpyridine (qpy), a ligand which is rigid. Apart from being  a 
tridentate ligand, qpy can also bind with a second metal centre via the nitrogen atom of 
the appended pyridine ring on the terpyridine moiety.21 This ligand has a very versatile 
coordination chemistry; forming mononuclear compounds with pendant groups,21a,22 
metal coordinated polygons23 and polymers.24 It is postulated to interact with DNA 
favourably due to its extended aromaticity apart from the substitution at the terminal 
Pt(II) metal centre.11c  
 
We therefore synthesized three complexes viz; cis-[Pt(en)(py)H2O](NO3) (Pt1), cis-
[(tpy)Ru(qpy)Pt(en)H2O](NO3)3 (Pt2) and cis-
[H2Ol(en)Pt(qpy)Ru(qpy)Pt(en)H2O](NO3)4 (Pt3). The mononuclear platinum complex, 
Pt1 is included for comparison reasons so that the effect on reactivity of the complexes 
due to the cis ligand to the Pt(II) centre or the linker (qpy) could be quantified. The cis 
geometry is purposely chosen as it endows enhanced stability to metabolic 
deactivation. It is known that the cis complexes react slower compared to their trans 
counterparts.25 Studies have also shown that complexes such as [{cis-PtCl(NH3)2-μ-y]n+ 
(where y = NH2(CH2)6NH2)26 do not undergo degradation of the linker with strong 
sulfur donor nucleophiles as compared to their trans analogues.1d However, the factors 
which facilitate these reactions are not fully understood. Furthermore, the invariant 
ethylenediamine chelate coordinated to the Pt(II) centre is deliberately designed into 
all the complexes since our interest was to investigate the effect of the octahedral 
Ru(tpy)2 moiety making up the linker on the reactivity of the terminal Pt(II) ions. Thus, 




it is anticipated that structurally improved architecture of the complexes will have 
better advantages over the well-known trinuclear anticancer compound, BBR346427 
and other well-known alkyldiamine6c,28 complexes since their DNA cross links will be 
differently recognised by cellular proteins and are potential to cause cell death via 
different pathways.  
 
The reactivities of the complexes were studied in aqueous medium at pH 2 using 
thiourea nucleophiles. Thiourea nucleophiles are used because of the multiple role of 
sulfur containing bio molecules inside the cells. This is also facilitated by their 
solubility, high nucleophilicity and neutral character.28 The structures of the complexes 

























































pH buffer standards of pH 4.0, 7.0 and 10.0 were bought from Merck. 4’-chloro-
2,2’:6’,2”-terpyridine (99%), ruthenium(III)chloride trihydrate (99%) and 1,5-
cyclooctadiene were purchased from Aldrich. All other chemicals were procured from 
Sigma Aldrich and used as received. For preparation of all aqueous solutions, ultra-pure 
water was used. The ruthenium precursors; [Ru(tpy)Cl3],29 [Ru(qpy)Cl3]11c and 0.1 M 
Ru(III) solution11c were synthesized as described in literature.   




4.2.2 Synthesis of Ligand and Ruthenium Moieties 
The ligand, 4’-pyridyl-2,2’:6’,2”-terpyridine (qpy) was synthesized as in literature.30 A 
perspective X-ray crystal structure is given under Supporting Information. Summary of 
the experimental procedure and the characterization data are given under supporting 
information. Acidic Ru(III) solution was prepared following the literature procedure.11c 
The Ru complexes, [Ru(tpy)CI3],29 [Ru(qpy)Cl3],11c Ru(qpy)(tpy)Cl211c and 
[Ru(qpy)2]Cl211c are synthesized following the literatures. Experimental procedures are 
summarized under Supporting Information.  
 
The purity of the complexes was confirmed by 1H NMR and mass spectroscopy. The X-
ray crystal structure obtained for the ligand qpy further confirms the correct 
identification of the qpy ligand. 
 
4’-pyridyl-2,2’:6’,2”-terpyridine (qpy) Yield: 0.509 g, (70%), Colourless needles. 1H 
NMR (400 MHz, CDCl3) δ/ ppm: 8.79 (2H, m, 2’’’ 6’’’), 8.77 (2H, s, 3’ 5’), 8.74 (2H, br dm, 
6 6’’), 8.67 (2H, dd, 3 3’’), 7.90 (2H, td,  4 4’’), 7.80 (2H, dd, 3’’’ 5’’’), 7.39 (2H, ddd, 5, 5’’) .  
TOF MS-ES+, m/z: 333.1114, (M+Na)+. 
 
Ru(qpy)(tpy)Cl2 Yield: 35 mg, 0.0489 mmol (61%), Dark red powder. 1H NMR (400 
MHz, DMSO-d6) δ/ ppm: 9.58 (2H, s, I3’ 5’), 9.12 (2H, d, I33”), 9.10 (2H, s, II3’ 5’), 8.99 
(2H, d, I2’’’ 6’’’), 8.85 (2H, d, II3 3’), 8.56 (2H, t, II4’), 8.45 (2H, d, I3’’’, 5’’’), 8.09 (2H, t, I4 
4’’), 8.03 (2H, t, II4 4’’), 7.52 (2H, d, II6 6’’), 7.46 (2H, d, I6 6’’), 7.30 (2H, t, I5 5’’), 7.25 
(2H, t, II5 5’’). TOF MS-ES+, m/z: 366.5616, (M2+). Anal. Calc. for C35H25Cl2N7Ru: C 58.75, 
N 13.70, H 3.52. Found: C 58.32, N 13.21, H 3.12. 
 
[Ru(qpy)2]Cl2 Yield: 50 mg, (46 %), Dark maroon powder. 1H NMR (400 MHz, DMSO-
d6) δ/ ppm: 9 .61 (2H, s, 3’ 5’),9.12 (2H, d, 2’’’ 6’’’), 9,00 (2H, d, 3 3’’), 8.45 (2H, d, 3’’’ 5’’’), 
8.09 (2H, t, 4 4’’), 7.57 (2H, d, 6 6’’), 7.29 (2H, t, 5 5’’). TOF MS-ES+, m/z: 361.1088, 












4.2.3 Synthesis of Platinum(II) Complexes 
The platinum precursor, Pt(en)Cl2 was synthesized following a literature procedure.31 
Details of the experimental procedure and characterization data are summarized under 
Supporting Information. The platinum complexes, Pt1 Cl, Pt2 Cl and Pt3 Cl are 
synthesized following a similar approach reported.11c 
 
(Pt1-Cl) The compound was synthesized by a slight modification of the literature 
method.11c To a stirred solution of [Pt(en)Cl2] (42 mg; 0.126 mmol) in 10 mL of DMF at 
310 K, silver nitrate (AgNO3) (21 mg, 0.126 mmol) in dimethylformamide (DMF) (5 mL) 
was added drop wise. The reaction mixture was stirred for 24 hours at 313 K. After 
filtration of silver chloride (AgCl) precipitate using a 0.45 μm nylon membrane filter 
(Millipore), pyridine (0.010 mL, 0.126 mmol) was added to the filtrate and the mixture 
was stirred for another 18 hours. The reaction mixture was filtered and coevaporated 
using EtOH/MeOH (v: v = 50:50) (20 mL) to remove DMF. The precipitate was 
dissolved in MeOH. The product was precipitated by slow diffusion of diethyl ether.  
 
The purity and the identity of the complexes were confirmed by 1H NMR, 195Pt NMR, 
mass spectroscopy and elemental analyses. The 195Pt NMR of all the complexes 
exhibited a characteristic signal at about -2500 ppm, typical to platinum coordinated to 
NNN chelate and a chloride. Due to the high charge and complexity of the complexes, 
the mass spectra obtained show characteristic fragmentations. 
 
Yield: 0. 032 g, (60%), off-white crystalline powder.  1H NMR (400 MHz, DMF) δ/ ppm: 
8.62 (2H, dd , J= 6.9, 1.4), 7.89 (1H, tt, J= 7.8, 1.5), 7.40 (2H, br), 6.04 (2H, br), 5.65 (2H, 
br), 3.01 (2H, t), 2.92 (2H, br), 195Pt NMR (500 MHz, DMF) δ/ ppm: -2501. TOF MS-ES+, 
m/z: 369.0449, (M+). Anal. Calc. For C7H13ClN4O3Pt: C 19.47, N 12.98, H 2.96. Found: C 
19.21, N 12.51, H 2.98. 
 
(Pt2-Cl) Yield: 28 mg (15 %), Dark red powder.  1H NMR (400 MHz, D2O) δ/ ppm: 
9.11 (2H, s, I3 5’), 9.00 (2H, d, I2’’’ 6’’’), 8.78 (2H, d, II3’ 5’), 8.61 (2H, d, I3 3’’), 8.50 (2H, 
d, II3 3’’), 8.42 (2H, t, II4’), 8.25 (2H, d, I3’’’ 5’’’), 7.93 (2H, t, I4 4’’), 7.89 (2H, t, II4 4’’), 
7.45 (2H, d, II6 6’’), 7.35 (2H, d, I6 6’), 7.17 (2H, t, I5 5’’), 7.11 (2H, t. II5 5’’), 2.73 (2H, br, 
b), 2.66 (2H, br, c), 195Pt NMR (500 MHz, D2O) δ/ ppm: -2530. TOF MS-ES+, m/z: 
322.5963, (for water substituted M4+).  Anal. Calc. For C37H33ClN12O9PtRu·4H2O: C 37.24, 
N 14.08 , H 3.46. Found: C 36.81, N 13.76, H 3.01. 
 




(Pt3-Cl) Yield: 0. 035 g, (22 %), dark red powder.  1H NMR (400 MHz, D2O) δ/ ppm: 
9.13 (2H, s, I3’ 5’), 9.01 (2H, d, I2’’’ 6’’’), 8.62 (2H, d, I3 3’’), 8.25 (2H, d, I3’’’ 5’’’), 7.93 
(2H, t, I4 4’’), 7.45 (2H, d, II6 6’’), 7.17 (2H, t, I5 5’’), 2.80 (2H, br, b), 2.73 (2H, br c) 195Pt 
NMR (500 MHz, D2O) δ/ ppm: -2532. TOF MS-ES+, m/z: 2901.0024, (for water 
substituted M6+ -H2O). Anal. Calc. For C44H44Cl2N16O12Pt2Ru·5H2O: C 32.90, N 13.95, H 
3.64. Found: C 32.69, N 13.98, H 3.31. 
 
4.2.4 Preparation of Aqua Complexes 
The desired solutions for kinetic studies of aqua complexes (Pt1, Pt2 and Pt3) were 
prepared according to the literature procedure which is summarized in Scheme 4.1.32
 
To a stirred solution of the Pt(II) compound (Pt1-Cl, Pt2-Cl and Pt3-Cl) (0.4 mmol) in 




H) (40 mL) was added silver triflate (AgSO3CF3)
 
(equal 
amounts for mono chloro complexes, (Pt1-Cl and Pt2-Cl) and 2 equivalences for the 
dichloro complex, (Pt3-Cl)). The mixture was stirred for 24 hours at 50 
o
C in dark. The 
precipitated silver chloride was removed by filtration using a 0.45 μm nylon membrane 




H which had 
an ionic strength of 0.02 M adjusted with LiSO3CF3. For all kinetic studies, the pH of the 
solution was kept at pH 2, ionic strength of 0.02 M adjusted with lithium triflate 
(LiSO3CF3). A pH of 2 was chosen to prevent the formation of the hydroxo species which 
are substitutionally inert.28,33 The solutions for pKa determination were prepared by 
diluting the metal complexes with ultra-pure water and keeping the pH of the desired 




H. The initial absorbance of the peaks of the 
complexes were kept between 0.2 - 1.5. The schematic representation of the aquation 
process is given in Scheme 4.1. 
 
 N  Pt
H2N
Cl









n = 1 in  Pt1-Cl, 3 in Pt2-Cl and 5 in Pt3-Cl
(n+1)+
X = H in Pt1, (tpy)Ru(tpy) in Pt2 and (tpy)Ru(tpy)Pt(py)(en)Cl in Pt3
v =  no of moles of AgCF3SO3 = 1 for Pt1-Cl and Pt2-Cl and 2 for Pt3-Cl
 
Scheme 4.1  Schematic representation of preparation of aqua complexes. 
 




4.2.5 Instrumentation and Measurements 
1H NMR were recorded on either a Bruker Avance DPX 400 or 500 MHz spectrometer, 
at 303 K using Si(CH3)4 as the reference for the chemical shifts. 195Pt NMR were done on 
a 500 MHz spectrometer (195Pt, 107.5 MHz) and chemical shifts externally referenced to 
K2[PtCl6]. Low resolution electron spray ionization (ESI+) mass spectra were recorded 
on a TOF Micromass spectrometer. Elemental analyses were performed by a Thermal 
Scientific Flash 2000. X-ray crystal structure for the ligand qpy was solved using an 
Oxford Diffraction Xcalibur 2 CCD 4-circle diffractometer linked to an Oxford Cryostat 
System. The data collection was done at 100 K. 
 
UV/visible spectra for wavelength determination and kinetic measurements of slow 
reactions were studied on Varian Cary 100 Bio UV/visible spectrophotometer with an 
attached Varian Peltier temperature-controller with an online kinetic applications 
having temperature controlled to within ± 0.05 
o
C. Kinetic measurements of fast 
reactions were studied on an Applied Photophysics SX 20 stopped-flow reaction 
analyser coupled with an online data acquisition system with controlled temperature 
having an accuracy of ± 0.1 
o
C. The pH measurements were recorded on a Jenway 4330 
conductivity/pH meter equipped with a Jenway glass microelectrode calibrated with 
standard buffer solutions of pH 4.0, 7.0 and 10.0.  
 
4.2.6 Determination of pK
a 
of Aqua Complexes 
The acidity of the coordinated water ligands were studied prior to kinetic studies. The 
pKa titrations were carried out as described in literature28,34 by using NaOH as the base 
(Scheme 4.2). The pH titrations were carried out starting from pH 2 (0.01 M CF3SO3H 
solution), and increased by addition of small amounts of NaOH solution until pH 9 
(Figures 4.2, S4.1, S4.2). To avoid errors due to dilution effect, a large volume (200 mL) 
complex solution was used. Crushed NaOH pellets were added until a pH of 3 was 
reached. NaOH solutions of different concentrations were used to obtain evenly 
distributed spectra. The solution was stirred after each addition of NaOH before the pH 
measurement was taken. Small vials were used for sampling out the solution (2 mL) for 
pH measurements. After each pH measurement the sample aliquot used was discarded 
to avoid in situ precipitation of the chloride. Aliquots from spectral acquisitions were 
returned back to the titration solution. To ensure the presence of the aqua species in 
solution, the titrations were carried out using both NaOH and triflic acid with which the 




reversibility of the spectra were observed. The results obtained are summarised in 






















Scheme 4.2 The pKa titration reactions of the aqua complexes with OHˉ. 
Note: Equation 4.1 is true for Pt1 and Pt2, while Equations 4.2 and 4.3 hold for Pt3.  
 
Addition of the (tpy)Ru(II)(qpy) and (qpy)Ru(II)(qpy) moieties to Pt(II) centre 
increases the acidity and lability of the coordinated aqua ligand(s) resulting in a lower 
pKa for Pt2 and Pt3 relative to Pt1. A smaller pKa1 value for Pt3 compared to Pt2 
reflects that the additional π-acceptability due to the terpyridine capping is 
insignificant due to its orthogonal disposition in the octahedral geometry of the 
appended ruthenium moiety.   
 
4.2.7 Kinetic Measurements 
All substitution reactions were performed under pseudo first-order conditions. The 
concentrations of the nucleophiles studied were kept at least 10-fold excess over (Pt1 
and Pt2) or (20-fold excess for Pt3) metal complexes to ensure that the reactions go for 
completion. All kinetic runs were performed at pH of 2 and at a constant ionic strength 
of 0.02 M. All the wavelengths used for the kinetic runs were predetermined using 
UV/visible spectrophotometer by observing the absorbance of the reaction mixture 
(metal complex with the nucleophile) as a function of time. A summary of the 
wavelengths used for the kinetic studies is given as Supporting Information in Table 
S4.1. The temperature dependence studies for the reactions were performed in the 
range 15 - 40 °C at 5 °C intervals. Representative graphs are given in Figures S4.3 to 
S4.8. 




4.2.8 Computational Modelling 
Computational modelling for the complexes were performed at Density Functional 
Theoretical (DFT) level based on B3LYP/LanL2DZ35 (Los Alamos National Laboratory 2 
double ξ) level theory, with inner core electrons of platinum atom replaced by relative 
Effective Core Potential (ECP).  Due to low electronic spin of Pt(II), the DFT calculations 
of the complexes were done at singlet state. The complexes were computed in water 
taking into account the solvolysis effect by means of the Conductor Polarizable 
Continum Model (C-PCM).36 The Gaussian09 suite of programs was used for all 
computational calculations.37 A summary of respective bond lengths, the bond angles 
and DFT-calculated natural bond orbital (NBO) charges, highest occupied molecular 
orbital (HOMO) and lowest unoccupied molecular orbital (LUMO) energies obtained 
from the modelled structures of the platinum complexes are given in Table 4.2 (also see 
Tables S4.2 to S4.5) The numbering scheme used is as shown in Figure 4.1.  
 
DFT calculations in gas phase as cations of total charge +2, +4 and +6 respectively for 
Pt1, Pt2 and Pt3, were also repeated by using the software package, Spartan® ’08 for 
Windows®38 using the B3LYP35a density functional method (DFT)39 and the LACVP+** 
(Los Alamos Core Valence Potentials)35c pseudo potential basis set. The LACVP basis set 
employs effective core potentials for K-Cu, Pb-Ag, Cs-La and Hf-Au.40 However, 
somewhat similar results were obtained and are summarized in Table S4.5 for further 
references. 
 
4.3 Results and Discussion 
4.3.1 Synthesis and Characterization 
The three chloro derivatives of Pt(II) complexes were synthesized following literature 
methods11c,29,30 and characterised using 1H NMR, 195Pt NMR, MS and elemental analysis 
(Figures S4.9 to S4.22). The details of the characterisation and spectroscopic data are 
included in the experimental section and also under Supporting Information. The 1H 
NMR spectrum of (Pt1-Cl) (Figure S4.11), shows that one of the CH2 protons overlap 
with the solvent residual peak. Synthesis of Ru(II) moieties, [Ru(tpy)Cl3]29, 
[Ru(qpy)Cl3],11c [Ru(qpy)(tpy)]Cl2 and [Ru(qpy)2]Cl2 have been reported 
previously.21a,41,11c However, due to the poor solubility42 and the paramagnetic nature 
(due to the unpaired electron in one of the t2g orbital of low-spin Ru(III)11c) of 
[Ru(tpy)Cl3]29 and [Ru(qpy)Cl3],11c the two precursors were used as synthesized.21a In 
the 1H NMR spectra of the two heterometallic Ru(II)-Pt(II) complexes, the resonance 
peaks are well resolved and most importantly the ortho protons of the coordinated 




pyridyl ring shows a down field shift in the spectrum of Pt2-Cl relative to the free 
ligand (Figures S4.12 and S4.13). Due to the low symmetry (C2) of Pt3-Cl, chemical 
shifts corresponding only half of the molecule are detected.11c However, signals due to 
ammine groups are not detectable in D2O because of the rapid exchange with the 
deuterated solvent.11c The 195Pt NMR signals were observed between -2300 ppm to -
2600 ppm, typical for square planar NNN coordinated Pt(II) complexes.6c The 
characterization data agreed with the literature and the proposed chemical structures 
of the complexes.11c,21a,41  
 
4.3.2 Acid-base Equilibria of the Aqua Ptlatinum(II) Complexes 
The pKa values were determined from the titration spectra at a specific wavelength. 
Typical UV/visible pKa titration spectra obtained for Pt1 with NaOH is shown in Figure 
4.2. Distinct isosbestic points at the following wavelengths, 230 nm and 238 nm were 
observed as the solution became more basic. For Pt2 and Pt3, more absorbance peaks 
were observed as the ligand systems around the metal centres are more conjugated 
(Supporting Information Figures S4.1 and S4.2 for the corresponding spectra for Pt2 
and Pt3, respectively).  
 
Table 4.1 The pKa values of the deprotonation of the coordinated aqua ligand in mono-, di- 
and tri-nuclear complexes studied. 
Compound Pt1 Pt2 Pt3 
‡pKa1 5.53 ± 0.01 3. 61 ± 0.05 3.01 ± 0.01 
pKa2 N/A N/A 7.08 ± 0.03 
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Figure 4.2 UV/visible spectrum recorded for the titration of 0.019 mM Pt1 with NaOH, in the 
pH range 2 - 9 at 298 K. Inset is the plot of absorbance against pH at 275 nm. 
 
The pKa1 values for the deprotonation of the coordinated aqua ligand(s) follow the 
order, Pt3 (3.01 ± 0.01) < Pt2 (3. 61 ± 0.05) < Pt1 (5.53 ± 0.01) even though the chelate 
effect is kept constant. The observed decrease in the pKa in Pt2 and Pt3 compared to 
Pt1 is probably due to the replacement of the pyridyl by the octahedrally coordinated 
(qpy)Ru(tpy) or Ru(qpy)2 moiety as the chelate effect is kept constant.  
 
The pKa values indicate the degree of the electrophilicity of the metal complexes,43 
following the order; Pt3 > Pt2 > Pt1. Thus, introducing the Ru(II) moiety as a cis linking 
unit to the Pt(II) centre increases the overall charge and the electrophilicity of the 
heterometallic complex thereby increasing the overall acidity of the coordinated aqua 
ligand(s).7b As already known,6b,7b,34b this charge addition is prominent if the distance 
between the two platinum centres is shorter.  
 
The diaqua complex, Pt3, showed a stepwise deprotonation, with the lowest pKa value. 
This smallest pKa1 might be attributed to the higher overall positive charge (+6) which 
is a clear indication of an increased acidity on attaching a second Pt(en)py unit to Pt2, a 
factor which enhances substitution reactivity. It is also noted that the second 
deprotonation of the coordinated aqua ligand in Pt3 occurs at a higher pKa2 (7.08 ± 




0.03) than that of the first pKa1 (3.01 ± 0.01) and is attributed to decrease in the overall 
charge on the platinum complex by deprotonation of the first aqua ligand as reported 
previously.6a,b,6d,7b  
 
Since the position of the 195Pt NMR resonance influences the donor strength of the 
ligands coordinated to the Pt(II) centre, the observed pKa trend is further supported by 
the changes in the 195Pt NMR chemical shifts obtained for Pt1 (-2501), Pt2 (-2530) and 
Pt3 (-2534 ppm). As the ethylenediamine chelate ligand is kept constant for all the 
three complexes, the changes in the pKa is an indication of the strength of the σ-
inductive effect of the cis pyridyl moiety attached to the Pt(II) centre which controls the 
bacisity of the aqua complexes.  The smaller difference between the pKa1 values of Pt2 
and Pt3 (0.6) units indicate the similarity of the cis pyridyl moieties in Pt2 and Pt3 and 
hence the difference between them is a result of the increase in the overall charge.44 
 
4.3.3 Computational Calculations  
In order to understand the relation between the electronic structures and the 
substitution reactions of the aqua complexes, the molecules were optimized at the DFT 
level using B3LYP functional with LANL2DZ basis set as this setting has been reported 
to be reliable for Ru(II) complexes.45 An extract of the data obtained from gaussian09 















Table 4.2  Summary of DFT calculated data for the complexes using Gaussian09 software 
package based on B3LYP and LanL2DZ basis set.  
Parameter Pt1 Pt2 Pt3 
Bond lengths, Å     
Pt–OH2
 
    2.110     2.111     2.107 
Pt–Ntrans    2.052     2.052     2.050 
Pt–Ncis(HN2)    2.082     2.085     2.085 
Pt–Ncis(py)    2.051     2.057     2.058 
Ru–Pt   11.15   11.15 
Pt–Pt     22.31 
H(py) ortho –Pt   2.993    3.037     3.051 
Bond angles, °    
Twist of 4’-py from plane of terpyridine ligand    35.53   30.31 
deviation of py (relative to Pt(II) coord. plane) 87.93   92.84   92.95 
NBO charges    
Pt    0.736     0.740     0.742 
Ru      0.315     0.320 
Ntrans    -0.813    -0.837    -0.812 
Ncis (py)   -0.516    -0.510    -0.510 
Ncis (NH2)   -0.837    -0.812    -0.812 
O (H2O)   -0.913    -0.915    -0.914 
Orbital Energy / eV    
HOMO     -7.00    -6.30    -6.40 
LUMO    -2.11    -3.16    -3.25 
∆EHOMO - LUMO      4.89      3.14      3.15 
η / eV      2.44      1.57      1.58 
µ / eV    -4.56    -4.73    -4.83 
ω/ eV     4.25     7.13     7.38 
Point group     C1      C1      C2 
η = chemical hardness, μ = chemical potential and ω = global electrophilicity index.46 
 
DFT calculations reveal that the Pt(II) centres exhibit slightly distorted square planar 
arrangement, typical for Pt(NNN) coordinated centres (Table S4.4).47 The bite angle of 
octahedrally coordinated qpy to the Ru(II) centre is smaller than a typical square 
planar Pt(II)42a centre as expected for octahedral geometry.48 As exhibits from the 
perspective view of the complexes in Table 4.3, the 4’-pyridyl group of qpy is not co-
planar with the terpyridine ligand backbone which is bonded to Ru(II). This is 
necessary to reduce the steric strain due to the hydrogens on the 4’-pyridyl group and 
the hydrogens attached on the central pyridine ring of the terpyridine ligand.47a,49 Due 
for Pt 




to the steric effects caused by the trans NH2 protons of the ethylenediaminne chelate, 
the monodentate pyridyl group lies in a plane which is nearly orthogonal to the plane 
containing the Pt, N, N atoms7b (Figure 4.3). Thus, the π-backbonding between the Pt(II) 
metal centre and the cis pyridyl moiety is minimised11b,50 since the π-acceptor ligand is 





Figure 4.3 Optimized structure of Pt1 (obtained using Gaussian09 software package) 
showing the steric interactions of the protons on the 4’-pyridyl ring owing to the 
NH2 trans protons. Due to the longer distance between the NH2 cis protons and the 
aqua ligand, no hydrogen binding is possible.  
 
DFT calculated HOMO electron density of Pt1 is predominantly on the Pt(II) metal 
centre while in heterometallic complexes, the HOMO electron density mainly lies on the 
Ru(II) metal centre and sparsely on the coordinated pyridyl rings with no electron 
density at the Pt(II) metal centre. The LUMO electron density comprises the 
contributions from the metal centre to the ligands. Thus, the LUMO electrons are 
concentrated on the pyridyl ring in Pt1 while in Pt2 and Pt3, they are located on the 
qpy ligand. This is supported by the decrease in the HOMO-LUMO energy gap by 
incorporation of Ru(II) moiety as indicated in Table 4.2. 
 
A change in the cis-coordinated pyridyl group to a back coordinated Ru(qpy) increases 
the electrophilicity of the Pt(II) centres. However, when increased the number of qpy to 
2, linked by an octahedral Ru(II) does not double the electrophilicity and the reactivity. 
The reactivity of Pt2 and Pt3 are almost equal. This is because the two qpy ligands lie 
orthogonal to each other at the Ru(II) metal centre. Thus, prevents the continuous flow 
of electron density across the two qpy ligands because of orthogonal cut of extended π-
conjugation at the octahedral Ru(II) centre. 




Table 4.3 DFT calculated minimum energy structures and frontier molecular orbitals (HOMO and LUMO) of the complexes investigated. Calculations 
were done using Gaussian09 software package based on B3LYP and LanL2DZ basis set. 
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4.3.4 Kinetics Analyses 
The ligand substitution reactions of the coordinated aqua ligand(s) by thiourea 
nucleophiles were studied as a function of concentration of the nucleophiles at 25 °C. 
The substitution reactions of Pt1 with the nucleophiles were studied on the UV/visible 
spectrophotometer while those of Pt2 and Pt3 were studied on stopped-flow reaction 
analyzer. Only one reaction step, taken to be the substitution of the coordinated aqua 
ligand(s) was observed for all the studied complexes. A representative of time resolved 
kinetic step of the complex Pt2 with DMTU is shown in Figure 4.4. Representative 
spectra for the Pt1 and Pt3 are shown in Figures S4.3 and S4.4. 
 

















Figure 4.4 Kinetic trace obtained at 291 nm for the reaction between Pt2 (2.86 x 10-5 M) and 
DMTU (8.58 x 10-4 M) on stopped-flow at 298 K, I = 0.02 M LiCF3SO3, adjusted with 
LiCl.  
 
The heterometallic complex, Pt3 is symmetrical and the terminal Pt(II) centres are 
spaced sufficiently far apart (22.31 Å), thus, their behaviour is expected to be 
independent from each other.52 Hence, the two square planar Pt(II) centres cannot be 
differentiated by the strong labile thiourea nucleophiles7b,52a as reported by Jaganyi et 
al.7b and van Rudi et al6b,c for dinuclear Pt(II) complexes. Thus, reactivity at each Pt(II) 
centre is independent of the other metal centre. This assertion is further supported by 
the calculated NBO charges on the platinum atoms for Pt3. As a result, the aqua ligands 




of Pt3 are simultaneously substituted. To confirm this, the substitution reaction of Pt3  
as a chloride compound, [Cl(en)Pt(qpy)Ru(qpy)Pt(en)Cl](NO3)4 with excess TU (2 to 
6 equivalence, eqv), was studied by 195Pt NMR spectroscopy at 25 °C. 195Pt NMR 
spectroscopy is a useful method to study the coordination behaviour of Pt(II) 
complexes since the 195Pt resonance is influenced characteristically by the nature of the 
atoms coordinated to the platinum centre.52b An array of the 195Pt NMR spectra for the 




Figure 4.5 195Pt NMR arrays showing the Pt3-Cl with 2 to 6 equivalents of TU, as a function of 
time. t = 0 spectrum of pure Pt3 (δ = -2506 ppm) and the subsequent spectra at t = 
3, 6 and 15 hours.  
 
Prior to the addition of the nucleophile, a signal (δ = -2506 ppm) due to the starting 
complex Pt3 was observed. A new upfield resonance peak, at δ = -3015 ppm appeared 
after 3 hours upon mixing the complex with 2 equivalents of TU. The 195Pt NMR reveals 
the formation of the TU substituted complex, [TU(en)Pt(qpy)Ru(qpy)Pt(en)TU]6+, 
which exhibits a chemical shift at δ = -3015 ppm, typical of PtN3S coordinated 
environment.53 Based on the results obtained for Pt3-Cl by NMR spectroscopy, it is 
clear that the aqua ligands in Pt3 are substituted simultaneously. Furthermore, 195Pt 
NMR spectrum shows that there was no dechelation of the chelate ligand, induced by 
the substituted thiourea nucleophile. A similar observation for complexes that possess 




B = TU susbstituted product
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t = 3 hours
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cis geometry at the Pt(II) centre have been reported with strong sulfur donor 
nucleophiles.26 
 
In all cases the substitution reactions fitted perfectly to a single exponential equation. 
The observed pseudo first-order rate constant, kobs varied linearly with the 
concentration of the nucleophiles and their plots passed through the origin. 
Representative plots of kobs against nucleophiles of the concentration are shown in 
Figure 4.6 (also Supporting Information, Figures S4.5 and S4.6). 



















Figure 4.6 Concentration dependence of the pseudo first-order rate constant, kobs for the 
substitution of aqua ligand in Pt2 with the thiourea nucleophiles at pH = 2, T = 
298 K, I = 0.02 M HCF3SO3, adjusted with LiCF3SO3.   
 
The slopes of the concentration dependence graphs gave the second-order rate 
constants, k2, at 25 °C for the direct attack of the nucleophiles and are summarized in 
Table 4.4. The absence of non-zero intercepts for all the complexes suggest that the 
reactions are irreversible in nature as proposed in Scheme 4.3.  
 




Table 4.4  Summary of the second-order rate constants, k2 and activation parameters, with 
the corresponding standard deviations for the substitution of the aqua ligand(s) 
by a series of thiourea nucleophiles at pH = 2, I = 0.02 M HCF3SO3, adjusted with 
LiCF3SO3. 
Complex Nu k2/M-1 s-1 SΔ /J K-1 mol-1 HΔ / kJ mol-1 
Pt1 TU  22 ± 0.5  -109 ± 6  33± 2 
DMTU  12 ± 0.2  -116 ± 5  33 ± 2  
TMTU    6 ± 0.1    -88 ± 3  42 ± 1 
Pt2 TU 61  ± 0.9     -24 ± 9   57 ± 3 
DMTU 38  ± 0.5     -30 ± 10  57 ± 3 
TMTU     6 ± 0.1   -68  ± 2  48  ± 1  
Pt3 TU  66 ± 0.7     -23 ± 5  56 ± 2 
DMTU 41  ± 0.7     -81 ± 4 39  ± 1   
TMTU   8  ± 0.2     -53 ± 11    54 ± 4  
 




































Nu = TU, DMTU and TMTU
n = 2 in  Pt1, 4 in Pt2 and 6 in Pt3
x = 1 in Pt1 and Pt2, 2 in Pt3
+  xH2O
 
Scheme 4.3 Proposed reaction mechanism for the substitution of aqua ligand(s) by thiourea 
nucleophiles studied. 
Thus, the corresponding associative rate law can be written as Equation 4.4: 
                                                           kobs = k2[Nu]                                                                         (4.4) 
The temperature dependence of the second-order rate constants were studied over a 
temperature range of 15 °C - 40 °C in 5 °C intervals. The resulting thermodynamic 
activation parameters, entropy of activation ( S ) and enthalpy of activation ( H ) 
were obtained by Eyring equation and the data obtained are summarized in Table 4.4 
and representative Eyring plots are shown in Figure 4.7 (also Supporting Information 
Figures S4.7, S4.8 and Tables S4.6 to S4.11).  


























Figure 4.7 Eyring plots for the reaction of Pt2 with the nucleophiles for the substitution 
reactions over the temperature range 15 - 40 °C at pH = 2, T = 298 K, I = 0.02 M 
HCF3SO3, adjusted with LiCF3SO3. 
 
Data in Table 4.4 clearly indicate that when a Ru(qpy) moiety replaces the pyridyl 
ligand of Pt(en)(py) through the 4’-pyridine ring of Ru(qpy), the resultant cis 
heterometallic complex is more reactive towards the incoming nucleophiles studied. 
When the rate constants of the aqua complexes are compared, using Pt1’s rate constant 
as the common denominator, the ratio of the rate constants for the substitution of aqua 
ligands by TU is 1 : 2.78 : 2.98, respectively for Pt1, Pt2 and Pt3. A similar trend is 
observed for the substitution of aqua ligand by DMTU and TMTU. Thus, the rate of 
substitution of aqua ligand(s) by the S-donor thiourea nucleophiles increased in the 
order: Pt3 ≈ Pt2 > Pt1.  
 
The reactivity increased by almost three fold from Pt1 to Pt2 by incorporation of the 
(tpy)Ru(qpy) moiety. DFT calculations show that attachment of the (qpy)Ru(tpy) 
moiety slightly increases the Pt―Ncis(py) bond from Pt1 (2.051 Å) to Pt2 (2.057 Å), this 
small change may be attributed to the pulling of bonding electrons towards the qpy 
linker. The net effect of this is a slight increase in the positive NBO charge on the Pt(II) 
metal centre of Pt2. Thus, it seems that tridentate coordination of qpy to Ru(II) 
enhances the electronic transitions from the Pt(II) metal centre towards the pyridyl 




group.54 Electrochemical and TD-DFT computational studies reported by Gagliardo      
et al.55 for heterometallic Ru(II)-Pd(II) complexes linked by a similar terpyridine linker, 
4’-{4-BrC6H2(CH2NMe2)2-3,5}-2,2’:6’,2’’-terpyridine (TPBr) showed the existence of 
electronic intermetal communication between Ru(II) and Pd(II) metal centers, due to 
the presence of the aromatic linker.55 Such intermetal electronic communications 
between the adjoining metal centers have also been reported for polymetallic Ru(II) 
complexes with tetra-2-pyridyl-1,4-pyrazine (tppz) aromatic linkers.56 However, unlike 
the work reported in Chapter 3, electronic interactions between the metal centres 
decrease when the pyridyl group was attached to the 4’-position of the terpyridine 
moiety as such electronic interactions become less effective with longer separations 
between the metal centres.57 Also, in Pt2, the orthogonal geometry of the cis pyridyl 
moiety to the plane of Pt(II) centres further reduces possible electronic transitions 
between the two metal centres.  
 
Coordination of Ru(II) moiety to Pt1 decreases the energy of LUMO (π*) orbitals 
resulting in a smaller HOMO-LUMO gap as in Pt2 (3.14 eV) to that of Pt1 (4.89 eV). This 
makes it easier to transfer the electrons from the HOMO to the empty LUMO (π*) 
orbitals. Such decrease in HOMO-LUMO gaps have been reported12d for heterometallic 
Ru(II)-Pt(II) complexes and was attributed to the stabilization of the anti-bonding 
orbital of the aromatic bridging ligand on coordinating the Ru(II) moiety to the Pt(II) 
metal centre. The decrease in LUMO energy stabilizes the five coordinate transition 
state complex by enhancing the transfer of electrons from the 18 electron transition 
state complex to the qpy ligand, which in turn enhances the approach of the incoming 
nucleophile.11b,42b,52 Furthermore, reactivity increases with the increase in deviation of 
the pyridyl group from the square planar Pt(II) plane from 87.93° to 92.84° 
respectively for Pt1 to Pt2, however small, might enhancing the ease of the nucleophile 
to approach the metal centre.11b  
 
Additionally, in each case, the cis pyridyl group is nearly perpendicular to the Pt(II) 
centre, in such a way that the ortho-hydrogen atoms (Hortho) on the pyridyl group 
imposes some degree of steric hindrance to the aerial approach of the nucleophiles.44 
An equal amount of steric hindrance would be felt on both above and below the square 
planar Pt(II) metal centre. This aerial steric hindrance, despite small, decreases on 
moving from Pt1 (2.993 Å) to Pt2 (3.037 Å) to Pt3 (3.051 Å) (Figure 4.8, Table 4.2). As 
expected, the decrease in steric hindrance results in an increase in the substitution 




reactivity from Pt1 to Pt2 to Pt3. This steric influence certainly plays a role in 







Figure 4.8 Schematic representation of the aerial steric effect due to the ortho-H atoms on 
the cis pyridyl moiety. Optimized structure obtained for Pt1 from computational 
calculations using Gaussian09 software package. 
 
Another factor which may lead to the higher reactivity of Pt2 compared to Pt1 is the 
increase in the overall charge of the complex which enhances the electrophilicity and 
hence, the reactivity of the complex. The DFT calculated HOMO electron density of Pt1 
lies on the Pt(II) metal centre while in Pt2 it is centred on the Ru(II) metal centre and 
the capped tpypyridine ligand leaving the Pt(II) metal centre electron free. This 
indicates that Ru(II) moiety accommodates the electron density. DFT calculated higher 
global electrophilicity index46c along with the smaller pKa1 obtained for Pt2 further 
support its higher electrophilicity compared to that of Pt1.6a,b,11b,47c If all the facts are 
combined together, it can be concluded that the (tpy)Ru(qpy) lowers the energy of anti-
bonding LUMO, hence enhances the removal of electron density from the Pt(II) centre 
making it more electrophilic whereby increasing the substitution reactivity.  
 
A comparison of the reactivity of Pt3 is not significantly different from that of Pt2 
despite the increase in the overall charge of the complex.6c,9 The octahedral geometry of 
the linking Ru(qpy)2 does not permit extended π-conjugation between the coordinated 
qpy ligands, which would further increase the reactivity. As such, the effect of the 
octahedrally coordinated qpy ligands on the reactivity is independent of each other 
since the π-extended molecular orbital in each qpy are mutually orthogonal at the 
Ru(II) metal centre. The Ru(II) ion acts as an orthogonal shatter to the flow of 
delocalization of π-electron density across the entire semi-rigid linker.   
 




Keeping in mind that coordination of the Ru(II) moiety to the Pt(II) metal centre 
stabilizes the π* orbitals of the aromatic bridging linker, one notices that when the 
second Pt(II) moiety is added to Pt2, the resulting LUMO orbitals of Pt3 decreases 
slightly compared to the difference observed between Pt1 and Pt2. The slightly higher 
reactivity of Pt3 to that of Pt2 is attributed to the increased overall charge along with 
the DFT calculated slightly decreased LUMO (π*) energy and the higher global 
electrophilicity index, (ω) of Pt3.46a,b,58 Thus, Pt3 has a slightly greater potential to 
accept electrons from the incoming nucleophiles, despite its lower HOMO energy,46a,59 
hence, the observed reactivity.46c,d The similar reactivity is further supported by the 
similar pKa1 values obtained for both Pt2 and Pt3. 
 
The slightly higher reactivity of Pt3 can also be due to the enhanced metal-metal 
couplings in Pt3. Since qpy is a semi-rigid linker, there is some degree of 
conformational freedom in terms of rotation around the C―C single bond (C1 C1’, 
Figure 4.1 and also see Figure S4.23, Table S4.12) between the parent terpyridine 
backbone and the 4’-pyridyl moiety. Such tilt angles between the subunits of aromatic 
linkers play a crucial role on the degree of metal-metal interactions and electronic 
transitions in supramolecular complexes.60 Since the DFT calculated tilt angle between 
the 4’-pyridyl group and the plane of terpyridine backbone, in Pt3 (30.31 °) is slightly 
smaller than that of Pt2 (35.53 °), the metal-metal interactions and electronic 
transitions in Pt3 is expected to be slightly higher. This somewhat influences the 
reactivity. Furthermore, the slight increase in the planarity of the qpy linker in Pt3 is 
also responsible for the observed red shifted metal to ligand charge transfer (MLCT) 
absorption maximum in Pt3 as depicted in Figure 4.9. This has been reported60-61 and 
was attributed to the enhanced metal-metal coupling and electronic interactions along 
with the enhanced π-backbonding within the complex.60  





















Absorption maxima at 
490 nm shifted to the
red in Pt3
 
Figure 4.9 UV/visible spectra of Pt1-Cl, Pt2-Cl and Pt3-Cl in methanol (0.008 mM). 
 
The complexes investigated are sensitive towards the steric hindrance of the incoming 
nucleophiles. In all cases, the rate was fastest for TU, following the order TU > DMTU > 
TMTU and is in line with the steric effect of DMTU and TMTU.7b,47a TMTU was the 
slowest due to the bulkiness of the nucleophile. 
 
The observed relatively low enthalpy of activation ( H ) and negative entropy of 
activation ( S ) support for associative mode of activated process, typical for square 
planar platinum complexes.6b,62 The characteristic negative S  values is a result of 
bond formation in the transition state.6b,62e However, the smaller entropy of  activation 
obtained for both Pt2 and Pt3 compared to that Pt1 might be due to the re-
organisation of the solvent52a causing an increase in the entropy which cancels out the 










In conclusion, the results of the 195Pt NMR experiment shows that cis geometry confers 
stability26 which precludes labilization of the Ru(qpy) linker unlike what has been 
reported for substitution reactions involving complexes of trans geometry with sulfur 
donors.63,44 Also unlike bridged cis Pt(II) complexes reported,28,50 the cis Ru(II) moiety 
enhances the substitution reactivity. Apart from the increased overall charge and the 
electrophilicity, the octahedrally coordinated Ru(II) moiety lowers the energy of anti-
bonding LUMO (π*) orbitals whereby enhancing the metal-metal interactions and 
electronic transitions within the molecule. This seems to have changed the electronic 
structure of the system sufficiently enough to promote the reactions as observed from 
the reactivity trend Pt3 ≈ Pt2 > Pt1. The reactivity of Pt2 and Pt3 are almost equal 
since the qpy ligands lie near orthogonal planes at the Ru(II) metal centre, which 
prevents the efficient flow of extended π-electron density through the three metal 
centres as supported by the pKa1. However, DFT calculations and the spectroscopic data 
show a slight increase in metal-metal coupling on increasing the number of metal 
centres and the qpy ligand in Pt3 compared to Pt2. The observed enthalpy of 
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4.6 Supporting Information 
A summary of wavelengths at which the kinetic studies were performed, spectra 
obtained for titrations of Pt2, Pt3 with NaOH, spectral absorbance change for Pt1 with 
TU and plots of the dependence of kobs against concentration of the nucleophiles and 
plots from temperature dependence studies along with tables of kinetic data, graphs of 
exemplary mass spectra for qpy ligand and Pt1, exemplary spectrum for microanalysis 
of Pt1 and the representative spectra for 1H NMR and 195Pt NMR work reported in this 
study are given as electronic supporting information (ESI). 
  
Table S 4.1 Summary of the wavelengths (nm) used to study the substitution reactions of the 
complexes with thiourea nucleophiles. 
Complex Nu Wavelength (λ), nm 
 TU 273 
Pt1 DMTU 274 
 TMTU 274 
 TU 291 
Pt2 DMTU 291 
 TMTU 296 
 TU 284 
Pt3 DMTU 284 















Table S 4.2  Geometry-optimised structures of the platinum complexes investigated and 
distribution of the electron density on the platinum complexes investigated. The 
blue area indicates the most electropositive areas and the red region indicates the 





















Table S 4.3  Calculated minimum energy structures, frontier molecular orbitals (HOMO and 
LUMO) for the Ru terpyridine moieties; Ru(tpy)2 and Ru(qpy)2. 

























Table S 4.4  Summary of DFT calculated data for the complexes investigated. Included are the 
data obtained for the DFT calculated Ru(II) analogues; Ru(tpy)2, Ru(tpy)(qpy) and 
Ru(qpy)2 for comparisons. 
Parameter Pt1 Pt2 Pt3 Ru(tpy)2 Ru(tpy)(qpy) Ru(qpy)2 
Bond lengths, Å        
Ru – Pt  11.15 11.247    
C3–C1’(dipyridine)  1.485 1.488  1.488 1.488 
Ru–Ntrans(qpy)  2.002 2.016  2.004 2.005 
Ru– Ntrans(tpy)  2.013  - 2.009 2.011  
Bond angles, °       
Ncis–Pt–Ncis
 
 177.99 177.95 178.16    
OH2 – Pt - Ntrans 174.51 175.36 174.99    
Ntrans–Pt–Ncis(py) 94.07 94.25 94.46    
Ntrans–Pt–Ncis(NH2) 83.93 83.76 83.83    
Ncis(py) –Pt–OH2 91.17 90.35 90.57    
Ncis(NH2) –Pt–OH2 90.83 91.62 91.18    
Ncis–Ru–Ncis (tpy)  157.64  157.80 157.77  
Ncis–Ru–Ncis (qpy)  157.82 157.65  157.72 157.60 
Ntrans–Ru–Ntrans   179.97 179.90 179.99 179.97 179.99 
Deviation of (en) 
(relative to coord. 
plane) 
12.23 14.13 14.29    
Angle of inclination of 
water from Pt plane 
1.64 4.59 5.23    
NBO charges       
O (H2O)   -0.913  -0.915  -0.914    
Ru    0.302 0.312 0.316 
Ncis (py)     -0.528 -0.528 
N4  -0.404 -0.510 -0.410 -0.408 -0.409 
N5  -0.420 -0.405 -0.421 -0.420 -0.421 
N6  -0.420 -0.420 -0.421 -0.420 -0.421 
N7  -0.412 -0.510 -0.410 -0.421  
N8  -0.421 -0.420 -0.421 -0.411  
N9  -0.421 -0.420 -0.421 -0.421  
C1 -0.087 0.105 0.104  0.061 0.061 
C2 -0.226 -0.212 -0.211  -0.234 -0.234 
C3 -0.148 0.005 0.004  -0.030 -0.030 
C4 -0.226 -0.212 -0.211  -0.234 -0.234 
C5 -0.088 0.103 0.106  0.061 0.061 
C1’       - -0.008 0.005  0.002 0.002 
C6 -0.207 -0.207 -0.207       -     - 
C7 -0.210 -0.209 -0.210       -     - 
Energy gap, eV        
HOMO    -6.18 -6.23 -6.26 
LUMO    -2.78 -2.99 -2.96 
∆EHOMO - LUMO    3.40 3.24 3.30 
Symmetry    D2d C2 C2 




Table S 4.5  Summary of DFT calculated data from Spartan08 Computational calculations for 
the complexes investigated. Data included for references. 
Parameter Pt1 Pt2 Pt3 
Bond lengths, Å     
Pt–OH2
 
 2.136 2.136 2.136 
Pt–Ntrans 2.052 2.056 2.057 
Pt – Ncis(HN2) 2.105 2.093 2.088 
Pt – Ncis(py) 2.066 2.091 2.108 
Ru – Pt  11.19 11.24 
Pt–Pt   22.49 
Bond angles, °    
Twist of 4’-py from plane of tpy ligand  36.10 39.44 
deviation of py (relative to Pt(II) coord. plane) 89.83 94.98 96.61 
NBO charges    
Pt   1.182  1.185 1.186 
Ru   0.999 0.996 
Ntrans  -0.943 -0.943 -0.944 
Ncis (py) -0.653 -0.652 -0.642 
Ncis (NH2) -0.974 -0.967 -0.963 
Energy gap, eV     
HOMO -14.52 -14.14 -16.78 
LUMO -9.37 -11.87 -13.77 
∆EHOMO - LUMO   5.15   2.27   3.01 
η /eV   2.58   1.14   1.51 
µ/ eV -11.95  -13.01  -15.28 
ω/ eV   27.65   74.19   77.26 
 





























Figure S 4.1 UV/visible spectrum for the titration of Pt2 (5.0 x 10-5 M) with NaOH, pH range 
from 2 - 9 at 298 K. Inset is the titration graph of absorbance verses pH at 327 nm 
from pH 2 - 6. 





















































Figure S 4.2  UV/visible spectrum for the titration of Pt3 (2.5 x 10-5 M) with NaOH from pH 2 - 9 
at 298 K. Inset are the titration graphs of absorbance verses pH at 297 nm. 
































Figure S 4.3 Spectrum obtained from Cary UV/Visible spectrophotometer for the substitution 
of H2O from Pt1 (1.850 x 10-5 mol dm-3) with Tu (2.780 x 10-4 mol dm-3) in 
methanol solution at pH = 2, T =  298 K, I = 0.02 M HCF3SO3, adjusted with 
LiCF3SO3. Inset is the time resolved kinetic trace obtained at 273 nm. 




















Figure S 4.4 Kinetic trace at 284 nm for the reaction of Pt3 (1.248 x 10-5 mol dm-3) with TU 




Figure S 4.5  Concentration dependence of the pseudo first-order kobs for the substitution of 
aqua ligand in Pt1 with the thiourea nucleophiles at pH = 2, T =  298 K, I = 0.02 M 
HCF3SO3, adjusted with LiCF3SO3. 
  
 






















Figure S 4.6 Concentration dependence of the pseudo first-order kobs for the substitution of 
aqua ligand in Pt3 with the thiourea nucleophiles at pH = 2, T =  298 K, I = 0.02 M 
HCF3SO3, adjusted with LiCF3SO3. 
 
 
Figure S 4.7 Eyring plots obtained for Pt1 with the nucleophiles for the substitution reactions 
over the temperature range 15-40 oC at pH = 2, T =  298 K, I = 0.02 M HCF3SO3, 
adjusted with LiCF3SO3. 
 











































Figure S 4.8 Eyring plots obtained for Pt3 with the nucleophiles for the substitution reactions 
over the temperature range 15-40 oC at pH = 2, T =  298 K, I = 0.02 M HCF3SO3, 
adjusted with LiCF3SO3. 
 
Table S 4.6  Average observed rate constants, kobs s-1, for the displacement of the aqua ligand 
in Pt1 with thiourea nucleophiles, at pH = 2, T =  298 K, I = 0.02 M HCF3SO3, 
adjusted with LiCF3SO3. 
TU DMTU TMTU 
Conc, mM kobs., s-1 Conc, mM kobs., s-1 Conc, mM kobs., s-1 
0.093 0.00185 0.093 0.00121 0.093 0.000473 
0. 185 0.00363 0. 185 0.00218 0. 185 0.00102 
0. 278 0.00591 0. 278 0.00322 0. 278 0.00165 
0. 370 0.00811 0. 370 0.00469 0. 370 0.00213 






























Table S 4.7  Temperature dependence of k2 M-1s-1, for the displacement of the aqua ligand in 
Pt1 by thiourea nucleophiles at 30-fold excess over [Pt1], pH = 2, I = 0.02 M 
HCF3SO3, adjusted with LiCF3SO3. 
TU DMTU TMTU 
1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 
0.00347 -3.04956 0.00347 -3.65076 0.00347 -4.5056 
0.00341 -2.8304 0.00341 -3.40433 0.00341 -4.21024 
0.00335 -2.64079 0.00335 -3.24791 0.00335 -3.91537 
0.0033 -2.4258 0.0033 -2.98288 0.0033 -3.60702 
0.00325 -2.13686 0.00325 -2.76149 0.00325 -3.37426 
 
Table S 4.8  Average observed rate constants, kobs s-1, for the displacement of the aqua ligand 
in Pt2 with thiourea nucleophiles, at pH = 2, T =  298 K, I = 0.02 M HCF3SO3, 
adjusted with LiCF3SO3. 
TU DMTU TMTU 
Conc, mM kobs., s-1 Conc, mM kobs., s-1 Conc, mM kobs., s-1 
0.143 0.00956 0.286 0.00954 0.286 0.00172 
0.286 0.01813 0.572 0.02208 0.572 0.00343 
0.429 0.02732 0.857 0.0341 0.857 0.00513 
0.572 0.03543 1.14 0.04421 1.14 0.00647 
0.715 0.04252 1.43 0.05356 1.43 0.0081 
 
Table S 4.9  Temperature dependence of k2 M-1s-1, for the displacement of the aqua ligand in 
Pt2 by thiourea nucleophiles at 60-fold excess over [Pt1], pH = 2, I = 0.02 M 
HCF3SO3, adjusted with LiCF3SO3. 
TU DMTU TMTU 
1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 1/T, K-1 In(k2/T) 
0.00341 -2.32889 0.00341 -2.26821 0.00347 -4.56526 
0.00335 -2.0545 0.00335 -1.8327 0.00341 -4.24356 
0.0033 -1.58638 0.0033 -1.40179 0.00335 -3.90906 
0.00325 -1.20635 0.00325 -1.11602 0.0033 -3.55237 
0.00319 -0.89219 0.00319 -0.84015 0.00319 -2.96939 
  
  




Table S 4.10  Average observed rate constants, kobs s-1, for the displacement of the aqua ligand 
in Pt3 with thiourea nucleophiles, at pH = 2, T =  298 K, I = 0.02 M HCF3SO3, 
adjusted with LiCF3SO3. 
TU DMTU TMTU 
Conc, mM kobs., s-1 Conc, mM kobs., s-1 Conc, mM kobs., s-1 
0.25 0.01647 0.312 0.01496 0.312 0.00266 
  
0.624 0.02546 0.624 0.00435 
0.374 0.02535 0.936 0.04083 0.936 0.0078 
0.499 0.0331 1.25 0.05032 1.25 0.00991 
0.624 0.0402 1.56 0.06337 1.56 0.01342 
 
Table S 4.11  Temperature dependence of k2 M-1s-1, for the displacement of the aqua ligand in 
Pt3 by thiourea nucleophiles at 60-fold excess over [Pt1], pH = 2, I = 0.02 M 
HCF3SO3, adjusted with LiCF3SO3. 
TU DMTU TMTU 
1/T, K-1 In(k2/T) 1/T, K-1 1/T, K-1 In(k2/T) 1/T, K-1 
  0.00347 -2.41624 0.00347 -4.45185 
0.00341 -1.87293 0.00341 -2.13461 0.00341 -4.05136 
0.00335 -1.48116 0.00335 -1.92194 0.00335 -3.57791 
0.0033 -1.13116 0.0033 -1.57576 0.0033 -3.3836 
0.00325 -0.71432 0.00325 -1.39421 0.00325 -3.01378 
0.00319 -0.42996 0.00319 -1.09062   
 






























































































































































































































































































Figure S 4.14 195Pt NMR spectrum of Pt3-Cl. 
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Figure S 4.17  High resolution ESI mass spectrum of 4’-(4’’’-pyridyl)2,2’:6’,2’’-terpyridine (qpy). 
 





Figure S 4.18 High resolution ESI mass spectrum of Pt1-Cl. 





Figure S 4.19 Low resolution ESI mass spectrum of [Ru(qpy)(tpy)Cl2]. 





Figure S 4.20 Low resolution ESI mass spectrum of Pt2-Cl. 





Figure S 4.21  Low resolution ESI mass spectrum of [Ru(qpy)2Cl2]. 
 





Figure S 4.22 Low resolution ESI mass spectrum of Pt3-Cl.






2-acetylpyridine (5 g, 4.13 mol), was added to a suspension of NaOH in polyethylene 
glycol (PEG 300) (35 mL) and the reaction mixture was stirred for 10 minutes at 0 °C. 
4-pyridine carboxaldehyde (2.21 g, 2.06 mol) was added to the suspension and left at 0 
°C for 2 hours. The reaction mixture was stirred manually in every 15 minutes due to 
the high viscosity of the reaction mixture.  After this time, excess NH4OAc (10 g) was 
added and the suspension was heated at 100 °C for 2 hours. Brown precipitate was 
formed from the initially formed red solution. Water (75 mL) was added to the 
precipitate. The precipitate was filtered, washed with more water (50 mL) followed by 
cold ethanol (10 mL). The ligand was recrystallized from ethanol. Yield: 3.5 g, (55 %). 
Crystal good for X-ray determinations were obtained by recrystallizing the ligand in 
ethanol and slow evaporation of the solvent.  
 
Preparation of about 0.1 M Ruthenium(III) Solution 
RuCl3·3H2O (~1.5 g, 5.7 mmol) was refluxed in a mixture (70 mL) of a 1 M HCl and 
EtOH (v:v = 1:1) for 3 hours. The mixture was cooled and filtered. The filtrate was 
reduced in vacuo to 10 mL. An aqueous solution of 1 M HCl was used to dilute the 
solution to the required acidified ~ 0.1 M Ru(III) solution. 
 
[Ru(tpy)CI3]  
Equal amounts of RuCl3· 3H20 (~150 mg, 0.574 mmol) and terpyridine were refluxed in 
absolute EtOH (125 mL) for 3 hours. The resulting reaction mixture was cooled toom 
temperature and the precipitate was filtered, washed with cold absolute EtOH (5 mL) 
followed by copious amount of eithethylether and dried under vacuo. Yield: 191 mg, 
433 mmol, (76 %), brown precipitate. 
 
[Ru(qpy)Cl3] 
The Ru moiety was synthesized following the literature. The ligand qpy (100 mg; 
0.323 mmol) was refluxed in MeOH (25 mL) until it dissolved. To this solution, a 
0.1 M Ru(III) solution (3.25 mL; 0.33 mmol) was added drop-wisely. The 
reaction mixture was refluxed for 1.5 hours. The precipitated crude product was 
filtered hot. The filtrated was cooled to 253 K, which resulted in the 
precipitation of a relatively pure product. The product was filtered and dried. 
Yield: 84 mg, 0.162 mmol (49%). 





This Ru moiety was synthesized by a slight modification of the literature method.11c To 
a filtered solution of AgBF4 (240 mg; 1.232 mmol) in acetone (15 mL), [Ru(tpy)Cl3] 
(40 mg; 0.080 mmol) was added. The reaction mixture was refluxed for 18 hours in the 
dark after which the precipitated AgCl was removed by filtration. The filtrate was 
concentrated to 1 mL in vacuo. Into the resulting green oil the ligand qpy (43 mg, 0.148 
mmol) was added and the mixture was refluxed for 2 hours in DMF (20 mL) which 
reduced Ru(III) to Ru(II).  The reaction mixture was filtered and concentrated in vacuo 
to (1.0 mL) which gave a red oil. A saturated solution of LiCl (2 mL) in EtOH was added 
to the red oil. A precipitate was formed on adding the oil to acetone (200 mL). The 
precipitate obtained was purified by column chromatography on neutral alumina using 
CH3CN: EtOH (50: 50) as the eluent. The first red band was collected and was 
lyophilised with diethylether.  Recrystallization of the precipitate with a mixture of 
MeOH and diethylether yielded a relatively pure product. 
 
[Ru(qpy)2]Cl2 
The Ru moiety was synthesized by a slight modification of the literature method.11c  To 
a filtered solution of AgBF4 (350 mg; 1.798 mmol) in acetone (20 mL), [Ru(qpy)Cl3] 
(68.9 mg; 0.133 mmol) was added. The reaction mixture was refluxed for 18 hours in 
the dark after which the precipitated AgCl was removed by filtration. The filtrate was 
concentrated to 1 mL in vacuo. To the resulting green oil, the ligand qpy (46 mg, 0.147 
mmol) was added and the mixture was refluxed for 2 hours in DMF (25 mL) which 
reduced Ru(III) to Ru(II). The reaction mixture was cooled to room temperature and 
filtered. The red filtrate was reduced to 1 mL to afforded a  red oil. A saturated solution 
of LiCl (6 mL) in EtOH was then added to the red oil. A precipitate was formed on 
adding acetone (400 mL). The precipitate was purified by column chromatography on 
neutral alumina using acetone: MeOH: EtOH (3: 6: 1) as the eluent. The first red band 
was collected and lyophilized with diethylether gave a relatively pure product. 
 
Pt(en)Cl2 
The platinum complex was synthesized following a literature procedure.31 Into an 
aqueous solution of K2PtCl4 (125 mg, 0.300 mmol), an aqueous solution of ethane-1,2-
diamine (0.018, 0.300 mmol) was added drop wise. The pH of the solution was brought 
to 6. The reaction mixture was stirred at 313 K. During the reaction, the pH of the 
solution was maintained between 5- 6 using 0.1 M NaOH. The reaction was stopped 




when the pH of the solution no longer changed. The yellow precipitate which formed 
was filtered, washed with water and ethanol and dried.  
Yield: 0. 068 g, (70%), yellow powder.  1HNMR (400 MHz, DMF) δ/ ppm: 5.54 (4H, br , 
NH), 2.79 (4H, br), 195Pt  (-3298).  
 
Pt2-Cl 
This compound was synthesized by a slight modification of the literature method.11c  To 
a stirred solution of [Pt(en)(py)Cl]Cl (56 mg, 0.168 mmol)) in 5 mL of DMF at 310 K, 
AgNO3 (28 mg, 0.168 mmol) in DMF (10 mL) was added drop wise over three hours. 
Subsequently the reaction mixture was stirred for 24 hours at 313 K. After removing 
the formed AgCl precipitate using a 0.45 μm nylon membrane filter (Millipore), 
[Ru(tpy)(qpy)]Cl2 (120 mg, 0.168 mmol) was added to the filtrate and the mixture was 
stirred for another 18 hours. The reaction mixture was cooled to room temperature 
and filtered. The filtrate was concentrated in vacuo and co-evaporated three times with 
EtOH/MeOH (50: 50) (20 mL) to remove DMF. The precipitate formed was redissolved 
in MeOH. The desired product was precipitated with slow addition of diethylether. 
 
Pt3-Cl 
The compound was synthesized by a slight modification of the literature method.11c To 
a stirred solution of [Pt(en)(py)Cl]Cl (84 mg, 0.252 mmol)) in 20 mL of DMF at 310 K, 
AgNO3 (43 mg, 0.252 mmol) in DMF (15 mL) was added drop wise over three hours. 
Subsequently the reaction mixture was stirred for 24 hours at 313 K. After removing 
the formed AgCl precipitate using a 0.45 μm nylon membrane filter (Millipore), 
[Ru(qpy)2Cl2] (100 mg, 0.126 mmol) was added to the filtrate and the mixture was 
stirred for another 18 hours. The reaction mixture was cooled to room temperature 
and filtered. The filtrate was concentrated in vacuo and co-evaporated three times with 
EtOH/MeOH (50: 50) (25 mL) to remove DMF. The precipitate formed was redissolved 













Needle-like crystals good for X-ray crystallography were obtained by recrystallizing the 
ligand in ethanol. The X-ray crystal structure obtained for qpy ligand which shows that 
the qpy ligand is not planar. The terminal pyridine ring systems adopt a trans-trans 
conformation about the interannular bonds C2—C2’ and C6’—C2’’ (Figure S4.23, Table 
S4.12) as reported previously for terpyridine and 4’-functionalized terpyridine ligand 
systems. Of particular interest is the C5’’’—C4’’’—C4’—C5’ torsion angle since this has 
been shown to be important in determining the crystal structures of platinum 
complexes of the 4´-pyridyl (terpyridine) ligand systems. The value is 25.95°, showing a 
large twist of the 4’-pyridyl group about the C4’’’—C4’ interannular bond i.e. the 4’-
pyridyl group twists out of the plane of the central pyridine ring by a large amount in 
order to minimise steric repulsion between the methyl group and the hydrogen atom 
























Figure S 4.23 Perspective view showing the molecular geometry and atom numbering scheme 
for the qpy ligand. Non-H atoms are drawn as 50% thermal ellipsoids and the H 
atoms as spheres of arbitrary radius. 
 
  




Table S 4.12  Crystal structure, data collection and refinement details 
Parameter  
Empirical formula C10 H7 N2 
Formula weight 155.18 
Temperature 100(2) K 
Wavelength 0.71073 Å 
Crystal system Orthorhombic 
Space group pbcn 
Unit cell dimensions a = 11.082(5) Å α= 90.000(5)°. 
 b = 11.408(5) Å = 90.000(5)°. 





Density (calculated) 1.343 Mg/m3 
Absorption coefficient 0.083 mm-1 
F(000) 648 
Crystal size 0.10 x 0.100 x 0.35 mm3 
Theta range for data collection 2.56 to 31.08°. 
Index ranges -15<=h<=16, -16<=k<=16, -12<=l<=17 
Reflections collected 9744 
Independent reflections 2440 [R(int) = 0.0319] 
Completeness to theta = 25.00° 99.3 % 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2440 / 0 / 111 
Goodness-of-fit on F2 1.041 
Final R indices [I>2sigma(I)] R1 = 0.0519, wR2 = 0.1421 
R indices (all data) R1 = 0.0713, wR2 = 0.1563 
Largest diff. peak and hole 0.308 and -0.224 e.Å-3 
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Understanding the Role of Flexible 4’-Functionalised 
Polyethylene glycoxy Chains on the Behaviour of Platinum(II) 
(4’-(ethylene glycoxy)-2,2':6',2''-terpyridine- A kinetic and a 
Mechanistic Study 
5.0 Abstract 
The ligand substitution kinetics of  4’-functionalized mono nuclear Pt(II) (4’-(ethylene 
glycoxy)-2,2':6',2''-terpyridine complexes of the form; [Pt(nY-tpy)Cl)Cl] (where Y = 
ethylene glycoxy, n = number of ethylene glycoxy units = 1, 2, 3 and 4, tpy = 2,2':6',2''-
terpyridine) with thiourea (TU), 1,3-dimethyl-2-thiourea (DMTU), 1,1,3,3-tetramethyl-
2-thiourea (TMTU) and iodide (Iˉ) were investigated under pseudo first-order 
conditions as a function of concentration and temperature by conventional stopped-
flow technique. The observed first-order rate constants followed the simple rate law 
kobs = k2[Nu]. The data obtained shows that the ethylene glycoxy pendant, trans to the 
leaving group, acts as a σ-donor into the terpyridine ligand and is effective only up to    
n = 1, beyond which the substitution reactivity of the complexes are controlled by the 
steric influence of the appended ethylene glycoxy pendant units, which decreases with 
the increase in the number of ethylene glycoxy units. The activation parameters 
obtained support an associative mode of mechanism, where bond formation in the 
transition state is favoured. The observed reactivity trends were supported by density 
functional theory (DFT) calculations. 
 
5.1 Introduction 
The tridentate N-donor ligand, 2,2':6',2''-terpyridine, also known as tpy, first reported 
by Burstall1 and Morgan,1-2  is one of the most attractive ligands for metal coordination. 
The ligand has very rich chemistry since it can easily form transition metal complexes 
with potential applications in various fields such as biochemistry, photochemistry,3 
nanoscience and supramolecular chemistry.4 In the biomedical applications, 
terpyridine and its derivatives are used as potential sensors for tumour cells5 due to 
their ability to interact with double strand DNA and proteins.3c,6 Some complexes of 
terpyridine were found to be cytotoxic against human ovarian cancer.6b,7 However, 
interactions of some of these complexes with certain biomolecules such as sulfur 




donors were found to exhibit toxic side effects.8 Therefore, the search for obtaining 
better cytotoxic agents with improved side effects is of great focus. So there is need for 
investigating the mechanism of interactions of these compounds with biomolecules and 
DNA. 
 
Recent synthetic techniques have opened new possibilities for the synthesis of 
functionalized terpyridine complexes. More importantly, functionalization in the 4’ 
position by using substituted terpyridine ligands such as 4’-chlorterpyridine or 4’-
hydroxyterpyridine derivatives are of great interest today.9 However, applications of 
functionalized terpyridine complexes have not been fully studied. 
 
In this regard, square planar terpyridine derivatives are useful models for studying the 
substitution behaviour of Pt(II) complexes.9b,10 Only the ligand in the fourth coordinate 
position of terpyridine is replaced in a simple substitution reaction.11 During 
substitution, the π-acceptor orbitals of pyridine units in terpyridine ligand accepts the 
electrons from metal centre including those from the incoming ligand and stabilizes the 
transition state intermediate.12 This π-acceptor effect is responsible for the high 
reactivity of the unfunctionalized Pt(II) terpyridine type complexes. Literature data 
focusing on understanding the substitution kinetics of unfunctionalized terpyridine 
complexes and its derivatives is available.9b,10,13  
 
Mono nuclear Pt(II) terpyridine complexes have been useful in understanding the effect 
of a non-carrier ligand on the rate of substitution at the metal centres.14 It has been 
illustrated from previous studies, that the structure and the electronic properties of the 
chelate ligand backbone control the rate of the ligand substitution of square planar 
metal complexes.10,15 Furthermore, it has also been established that the degree of 
lability of the leaving group is influenced by the σ and π- structural features of the 
ancillary group of the terpyridine ligand system.10,15  
 
The effect of the ancillary group on the π-acceptor property of the terpyridine 
complexes of the form: [Pt(R-tpy)X]+ (where R = H; Ph; Ph(o-CH3); Ph(o-Cl); where Ph = 
phenyl group, X = Cl, OH) has been investigated previously.10,13g,15h Data obtained from 
these studies reveals that electron withdrawing groups on the terpyridine ancillary 
ligand increases the rate of ligand substitution while electron donating groups have the 
opposite effect. The influence of the ligand substitution is also controlled by the extent 
of the π-backbonding from the metal centre to the terpyridine ligand backbone.10,15   




Basolo et al.16 and Tobe et al.17 reported that substitution kinetics of bis(2-
pyridylmethyl)amine complexes possessing appending ancillary groups on the trans 
position of the non-labile ligand system showed that the trans effect was more 
dominant over π-acceptor effect. When electron donating head groups were attached to 
the trans N atom, an increase in the rate of ligand substitution was observed.18 This 
increase in the reactivity was thought to be due to the increased ground state 
stabilization caused by the trans effect of the appended group. Structural variations due 
to such appending groups were thought to enhance the anti-tumour activity of the 
complex in biological systems.19  
 
To extend this understanding we functionalized the terpyridine at 4’-position by 
polyethylene glycoxy groups. We have investigated the ligand substitution behaviour of 
4’-functionalized mono nuclei Pt(II) terpyridine complexes of the form; [Pt(nY-
tpy)Cl)Cl] (where Y = ethylene glycoxy, n = number of ethylene glycox units = 1, 2, 3 
and 4, tpy = 2,2':6',2''-terpyridine) with TU, DMTU, TMTU and Iˉ. The length of the 
polyethylene glycoxy tail is systematically increased by incorporating base 2 – 4 units. 
It is our expectation that the results of this study will reveal the role of flexible poly 
glycoxy pendant groups on the substitution reactions of Pt(II) terpyridine. The 
















































Figure 5.1 Structures of polyethylene glycoxy appended Pt(II) complexes studied. Shown on 
the diagram is the numbering scheme used. Pttpy is included for reference. 
 





5.2.1 Materials  
Methanol (Merck) was distilled over magnesium20 prior to use for kinetic analysis. 
Dimethylsulfoxide (99.9%) from Aldrich was used without any further purification. 
Ethylene glycol (99.8%), diethylene glycol (99%) and triethylene glycol (99%) were 
bought from Sigma Aldrich. The ligand, 4’-chloro,2,2':6',2''-terpyridine (97%), 
tetraethylene glycol (99%), and the platinum salt, potassium tetrachloroplatinate (II) 
(99.9%) were bought from Aldrich. All other chemicals were purchased from Sigma 
Aldrich and were used without further purification. 
 
5.2.2 Synthesis of Ligands   
The syntheses of ligands were carried out by literature procedures.21  To a suspension 
of KOH in dry DMSO at 50 °C was added the ethylene glycol and its respective polymer 
(n = 2, 3, 4) in excess. After stirring for 30 minutes, 4'-chloro-2,2':6',2''-terpyridine was 
added  and the reaction mixture stirred for 20 hours at this temperature. Upon cooling 
to room temperature, the reacting mixture was treated with deionised water and 
filtered. The crude product was extracted from the filtrate in dichloromethane (3 x 30 
mL) dried over anhydrous magnesium sulfate and the solvent removed. 4'-[2-(2-
Hydroxyethoxy)ethoxy]-2,2':6',2''-terpyridine (tpyeg) and 4'-[2-(2-
Hydroxyethoxy)ethoxy]-2,2':6',2''-terpyridine (tpydeg) gave a white paste and a white 
powder respectively. Crude products were purified in THF to give white solids. Ligands, 
4'-{2-[2-(2-Hydroxyethoxy)ethoxy]ethoxy-2,2':6',2''-terpyridine (tpyteg) and 4'-{2-{2-
[2-(2-Hydroxyethoxy)ethoxy]ethoxy}ethoxy}-2,2':6',2''-terpyridine (tpytteg) yielded 
pale yellow oils, pure enough for platination. 
 
The purity of the ligands was confirmed by 1H NMR and mass spectroscopy. The 1H 
NMR spectra obtained show similarity in the aromatic region for the ligands. 
 
(tpyeg): Yield: 250 mg, (70%), off white paste. 1H NMR (400 MHz, CDCl3)† δ/ ppm: 8.63 
(d, 2H, 6 6’’), 8.55 (2H, d, 3 3’’), 7.99 (2H, s, 3’ 5’), 7.79 (dt, 2H, 4 4’’), 7.29 (dt, 2H, 5 5’’), 
4.23 (t, 2H, CH2), 3.97 (t, 2H, CH2). 13C NMR (77 MHz, CDCl3), δ / ppm: 61.1, 69.6, 107.6, 
121.5, 123.8, 136.9, 148.9, 155.6, 157.2, 167.1. TOF MS-ES+, m/z: 316.1062, (M+Na)+. 
                                                          
† s = singlet, d = doublet, t = triplet, dt = doublet of a triplet. The same representation is used for 
the other complexes. 
 




 (tpydeg): Yield: 190 mg, (80%), white powder. 1H NMR (400 MHz, CDCl3) δ/ ppm: 8.69 
(d, 2H, 6 6’’), 8.62 (d, 2H, 3 3’’), 8.13 (s, 2H, 3’ 5’), 7.87 (t, 2H, 4 4’’), 7.35 (t, 2H, 5 5’’), 
4.46 (t, 2H, CH2), 3.94 (t, 2H, CH2), 3.77 (t, 2H, CH2), 3.69 (t, 2H, CH2). 13C NMR (77 
MHz, CDCl3), δ / ppm: 61.7, 68.1, 69.9, 72.8, 108.3, 121.6, 124.0, 137.1, 148.9, 155.7, 
156.7, 167.3. Anal. Calc. for C19H19N3O3: C, 67.64; H, 5.68; N, 12.46; Found: C, 68.00; H, 
5.81; N, 11.97.  TOF MS-ES+, m/z: 360.1324, (M+Na)+. 
 
(tpyteg): Yield: 175 mg, colourless oil (70%). 1H NMR (400 MHz, CDCl3) δ/ ppm: 8.66 
(d, 2H, 6 6’’), 8.59 (d, 2H, 3 3’’), 8.03 (s, 2H, 3’ 5’), 7.83 (t, 2H, 4 4’’), 7.31 (t, 2H, 5 5’’), 
4.40 (t, 2H, CH2), 3.92 (t, 2H, CH2), 3.73 (m, 4H, CH2), 3.69 (t, 2H, CH2), 3.60 (t, 2H, 
CH2). 13C NMR (77 MHz, CDCl3), δ / ppm: 61.7, 67.9, 69.8, 70.4, 71.0, 72.9, 107.8, 121.4, 
123.9, 136.9, 148.9, 155.9, 157.0, 167.1. TOF MS-ES+, m/z: 404.1580, (M+Na)+. 
 
(tpytteg): Yield: 183 mg, (74%), pale brown oil. 1H NMR (400 MHz, CDCl3) δ/ ppm: 8.38 
(d, 2H, 6 6’’), 8.30 (d, 2H, 3 3’’), 7.72 (s, 2H, 3’ 5’), 7.58 (t, 2H, 4 4’’), 7.07 (t, 2H, 5 5’’), 
4.11 (t, 2H, CH2), 3.63 (t, 2H, CH2), 3.44 (t, 2H, CH2), 3.37 (m, 6H, CH2), 3.27 (m, 4H, 
CH2). 13C NMR (77 MHz, CDCl3), δ/ ppm: 39.5, 40.6, 42.4, 60.9, 60.9, 67.5, 69.1, 69.8, 
70.0, 70.2, 70.3, 70.5, 72.5, 72.5, 107.2, 121.1, 123.8, 136.8, 148.8, 155.4, 156.7, 166.7. 
TOF MS-ES+, m/z: 448.1848, (M+Na)+. 
 
5.2.3 Synthesis of Platinum(II) Complexes 
The synthesis of the complexes was carried out using the following procedure: To a 
stirred solution of [Pt(cod)Cl2]15h in dry methanol at room temperature, a suspension of 
the ligand in dry methanol was added at 55 °C. The reaction mixture was stirred for 24 
hours at the same temperature, after which the solution was cooled and filtered. When 
the bright yellow filtrate was concentrated under vacuo, the desired compound 
precipitated as pale yellow solid. The compound was filtered, washed with chloroform 
(20 mL), cold methanol (1 x 5 mL), diethylether (2 x 15 mL) and dried and stored in a 
desiccator.  
 
The identity and the purity of the final complexes were confirmed by using 1H NMR, 13C 
NMR, 195Pt NMR, elemental analyses, IR and mass spectroscopy. The 1H NMR spectra 
obtained show similarity in the aromatic region. Presence of a peak at about -2700 ppm 
on the 195Pt NMR spectra confirms the Pt(NNN) coordination.  
 




(Pttpyeg): Yield: 35 mg, (55%), pale yellow powder. 1H NMR (400 MHz, CD3OH) δ/ 
ppm: 10.23 (2H, d, 6 6’’), 9.79 (2H, d, 3 3’’), 9.78 (t, 2H, 4 4’’), 9.39 (2H, s, 3’ 5’), 9.20      
(t, 2H, 5 5’’), 5.88 (t, 2H, CH2), 5.44 (t, 2H, CH2). 195Pt NMR  (CD3OH) δ/ ppm:  -2715. IR 
(4000-650 cm
-1
) υ: 3237 (O-H), 3062 (C-H stretch), 1607 (C=H, pyridine), 1476 - 1423 
(C-H stretch), 1222.43 (C-O), 788 (C-H stretch). Anal. Calc. for C17H15Cl2N3O2: C, 36.51; H, 
2.70; N, 7.51; Found: C, 36.38; H, 3.20; N, 7.92. TOF MS-ES+, m/z: 524.0482, (M+1)+. 
 
(Pttpydeg): Yield: 46 mg, (64%), crystalline yellow powder. 1H NMR (400 MHz, CD3OH) 
δ/ ppm: 9.76 (d, 2H, 6 6’’), 9.67 (d, 4H, 3 3’’), 9.65 (t, 2H, 4 4’’), 9.17 (s, 2H, 3’ 5’), 9.07   
(t, 2H, 5 5’’), 5.87 (t, 2H, CH2), 5.38 (t, 2H, CH2), 5.21 (t, 2H, CH2), 5.11 (t, 2H, CH2). 13C 
NMR (77 MHz, CD3OH), δ / ppm: 62.26, 69.93, 72.01, 74.07, 112.07, 126.95, 130.28, 
142.73, 152.27, 156.70, 159.58, 170.89. 195Pt NMR  (CD3OH) δ/ ppm:  -2705. IR (4000-
650 cm
-1
) υ: 3338 (O-H), 3071 (C-H stretch), 1607 (C=H, pyridine), 1476 - 1430(C-H 
stretch), 1219 (C-O), 773(C-H stretch). Anal. Calc. for C19H21Cl2N3O4: C, 37.73; H, 3.41; N, 
6.76; Found: C, 37.35; H, 3.75; N, 6.34.  TOF MS-ES+, m/z: 568.0847, (M+1)+. 
 
(Pttpyteg): Yield: 38 mg, dark orange powder (60%). 1H NMR (400 MHz, CD3OH) δ/ 
ppm: 9.98 (dd, 2H, 6 6’’), 9.73 (s, 2H, 3’ 5’), 9.71 (d, 2H, 3 3’’), 9.29 (t, 2H, 4 4’’), 9.13      
(t, 2H, 5 5’’), 5.90 (t, 2H, CH2), 5.40 (t, 2H, CH2), 5.22 (m, 2H, CH2), 5.14 (t, 2H, CH2), 
5.11 (t, 2H, CH2), 5.04 (t, 2H, CH2). 195Pt NMR (CD3OH) δ/ ppm: -2708. IR (4000-650 
cm
-1
) υ: 3332 (O-H), 3071 (C-H stretch), 1607 (C=H, pyridine), 1448 – 1429 (C-H 
stretch), 1220 (C-O), 774 (C-H stretch). Anal. Calc. for C21H23Cl2N3O4: C, 38.96; H, 3.58; N, 
6.49; Found: C, 38.48; H, 3.41; N, 6.32. TOF MS-ES+, m/z: 612.1027, (M+1)+. 
 
(Pttpytteg): Yield: 30 mg, (65%), mustard yellow powder. 1H NMR (400 MHz, CD3OH) 
δ/ ppm: 8.75 (d, 2H, 6 6’’), 8.60 (d, 2H, 3 3’’), 8.49 (t, 2H, 4 4’’), 8.25 (s, 2H, 3’ 5’), 7.90    
(t, 2H, 5 5’’), 4.51 (t, 2H, CH2), 3.90 (t, 2H, CH2), 3.67 (t, 2H, CH2), 3.60 (t, 2H, CH2), 3.53 
(m, 4H, CH2), 3.47 (t, 2H, CH2), 3.40 (t, 2H, CH2). 13C NMR (77 MHz, CD3OH), δ/ ppm: 
39.4, 40.7, 41.0, 60.7, 70.2, 70.4, 70.5, 72.8, 111.2, 125.3, 126.3, 129.9, 143.2, 155.9 
158.9, 169.5. 195Pt NMR  (CD3OH) δ/ ppm:  -2710. IR (4000-650 cm
-1
) υ: 3246 (O-H), 
3064 (C-H stretch), 1607 (C=H, pyridine), 1476 – 1423 (C-H stretch), 1220 (C-O), 773 
(C-H stretch). Anal. Calc. for C23H27Cl2N3O5: C, 40.47; H, 3.54; N, 5.92; Found: C, 40.27; H, 
3.17; N, 5.60. TOF MS-ES+, m/z: 657.1368, (M+1)+. 
 
 




5.2.4 Physical Measurements 
1H NMR and 13C NMR were recorded on either a Bruker Avance DPX 400 or 500 MHz 
spectrometer, at 303 K using Si(CH3)4 as the reference for the chemical shifts. 195Pt 
NMR were done on a 500 MHz spectrometer (195Pt, 107.5 MHz) chemical shifts 
externally referenced to K2[PtCl6]. Low resolution electron spray ionization (ESI+) mass 
spectra were recorded on a TOF Micromass spectrometer. Infrared (IR) spectra were 
recorded by using Perkin Elmer Spectrum 100 FT-IR spectrometer. Elemental analyses 
were performed by a Thermal Scientific Flash 2000. Kinetic analyses were studied on 
an Applied Photophysics SX 20 stopped-flow reaction analyser coupled with an online 
data acquisition system with controlled temperature within ± 0.1 °C. The wavelengths 
for the kinetic analysis were predetermined on Varian Cary 100 Bio UV/visible 
spectrophotometer with an attached Varian Peltier temperature-controller and an 
online kinetic application. X-ray crystal structure for the ligand qpy was solved using an 
Oxford Diffraction Xcalibur 2 CCD 4-circle diffractometer linked to an Oxford Cryostat 
System. The data collection was done at 100 K. 
 
5.2.5 Computational Modelling 
Computational modelling for the complexes was performed at Density Functional 
Theoretical (DFT) level based on B3LYP/LanL2DZ22 (Los Alamos National Laboratory 2 
double ξ) level theory, with inner core electrons of Pt atom replaced by relative 
Effective Core Potential (ECP). Due to low electronic spin of Pt(II), the DFT calculations 
of the complexes were done at singlet state. The complexes were computed in methanol 
solution taking into account the solvolysis effect by means of the Conductor Polarizable 
Continum Model (C-PCM).23 The Gaussian09 suite of programs was used for all 
computational calculations.24   
 
5.2.6 Kinetic Analyses 
 All kinetic measurements were performed under pseudo first-order conditions using at 
least 10-fold excess of the nucleophile in 0.02 M ionic solution, made by dissolving the 
required amount of LiCF3SO3 (0.018 M) and LiCl (0.002 M) in dry methanol. LiCl was 
added to suppress the solvolysis reactions. Since CF3SO3ˉ does not coordinate with the 
Pt(II) metal centre25, all substitution kinetics were studied in this media.  
 
Pt(II) complex solutions were prepared by dissolving the required amount of the 
complex in the ionic solution. Nucleophile solutions were prepared at 50 times the 
concentration of the Pt(II) complex. Subsequent dilutions of the nucleophile stock 




solution afforded solutions of 10, 20, 30 and 40 times the concentration of metal 
complex. The wavelengths chosen for the kinetic investigations were pre-determined 
using UV/visible absorption spectra (See Table S5.1). A typical kinetic trace for the 
reaction of Pttpydeg with TU at 330 nm and 298 K is shown in Figure 5.2 and Figure 
S5.1. 



















Figure 5.2 Kinetic trace for the reaction of Pttpydeg (4.0 x 10-5 M) with TU (6.0 x 10-4 M) in 
methanol solution (I = 0.02 M) at 330 nm at 298 K. 
 
Substitution reactions were fast, and were studied on an Applied Photophysics SX 20 
stopped-flow system coupled with an online data acquisition system. All measurements 
were carried out in a thermostatted environment to within ± 0.1 °C. All data were 
graphically analysed using the software package, Origin 7.5®26 to determine the 
observed rate constants, kobs. All kinetic data obtained were fitted to first-order 
exponential decay function to generate the observed pseudo first-order rate constants, 
(kobs), using Equation 5.127 at all concentrations and temperatures.  
 
)tk()AA(AA 00t obs expt                                                                        (5.1) 
where A0,  At  and A∞ represent the absorbance of the reaction mixture initially, at time, t 
and at the end of the reaction respectively.  





The observed rate constants, kobs, for the nucleophiles at different concentrations were 
determined in the same manner. The values used were averages of seven to ten 
independent runs. Linear graphs with zero intercepts were obtained for the 
nucleophiles studied. The second-order rate constants, k2, for the reactions of the 
platinum complexes with the nucleophiles were obtained from the slopes and the 
intercepts of the graphs of kobs versus the concentration of the nucleophiles (Equation 
5.2).27 Representative plots for Pttpydeg, shown in Figure 5.3 clearly indicate that the 
substitution reactions were first-order with respect to the incoming nucleophile.  
                              
][obs Nukk 2                                                                                        (5.2) 
where k2 is the second-order rate constant. 
 




















Figure 5.3 Dependence of the pseudo first-order rate constants (kobs) on the concentrations 
of the nucleophiles for the chloride substitution from Pttpydeg (4.0 x 10-5 M) in 










The temperature dependence studies were done in a similar manner, using a single 
nucleophile concentration in the temperature range 15 - 40 °C in 5 °C intervals. The 
activation parameters, entropy of activation (
S ) and enthalpy of activation ( H ) 
were obtained using the Eyring equation.27 Figure 5.4 shows the representative plots 
obtained for Pttpydeg with the nucleophiles for the forward reactions with the 
nucleophiles. Representative graphs are also given in Figures S5.2 to S5.9. 
























Figure 5.4 Eyring plots obtained for Pttpydeg with the nucleophiles for the forward reactions 
over the temperature range 15 - 35 °C. 
 
5.3 Results and Discussion 
5.3.1 Synthesis and Characterization 
In this study, four square planar 4’-functionized Pt(II) terpyridine complexes of 
polyethylene glycoxy pendant groups, which vary by the number of appended ethylene 
glycoxy units or monomers, were synthesized and characterized. The ligands have been 
synthesized by different methods.21a,b,28 Details of the synthesis and the spectroscopic 
data were given under experimental. The spectroscopic data obtained were in good 
agreement with the literature22b and the proposed chemical structures of the ligands 
and the complexes. To avoid the formation of the diterpyridine ligand, ethylene glycol 
reagent was added in large excess.21b Representative 1H NMR, 13C NMR, 195Pt NMR, IR 
and mass spectra are given in Figure S5.10 to Figure S5.34 (Supporting Information). 
The peak due to the OH proton is not seen in any of the 1H NMR spectra due to the 




proton exchange with the solvent, methanol.28 The 195Pt NMR signals for all the 
complexes appeared at around -2700 ppm, typical for N^N^N coordinated square 
planar Pt(II) centre.18,29 Furthermore, the IR spectra of the complexes show distinct 
broad bands at around 3200 to 3300 cm-1 due to the OH stretches along with the CH 
peaks at around 3000 cm-1.30 Additionally, the crystal structure obtained for Pttpydeg 
(Figure S5.35) confirms the synthesis of the anticipated complex. However, the 
compound could not be resolved to a satisfactory quality due to desolvation.  
 
5.3.2 DFT Calculations 
In order to obtain further insight on how the ethylene glycoxy pendant groups 
influence the substitution kinetics of the Pt(II) complexes, the electronic properties of 
the complexes were  investigated at DFT level. The DFT calculated geometry optimized 
structures (also Table S5.2) along with the DFT calculated data are given in Figure 5.5 
and Table 5.1 respectively. Table S5.3 (Supporting Information) shows that the 
geometry at the Pt(II) centre is slightly distorted square planar which is common to 
Pttpy type of complexes.10,13g   
 
When compared the DFT calculated natural bond orbital (NBO) charges on the 
platinum and Ntrans atoms of Pttpy and Pttpyeg, the value for platinum decreases from 
Pttpy to Pttpyeg. The same is true for the charge on Ntrans, i.e, it becomes more 
negative. This difference can be linked to the attachment of ethylene glycoxy pendant to 
the 4’-position of the parent Pttpy molecule. However, when the NBO charges of the 
corresponding atoms of the ethylene glycoxy appended molecules (i.e Pttpyeg to 
Pttpytteg) are compared, the values are observed to be constant. The results show that 
the inductive effect to the 4’-position of the complex is limited to the first glycoxy unit 
only. The subsequent units have little or no effect. This implies that the electronic effect 
beyond the first unit have little or no influence on the reactivity of the complexes. 
 
Since reactivity parameters are explained by various associated electronic structure 
principles, the DFT calculated computational data was further analysed to understand 
the global chemical reactivity descriptors31 such as chemical hardness (η, which relates 
to the thermodynamic stability of the molecule),32 electronic chemical potential (µ, 
which defines the electronegativity of the molecule) and electrophilicity index (ω, 
which measures the propensity of a species to accept electrons).33 DFT calculated μ and 
ω further support the observed changes in the NBO charges as already discussed. The 
electrophilicity index shows that the ability of the complex to accept electron decreases 




from Pttpy to Pttpyeg after which it remains constant. This is an indication of 
reduction of π-backbonding ability of the terpyridine moiety from Pttpy to Pttpyeg 
due to the introduction of the attachment of ethylene glycoxy pendant. 
 
Table 5.1  Summary of DFT calculated data for the complexes investigated. Included is the 
data obtained for the DFT calculated Pttpy complex for comparisons. 
Complex  Pttpy Pttpyeg Pttpydeg Pttpyteg Pttpytteg 
Bond Length (Å)      
Pt1―Cl   2.446     2.445   2.446   2.446   2.446 
Pt―N1(trans)   1.961     1.961   1.961   1.961   1.961 
4’C―O1      1.368   1.368   1.368   1.386 
Ntrans―O1      4.111   4.110   4.110   4.121 
Bond angles (o)      
Elelvation angle of ethylene 
glycoxy pendant (α) 
   37.55 36.44 19.38 17.32 
NBO charges      
Pt1    0.604     0.592   0.591  0.591  0.590 
N1(trans)  -0.453   -0.471 -0.470 -0.471 -0.470 
Cl  -0.502   -0.505 -0.505 -0.505 -0.504 
EHOMO/eV  -7.04   -6.87 -6.88 -6.87 -6.86 
ELUMO/eV  -3.35   -3.21 -3.22 -3.23 -3.24 
∆E   3.69     3.66   3.66   3.64   3.62 
Dipole moment 13.30   11.21 10.72   6.83   4.20 
η /eV   1.85     1.83   1.83   1.82   1.81 
µ/ eV  -5.20    -5.04  -5.05  -5.05   5.05 
ω/ eV   7.31      6.94    6.97   7.00   7.05 






Figure 5.5 DFT calculated minimum energy structures, frontier molecular orbitals (HOMO and LUMO) and the planarity of the complexes investigated. 
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Substitution kinetics of coordinated chloride from the Pt(II) complexes  (Figure 5.1) by 
four different nucleophiles, i.e. TU, DMTU, TMTU and an ionic nucleophile, Iˉ were 
studied under pseudo first-order conditions using the conventional stopped-flow 
technique. Only one step, taken to be the substitution of the chloride ligand was 
observed with no solvation pathway. Thus, the proposed substitution mechanism for 
the complexes studied can be represented as shown in Scheme 5.1. The kinetic data 
obtained are summarized in Table 5.2. Additional data are given in Tables S5.4 to S5.12) 
 






n = 1 in Pttpyeg, 2 in Pttpydeg, 3 in Pttpyteg and 4 in Pttpytteg














Scheme 5.1 Proposed mechanism for the substitution of chloride ligand from the Pt(II) 
complexes. 
 
To understand the role of the polyethylene glycoxy pendant units on the rate of 
chloride substitutions, the reactivities of Pttpy and Pttpyeg were compared. The 
difference between them is the appended ethylene glycoxy pendant group in Pttpyeg. 
When a single ethylene glycoxy pendant group is attached to the 4’-position of the 
terpyridine chelate ligand, the reactivity of the resultant metal complexes is reduced by 
almost five times that of Pttpy showing that the polyethylene glycoxy pendant is acting 
as a σ-donor including the trans phenyl ring as supported by the DFT calculations. 
Furthermore, through π-resonance effect, the lone pair of electrons on the O1 atom of 
the glycoxy pendant is donated towards the Pt(II) centre. As can be seen from Table 5.1, 
the inductive σ-electron donation along with the π-electron contribution from the 
ethylene glycoxy pendant increases the negative charge on the Ntrans atom of Pttpyeg 
compared to Pttpy. Consequently, the positive charge on the Pt(II) centre decreases 
marginally from 0.604 (Pttpy) to 0.592 (Pttpyeg), indicating that the electron density 
flow is towards the metal centre, and can be attributed to the well-known trans effect.34 
As reported previously, electron donating groups on the ancillary position of 
terpyridine reduces the positive charge at the metal centre, thereby lowering the 
electrophilicity of the metal centre.13g,h,15h,35 This observation in this study is supported 




by the DFT calculated global electrophilicity index, ω, which clearly indicates that the 
ability of the parent Pttpy to accept the electron density from the incoming nucleophile 
gets considerably decreased when the ethylene glycoxy pendant unit is attached to 4’-
position of the terpyridine backbone.31,36 In addition, from the perspective that a high 
dipole moment favours higher π-back donation character,37 the observed smaller 
dipole moment of Pttpyeg further supports its lower reactivity relative to Pttpy. 
Additional support is obtained by the energy levels of the molecular orbitals, HOMO 
and LUMO. The fact that the LUMO energy of the Pttpyeg is slightly raised (-3.21 eV) 
related to Pttpy (-3.35 eV), makes it difficult to π-back donate. Thus, reduces the 
transfer of electron density from the 18- electron five coordinate Pt(II) dxz orbital into 
the tridentate terpyridine ligand, thereby making the transition state less stable. This 
can be reflected on from the observed slightly higher activation enthalpy, H  of 
Pttpyeg, which indicates the slightly higher energy barrier associated with the 
formation of transition state complex. The net effect is the observed decrease in the 
electron acceptability of the terpyridine moiety in comparison to that of Pttpy, 
resulting in a decreased rate of substitution of chloride in Pttpyeg.  
 
  




Table 5.2 Summary of second-order rate constants, k2 and activation parameters, with the 
corresponding standard deviations for the substitution of the chloro ligand by a 
series of thiourea nucleophiles and iodide at I = 0.02 M LiCF3SO3, adjusted with 
LiCl. Given in brackets for TU is the data for Pttpy taken from literature13g and 
included for comparison. 
 
This retardation effect observed between Pttpy and Pttpyeg has also been noted 
previously by Schmülling et al.38 where an electron donating methoxy (OCH3) group 
was attached to the ancillary ligand of a Pt(II) complex of the form 
[Pt{C6H3X(CH2NMe2)}(NC5H4SO3)(H2O)] where X = OMe. The decrease in the reactivity 
was accounted for in terms of the σ-inductive donation from the methoxy group to the 
metal centre making it less electrophilic. A similar effect due to electron donating 
groups attached at the 4’-position of the terpyridine ligand has also been reported 
previously by Jaganyi et al.13g,15h 
 
Complex Nu k2/M-1  s-1 SΔ / J K-1 mol-1 HΔ / kJ mol-1 
Pttpy TU  (1494 ± 10) 
 1421 ± 25 
 (-88 ± 5) 
   -76 ± 4 
    (29 ± 2) 
      35 ± 1  
DMTU     448 ± 10    -73 ± 4      36  ± 1 
TMTU        82 ± 4    -91 ± 8      35  ± 2  
Iˉ     243 ± 4    -42 ± 11       47 ± 4  
Pttpyeg TU      257 ± 5    -56  ± 6        43 ± 2  
DMTU         81 ± 1    -98 ± 6         33 ± 2  
TMTU         22 ± 1    -57  ± 7         40 ± 2  
Iˉ        95 ± 2    -32 ± 9        53 ± 3 
Pttpydeg TU      265 ± 1     -66 ± 5        40 ± 2  
DMTU        83 ± 1    -54 ± 9        46 ± 3 
TMTU         23 ± 1    -83 ± 7        41 ± 2 
Iˉ        91 ± 2    -44 ± 9        48 ±3 
Pttpyteg TU      277 ± 1     -60 ± 3        41 ± 1  
DMTU        93 ± 1     -57 ± 3       45 ± 1  
TMTU         19 ± 0.3    -65 ± 6       46 ± 2  
Iˉ        91 ± 1    -48 ± 6       48 ± 2 
Pttpytteg TU       321 ± 4    -67 ± 5       39 ± 2  
DMTU       102 ± 1     -46 ± 2        48 ± 2 
TMTU          13 ± 1    -88 ± 6       40 ± 2 
Iˉ      156 ± 2     -44 ± 5       48 ± 2  




Furthermore, the decrease in the rate of substitution of Pttpyeg is also attributed to the 
steric contribution imposed on one side of the Pt(II) coordination sphere by the 
inclined appended ethylene glycoxy unit (Figure 5.6) thereby hindering the approach of 
the axially incoming nucleophile. This steric influence exists in Pttpyeg since the angle 
of inclination, α, is absent in Pttpy. Therefore, it can be concluded that the difference in 
the rate of substitution between Pttpy and Pttpyeg is due to both steric and electronic 
effects.  
 
The analysis of the reactivity of the other complexes having ethylene glycoxy pendant 
shows a slight increase in the rate of substitution with the increase in the number of 
ethylene glycoxy units. One would have expected the reactivity to decrease due to 
increase in the σ-inductive effect, however that is not the case and is supported by the 
DFT calculations. The observed NBO charges on the Pt(II) centre and Ntrans atom of 
Pttpyeg to Pttpytteg are all constant indicating that no change is being experienced by 
the Pt(II) centres as the pendant unit is increased. The σ-donation and the π-resonance 
contribution (due to O1) is effective only up to the first glycol unit. The global 
electrophilicity index shows a very small increase with an increase in the pendant unit 
which might be linked to the increase in electrons within each pendant unit. Therefore, 
the remaining factor that accounts for the observed reactivity from Pttpyeg to 
Pttpytteg is steric hindrance due to the inclination of the ethylene glycoxy pendant 
group to the plane containing Pt(II). This angle α, which has also been reported in 
literature by Jaganyi et al.,39 when investigating the reactivity of Pt(II) complexes 
having appended poly alkyl groups, decreases from Pttpyeg (37.55 °) to Pttpytteg 
(17.32 °) as depicted in Figure 5.6. This means that one side of these complexes 
experiences steric hindrance which decreases as the angle of inclination decreases with 
increase in the number of pendant unit. This results in reactivity increasing slightly 
from Pttpyeg to Pttpytteg.  
 







Figure 5.6 Aerial view showing the angles of inclination, α, of the pendant units in the DFT 
calculated structures of Pttpyeg and Pttpytteg  
 
There is also a possibility that very weak intramolecular hydrogen bonding between 
the lone pair of electrons on the oxygen atoms and the neighbouring H atoms or the 
OH,40 might be contributing to the stabilization of the five coordinate transition state, 
which increases with the increase in the number of oxygen atoms in the pendant 
(Scheme  S5.1, Supporting Information).  
 
If all the facts are put together, it explains the observed substitution reactivity trend: 
Pttpy >> Pttpytteg > Pttpyteg > Pttpydeg > Pttpyeg.  If the reactivity of Pttpy with TU 
is taken as a reference, the ratio of reactivity follows: 1.00 : 0.17: 0.18: 0.19: 0.22 
respectively for Pttpy, Pttpyeg, Pttpydeg, Pttpyteg and Pttpytteg. The slight changes 
in reactivity for the ethylene glycoxy pendant complexes are sterically controlled with 
minor or no electronic effects. 
 
The data in Table 5.2 clearly shows a dependence of the chloride substitution on the 
steric hindrance of the incoming nucleophiles. In all cases, TU has the highest rate 
constant and the rate constant decreases as the incoming nucleophile gets more bulky; 
i.e, rate constants for DMTU and TMTU are significantly lower compared to TU. The 
results show that the complexes are sensitive to the steric hindrance of the incoming 
nucleophiles which is typical of an associative substitution reaction. In case of the ionic 
nucleophile, Iˉ, the rate of substitution of the chloride ligand was slower than TU. This 
difference in reactivity has been explained to be a result of the electrostatic attraction 
between the anionic iodide and the cationic metal centre facilitated by the high 
polarisability of the  Iˉ ion.39 
 




The activation parameters obtained for the substitution of the chloride ligands support 
an associative mode of mechanism.41 The large and negative entropy of activation           
(
S ) suggests a more ordered transition state. The small enthalpies of activation          
( H ) support the ease of bond formation in the transition state.10,13g This is typical for 
substitution of d8 square planar Pt(II) complexes.10,15h,18,39,40b,42 
 
5.4 Conclusions 
This study demonstrates that the polyethylene glyoxy pendant attached trans to the 
leaving group of Pttpy, acts as a σ-donor towards the Pt(II) centre, thereby decreasing 
the reactivity compared to the parent Pttpy molecule. The σ-donation due to the 
pendant unit and the and π-electronic contribution due to O1 is effective only up to one 
unit of the ethylene glycoxy pendant, beyond which there is no significant electronic 
effect on the Pt(II) metal centre. Thus, the retardation of the reactivity from Pttpy to 
Pttpyeg is mostly due to both steric and electronic effects caused by the appended 
ethylene glycoxy pendant. However, the slight increase in substitution reactivity from 
Pttpyeg to Pttpytteg is mainly sterically controlled as the angle of inclination of the 
appended ethylene glycoxy pendant decreases from the Pt(II) plane. The complexes are 
sensitive to the incoming nucleophiles as demonstrated by the decrease in rate 
constant depending on the size. The activation parameters, enthalpy of activation and 
entropy of activation well support an associative mode of mechanism, where bond 
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5.6 Supporting Information 
A summary of wavelengths at which the kinetic studies were performed, plots of the 
dependence of kobs against concentration of the nucleophiles and plots from 
temperature dependence studies along with tables of kinetic data, graphs of exemplary 
mass spectra and the representative spectra for 1H NMR and 195Pt NMR work reported 
in this study are given as electronic supporting information (ESI). 
  
Table S5.1  Summary of the wavelengths (nm) used to study the substitution reactions of the 








Complex Nu Wavelength (λ), nm 




















Table S5.2  Geometry-optimised structures of the platinum complexes investigated and 
distribution of the electron density on the platinum complexes investigated. The 
blue area indicates the most electropositive areas and the green region indicates 















Figure S5.1 Kinetic trace at 284 nm for the reaction of Pttpyeg (1.3 x 10-5 mol dm-3) with Tu 
(3.7 x 10-4 mol dm-3) at 298 K, I = 0.02 M LiCF3SO3, adjusted with LiCl. 
 


















Figure S5.2  Dependence of the pseudo first-order rate constants (kobs) on the concentrations 
of TU for the chloride substitution from Pttpy (4.0 x 10-5 M) and 




















Figure S5.3 (a)Dependence of the pseudo first-order rate constants (kobs) on the 
concentrations of TU for the chloride substitution from Pttpy (4.0 x 10-5 M) and 
(b) Eyring plot obtained for Pttpy with TU for the over the temperature range 15- 


















Table S5.3  Summary of DFT calculated data for the complexes investigated. Included is the 
data obtained for the DFT calculated Pttpy complex for comparisons. 
Complex  Pttpy Pttpyeg Pttpydeg Pttpyteg Pttpytteg 
Bond Length (Å)      
Pt1―N2(cis) 2.0486 2.0510 2.0490 2.0508 2.0488 
Pt―N3(cis) 2.0486 2.0491 2.0532 2.0513 2.0501 
O1―O2  2.9737 2.9705 2.9734 2.9709 
O2―O3   2.8311 3.1122 3.0948 
O3―O4    2.8679 3.1265 
O4―O5      3.6670 
O1-O5/O1-O3/O1-O4   4.4784 8.3258 9.0097 
Pt1―O1  6.0703 6.0704 6.0701 6.0814 
Cl―H/O3/O4/O5  11.4700 10.7616 16.4473 17.0570 
Pt―O2/ O3/O4/O5  8.8644 9.0628 14.2687 14.0313 
Ntrans―O1  4.11104 4.1102 4.1101 4.1210 
Bond angles (o)      
N1―Pt―Cl 179.99 179.543 179.60 179.40 179.57 
N2―Pt―Cl 99.05 99.030 98.92 99.31 98.72 
N3―Pt―Cl 99.05 99.426 99.52 99.14 99.50 
N3―Pt―N2 161.90 161.544 161.56 161.55 161.78 
N2―Pt―N1 80.95 80.799 80.73 80.86 80.90 
N1―Pt―N3 80.95 80.746 80.83 80.69 80.88 
Dihedral -cl 0.007 0.848 0.118   0.698  0.678 
NBO charges      
N2 -0.493 -0.493 -0.492 -0.492 -0.493 
N3 -0.493 -0.492 -0.494 -0.493 -0.493 
O1  -0.559 -0.560 -0.560 -0.608 
O2  -0.814 -0.658 -0.650 -0.656 
O3   -0.821 -0.665 -0.658 
O4    -0.824 -0.657 
O5     -0.826 
C 4 -0.134 0.408 0.408 0.408 0.387 
Point Group C2 C1 C1 C1 C1 































Figure S5.4 Dependence of the pseudo first-order rate constants (kobs) on the concentrations 
of the nucleophiles for the chloride substitution from Pttpyeg (4.0 x 10-5 M) in 
methanol solution (I = 0.02 M LiCF3SO3, adjusted with LiCl.) at 298 K. 
 




















Figure S5.5 Dependence of the pseudo first-order rate constants (kobs) on the concentration of 
the nucleophiles for the chloride substitution from Pttpyteg (4.00 x 10-5 M) in 
methanol solution (I = 0.02 M LiCF3SO3, adjusted with LiCl.) at 298 K. 
 

























Figure S5.6 Dependence of the pseudo first-order rate constant (kobs) on the concentration of 
the nucleophiles for the chloride substitution from Pttpytteg (4.00 x 10-5 M) in 
methanol solution (I = 0.02 M LiCF3SO3, adjusted with LiCl.) at 298 K. 
 
























Figure S5.7 Eyring plots obtained for Pttpydeg with the nucleophiles for the forward reactions 
over the temperature range 15 - 35 °C. 

























Figure S5.8 Eyring plots obtained for Pttpyteg with the nucleophiles for the forward reactions 
over the temperature range 15 - 35 °C. 























Figure S5.9 Eyring plots obtained for Pttpytteg with the nucleophiles for the forward 
reactions over the temperature range 15 - 35 °C. 
 
 




Table S5.4  Average observed rate constants, for the displacement of the chloride ligand in 
Pttpy with TU, at T = 298 K and Temperature dependence of k2 M-1s-1, for the 
displacement of the chloride ligand in Pttpy by TU at 30-fold excess over [Pttpy], I 
= 0.02 M LiCF3SO3, adjusted with LiCl. 
Conc, mM kobs., s-1 1/T, K-1 In(k2/T) 
0.100 0.12503 0.00347 0.21285 
0.200 0.26255 0.00341 0.45944 
0.300 0.40997 0.00335 0.65416 
0.400 0.57142 0.0033 0.94986 
0.500 0.73003 0.00325 1.14465 
 
  
Table S5.5  Average observed rate constants, kobs s-1, for the displacement of the chloride 
ligand in Pttpyeg with the nucleophiles, at T =  298 K, I = 0.02 M LiCF3SO3, adjusted 
with LiCl. 
TU DMTU TMTU Iˉ 
Conc., mM kobs., s-1 Conc., mM kobs., s-1 Conc., mM kobs., s-1 Conc., mM kobs., s-1 
0.232 0.06831 0.232 0.02068 0.232 0.00588 0.232 0.03115 
0.465 0.12859 0.465 0.03861 0.465 0.01073 0.465 0.04615 
0.697 0.18792 0.697 0.0564 0.697 0.01632 0.697 0.06969 
0.930 0.2332 0.930 0.07593 0.930 0.02168 0.930 0.08915 
1.160 0.29235 1.160 0.09408 1.160 0.02474 1.160 0.1061 
 
 
Table S5.6  Temperature dependence of k2 M-1s-1, for the displacement of the chloride ligand 
in Pttpyeg by the nucleophiles at 30-fold excess over [Pttpyeg], at T =  298 K, I = 
0.02 M LiCF3SO3, adjusted with LiCl. 
TU DMTU TMTU Iˉ 
1/T, K-1 In(k2/T) 1/T, K-1 1/T, K-1 In(k2/T) 1/T, K-1 1/T, K-1 In(k2/T) 
0.00347 -0.77375 0.00347 -1.85666 0.00347 -3.29982 0.00347 -1.83455 
0.00341 -0.41648 0.00341 -1.55805 0.00341 -2.91201 0.00341 -1.52821 
0.00335 -0.1006 0.00335 -1.30418 0.00335 -2.53604 0.00335 -1.09253 
0.0033 0.13394 0.0033 -1.15741 0.0033 -2.31879 0.0033 -0.71143 








Table S5.7  Average observed rate constants, kobs s-1, for the displacement of the chloride 
ligand in Pttpydeg with the nucleophiles, at T =  298 K, I = 0.02 M LiCF3SO3, 
adjusted with LiCl. 
TU DMTU TMTU Iˉ 
Conc., mM kobs., s-1 Conc., mM kobs., s-1 Conc., mM kobs., s-1 Conc., mM kobs., s-1 
0.200 0.0533 0.200 0.01594 0.200 0.00557 0.200 0.02111 
0.400 0.10391 0.400 0.03404 0.400 0.00991 0.400 0.04101 
0.600 0.15373 0.600 0.04892 0.600 0.01392 0.600 0.05605 
0.800 0.20663 0.800 0.06539 0.800 0.01813 0.800 0.07142 
1.00 0.26106 1.00 0.0845 1.00 0.02223 1.00 0.09049 
 
  
Table S5.8  Temperature dependence of k2 M-1s-1, for the displacement of the chloride ligand 
in Pttpydeg by the nucleophiles at 30-fold excess over [Pttpyeg], at T =  298 K, I = 
0.02 M LiCF3SO3, adjusted with LiCl. 
TU DMTU TMTU Iˉ 
1/T, K-1 In(k2/T) 1/T, K-1 1/T, K-1 1/T, K-1 In(k2/T) 1/T, K-1 1/T, K-1 
0.00347 -0.71115 0.00347 -1.97003 0.00347 -3.1435 0.00347 -1.80055 
0.00341 -0.36447 0.00341 -- 0.00341 -2.80919 0.00341 -1.37186 
0.00335 -0.15161 0.00335 -1.29658 0.00335 -2.56486 0.00335 -1.17219 
0.0033 0.14608 0.0033 -0.94055 0.0033 -2.3508 0.0033 -0.80536 
0.00325 0.37893 0.00325 -0.74569 0.00325 -1.99632 0.00325 -0.44109 
 
  
Table S5.9  Average observed rate constants, kobs s-1, for the displacement of the chloride 
ligand in Pttpyteg with the nucleophiles, at T =  298 K, I = 0.02 M LiCF3SO3, 
adjusted with LiCl. 
TU DMTU TMTU Iˉ 
Conc., mM kobs., s-1 Conc., mM kobs., s-1 Conc., mM kobs., s-1 Conc., mM kobs., s-1 
0.221 0.06301 0.221 0.02378 0.221 0.00483 0.221 0.02073 
0.441 0.11921 0.441 0.04244 0.441 0.009 0.441 0.03996 
0.662 0.1792 0.662 0.06119 0.662 0.01256 0.662 0.0612 
0.883 0.2252 0.883 0.08255 0.883 0.01699 0.883 0.0816 








Table S5.10  Temperature dependence of k2 M-1s-1, for the displacement of the chloride ligand 
in Pttpyteg by the nucleophiles at 30-fold excess over [Pttpyeg], at T =  298 K, I = 
0.02 M LiCF3SO3, adjusted with LiCl. 
TU DMTU TMTU Iˉ 
1/T, K-1 In(k2/T) 1/T, K-1 1/T, K-1 1/T, K-1 In(k2/T) 1/T, K-1 1/T, K-1 
0.00347 -0.66929 0.00347 -1.80685 0.00347 - 0.00347 -1.75361 
0.00341 -0.34999 0.00341 -1.51259 0.00341 -3.11426 0.00341 -1.46934 
0.00335 -0.0966 0.00335 -1.17105 0.00335 -2.75475 0.00335 -1.17101 
0.0033 0.1892 0.0033 -0.89035 0.0033 -2.49374 0.0033 -0.81608 
0.00325 0.46045 0.00325 -0.6124 0.00325 -2.17086 0.00325 -0.47009 
 
 
Table S5.11  Average observed rate constants, kobs s-1, for the displacement of the chloride 
ligand in Pttpytteg with the nucleophiles, at T =  298 K, I = 0.02 M LiCF3SO3, 
adjusted with LiCl. 
TU DMTU TMTU Iˉ 
Conc., mM kobs., s-1 Conc., mM kobs., s-1 Conc., mM kobs., s-1 Conc., mM kobs., s-1 
0.188 0.06242 0.188 0.02311 - - 0.188 0.03314 
0.376 0.12927 0.376 0.04156 0.376 0.00529 0.376 0.05969 
0.564 0.18476 0.564 0.06049 0.564 0.00823 0.564 0.09101 
0.752 0.2388 0.752 0.07858 0.752 0.00931 0.752 0.11915 
0.940 0.29756 0.940 0.09822 0.940 0.01206 0.940 0.14317 
 
  
Table S5.12  Temperature dependence of k2 M-1s-1, for the displacement of the chlorideligand 
in Pttpytteg by the nucleophiles at 30-fold excess over [Pttpyeg], at T =  298 K, I = 
0.02 M LiCF3SO3, adjusted with LiCl. 
TU DMTU TMTU Iˉ 
1/T, K-1 In(k2/T) 1/T, K-1 1/T, K-1 1/T, K-1 In(k2/T) 1/T, K-1 1/T, K-1 
0.00347 -0.45212 0.00347 -1.80917 0.00347 -3.60789 
  0.00341 -0.22695 0.00341 -1.41566 0.00341 -3.38006 0.00341 -0.98071 
0.00335 0.09414 0.00335 -1.06236 0.00335 -3.05708 0.00335 -0.61393 
0.0033 0.37004 0.0033 -0.77722 0.0033 -2.84358 0.0033 -0.21246 
0.00325 0.56892 0.00325 -0.50865 0.00325 -2.51069 0.00325 0.05868 
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Figure S5.23 High resolution ESI mass spectrum of tpyeg. 





Figure S5.24 High resolution ESI mass spectrum of tpydeg. 
 





Figure S5.25  High resolution ESI mass spectrum of tpyteg. 





Figure S5.26 High resolution ESI mass spectrum of tpytteg. 
 





Figure S5.27 High resolution ESI mass spectrum of Pttpyeg. 





Figure S5.28 High resolution ESI mass spectrum of Pttpydeg. 





Figure S5.29 High resolution ESI mass spectrum of Pttpyteg. 





Figure S5.30 High resolution ESI mass spectrum of Pttpytteg. 
 





Figure S5.31 IR Spectrum of Pttpyeg. 















































Figure S5.32 IR Spectrum of Pttpydeg. 

















































Figure S5.33  IR Spectrum of Pttpyteg. 
 
























































Figure S5.34 IR Spectrum of Pttpytteg. 



















































Figure S5.35 Perspective view showing the molecular geometry and atom connectivity for the 
Pttpydeg complex. Non-H atoms are drawn as 50% thermal ellipsoids and the H 












Interactions of lone pair 
electrons with the near by H 
atoms
 
Scheme S5.1 Possible electronic interactions and hydrogen bodings within the molecule and 
between the molecules and solvent. 
 
DFT calculations 
DFT calculated HOMO and LUMO energies are used to calculate the chemical hardness 
(η), electronic chemical potential (µ) and electrophilicity index (ω) by following the 
Equations (S5.1), (S5.2) and (S5.3) respectively. 
η = (εLUMO + εHOMO)/2                                                                            (S5.1) 
µ = (εHOMO + εLUMO)/2                                                                            (S5.2) 
ω = µ2/2η                                                                                                (S5.3) 
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A Kinetic and Mechanistic Investigation of Polyethyleneglycol 
Ether Bridged Dinuclear Platinum(II) 2,2′:6′,2′′-Tpyridine 
Complexes  
6.0 Abstract 
A series of dinuclear Pt(II) complexes bridged with polyethyleneglycol ether of the type 
[ClPt(tpy)-O(CH2CH2O)n(tpy)PtCl]Cl2 where n = 1 (Ptdteg), 2 (Ptdtdeg), 3 (Ptdtteg), 4 
(Ptdttteg) and linker free complex, ClPt(tpy)-(tpy)PtCl]Cl2, (Ptdt),  (where tpy = 
2,2':6',2''-terpyridine) were synthesized and characterized to investigate the role of 
bridging  polyethyleneglycol ether linker  on the substitution reactivity of the dinuclear 
Pt(II) complexes. Substitution reactions were studied using thiourea nucleophiles viz. 
thiourea (TU), 1,3-dimethyl-2-thiourea (DMTU), 1,1,3,3-tetramethyl-2-thiourea 
(TMTU) under pseudo first-order conditions as a function of concentration and 
temperature by conventional stopped-flow reaction analyser. The reactions gave single 
exponential fits following the rate law kobs = k2[Nu]. Introduction of polyethyleneglycol 
ether linker decreases the electrophilicity of the platinum centre and the whole 
complex. The results obtained indicate that the rate of substitution reactions is 
controlled by both electronic and steric hindrance which increases with the length of 
the linker. Experimental results are supported by the density functional theory (DFT) 
calculations and structures obtained at LanL2DZ/ B3LYP level. The order of the 
reactivity of the nucleophiles is TU > DMTU > TMTU. The magnitude and the size of the 
enthalpy of activation and entropy of activation support an associative mode of 
mechanism, where bond formation in the transition state is favoured.  
 
6.1 Introduction 
Platinum metallodrugs play an important role in the treatment of cancer and 
modification of nucleic acids.1 Today, multinuclear platinum complexes comprise a new 
class of promising anticancer agents with comparable cytotoxicity.2 Compared to 
cisplatin, they are more water soluble and offer better DNA interactions due to their 
high charge.3 The multinuclear Pt(II) complexes that can interact with DNA were first 
synthesized by Farrell et al.2f,4 The most successful of these complexes are the 
monodentate amine complexes, [[{trans-PtCl(NH3)2}2{µ-trans-





Pt(NH3)2(NH2(CH2)6NH2)2}]4+ (BBR3464) and [{trans-PtCl(NH3)2}2{µ-
C2H4(NH2(CH2)6NH2)2}]4+ (BBR3610).2i,4b,5 The complexes show enhanced cytotoxicity 
against lung, pancreatic and melanoma cancers.2b  The interaction of these complexes 
with DNA were found to be based on their structural-activity relationships that depend 
on the length of the linker and the average distance between the Pt(II) centres.2a,4a,6 
Furthermore, for dinuclear Pt(II) complexes it was found that the reactivity of the first 
metal centre is independent of the other.7 However, in some cases the interactions 
between the two Pt(II) centres have been reported.8 Therefore, there is limited data in 
literature for one to formulate a clear relationship between the nature of the bridging 
ligands and the reactivity of the Pt(II) centres.9 
 
Apart from the Pt···Pt distances, the nature of the linker or the spacer plays a crucial 
role in the cytotoxicity and the reactivity of multinuclear complexes.9-10 For example, 
the flexibility and the hydrophilicity of the linker influences the reactivity and the 
cytotoxicity of the complexes in a biological environment.9 The hydrophilicity of the 
linker can be increased by introducing polar groups into its linker.11 The advantage of 
having a flexible linking unit over a mono nuclear complex is that the linker provides a 
variable flexibility and reduces the steric hindrance between the two monomer binding 
units.11 Furthermore, hydrophilic flexible bridging linkers between two platinum 
centres can provide additional interactions with the proteins and the biomolecules in 
the body which in turn might enhance the transport of drug carrying ability in the 
body.11 For instance,  in the case of BBR3464, one of the factors accounted for its 
higher activity against tumour cells was attributed to its ability to form long range 
flexible intrastand cross links,  straddling over four nucleobases of DNA.12 
 
2,2′:6′,2′′-tpyridine, most commonly known as tpy and its derivatives are extensively 
used in research applications mostly due to their excellent photochemical and DNA 
intercalating properties.7a,11 In some cases, coordinated compounds of terpyridine do 
not show cytotoxic behaviour.13 However, coupling of two active terpyridine moieties 
with flexible linkers were found to improve this activity.10a Good examples of such 
flexible linkers include alkyldiamine and ethyleneglycol ligands. The ethyleneglycol 
ether linker increases the flexibility of the ligand so that it can wrap around the DNA.10a 
Previous studies have shown that a number of multinuclear complexes have been 
synthesized using this linker and 4’-chloroterpyridine ligand. Biological activities of 
such complexes have been studied using 9-ethylguanine, (Etg). 
 





DNA interaction of the dinuclear Pt(II) complex, [ClPt(dtdeg)PtCl] (where dtdeg = 
bis[4’-(2,2’:6’,2”-tpyridyl)]-diethyleneglycol ether) studied by using Calf Thymas (CT) 
DNA as a substrate,10a was reported to show very high activity against all the cancer cell 
lines tested. In some cases the activity was found to be greater than the well know 
anticancer drug, cisplatin.10a Furthermore, the  activity of the dinuclear complex was 
found to be higher than its mononuclear complex, [Pt(tpy)Cl]Cl, indicating that the 
modification of the primary terpyridine ligand system improves the biological activity 
of the complex.10a However, to understand the behaviour of interaction with DNA, one 
needs to understand the mechanism of action of substitution behaviour of such 
complexes with the biological molecules.  
 
The mechanistic understanding of how flexible linkers control the ligand substitution 
behaviour at the platinum centres has not been studied extensively. Recently, a number 
of ligand substitution reactions of dinuclear Pt(II) complexes have been reported.10b,14 
Studies have shown that reactivity is controlled by the distance between the platinum 
centres and the symmetry of the complexes.14b,c The increase in reactivity was 
attributed to an increase in charge density around the platinum centre facilitated by the 
increase in the electrostatic interactions with simultaneous reduction of the σ-donation 
to each platinum centre.14c Substitution of aqua ligands from an alkyldiamine bridged 
dinuclear platinum complexes further support the decrease in the reactivity with the 
increase in the length of the flexible alkyldiamine linker.14a,b Furthermore, the results 
obtained showed a greater reactivity for the odd number of CH2 groups in the 
alkyldiamine ligand due to their geometry.14a,14c 
 
In Chapter 5, with the mononuclear Pt(II) complexes, it was found that the σ-donacity 
of polyethylene glycoxy linker reduces the π-acceptability of terpyridine. In this study, 
our aim is to increase our understanding of the role of flexible polyethyleneglycol ether 
linkers on the reactivity of dinuclear Pt(II) terpyridine complexes when a second 
terpyridine group is coupled with the polyethylene glycoxy pendant. To accomplish 
this, we have synthesized and characterized five dinuclear Pt(II) complexes, of which, 
four complexes are linked by  polyethyleneglycol ether units of different monomer 
units. The linker-free dinuclear complex, Ptdt was used to gain an in-depth 
understanding on the role of the ethyleneglycol ether linker on controlling the 
reactivity of the dinuclear complexes. The monomeric unit, [Pt(tpy)Cl]+ and Pt(II) (4’-
(ethylene glycoxy)-2,2':6',2''-terpyridine (Pttpyeg) from Chapter 5 is used to compare 





the reactivity of the dinuclear complexes. The complexes used in this investigation are 






























































Figure 6.1  Structures of polyethyleneglycol ether linked dinuclear Pt(II) complexes studied. 




6.2.1 Materials  
Methanol (Merck) was distilled over magnesium prior to use for kinetic analysis.15 
Dimethylsulfoxide (99.9%) from Aldrich was used without any further purification. 
Ethylene glycol (99.8%), diethylene glycol (99%) and triethylene glycol (99%) were 
bought from Sigma Aldrich. The ligand, 4’-chloro,2,2':6',2''-tpyridine (97%), 
tetraethylene glycol (99%), and the platinum salt, potassium tetrachloroplatinate (II) 
(99.9%) were bought from Aldrich. All the other chemicals were purchased from Sigma 
Aldrich and were used without further purification. 
 





6.2.2 Synthesis of Ligands   
The ligand 6’,6”-Bis(2-pyridyl)-2,2’:4’ ,4’’ :2 ”,2’’’-quaterpyridine (dt) was synthesized 
following a literature method16 and ethyleneglycol ether linked ligands were 
synthesized according to the literature procedure.17 
 
6’,6”-Bis(2-pyridyl)-2,2’:4’,4’’ :2 ”,2’’’-quaterpyridine (dt)16  
To a solution of [Ni(PPh3)2Cl2] (2.94 g, 4.5 mmol) and PPh3 (2.36 g, 9 mmol) in DMF (15 
mL) was added zinc dust (0.30 g, 4.5 mmol) and the reaction mixture was stirred at 
room temperature for 30 minutes. The resulting red suspension was treated with 4’-
chloro-2,2’:6’,2”-terpyridine (0.6 g, 4.5 mmol) which immediately changed to dark 
green. After stirring the reaction mixture at room temperature for 8 hours, the solvent 
was removed in vacuo. The residue obtained was boiled in water (50 mL) for 10 
minutes, cooled and filtered. The greenish brown filtrate was treated with 
ammoniumhexafluorophosphate (1.5 g, 9 mmol). The precipitate formed was filtered 
and the solid was dissolved in a mixture of acetonitrile and water (1 : 4, 50 mL) and 
refluxed for one hour with sodium cyanide (1.5 g, 30 mmol). The yellow solid formed 
was filtered, washed with methanol and dried. Recrystallization of the solid in 
methanol (20 mL) gave colourless needles.  
Yield: 111 mg, (69%), colourless needles. The 1H NMR spectra and the mass spectra are 
in good agreement with the proposed chemical structure.  1HNMR (400 MHz, CDCl3) δ/ 
ppm†: 8.72 (4H, d, 6 6’’), 8.61 (4H, d, 3 3’’), 8.51 (4H, s, 3’ 5’), 7.88 (4H, dt, 4 4’’), 7.35 
(4H, dt, 5 5’’). TOF MS-ES+, m/z: 487.1639, (M+Na)+. 
 
Synthesis of bis[4’-(2,2’:6’,2”-tpyridyl)]- ethyleneglycol ether Ligands17 
A mixture of ethyleneglycol (with variable chain lengths viz. ethyleneglycol, 
diethyleneglycol, triethyleneglycol and tetraethyleneglycol) with 2 equivalents of 4’-
chloro-2,2’:6’,2”-tpyridine and excess KOH were stirred in dry DMSO at 60 °C for 24 
hours, under nitrogen. After cooling the reaction mixture to room temperature, water 
was added, which resulted in a white precipitate. The precipitate was filtered, washed 
with water and air dried. The crude product was refluxed in Ethanol (98%) for half an 
hour. The pure product was precipitated upon cooling the mixture in ice for about 30 
minutes. The precipitate was filtered, washed with a small amount of ice cold ethanol 
and air dried. 
                                                             
†  s = singlet, d = doublet, t = triplet, dt = doublet of a triplet. The same representation is used for 
the other complexes. 





The purity of the ligands was confirmed by using 1H NMR and mass spectroscopy. The 
1H NMR spectra obtained show similarity in the aromatic region for the ethyleneglycol 
ether linked ligands.  
 
Bis[4’-(2,2’:6’,2”-terpyridyl)]- ethyleneglycol ether (dteg): Yield: 109 mg, (54%), off 
white powder. 1H NMR (400 MHz, CDCl3) δ/ ppm: 8.72 (4H, d, 6 6’’), 8.65 (4H, d, 3 3’’), 
8.15 (4H, s, 3’ 5’), 7.88 (4H, dt, 4 4’’), 7.35 (4H, dt, 5 5’’), 4.71 (4H, t, CH2), TOF MS-ES+, 
m/z: 547.1857, (M+Na)+. 
 
Bis[4’-(2,2’:6’,2”-terpyridyl)]- diethyleneglycol ether (dtdeg): Yield: 185 mg, 
(80%), off white powder. 1H NMR (400 MHz, CDCl3) δ/ ppm: 8.69 (4H, d, 6 6’’), 8.61 
(4H, d, 3 3’’), 8.08 (4H, s, 3’ 5’), 7.85 (4H, dt, 4 4’’), 7.33 (4H, dt, 5 5’’), 4.47 (4H, t, CH2), 
4.07 (4H, t, CH2), TOF MS-ES+, m/z: 591.2115, (M+Na)+. 
 
Bis[4’-(2,2’:6’,2”-terpyridyl)]- triethyleneglycol ether (dtteg): Yield: 103 mg, 
(65%), off white powder. 1H NMR (400 MHz, CDCl3) δ/ ppm: 8.69 (4H, d, 6 6’’), 8.61 
(4H, d, 3 3’’), 8.05 (4H, s, 3’ 5’), 7.84 (4H, dt, 4 4’’), 7.32 (4H, dt, 5 5’’), 4.42 (4H, t, CH2), 
3.97 (4H, t, CH2), 3.81 (4H, t, CH2), TOF MS-ES+, m/z: 635.2371, (M+Na)+. 
 
Bis[4’-(2,2’:6’,2”-terpyridyl)]- tetraethyleneglycol ether (dttteg): Yield: 98 mg, 
(67%), off white powder. 1H NMR (400 MHz, CDCl3) δ/ ppm: 8.69 (4H, d, 6 6’’), 8.61 
(4H, d, 3 3’’), 8.05 (4H, s, 3’ 5’), 7.84 (4H, dt, 4 4’’), 7.31 (4H, dt, 5 5’’), 4.40 (4H, t, CH2), 
3.94 (4H, t, CH2), 3.78 (4H, t, CH2), 3.72 (4H, t, CH2),  TOF MS-ES+, m/z: 679.2626, 
(M+Na)+. 
 
6.2.3 Synthesis of Platinum(II) Complexes 
Synthesis of 6’,6”-Bis(2-pyridyl)-2,2’:4’,4’’ :2 ”,2’’’-quaterpyridine Platinum(II), 
(Ptdt) 
The silver salt AgSbF6 (68.5 mg, 0.200 mmol) was dissolved in acetonitrile (5 mL) and 
added to a suspension of platinum salt, [Pt(PhCN)2Cl2] (99 mg, 0.200 mmol) in 
acetonitrile (10 mL). The mixture was refluxed overnight under an inert atmosphere 
and the resultant precipitate of AgCl was filtrated. An equimolar amount of 6’,6”-Bis(2-
pyridyl)-2,2’:4’ ,4’’ :2 ”,2’’’-quaterpyridine (92.9 mg, 0.200 mmol) was added to the 
filtrate and the mixture was refluxed for an additional 24 hours. Once the reflux was 
complete, the mixture was filtered hot and the solvent partially removed under vacuo 
resulting in the precipitation of [Pt{6’,6”-Bis(2-pyridyl)-2,2’:4’ ,4’’ :2 ”,2’’’-





quaterpyridineCl](SbF6)2. The product was washed on the frit with copious amounts of 
diethyl ether and then smaller amounts of cold acetonitrile. The purity of the complex 
was confirmed using 1H NMR, 195Pt NMR, elemental analysis and mass spectroscopy. 
 
Yield: 37 mg, (65%), brown powder. 1H NMR (400 MHz, DMSO-d6) δ/ ppm: 8.82 (4H, s, 
3’ 5’), 8.79 (4H, d, 3 3’’), 8.08 (4H, s, 6 6’’), 7.85 (4H, dt, 4 4’’), 7.33 (4H, dt, 5 5’’). 195Pt 
NMR (DMSO-d6) ppm:  -2710. TOF MS-ES+, m/z: 498.0071, (M2+) (C15H10Cl2N3Pt 
species). Anal. Calc. for C30H20Cl2N6Pt2Sb2F12·7H2O: C, 23.66; H, 2.25; N, 5.52; Found: C, 
23.57; H, 2.65; N, 5.31.   
 
Synthesis of Ethyleneglycol ether Linked Dinuclear Platinum(II) Complexes 
The synthesis of the complexes was carried out using the following literature 
procedure:10a To a stirred solution of [Pt(cod)Cl2] in dry methanol at room 
temperature, a suspension of the ligand in dry methanol was added at 65 °C drop wise. 
The reaction mixture was stirred for 24 hours at 45 °C, after which the solution was 
cooled and filtered. When the bright yellow filtrate was concentrated under vacuo, the 
desired compound precipitated. The compound was filtered, washed with chloroform 
(20 mL), cold methanol (1 x 5 mL), diethyl ether (2 x 15 mL) and dried and stored in a 
desiccator.  
 
The identity and the purity of the final complexes were confirmed by using 1H NMR, 
195Pt NMR, elemental analyses and mass spectroscopy. The 1H NMR spectra obtained 
show similarity in the aromatic region. Presence of a peak at about -2500 to -2700 ppm 
on the 195Pt NMR spectra confirms the coordination of the ligand to platinum metal.  
 
(Ptdteg): Yield: 35 mg, (45%), red brown powder. 1H NMR (400 MHz, DMSO-d6) δ/ 
ppm: 8.97 (4H, s, 3’ 5’), 8.94 (4H, d, 6 6’’), 8.70 (4H, d, 3 3’’), 8.55(4H, dt, 4 4’’), 7.99 (4H, 
dt, 5 5’’), 4.71 (4H, t, CH2), 195Pt NMR  (DMSO-d6) ppm:  -2714. TOF MS-ES+, m/z: (M2+), 
464.1578 (C15H11ClN3Pt species). Anal. Calc. for C32H24Cl4N6O2Pt2: C, 36.38; H, 2.29; N, 
7.95; Found: C, 35.89; H, 2.72; N, 7.51.   
 
(Ptdtdeg): Yield: 47 mg, (51%), orange powder. 1H NMR (400 MHz, DMSO-d6) δ/ ppm: 
8.57 (4H, d, 6 6’’), 8.43 (4H, d, 3 3’’), 8.2 (4H, dt, 4 4’’), 8.17 (4H, s, 3’ 5’), 7.80 (4H, dt, 5 
5’’), 4.66 (4H, t, CH2), 4.01 (4H, t, CH2), 195Pt NMR  (DMSO-d6) ppm:  -2699. TOF MS-
ES+, m/z: 568.1068, (M2+) (C19H18ClN3O3Pt species). Anal. Calc. for C34H28Cl4N6O3Pt2: C, 
37.10; H, 2.56; N, 7.64; Found: C, 36.78; H, 2.92; N, 7.17.   





(Ptdtteg): Yield: 56 mg, (57%), orange powder. 1H NMR (400 MHz, DMSO-d6) δ/ ppm: 
8.71 (4H, d, 6 6’’), 8.60 (4H, t, 4 4’’), 8.18 (4H, br, 3 3’’), 8.06 (4H, s, 3’ 5’), 7.95 (4H, dt, 5 
5’’), 4.70(4H, br, CH2), 4.22 (4H, br, CH2), 4.14(4H, t, CH2),  195Pt NMR  (DMSO-d6) ppm:  
-2683. TOF MS-ES+, m/z: 568.1073, (M2+) (C19H18ClN3O3Pt species). Anal. Calc. for 
C36H32Cl4N6O4Pt2: C, 37.77; H, 2.82; N, 7.34; Found: C, 37.38; H, 3.30; N, 6.91.   
(Ptdttteg): Yield: 56 mg, (57%), orange powder. 1H NMR (400 MHz, DMSO-d6) δ/ ppm: 
8.71 (4H, d, 6 6’’), 8.61 (4H, t, 4 4’’), 8.38 (4H, br, 3 3’’), 8.03 (4H, s, 3’ 5’), 7.98 (4H, dt, 5 
5’’), 4.48(4H, br, CH2), 4.06 (4H, br, CH2), 4.01(4H, br, CH2), 4.00(4H, br, CH2), 195Pt 
NMR  (DMSO-d6) ppm:  -2691. TOF MS-ES+, m/z: 887.2581, (M2+), (C38H36ClN6O5Pt 
species). Anal. Calc. for C38H36Cl4N6O5⋅7H2O: C, 34.02; H, 3.64; N, 6.61; Found: C, 34.49; 
H, 3.41; N, 6.15.  
Details of the characteristic data agree well with the proposed chemical structures of 
the complexes. Representative spectra for analysis are given under Supporting 
Information.  
 
6.2.4 Instrumentation and Physical Measurements 
1H NMR were recorded on either a Bruker Avance DPX 400 or 500 MHz spectrometer, 
at 303 K (unless or otherwise stated) using Si(CH3)4 as the reference for the chemical 
shifts. 195Pt NMR were done on a 500 MHz spectrometer (195Pt, 107.5 MHz) chemical 
shifts externally referenced to K2[PtCl6]. Low resolution electron spray ionization (ESI+) 
mass spectra were recorded on a TOF Micromass spectrometer. Elemental analyses 
were performed by a Thermal Scientific Flash 2000. Kinetic analyses were studied on 
an Applier Photophysics SX 20 stopped-flow reaction analyser coupled with an online 
data acquisition system with controlled temperature within ± 0.1 °C. The wavelengths 
for the kinetic analysis were predetermined on Varian Cary 100 Bio UV/visible 
spectrophotometer with an attached Varian Peltier temperature-controller within ± 0.1 
°C and an online kinetic application.  
 
6.2.5 Computational Modelling 
Computational modelling for the complexes were performed at Density Functional 
Theoretical (DFT) level based on B3LYP/LanL2DZ18 (Los Alamos National Laboratory 2 
double ξ) level theory, with inner core electrons of Pt atom replaced by relative 
Effective Core Potential (ECP). Due to low electronic spin of Pt(II), the DFT calculations 
of the complexes were done as singlet state. The complexes were computed in 
methanol solution taking into account the solvolysis effect by means of the Conductor 





Polarizable Continum Model (C-PCM).19 The Gaussian09 suite of programs was used for 
all computations.20   
 
 
6.2.6 Kinetic Analyses 
 All kinetic measurements were performed under pseudo first-order conditions using at 
least 20-fold excess (a 10-fold excess of nucleophile at each Pt(II) centre) of the 
nucleophile in 0.02 M ionic solution, made by dissolving the required amount of 
LiCF3SO3 (0.018 M) and LiCl (0.002 M) in dry methanol. LiCl was added to suppress any 
possibility of solvolysis reactions. Since CF3SO3ˉ does not coordinate with the Pt(II) 
metal centre,21 all substitution kinetics were studied in this media. Nucleophiles were 
used in large excess in order to drive the reactions to completion. 
 
Pt(II) complex solutions were prepared by dissolving the required amount of the 
complex in the ionic solution. Nucleophile solutions were prepared at 100 times the 
concentration of the Pt(II) complex. Subsequent dilutions of the nucleophile stock 
solution afforded solutions of 20, 40, 60 and 80 times the concentration of metal 
complex. The wavelengths chosen for the kinetic investigations were pre-determined 
by monitoring the change in absorbance of the mixture of the metal complex and the 
nucleophile as a function of time using UV/visible absorption spectra and are 
summarised in Table S6.1 (Supporting Information). All data were graphically analysed 
using the software package, Origin 7.5®22 to determine the observed rate constants, kobs. 
 
6.3 Results 
Substitution kinetics of coordinated chlorides from the Pt(II) complexes by thiourea 
nucleophiles, viz. TU, DMTU and TMTU were investigated under pseudo first-order 
conditions using conventional stopped-flow reaction analyzer. An example of a time 
resolved kinetic trace obtained from a stopped-flow analyzer for the simultaneous 
substitution of the chloride ligands in Ptdtteg (3.0 x 10-5 mol dm-3) with DMTU (0.899 
mol dm-3) at 298 K is given in Figure 6.2. 





















Figure 6.2  Kinetic trace at 301 nm for the reaction of Ptdtteg (3.0 x 10-5 mol dm-3) with DMTU 
(8.99 x 10-4 mol dm-3) at 298 K, I = 0.02 M LiCF3SO3, adjusted with LiCl. 
 
All kinetic data obtained were fitted to first-order exponential decay function to 
generate the observed pseudo first-order rate constants, (kobs), which were plotted 
against the concentration of the incoming nucleophiles. The values used represent an 
average of at least eight independent runs. Straight line graphs with zero intercepts 
were obtained for each of the nucleophile, indicating that the reactions were 
irreversible in nature and can be represented by Scheme 6.1 and the corresponding rate 
law given by Equation 6.1.23 Representative plots for Ptdteg, shown in Figure 6.3 clearly 
indicate that the substitution reactions were first-order with respect to the incoming 
nucleophile. Kinetic data obtained from the slope of the Equation 6.1 are summarized in 
Table 6.1.  
 






















O OL = 0 (Ptdt), (Ptdteg), (Ptdtdeg), (Ptdtteg), (Ptdttteg)O O 2x 3x 4xO O O O  
Scheme 6.1 Proposed substitution mechanism for the dinuclear Pt(II) complex system with 
thiourea nucleophiles. 
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Figure 6. 3 Dependence of the pseudo first-order rate constants (kobs) on the concentrations 
of the nucleophiles for the chloride substitution from Ptdteg (2.65 x 10-5 M) in 









The temperature dependence studies were performed in a similar manner, using a 
single nucleophile concentration in the temperature range 15 - 40 °C in 5 °C intervals. 
The activation parameters, entropy of activation ( S ) and enthalpy of activation          
( H ) were then obtained by using the Eyring equation.23 Figure 6.4 shows the 
representative plots obtained for Ptdteg with the different nucleophiles for the 
forward reactions. The data obtained are summarized in Table 6.1. Representative 
graphs are given in Figures S6.1 to S6.8. 
 
Table 6.1  Summary of the second-order rate constants, k2 and activation parameters, with 
the corresponding standard deviations for the substitution of the chloro ligands 
by a series of thiourea nucleophiles at I = 0.02 M LiCF3SO3, adjusted with LiCl. Data 
for Pttpy is taken from literature24 and included for comparison. 
Complex Nu k2/M-1 s-1 SΔ / J K-1 mol-1 HΔ / kJ mol-1 
Pttpy TU  1494 ± 10    -88 ± 5 29 ± 2 
 DMTU    448 ± 10    -73 ± 4 36 ± 1  
 TMTU       82 ± 4    -91 ± 8 35 ± 2  
Ptdt TU  1520 ± 28    -85 ± 6 30 ± 2 
 DMTU    838 ± 14    -31 ± 7 48 ± 2  
 TMTU    139 ± 3    -50 ± 8 46 ± 3 
Ptdteg TU     281 ± 2    -52 ± 6 44 ± 2 
DMTU        90 ± 1    -59 ± 3 54 ± 1  
TMTU        52 ± 1    -96 ± 2 35 ± 1 
Ptdtdeg TU      132 ± 2    -50 ± 3 46 ± 1  
DMTU        43 ± 0.6    -89 ± 4 37 ± 1 
TMTU        27 ± 0.2    -88 ± 3 39 ± 1 
Ptdtteg TU     100 ± 1    -96 ± 5 33 ± 2 
DMTU        40 ± 0.6    -62 ± 6 45 ± 2 
TMTU        14 ± 0.2    -49 ± 12 51 ± 4 
Ptdttteg TU        43 ± 0.7   - 49 ± 5 49 ± 2 
DMTU        28 ± 0.4    -69 ± 6 45 ± 2 
TMTU        22 ± 0.4    -78 ± 8 42 ± 3 
 


























Figure 6.4 Eyring plots obtained for Ptdteg with the nucleophiles for the forward reactions 
over the temperature range 15 - 35 °C. 
 
6.3.1 Computational Modelling 
The geometry optimized structures of the platinum complexes investigated are shown 
in Table 6.2 (also see Table S6.2) while the data obtained are summarized in Table 6.3 
and Table S6.3 (Supporting Information). The geometry around the Pt(II) centre is 
slightly distorted square planar which is typical for Pt(II) terpyridine complexes.24-25 
The highest occupied molecular orbital (HOMO) electron density of the complexes are 
predominantly concentrated on the Pt(II) centre and the chloride ligands whereas the 
lowest unoccupied molecular orbital (LUMO) mainly lie on the terpyridine ligand 
backbone. The π systems of the two terpyridine moieties of the ligand interact with the 
Pt(II) metal centre through the metal d orbitals. This makes the two halves of the 
complex to orient at an angle to each other which decreases with increase in the length 
of the linker (δ as represented in Figure 6.5 in Ptdteg, Ptdtdeg and Ptdtteg). This 
bonding orientation to the platinum metal centre prevents possibility of π interaction 
across the system.26 As expected, in the back to back terpyridine complex, Ptdt, the 
HOMO and LUMO electron density span throughout the molecule due to the extended 
π-conjugation (Figure 6.6, Table 6.2). In the case of the shortest linker (Ptdteg), due to 
the interaction of the lone pair of electrons on O1 atoms with the electrons on the 





terpyridine ligands,27 the π electron density spreads throughout the ligand system and 
hence the observed DFT calculated HOMO and LUMO electron density.28 However, DFT 
calculations show that the HOMO and LUMO electrons are restricted on one side of the 
molecules as the length of the spacer between the two terpyridine ligands was 
increased (Figure S6.9, Supporting information). This is because the electronic charge 
distribution depends on the degree of metal-metal coupling and the perturbations in 
the molecular environment; such that, increase in the length of the linker decreases the 
metal-metal coupling leading to modest perturbations whereby localizing the charge on 
one metal centre of the complex.29 Thus, it seems that the two Pt(II) terpyridine 
moieties become independent of each other with increase in the chain length. 
Furthermore, the two terpyridine moieties lies at an inclined angle, α, which increases 
with increase in the chain length as exemplified in the Figure 6.5. 
 
On comparing the DFT calculated natural bond orbital (NBO) charges on the platinum 
and Ntrans atoms of Pttpy and back to back linked complex, Ptdt, the charge on Pt(II) 
centre increases from Pttpy to Ptdt while it decreases for Ntrans from Pttpy to Ptdt. 
However, when Ptdt was compared with Ptdteg, the opposite was observed, i.e. the 
NBO charge on the platinum centre decreases from Ptdt to Ptdteg then remains 
constant, while the opposite is true for Ntrans which becomes more negative and remains 
constant as the chain length increases. This observation for Ptdt and Ptdteg is due to 
the inductive σ-donation from the ethyleneglycol ether linker to the Pt(II) centre. 
Nevertheless, the fact that the values are roughly constant as the length of the 
polyethyleneglycol ether linker is increased indicates that the σ-inductive effect does 
not play a significant role on increasing the length of the linker beyond one unit of 
ethyleneglycol ether. Furthermore, since the DFT-based global electrophilicity index 
(ω, related to the capacity of the molecule to accept electrons),30 obtained by using the 
chemical hardness (η)31 and electronic potential (μ),30c is a strong tool to determine the 
chemical reactivity, this parameter was calculated and the values show similar trend 






















Figure 6.5 Aerial view showing the angles of inclination, α, in the DFT calculated distorted 
slip-up stair case like linkers and the angle of twisting (δ) of the tpy moieties from 
each other.   


















































Figure 6.6  DFT calculated minimum energy structures, frontier molecular orbitals (HOMO and LUMO) of Pttpy, Ptdt and Ptdteg. Data for Pttpy is 
included for comparisons. Data for Ptdtdeg, Ptdtteg and Ptdttteg are included in Figure S6.9 (Supporting Information). 





Table 6.3  Summary of DFT calculated data for the complexes investigated. Included is the 
data obtained for the DFT calculated Pttpy complex for comparisons. 
Complex  Pttpy Ptdt Ptdteg Ptdtdeg Ptdtteg Ptdttteg 
Bond Length (Å)       
Pt―Cl 2.443 2.440 2.441 2.441 2.445 2.443 
Pt―N1(trans) 1.961 1.954 1.960 1.960 1.961 2.961 
Length of linker - - 2.926 5.040 8.316 11.65 
Pt···Pt - 10.95 14.34 16.99 19.95 21.87 
Bond angles (o)       
Dihedral angle (δ) - 3.27 65.45 56.55 55.95 10.60 
Inclination angle ( α) - 0.01 20.44 25.79 26.00 45.14 
NBO charges       
Pt1/Pt2 0.604 0.620 0.595 0.593 0.593 0.592 
N1 (trans) -0.453 -0.446 -0.469 -0.471 -0.470 -0.471 
Cl -0.502 -0.496 -0.504 -0.504 -0.505 -0.505 
∆E / eV 3.69 3.10 3.61 3.64 3.64 3.64 
η / eV 1.85 1.55 1.83 1.82 1.82 1.82 
µ/ eV -5.20 -5.49 -5.11 -5.09 -5.08 5.07 
ω/ eV 7.31 9.72 7.13 7.12 7.09 7.06 
Symmetry C2 C1 C1 C1 C1 C1 
η = chemical hardness, μ = chemical potential and ω = global electrophilicity index.30-31 
 
6.4 Discussion 
The complexes were synthesized and characterized using 1H NMR, 195Pt NMR, MS and 
elemental analysis (See Figures S6.10 to S6.29). In the current study, substitution 
kinetics of chloride ligands from the dinuclear Pt(II) complexes by thiourea 
nucleophiles occurred simultaneously by a single step. Data summarized in Tables 6.1 
and 6.3 (also Tables S6.4 to S6.13) show that the Pt(II) complexes are somewhat 
symmetrical such that the nucleophiles cannot differentiate the two Pt(II) centres. The 
symmetrical nature of the Pt(II) centres is supported by the DFT calculated similar NBO 
charges on the Pt(II) centres (Table 6.3) indicating that the two Pt(II) centres are in 
similar chemical environments regardless of the distance between the two Pt(II) 
centres. Similar substitution behaviour has been reported previously by Jaganyi and co-
workers32 for dinuclear Pt(II) complexes containing flexible diamine linkers.  
 
Simultaneous substitution of the chloride ligands is further confirmed using 195Pt NMR 
of Ptdtteg with TU (2 to 4 eqv) in DMF- d6 (Figure 6.7). At t = 0, a signal due to the 
starting complex (Ptdtteg) is observed at δ = -2687 ppm, represented as A. This 





chemical shift at δ = -2687 ppm has moved to δ = -3099 ppm, (B) after 3 hours and is 
attributed to the formation of TU substituted product which exhibits a chemical shift 
due to Pt(NNN)TU centres as reported by Jaganyi et al.14e Unlike the previous findings 
for dinucelar Pt(II) complexes with flexible diamine,14a,14c rigid azine14e and cyclic10b 
linkers, the dinuclear complexes reported in this work are more stable showing no 




Figure 6.7 195Pt NMR the reaction mixture of Ptdtteg (2 x 10-2 M) with six equivalents of TU 
(2.0 M), showing a peak for pure dinuclear Pt(II) complex at δ = -2687 ppm before 
the reaction (t = 0) and the final substituted product (B, δ = -3099 ppm) 
corresponding to [(TU)Pt(dtteg)Pt(TU)]4+, over a period of  4.5 hours after the 
reaction begins. 
 
When compared the mononuclear analogue, Pttpy with the linker free back to back 
terpyridine complex, Ptdt, the reactivity increases slightly which can be attributed to 
the expansion of the π-conjugated electron system over the two Pt(II) centres. This 
increases the electronic communication within the terpyridine ligand system. Thus, 
decreases the electron density at the Pt(II) metal centre due to the enhanced π-
backbonding ability of the ligand system.33 As a result, the Pt(II) metal centres in Ptdt 
become more electrophilic thereby enhancing the binding of the incoming nucleophile. 
This is clearly seen from the DFT calculated NBO charges on the platinum centres 
which increases from Pttpy to Ptdt. Further support for this comes from the 
remarkably higher DFT calculated global electrophilicity index of Ptdt compared to 
Pttpy, a clear indication of the greater ability of Ptdt to accept electron density from 

































the incoming nucleophile to that of Pttpy.30b,c,34 This, together with the increased 
overall charge, (2+)7b,14c attributes to the higher substitution reactivity of Ptdt. 
Compared to Pttpy and to the rest of the complexes, steric hindrance is an additional 
factor. 
 
To understand the role of the linker on the rate of substitution of chloride ligands, the 
reactivity of Ptdt and Ptdteg are compared so as to explain the huge drop in the 
reactivity. The difference between them is the presence of the ethyleneglycol ether 
linker in the case of Ptdteg. The kinetic data shows that the reactivity of Ptdt is five 
times greater than Ptdteg which implies that, as reported in Chapter 5, the 
ethyleneglycol ether linker acts as a σ- donor using the two lone pair of electrons on the 
O1 atoms. This inductive σ-donation increases the charge on the Ntrans atom from Ptdt 
(-0.446) to Ptdteg (-0.469) which in turn decreases the NBO charge on the platinum 
centres from Ptdt (0.620) to Ptdteg (0.595). This is in line with the reported 
literatures,1c,24,35 where electron donating groups on the ancillary position of 
terpyridine reduces the positive charge at the metal centre, thereby decreasing its 
electrophilicity. Further support for this comes from the significant decrease in the DFT 
calculated global electrophilicity index for Ptdteg (7.13 eV) to that of Ptdt (9.72 eV). 
Hence, Ptdt has a greater tendency to accept the incoming nucleophiles and thus, 
enhances the π-backbonding of electrons from the dxz orbital of platinum into the 
antibonding π* orbital of the ligand whereby stabilizing the transition state 
intermediate. In other words, the significantly slower reactivity of Ptdteg indicates that 
the nature of the bridging ligand in Ptdteg decreases the π-backbonding ability of the 
terpyridine moiety.33 This can also be seen from the greater tilt angle,36 δ, obtained for 
Ptdteg (65.45 °) compared to that of Ptdt (3.27 °), despite the π-delocalization noticed 
with O1 atoms of the linker in Ptdteg. Together with the mentioned electronic effects, 
the decrease in rate of substitution reactions from the linker free Ptdt to Ptdteg is also 
due to the presence of the axially imposed steric influences on one side of the Pt(II) 
coordination sphere as illustrated in Figure 6.5. 
 
Further analysis of the reactivity of the polyethyleneglycol ether linked complexes 
show a decrease in the reactivity as the length of the linker is increased from Ptdteg 
(2.926 Å) to Ptdettteg (11.65 Å). When viewed along the axis perpendicular to the 
mean planes containing the platinum atoms, the DFT calculated minimum energy 
structures show that the complexes adopt twisted slip up staircase like geometry so 
that the second terpyridine moiety lie in an inclination angle, α which is dependent on 





the length of the linker. Relative to the plane containing one of the terpyridine moieties, 
the other chelate moiety projected by the linker increases from 20.44 ° in Ptdteg  to 
45.14 ° in Ptdttteg. Thus, the steric imposition on one side of the Pt(II) coordinated 
sphere increases with the increase in the length of the linker, whereby impeding the 
approach of the axially incoming  nucleophile. This steric influence is the main factor 
responsible for the decreasing reactivity from Ptdteg to Ptdttteg. This deduction is 
also supported when one compares the trend at the reactivity of these dinuclear 
complexes to that of the mono nuclear complexes which shows the reactivity to be 
relatively constant as the linker is increased. The decrease in the reactivity is also due 
to the poor electronic transitions between the metal centres due to the longer spaces 
and large reorganizational energies caused by the highly twisted the systems as the 
length of the linker increases.36-37 It is known that the reactivity increases with increase 
in the coupling between the metal centres, which decreases with increase in the 
distance between the metal centres.37-38 This trend in the decrease in reactivity has 
been reported by van Eldik et al.9,14b and Jaganyi et al.32 for dinuclear Pt(II) complexes 
with flexible linkers.  
 
In addition to steric hindrance, the decrease in reactivity is also attributed to the fact 
that the charges on the metal centres do not affect each other9,39 thus, reducing the 
overall electrophilicity of the molecule as supported by the DFT calculation.30c It can 
also be argued that the other factor contributing to the observed decrease in the 
reactivity from Ptdteg to Ptdttteg is the increase in electrostatic attraction induced 
between the ethyleneglycol ether polymer units as well as the platinum metal centres 
and the terpyridine moieties by the lone pair of electrons on the oxygen atoms in the 
linker.40  
 
To further investigate the steric influence introduced by the linker, analysis of 1H NMR 
study of Ptdttteg (0.02 M) at six different temperatures (30 °C to 80 °C, Figure 6.8, also 
see Figure S6.30, Supporting Information) shows more down fielded chemical shifts 
with improved multiplicity (in case of proton 3 3’’ from broad to a doublet) as the 
temperature was increased. This is an indication of the disruption of the self-associated 
dimmers such as π-stacked molecules in solution at high temperature.41 However, since 
the kinetic investigations are performed at the concentration levels of 10-5 M, in such 
diluted solutions, the probability of formation of dimmers is unlikely.42 Therefore, the 
improved multiplicity is due to the relief of intrinsic steric effect within the complex 
which is due to the increase in rotations about the flexible linker. This increases with 





the increase in the length of the linker which imposes a greater degree of steric 
influence on the Pt(II) centre. This has a net effect of influencing the axial attack of the 
incoming nucleophile whereby slowing the reactivity.32  
 
 
Figure 6.8 1H spectra of Ptdttteg (0.02 M) in DMSO-d6 at temperatures, 30 °C to 80 °C. 
 
In general, when comparing the reactivity of the Pt(II) dinuclear complexes with their 
representative monomer (Chapter 5), the reactivity of the dinuclear complexes was 
slower than the reactivity of the mononuclear complexes. Unlike the nomonuclear 
complexes, the reactivity of the dinuclear complexes decreases with increase in the 
length of the linker. However, one notes that the reactivity of the Pt(II) dinuclear 
complex with the shortest linker Ptdteg is slightly faster (281 ± 2.0 M-1 s-1)  than its 
monomer, Pttpyeg (257 ± 5 M-1 s-1) (See Chapter 5, Table 5.2,). This increase in 



























distance between the two Pt(II) centres is small, the molecule behaves more like a 2+ 
charge at each metal centre than 1+.9  
The reactivity of the nucleophiles shows a clear dependence on the steric effects, which 
is typical of a mechanism involving bond making in the transition state.10b,14a In all cases 
TU has the highest reactivity and the rate decreases as the incoming nucleophile gets 
bulky, i.e. rate with TMTU is significantly slower. From the results obtained for 
activation parameters, the large entropies of activation, ( S ) suggest a more ordered 
transition state. The relatively small enthalpies of activation, ( H ) support an easy 
bond formation in the transition state which is typical for d8 square planar Pt(II) 
complexes  during associative mode of substitution.14c,14e,24-25,35b,43   
 
6.5 Conclusions 
The lability of the dinuclear polyethyleneglycol ether linked complexes; Ptdteg, 
Ptdtdeg, Ptdtteg and Ptdttteg differ significantly from the corresponding linker free 
dinuclear complex, Ptdt and the monomeric complex, Pttpy. The differences in 
reactivity can be accounted for in terms of the electronic as well as steric effect due to 
structural differences. The introduction of the linker results in decreased 
electrophilicity of the platinum centre and the whole complex because of the 
ethyleneglycol ether acts as a σ-donor by using the lone pair of electrons on the oxygen 
atoms. In addition, the reactivity of the ethyleneglycol ether linked complexes decrease 
with increase in the distance between the Pt(II) metal centres. This is due to steric 
hindrance which increases with the length of the linker. Unlike the mono nuclear Pt(II) 
complexes whose reactivity remains relatively constant, the reactivity of these 
dinuclear complexes decrease with increase in the length of the linker. 
 
The substitution reactions of these complexes have shown to be more stable with the  
S-donor nucleophiles compared to what has been reported in literature which showed 
dechelation of the ligand and linker.10b,14c,14e The substitution rates showed a positive 
dependence to the steric effects of the incoming nucleophiles, hence, the rate constants 
for TU are much faster than DMTU and TMTU. The activation parameters, enthalpy of 
activation and entropy of activation well support an associative mode of mechanism. 
This study clearly shows that the nature of the bridging ligand uniquely influences the 
rate of substitution reactions when compared to the similar studies reported in 
literature.9,14c   
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6.7 Supporting Information  
A summary of wavelengths at which the kinetic studies were performed, plots of the 
dependence of kobs against concentration of the nucleophiles and plots from 
temperature dependence studies along with tables of kinetic data, graphs of exemplary 
mass spectra and the representative spectra for 1H NMR and 195Pt NMR work reported 
in this study are given as electronic Supporting Information (ESI). 
 
Table S6.1 Summary of the wavelengths (nm) used to study the substitution reactions of the 
complexes with thiourea nucleophiles. 







Ptdteg TU 330 
DMTU 330 
TMTU 352 
Ptdtdeg TU 400 
DMTU 331 
TMTU 301 
Ptdtteg TU 356 
DMTU 301 
TMTU 330 
















Table S6. 2  Geometry- optimised structures of the platinum complexes investigated and 
distribution of the electron density on the platinum complexes investigated. The 
blue area indicates the most electropositive areas and the orange region indicates 


























Table S6. 3  Summary of DFT calculated data for the complexes investigated. Included is the 
data obtained for the DFT calculated PtTpy for comparisons. 
Complex  Pttpy Ptdt Ptdteg Ptdtdeg Ptdtteg Ptdttteg 
Bond Length (Å)       
Pt1―N2(cis) 2.049 2.050 2.049 2.049 2.052 2.051 
Pt―N3(cis) 2.049 2.050 2.049 2.049 2.051 2.051 
Pt―N1(trans) 1.961 1.954 1.960 1.960 1.961 2.961 
4’C―O1   1.371 1.370 1.368 1.368 
O1―O2   2.926 3.071 2.949 2.945 
O2―O3    3.071 3.014 3.013 
O3―O4      3.705 
O4―O5       3.002 
Pt1―O1   6.070 6.071 6.070 6.071 
Pt1---Pt2  10.952 14.344 16.993 19.948 21.874 
Cl---Cl  15.833  21.691 24.722 26.296 
4’C-4’C  1.495  7.998  13.769 
Bond angles (o)       
N1―Pt―Cl 179.99 179.99 179.29 179.71 179.55 179.63 
N2―Pt―Cl 99.05 99.20 99.03 98.92 99.25 99.36 
N3―Pt―Cl 99.05 99.19 99.34 99.46 99.21 99.09 
N3―Pt―N2 161.90 161.61 161.63 161.62 161.54 161.55 
N2―Pt―N1 80.95 80.80 80.91 80.91 80.84 80.84 
N1―Pt―N3 80.95 80.81 80.71 80.71 80.70 80.70 
Dihedral -cl 0.007 0.157 0.97 0.233 0.674 1.065 
NBO charges       
N2 -0.493 -0.492 -0.492 -0.492 -0.493 -0.492 
N3 -0.493 -0.492 -0.469 -0.493 -0.492 -0.493 
O1   -0.561 -0.566 -0.565 -0.558 
O2   -0.561 -0.647 -0.650 -0.649 
O3     -0.645 -0.645 
O4     -0.559 -0.645 
O5      -0.559 
C 4 -0.134 0.013 0.406 0.408/0.408 0.408 0.408 
EHOMO/ eV -7.04 -7.04 -6.94 -6.91 -6.90 6.89 
ELUMO/ eV -3.35 -3.94 -3.28 -3.27 -3.26 3.25 
Dipole moment 13.3 0.002 5.91 6.23 7.21 8.97 
 
  






Table S6. 4  Average observed rate constants, kobs, s-1, for the displacement of the chloride 
ligands in Ptdt with the nucleophiles, at T =  298 K, I = 0.02 M LiCF3SO3, adjusted 
with LiCl 
TU DMTU TMTU 
Conc., mM kobs., s-1 Conc., mM kobs., s-1 Conc., mM kobs., s-1 
0.321 0.56224 0.321 0.24 0.321 0.03699 
0.642 1.03629 0.642 0.55002 0.642 0.08896 
0.963 1.36725 0.963 0.7599 0.963 0.12844 
1.280 1.96703 1.280 1.11151 1.280 0.18886 
1.610 2.45658 1.610 1.35162 1.610 0.2194 
 
Table S6. 5  Temperature dependence of k2 M-1s-1, for the displacement of the chloride ligands 
in Ptdt by the nucleophiles at 60-fold excess over [dt], at T =  298 K, I = 0.02 M 
LiCF3SO3, adjusted with LiCl. 
TU DMTU TMTU 
1/T, K-1 In(k2/T) 1/T, K-1 1/T, K-1 In(k2/T) 1/T, K-1 
0.00347 1.10512 0.00347 0.02413 0.00347 -1.52777 
0.00341 1.35682 0.00341 0.45205 0.00341 -1.12132 
0.00335 1.56066 0.00335 - 0.00335 -0.80445 
0.0033 1.68841 0.0033 1.0636 0.0033 - 
0.00325 1.95483 0.00325 1.33994 0.00325 -0.26244 
 
 
Table S6. 6  Average observed rate constants, kobs, s-1, for the displacement of the chloride 
ligands in Ptdteg with the nucleophiles, at T =  298 K, I = 0.02 M LiCF3SO3, adjusted 
with LiCl 
TU DMTU TMTU 
Conc., mM kobs., s-1 Conc., mM kobs., s-1 Conc., mM kobs., s-1 
0.273 0.08029 0.273 0.02191 0.273 0.01364 
0.547 0.15586 0.547 0.04942 0.547 0.03339 
0.820 0.22643 0.820 0.07608 0.820 0.04063 
1.090 0.30329 1.090 0.09664 1.090 0.05598 













Table S6. 7  Temperature dependence of k2 M-1s-1, for the displacement of the chloride ligands 
in Ptdteg by the nucleophiles at 60-fold excess over [Ptdteg], at T =  298 K, I = 0.02 
M LiCF3SO3, adjusted with LiCl. 
TU DMTU TMTU 
1/T, K-1 In(k2/T) 1/T, K-1 1/T, K-1 In(k2/T) 1/T, K-1 
0.00347 -0.71663 0.00347 -1.73801 0.00347 -2.26834 
0.00341 -0.34561 0.00341 -1.44339 0.00341 -2.05389 
0.00335 -0.07635 0.00335 -1.16699 0.00335 -1.79427 
0.0033 0.24629 0.0033 -0.8345 0.0033 -1.55744 
0.00325 0.46319 0.00325 -0.54278 0.00325 -1.33352 
 
 
Table S6. 8  Average observed rate constants, kobs, s-1, for the displacement of the chloride 
ligands in Ptdtdeg with the nucleophiles, at T =  298 K, I = 0.02 M LiCF3SO3, 
adjusted with LiCl. 
TU DMTU TMTU 
Conc., mM kobs., s-1 Conc., mM kobs., s-1 Conc., mM kobs., s-1 
0.300 0.04376 0.300 0.0138   
0.599 0.0812 0.599 0.02517 0.599 0.01599 
0.899 0.11215 0.899 0.0406 0.899 0.02409 
1.200 0.15854 1.200 0.05333 1.200 0.03239 
1.500 0.20028 1.500 0.06342 1.500 0.03922 
 
  
Table S6. 9  Temperature dependence of k2 M-1s-1, for the displacement of the chloride ligands 
in Ptdtdeg by the nucleophiles at 60-fold excess over [Ptdtdeg], at T =  298 K, I = 
0.02 M LiCF3SO3, adjusted with LiCl. 
TU DMTU TMTU 
1/T, K-1 In(k2/T) 1/T, K-1 1/T, K-1 In(k2/T) 1/T, K-1 
0.00347 -1.52978 0.00347 -2.38665 0.00347 -2.95927 
0.00341 -1.20269 0.00341 -2.07121 0.00341 -2.64596 
0.00335 -0.87131 0.00335 -1.86044 0.00335 -2.40916 
0.0033 -0.53935 0.0033 -1.60949 0.0033 -2.13455 
0.00325 -0.2974 0.00325 -1.36041 0.00325 -1.90089 
 
 
   





Table S6. 10  Average observed rate constants, kobs, s-1, for the displacement of the chloride 
ligands in Ptdtteg with the nucleophiles, at T =  298 K, I = 0.02 M LiCF3SO3, 
adjusted with LiCl. 
TU DMTU TMTU 
Conc., mM kobs., s-1 Conc., mM kobs., s-1 Conc., mM kobs., s-1 
0.300 0.01937 0.300 0.01042 0.300 0.00165 
0.599 0.0569 0.599 0.02305 0.599 0.00815 
0.899 0.08797 0.899 0.03674 0.899 0.01289 
1.200 0.12138 1.200 0.04958 1.200 0.01637 
1.500 0.15091 1.500 0.05965 1.500 0.02175 
 
  
Table S6.11 Temperature dependence of k2 M-1s-1, for the displacement of the chloride ligands 
in Ptdtteg by the nucleophiles at 60-fold excess over [Ptdtteg], at T =  298 K, I = 
0.02 M LiCF3SO3, adjusted with LiCl. 
TU DMTU TMTU 
1/T, K-1 In(k2/T) 1/T, K-1 1/T, K-1 In(k2/T) 1/T, K-1 
0.00347 -1.56957 0.00347 -2.5684 0.00341 -3.51306 
0.00341 -1.30861 0.00341 -2.22585 0.00335 -3.03487 
0.00335 -1.11407 0.00335 -1.98735 0.0033 -2.83065 
0.0033 -0.91965 0.0033 -1.65603 0.00325 -2.50241 
0.00325 -0.63777 0.00325 -1.31503 0.00319 -2.07025 
 
  
Table S6. 12  Average observed rate constants, kobs, s-1, for the displacement of the chloride 
ligands in Ptdttteg with the nucleophiles, at T =  298 K, I = 0.02 M LiCF3SO3, 
adjusted with LiCl. 
TU DMTU TMTU 
Conc., mM kobs., s-1 Conc., mM kobs., s-1 Conc., mM kobs., s-1 
0.300 0.01435 0.274 0.00685   
0.599 0.0253 0.548 0.01407 0.548 0.01329 
0.899 0.03679 0.821 0.02253 0.821 0.01801 
1.200 0.05035 1.100 0.03109 1.100 0.02493 
1.500 0.06627 1.370 0.03848 1.370 0.03001 
 
 






Table S6. 13  Temperature dependence of k2 M-1s-1, for the displacement of the chloride ligands 
in Ptdttteg by the nucleophiles at 60-fold excess over [Ptdttteg], at T =  298 K, I = 
0.02 M LiCF3SO3, adjusted with LiCl. 
TU DMTU TMTU 
1/T, K-1 In(k2/T) 1/T, K-1 1/T, K-1 In(k2/T) 1/T, K-1 
0.00347 -2.61068 0.00347 -3.1753 0.00347 -3.28899 
0.00341 -2.28225 0.00341 -2.80547 0.00341 -2.92163 
0.00335 -1.98584 0.00335 -2.47622 0.00335 -2.70047 
0.0033 -1.59011 0.0033 -2.2582 0.0033 -2.4499 






























Figure S6.1 Dependence of the pseudo first-order rate constants (kobs) on the concentrations 
of the nucleophiles for the chloride substitution from Ptdt (3.2 x 10-5 M) in 
methanol solution (I = 0.02 M) at 298 K. 























Figure S6.2 Eyring plots obtained for Ptdt with the nucleophiles for the forward reactions 
over the temperature range 15 - 35 °C in methanol solution (I = 0.02 M). 






















Figure S6.3 Dependence of the pseudo first-order rate constants (kobs) on the concentrations 
of the nucleophiles for the chloride substitution from Ptdtdeg (3.0 x 10-5 M) in 
methanol solution (I = 0.02 M) at 298 K. 





















Figure S6.4 Eyring plots obtained for Ptdtdeg with the nucleophiles for the forward reactions 
over the temperature range 15-35 °C in methanol solution (I = 0.02 M). 
 



























Figure S6.5  Dependence of the pseudo first-order rate constants (kobs) on the concentrations 
of the nucleophiles for the chloride substitution from Ptdtteg (3.0 x 10-5 M) in 
methanol solution (I = 0.02 M) at 298 K. 





















Figure S6.6 Eyring plots obtained for Ptdtteg with the nucleophiles for the forward reactions 
over the temperature range 15-35 °C in methanol solution (I = 0.02 M). 
 

























Figure S6.7  Dependence of the pseudo first-order rate constants (kobs) on the concentrations 
of the nucleophiles for the chloride substitution from Ptdttteg (3.0 x 10-5 M) in 
methanol solution (I = 0.02 M) at 298 K. 



















Figure S6.8 Eyring plots obtained for Ptdttteg with the nucleophiles for the forward reactions 
over the temperature range 15-35 °C in methanol solution (I = 0.02 M). 
 





















Figure S6.9 DFT calculated minimum energy structures, frontier molecular orbitals (HOMO and LUMO) of the complexes instigated.  
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Figure S6.13 1HNMR spectrum of Ptdteg  in DMSO. Inset is the 195Pt NMR spectrum of the complex. 
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Figure S6.20 High resolution ESI mass spectrum of 6’,6”-Bis(2-pyridyl)-2,2’:4’,4’’ :2 ”,2’’’-quaterpyridine. 






Figure S6.21 Low resolution ESI mass spectrum of Ptdt. 
 
 


















Figure S6.23 Low resolution ESI mass spectrum of Ptdteg. 
 








Figure S6.24 High resolution ESI mass spectrum of dtdeg. 






Figure S6.25 Low resolution ESI mass spectrum of Ptdtdeg. 
 
 







Figure S6.26 High resolution ESI mass spectrum of dtteg. 






Figure S6.27 Low resolution ESI mass spectrum of Ptdtteg. 
 
 







Figure S6.28 High resolution ESI mass spectrum of dttteg. 
 
 







Figure S6.29  Low resolution ESI mass spectrum of Ptdttteg. 









Figure S6.30 1H spectra of Ptdtteg (0.02 M) in DMSO-d6 at temperatures, 30 °C (bottom 
spectrum) and 80 °C (top spectrum). 
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Role of Bridging Polyethyleneglycol Ether Linkers on the Rate of 
Ligand Substitution of Heterometallic Ruthenium(II)-
Platinum(II) Complexes  
7.0 Abstract 
The ligand substitution kinetics of heterometallic Ru(II)-Pt(II) complexes linked by 
polyethyleneglycol ether units viz; [(tpy)Ru(tpy)-O(CH2CH2O)n-(tpy)PtCl] (where tpy = 
2,2':6',2''-terpyridine and n = 1 (RuPtdteg), 2 (RuPtdtdeg), 3 (RuPtdtteg) and 4 
(RuPtdttteg)) with thiourea (TU), 1,3-dimethyl-2-thiourea (DMTU), 1,1,3,3-
tetramethyl-2-thiourea (TMTU) and iodide (Iˉ) were investigated under pseudo first-
order conditions as a function of concentration and temperature by using UV/visible 
spectrophotometry and conventional stopped-flow technique. The observed first-order 
rate constants followed the simple associative rate law kobs = k2[Nu]. Density functional 
theory (DFT) calculations at LanL2DZ/ B3LYP level of theory demonstrate that the rate 
of substitution reactions of the heterometallic complexes is geometrically controlled. 
Increasing the length of the polyethyleneglycol ether linker increases the entrapment 
effect of the nucleophiles due to the V-shape geometry of the complexes which in turn 
decreases the steric influence by the Ru(tpy)2 moiety on the reactive Pt(II) metal centre 
thereby increasing the reactivity. The electronic transitions between Ru(II) and Pt(II) is 
insignificant in the presence of a non-aromatic polyethyleneglycol ether linker. The 
activation parameters obtained support an associative mode of mechanism, where 
bond formation in the transition state is favoured.  
 
7.1 Introduction 
Cisplatin, cis-[PtCl2(NH3)2], is one of the most effective anticancer drugs available to 
date.1 However, due to its significant side effects, tumour resistance and poor solubility 
in water has resulted in the development of many other complexes for cancer 
treatment.2 Currently, the focus of research is on developing structurally new metal 
based complexes capable of cleaving DNA.1a-c,3 As a result, many transition metal 
complexes have been reported with systems which are promising as structural probes 
and therapeutic agents.4 In this regard, polypyridine Ru(II) complexes are considered 
as good candidates due to their light responsive properties5 such as their ability to 
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control the reaction, conversion of light energy to chemical energy and being highly 
targeted.4m,6  
 
Within this framework, Ru-based complexes have recently been reported as a new class 
of anticancer agents.2e,7 For example, the mononuclear antimetastatic coordinated 
imidazolium complexes, [trans-RuCl4 (1Himidazole)(DMSO-S)] (NAMI-A) and 
indazolium [trans-RuCl4(1H-indazole)2] (KP1019)7i were reported to exhibit potential 
toxicity and low levels of frequent side effects compared to cisplatin. The complexes 
were successful in phase-I clinical trials.8 Ru-based complexes are also potential 
candidates for photodynamic therapy (PDT) due to their ability to absorb visible light 
and photo cleaves DNA,4k,9 most likely due to their longer lived metal-to-ligand charge 
transfer transitions (MLCT).10 Furthermore, multinuclear Ru(II) complexes have gained 
a special interest on assumption that the greater size and the high charge would 
increase the DNA binding capacity relative to their mononuclear complexes.11 In this 
regard, Ru(II) complexes of polypyridyl ligand systems, especially, 2,2’:6’,2’’-
terpyridine (tpy) has been of interest in the area of multinuclear supramolecular 
chemistry.12  
 
In multinuclear complexes, the bridging ligand (BL) plays an important role in 
controlling the biological and spectroscopic properties. For example, the high toxicity 
shown by the Pt(II) complexes linked by polynuclear α,ω-diaminoalkane is thought to 
be due to their ability to form long-ranged DNA adducts.13 The complexes, BBR3464 
which contains two trans-[PtCl(NH3)2]+ units connected by a tetraamine 
[Pt(NH3)2{H2N(CH2)6NH2}2]2+ unit and the binuclear alkyldiamine complex [{cis-
PtCl2(NH3)}2(diamine)] known as 2,2/c,c-bn are expected to form different DNA 
adducts.14 Unfortunately, after the phase-II clinical trials, further evaluation of 
BBR3464 was limited due to its low activity.15 Apart from alkyldiamine bridged 
complexes, polyethyleneglycol linked complexes were also recently reported16 as 
possible anticancer agents. Examples include, flexible bis[4’-(2,2’:6’,2”-terpyridyl)]-
diethyleneglycol ether (dtdeg) and its coordinated metal complexes of platinum, 
ruthenium and copper which can modify calf thymas (CT) DNA.16 This ligand system 
was reported to form both heterometallic and homometallic compounds.17 
 
Incorporation of a labile Pt(II) complex coupled to a light absorbing  Ru(II) moiety 
results in a group of Ru(II)-Pt(II) supramolecular complexes that could alter the 
targeted PDT and optical excitation into therapeutic window.1d,3a,10c Integration of a 
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light absorbing (LA) unit into the structural framework increases the possibility of 
photoactivation. This alternatively affects the photophysical properties of the 
complex.18 The octahedral geometry of ruthenium metal centre, compared to that of 
square planar cisplatin, is also thought to impose unique interactions with DNA with a 
different anticancer profile.19 The development of polynuclear with heteronuclearity 
comprising Ru-Pt centres is a remarkable challenge. Selective reactivity may be 
achieved depending on the geometry at the metal centres displaying different 
mechanisms of actions. This expansion of mixed-metal Ru-Pt complexes may overcome 
the limitations of platinum based complexes and provide an alternative for more 
targeting metal based PDT agents, while keeping the photocleavage and DNA binding 
properties.9a  
 
Mixed metal complexes bridged with polyazine of the form [(bpy)2Ru(dpp)PtCl2]2+,18 
[(bpy)2Ru(dpq)PtCl2]2+ and [(bpy)2Ru(dpb)PtCl2]2+ (where bpy = 2,2’-bipyridine, dpp = 
2,3-bis(2-pyridyl, dpq = 2,3-bis(2-pyridyl)quinoxaline and dpb = 2,3-bis(2-pyridyl)-
benzoquinoxaline) have been reported where the latter two complexes exhibit DNA 
binding.20 These complexes have several advantages such as high solubility compared 
to the well-known neutral cisplatin. Thus, information obtained on such varied 
molecular framework would be an important tool for designing effective anticancer 
drugs. 
 
Based on the previous work on mono nuclear and dinuclear 4’-functionalised Pt(II) 
terpyridine complexes, this study aims to increase our understanding of the role of 
flexible ethyleneglycol ether linkers on the reactivity of the mixed metal Ru(II)-Pt(II) 
complexes when one end of the molecule is capped with Ru(II)terpyridine moiety. 
Keeping in mind that multinuclear Pt(II) complexes linked by flexible alkyldiamine 
bridged complexes show high activity against tumour cells which are cisplatin 
resistant,21 the complexes reported here are also dinuclear and comprise of different 
metal centres, which result in a vacant Pt(II) coordination site for DNA binding and a 
substitutionally inert but photodynamically active Ru(tpy)2 site. In this study, the two 
metal centres are connected by a flexible bis[4’-(2,2’:6’,2”-terpyridyl)]- ethyleneglycol 
ether ligands of different chain lengths. Our motivation for incorporating the Pt(II) 
moiety to the Ru(II) moiety is to investigate the effect of Ru(tpy)2 on the substitution 
reactivity at the Pt(II) centre. The complexes used in this investigation are shown in 
Figure 7.1. 
 
















































































Figure 7.1 Structure of heterometallic complexes investigated. Shown on the structure, 
RuPtdttteg is the numbering scheme employed for characterizations and DFT 
data. Rectangular inset shows the structures of additional mononuclear 
complexes, without the linker (Pttpy) and with the linker (Pttpyeg) for 
comparisons. The kinetic data for Pttpy is obtained from reference22 and Pttpyeg 
from our previous work (Chapter 5). 
 
7.2 Experimental 
7.2.1 Materials  
Methanol (Merck, South Africa) was distilled over magnesium prior to use for kinetic 
analysis.23 Dimethylformamide (99.9%) (Sigma-Aldrich) was used without further 
purification. 4’;chloro-2,2’:6’,2”-terpyridine (99%), the platinum salt, potassium 
tetrachloroplatinate (II) (99.9%) and ruthenium salt, RuCl3⋅3H2O (99%) were 
purchased from Aldrich. All other chemicals were bought from Sigma Aldrich and were 









The ligands linked by ethyleneglycol ether viz. bis[4’-(2,2’:6’,2”-terpyridyl)]-
ethyleneglycol ether (dteg), bis[4’-(2,2’:6’,2”-terpyridyl)]-diethyleneglycolether 
(dtdeg), bis[4’-(2,2’:6’,2”-terpyridyl)]-triethyleneglycolether (dtteg) and bis[4’-
(2,2’:6’,2”-terpyridyl)]-tetraethyleneglycolether (dttteg) were synthesized and 
characterized as reported in the previous chapter. The ruthenium precursor 
[Ru(tpy)CI3] was synthesized according to the literature procedure.24 
 
7.2.3 Synthesis of [(tpy)Ru(polyethyleneglycol ether)]Cl2 Moieties  
The polyethyleneglycol ether linked Ru(II)tpy moieties ([(tpy)Ru(dteg)]Cl2), 
[(tpy)Ru(dtdeg)]Cl2), [(tpy)Ru(dtteg)]Cl2) and [(tpy)Ru(dttteg)]Cl2)) (where tpy, 
dteg, dtdeg, dtteg and dttteg have the same meaning as stated previously) were 
synthesized following the literature procedure.25 To a filtered solution of excess silver 
tetrafluroborate (AgBF4) in acetone, was added Ru(tpy)Cl3 and the reaction mixture 
was refluxed in dark for 18 hours. The reaction mixture was then cooled to room 
temperature and the resulting silver chloride (AgCl) precipitate filtered. The filtrate 
was evaporated in vacuo resulting into a dark green oil. The diterpyridine 
ethyleneglycol ether linked ligand (dteg, dtdeg, dtteg and dttteg) was added and the 
mixture refluxed in DMF for 1.5 hours. The solvent DMF reduces Ru(III) to Ru(II). The 
reaction mixture was filtered, concentrated under vacuo resulting into a red oil. The oil 
was then added to a saturated solution of lithium chloride (LiCl) in ethanol to obtain 
the chloride salt. The crude product was obtained by precipitation with a large amount 
of acetone. The precipitate was column chromatographed on neutral alumina with 
acetone: methanol: ethanol (8 : 1 : 1). The pure product was obtained from the first red 
band and precipitated with diethyl ether.  
 
The purity of the products was confirmed by 1H NMR and mass spectroscopy. The 1H 
NMR spectra obtained show similarity in the aromatic region for all the Ru(tpy) linked 












Yield: 0.031 g, (30 %), dark red powder.  1H NMR (400 MHz, DMSO-d6) †δ/ ppm: 9.03 
(2H, d, II3’ 5’), 8.96 (2H, d, I’3 3’’), 8.90 (2H, d, II3 3’’), 8.89(2H, d, I6 6’’), 8.89 (2H, d, I3 
3’), 8.79 (2H, s, I’ 3’ 5’), 8.56 (1H, t, II4’), 8.55 (2H, m, I3’ 5’), 8.49 (2H, m, I4 4’’), 8.04 
(2H, m, I’4 4’’), 8.03 (2H, m, II6 6’’), 7.55 (2H, d, I5 5’’), 7.52 (2H, d, I’6 6’’), 7.31 (2H, t, 
II5 5’’), 7.28 (2H, t, I’5 5’’), 5.10 (2H, t, 1’), 5.10 (2H, t, 1). 
 
 [(tpy)Ru(dtdeg)]Cl2) 
Yield: 55 mg, (49%), Dark red powder. 1H NMR (400 MHz, DMSO-d6) δ/ ppm: 9.08 (2H, 
d, II3’ 5’), 8.87 (2H, d, I’3 3’’), 8.86 (2H, s, I’ 3’ 5’), 8.83 (2H, d, II3 3’’), 8.67 (2H, d, I6 6’’), 
8.62 (2H, d, I3 3’), 8.45 (1H, t, II4’), 8.03 (2H, s, I3’ 5’), 7.99 (2H, t, I4 4’’), 7.97 (2H, t, I’4 
4’’), 7.51 (2H, d, II6 6’’), 7.47 (2H, t, I5 5’’), 7.37 (2H, d, I’6 6’’), 7.25 (2H, t, II5 5’’), 7.22 
(2H, t, I’5 5’’), 4.77 (2H, t, 1’), 4.51 (2H, t, 1), 4.15 (2H, t, 2’), 4.07 (2H, t, 2). TOF MS-ES+, 
m/z: 451.6112, (M2+). 
 
[(tpy)Ru(dtteg)]Cl2) 
Yield: 41 mg, (46%), Dark red powder. 1H NMR (400 MHz, DMSO-d6) δ/ ppm: 9.06 (2H, 
d, II3’ 5’), 8.85 (2H, d, I’3 3’’), 8.83 (2H, d, II3 3’’), 8.80 (2H, s, I’ 3’ 5’), 8.67 (2H, d, I6 6’’), 
8.60 (2H, d, I3 3’), 8.47 (1H, t, II4’), 7.99 (2H, br, I4 4’’), 7.98 (2H, b, I’4 4’’), 7.96 (2H, s, 
I3’ 5’), 7.52 (2H, d, II6 6’’), 7.47 (2H, t, I5 5’’), 7.36 (2H, d, I’6 6’’), 7.26 (2H, t, II5 5’’), 7.21 
(2H, t, I’5 5’’), 4.71 (2H, t, 1’), 4.41 (2H, t, 1), 4.03 (2H, t, 2’), 3.91  (2H, t, 2) 3.78 (2H, br, 
3’), 3.77(2H, br, 3). TOF MS-ES+, m/z: 473.6598, (M2+). 
 
 [(tpy)Ru(dttteg)]Cl2) 
Yield: 35 mg, (44%), Dark red powder. 1H NMR (400 MHz, DMSO-d6) δ/ ppm: 9.05 (2H, 
d, II3’ 5’), 8.85 (2H, d, I’3 3’’), 8.81 (2H, s, I’ 3’ 5’), 8.80 (2H, d, II3 3’’), 8.68 (2H, d, I6 6’’), 
8.60 (2H, d, I3 3’), 8.46 (1H, t, II4’), 7.93 (2H, s, I3’ 5’), 8.00 (2H, br, I4 4’’), 7.97 (2H, b, 
I’4 4’’), 7.52 (2H, d, II6 6’’), 7.46 (2H, t, I5 5’’), 7.36 (2H, d, I’6 6’’), 7.26 (2H, t, II5 5’’), 
7.21 (2H, t, I’5 5’’), 4.68 (2H, t, 1’), 4.37 (2H, t, 1), 4.01 (2H, t, 2’), 3.85  (2H, t, 2) 3.73 
(2H, t, 3’), 3.67(2H, t, 3), 3.66 (2H, t, 4’), 3.64  (2H, t, 4). TOF MS-ES+, m/z: 495.6725, 
(M2+). 
 
                                                 
† δ ppm, s = singlet,  d = doublet, m = multiplet, dd = doublet of doublet, dt = doublet of triplets, t 
= triplet, br = broad (the same applies for all the ligands and complexes) 
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7.2.4 Synthesis of Platinum(II) Complexes 
The mixed metal complexes were synthesized following the literature procedure.25 The 
ditpyeneglycol ether linked Ru(II) moiety and Pt(cod)Cl226 were refluxed in dry 
methanol under nitrogen for six hours. The reaction mixture was cooled to room 
temperature, filtered and volume reduced to half. The required compound was 
precipitated with slow diffusion of diethyl ether, filtered and dried in desiccators.  
 
The purity of the final complexes was confirmed by 1H NMR, 195Pt NMR, elemental 
analyses and mass spectroscopy. The 1H NMR spectra obtained show similarity in the 
aromatic region for the heterometallic complexes. The 195Pt NMR of all the complexes 
exhibited a characteristic signal at about -2700 ppm which confirms the coordination of 




Yield: 0. 035 g, (78 %), dark red powder.  1H NMR (400 MHz, DMSO-d6) δ/ ppm: 9.04 
(2H, d, II3’ 5’), 8.96 (2H, d, I3 3’’), 8.91 (6H, m, I’6 6’, I3’ 5’, , II3 3’’), 8.80 (2H, d, I’3 
3’’), 8.54 (2H, m, I’ 3’ 5’, I’4 4’’), 8.78 (1H, t, II4 4’’), 8.01 (2H, t, II4 4’’), 8.00 (2H, t, I4 
4’), 7.99 (2H, t, I’5 5’’), 7.55 (2H, d, II6 6’’), 7.51 (2H, d, I6 6’’), 7.31 (2H, m, II5 5’’), 
7.29 (2H, m, I5 5’’), 5.09 (4H, m, 1,1’), 195Pt NMR (500 MHz, DMSO- d6) δ/ ppm: -
2706. Anal. Calc. for C47H35Cl4N9O2PtRu·5H2O: C, 43.90; H, 3.53; N, 9.80; Found: C, 
43.41; H, 3.91; N, 9.32. TOF MS-ES+, m/z: 385.9565, (M3++Na) 
 
RuPtdtdeg 
Yield: 0. 035 g, (78 %), dark red powder. 1H NMR (400 MHz, DMSO-d6) δ/ ppm: 9.08 
(2H, d, II3’ 5’), 8.95 (2H, d, I3 3’’), 8.92 (2H, d, I’6 6’), 8.89 (2H, s, I3’ 5’), 8.84 (2H, d, 
II3 3’’), 8.83 (2H, d, I’3 3’’), 8.55 (2H, s, I’ 3’ 5’), 8.49 (1H, t, II4 4’’), 8. 46 (2H, t, I’4 
4’’), 8.01 (2H, t, II4 4’’), 7.99 (2H, t, I4 4’), 7.93 (2H, t, I’5 5’’), 7.52 (2H, d, II6 6’’), 7.36 
(2H, d, I6 6’’), 7.28 (2H, t, II5 5’’), 7.22 (2H, t, I5 5’’), 4.77 (2H, t, 1), 4.73 (2H, t, 1’), 
4.14 (2H, t, 2), 4.11 (2H, t, 2’), 195Pt NMR (500 MHz, DMSO- d6) δ/ ppm: -2706. Anal. 
Calc. for C49H39Cl4N9O3PtRu·10 H2O: C, 41.44; H, 4.19; N, 8.91; Found: C, 41.65; H, 









Yield: 0. 030 g, (75 %), dark red powder. 1H NMR (400 MHz, DMSO-d6) δ/ ppm: 9.07 
(2H, d, II3’ 5’), 8.92 (2H, d, I’3 3’’), 8.87 (2H, d, II3 3’’), 8.84 (2H, d, I6 6’’), 8.81 (2H, s, I’ 
3’ 5’), 8.71 (2H, d, I3 3’), 8.49 (1H, t, II4’), 8.49 (2H, t, I’4 4’’),  8.41 (2H, s, I3’ 5’), 8.01 
(2H, br, I4 4’’), 8.01 (2H, t, II4 4’’), 7.94 (2H, t, I5 5’’), 7.52 (2H, d, II6 6’’), 7.37 (2H, d, I’6 
6’’), 7.27 (2H, t, II5 5’’), 7.212 (2H, t, I’5 5’’), 4.71 (2H, t, 1’), 4.41 (2H, t, 1), 4.03 (2H, t, 
2’), 3.91  (2H, t, 2), 3.78 (2H, br, 3’), 3.77(2H, br, 3), 195Pt NMR (500 MHz, DMSO- d6) δ/ 
ppm: -2715. Anal. Calc. for C51H43ClN9O4PtRu·2H2O: C, 37.16; H, 2.87; N, 7.65; Found: C, 
37.21; H, 3.00; N, 7.63.  TOF MS-ES+, m/z: 392.7272, (M3+). 
 
RuPtdttteg  
Yield: 0. 031 g, (76 %), dark red powder. 1H NMR (400 MHz, DMSO-d6) δ/ ppm: 9.07 
(2H, d, II3’ 5’), 8.95 (2H, d, I3 3’’), 8.87 (2H, d, I’6 6’), 8.84 (2H, d, II3 3’’), 8.82 (2H, s, I3’ 
5’), 8.71 (2H, d, I’3 3’’), 8.51 (2H, t, I’ 3’ 5’), 8.49 (1H, t, II4 4’’), 8. 41 (2H, s, I’4 4’’), 8.01 
(2H, t, II4 4’’), 7.99 (2H, t, I4 4’), 7.93 (2H, t, I’5 5’’), 7.51 (2H, d, II6 6’’), 7.38 (2H, d, I6 
6’’), 7.27 (2H, t, II5 5’’), 7.22 (2H, t, I5 5’’), 4.68 (2H, t, 1), 4.59 (2H, t, 1’), 4.00 (2H, t, 2), 
3.92 (2H, t, 2’) 3.73 (2H, t, 3’), 3.69(2H, t, 3), 3.66 (2H, t, 4’), 3.64  (2H, t, 4),  195Pt NMR 
(500 MHz, DMSO- d6) δ/ ppm: -2717. Anal. Calc. for C53H47Cl4N9O5PtRu·5H2O: C, 44.89; 
H, 4.05; N, 8.89; Found: C, 44.43; H, 4.25; N, 9.34.  TOF MS-ES+, m/z: 407.4033, (M3+). 
 
7.2.5 Instrumentation and Physical Measurements 
1H NMR were recorded on either a Bruker Avance DPX 400 or 500 MHz spectrometer, 
at 303 K using Si(CH3)4 as the reference for the chemical shifts. 195Pt NMR were done on 
a 500 MHz spectrometer (195Pt, 107.5 MHz) chemical shifts externally referenced to 
K2[PtCl6]. Low resolution electron spray ionization (ESI+) mass spectra were recorded 
on a TOF Micromass spectrometer. Elemental analyses were performed by a Thermal 
Scientific Flash 2000. Kinetic analyses were studied on an Applied Photophysics SX 20 
stopped-flow reaction analyser coupled with an online data acquisition system with 
controlled temperature within ± 0.1 °C. The wavelengths for the kinetic analysis were 
predetermined on Varian Cary 100 Bio UV/visible spectrophotometer with an attached 
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7.2.6 Preparation of Solution for Kinetic Analysis 
All kinetic measurements were performed under pseudo first-order conditions using at 
least 10-fold excess of the nucleophile in 0.02 M ionic solution, made by dissolving the 
required amount of lithium triflate (LiCF3SO3) (0.018 M) and LiCl (0.002 M) in dry 
methanol. LiCl was added to suppress the solvolysis reactions. Since CF3SO3ˉ does not 
coordinate to Pt(II) metal centre,27 all substitution kinetics were studies in this media. 
Nucleophiles were used in large excess in order to drive the reactions to completion. 
Ru(II)-Pt(II) complex solutions were prepared by dissolving the required amount of the 
complex in the ionic solution. Nucleophile solutions were prepared at 50 times the 
concentration of the Pt(II) complex. Subsequent dilutions of the nucleophile stock 
solution afforded solutions of 10, 20, 30 and 40 times the concentration of metal 
complex. The selected wavelengths for the kinetic runs are given in Table S7.1. 
 
7.2.7 Computational Modelling 
Computational modelling for the complexes were performed at Density Functional 
Theoretical (DFT) level based on B3LYP/LanL2DZ28 (Los Alamos National Laboratory 2 
double ξ) level theory, with inner core electrons of Pt atom replaced by relative 
Effective Core Potential (ECP). Due to low electronic spin of Pt(II), the DFT calculations 
of the complexes were done at singlet state. The complexes were computed in methanol 
solution taking into account the solvolysis effect by means of the Conductor Polarizable 
Continum Model (C-PCM).29 The Gaussian09 suite of programs was used for all 
computational calculations.30 A summary of respective bond lengths, bond angles and 
DFT calculated natural bond orbital (NBO) charges, highest occupied molecular orbital 
(HOMO) and lowest unoccupied molecular orbital (LUMO) energies obtained from the 
modelled structures of the platinum complexes are given in Table 7.1 and Figure 7.2 
(also Supporting Information Tables S7.2 and S7.3). The numbering scheme used is as 
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Table 7.1  Summary of DFT calculated data for the complexes investigated. Included for 
comparison purposes is the data for Pttpy and Pttpyeg. Calculations were 
performed at B3LYP/LanL2DZ level of theory in all the systems. 
Complex  Pttpy Pttpyeg RuPtdteg RuPtdtdeg RuPtdtteg RuPtdttteg 
Bond Length (Å)       
Pt1/―Cl 2.443 2.445 2.440          2.442         2.443        2.443 
Pt―N1(trans) 1.961 1.961         1.961          1.961          1.961         1.960 
Ru…Pt -      -    11.48     13.96     16.60     19.59 
X       -         9      13        15        16         19 
Bond angles (o)       
Ru-Pt cavity, δ        138         119         100         95 
NBO charges       
Pt  0.604 0.592 0.595 0.594   0.593 0.593 
Ru   0.307 0.307 0.307 0.307 
N1(trans) -0.453 -0.471 -0.469 -0.470  -0.470 -0.471 
EHOMO/eV  -7.04     -6.87     -6.28       -6.25      -6.24        -6.25 
ELUMO/eV  -3.35     -3.21     -3.34       -3.29      -3.28        -3.27 
∆E 3.69      3.66       2.94         2.96        2.96          2.98 
η / eV 1.85      1.83       1.47          1.48        1.48          1.49 
μ/ eV  -5.20     -5.04      -4.81        -4.77      -4.76         -4.76 
ω/ eV 7.31      6.94       7.87         7.69       7.65          7.60 
Point Group C2      C1        C1          C1       C1          C1 
Dipole moment 13.30    11.21     26.00       37.27      45.50        43.16 
η = chemical hardness, μ = chemical potential and ω = global electrophilicity index31 and X = Aerial 
distance between the Pt(II) centre and the capped terpyridine ligand. 
 
The mappings of the HOMO and LUMO orbitals are similar for all the eyleneglycol ether 
linked complexes, where the HOMO orbitals are predominantly concentrated on the 
Ru(II) centre and terpyridine moiety connected to the Ru(II) while the LUMO electron 
density purely lies on the Pttpy fragment. The HOMO-LUMO energy gap is somewhat 
the same along the series which is similar to what was reported previously for 
dinuclear Pt(II) complexes with alkyldiammine flexible linkers.32 The NBO charges on 
the Pt(II) centers of the dinuclear complexes of ethyleneglycol ether linker are 
practically constant indicating that there is no significant change in the Pt(II) 
environment with changing the length of the polyethylene glycol ether linker. 
 




























Figure 7.2 DFT calculated minimum energy structures, frontier molecular orbitals (HOMO and LUMO) of RuPtdteg showing the V-shape 
geometry. Included is the data obtained for the DFT calculated complexes, Pttpy and Pttpyeg for comparisons. Calculations were 
performed at B3LYP/LanL2DZ level of theory in all the systems. Data for Ptdtdeg, Ptdtteg and Ptdttteg are included in Figure S7.1 
(Supporting Information Figure S7.1)




Substitution kinetics of coordinated chlorides from the Pt(II) complexes by thiourea 
nucleophiles, viz. TU, DMTU and TMTU and an ionic nucleophile, Iˉ were investigated 
under pseudo first-order conditions using conventional stopped-flow reaction analyzer. 
The data obtained is supported by DFT calculations.  
 
7.3.1 Kinetic Studies on Substitution Reactions of Chloro Complexes 
The wavelengths chosen for the kinetic investigations were pre-determined by 
monitoring the change in absorbance of the mixture of the metal complex and the 
nucleophile as a function of time using UV/visible absorption spectra and are 
summarised in 7.1. All data were mathematically analysed using the software package, 
Origin 7.5®33 to determine the observed rate constants, kobs. An example of a time 
resolved kinetic trace obtained from a stopped-flow analyser for the substitution of the 
chloride ligand in RuPtdtdeg (1.0 x 10-5 M) with TU (3.0 x 10-5 M) at 298 K is given in 
Figure 7.3. 
 


















Figure 7.3 Kinetic trace for the substitution reaction of RuPtdtdeg (1.0 x 10-5 M) with TU (3.0 
x 10-5 M) in methanol solution (I = 0.02 M) at 330 nm at 298 K. 
Chapter 7   
13 
 
All kinetic data obtained were fitted to first-order exponential decay function to 
generate the observed pseudo first-order rate constants, (kobs), and were plotted against 
the concentration of the incoming nucleophiles. The values used represent an average 
of at least eight independent runs. Straight line graphs with zero intercepts were 
obtained indicating that the reactions were irreversible in nature and can therefore be 
represented by the corresponding associative rate law given by Equation 7.1.34 
Representative plots for RuPtdtdeg, shown in Figure 7.4 clearly indicate that the 
substitution reactions were first-order with respect to the incoming nucleophile. Data 
obtained from the slope of Equation 7.1 at 298 K is summarized in Table 7.2.  
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Table 7.2 Summary of second-order rate constants, k2 and activation parameters, with the 
corresponding standard deviations for the substitution of the chloro ligand by a 
series of thiourea nucleophiles and iodide at I = 0.02 M LiCF3SO3, adjusted with 
LiCl. Data for Pttpy is taken from literature22 and data on mononuclear complexes 
are from Chapter 5 and are included for comparison. 
Complex Nu k2/M-1 s-1 SΔ / J K-1 mol-1 HΔ / kJ mol-1 *k2/M-1 s-1 
Pttpy TU 1494 ± 10    -88 ± 5     29 ± 2  
DMTU    448 ± 10    -73 ± 4    36  ± 1   
TMTU      82 ± 4    -91 ± 8    35  ± 2   
Iˉ    243 ± 4    -42 ± 11    47  ± 3   
Pttpyeg TU    257 ± 5    -56 ± 6    43 ± 2  
 DMTU       81 ± 1    -98 ± 7     33 ± 2  
 TMTU       22 ± 1    -57 ± 7     40 ± 2  
 Iˉ       95 ± 2    -32 ± 8     53 ± 3  
RuPtdteg TU    288 ± 3  -115 ± 5     24 ± 2  
DMTU    104 ± 1    -99 ± 3     32 ± 1  
TMTU       33 ± 1  -111 ± 6      31 ± 2  
Iˉ    238 ± 3    -85 ± 6     35 ± 2  
RuPtdtdeg TU    298 ± 5  -112 ± 3     25 ± 1  265 ± 1  
DMTU    114 ± 2    -69 ± 1     41 ± 0.3    83 ± 1 
TMTU       44 ± 1    -90 ± 4     37 ± 1    23 ± 1 
Iˉ    192 ± 3    -80 ± 5     36 ± 2    91 ± 2 
RuPtdtteg TU    309 ± 5    -78 ± 7     38 ± 2  277 ± 1  
DMTU    175 ± 2   -121 ± 1     21 ± 0.3    93 ± 1  
TMTU      32 ± 1  -105 ± 1     33 ± 0.3    19 ± 0.3 
Iˉ    206 ±2     -89 ± 5     33 ± 2    91 ± 1 
RuPtdttteg TU    330 ± 5    -98 ± 4     30 ± 12  321 ± 4 
DMTU    108 ± 1  -119 ± 4     26 ± 12  102 ± 1  
TMTU       37 ± 1  -114 ± 5     30 ± 2    13 ± 1 
Iˉ    228 ± 2    -14 ± 5     55 ± 2  156 ± 2  
* = rate constants of the corresponding mononuclear complexes from Chapter 5. 
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Figure 7.4 Dependence of the pseudo first-order rate constants (kobs) on the concentrations 
of the nucleophiles for the chloride substitution from RuPtdtdeg (1.0 x 10-5 M) in 
methanol solution (I = 0.02 M) at 298 K.
 
 
The temperature dependence studies were performed using a single nucleophile 
concentration in the temperature range 15 - 35 °C in 5 °C intervals. The entropy of 
activation ( S ) and enthalpy of activation ( H ) were then obtained from the slopes 
and intercepts of the Eyring equation34 respectively as given in Equation 7.2. Figure 7.5 
shows the representative plots obtained for RuPtdtdeg with the nucleophiles for the 
forward reactions with the nucleophiles and the data obtained are summarized in   
Table 7.2. Representative data and graphs are also given in Tables S7.4 to S7.11 and 
Figure S7.2 to S7.7 respectively. 
 
                 ln(k2/T) = ˗
H /RT + (23.8 + S /R)                                                            (7.2) 
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Figure 7.5 Eyring plots obtained for RuPtdtdeg with the nucleophiles for the forward 
reactions over the temperature range 15 - 35 °C. 
 
7.3.2 Discussion 
In this study, four heterometallic Ru(II)-Pt(II) tpy complexes linked by 
polyethyleneglycol ether units of different lengths were synthesized and characterized 
following the literature procedure.25 The spectroscopic data obtained is in good 
agreement with those reported in  literature25 and the structural formulae (Figures S7.8 
to S7.23). 
 
Substitution kinetics of coordinated chloride from the Ru(II)-Pt(II) complexes  (Figure 
7.1) by four different nucleophiles (Nu), i.e. TU, DMTU, TMTU and an ionic nucleophile, 
Iˉ were studied under pseudo first-order conditions using the conventional stopped-
flow analyzer. Only one step, taken to be the substitution of the chloride ligand was 
observed which is typical for square planar Pttpy type complexes.22,35 Thus, the 
proposed substitution mechanism for the complexes studied can be represented as 










Scheme 7.1 The general reaction scheme for the reactions between the complexes and the 
nucleophiles studied. 
 
In Chapter 5, it is reported that the ethylene glycoxy pendant groups act as σ-donors 
decreasing the π-backbonding ability of the parent Pttpy by incorporating the lone pair 
electrons of the oxygen (O1) atom into the terpyridine moiety resulting in a decreased 
reactivity. A similar observation is made in this study as well. A glance at the rate 
constants for the displacement of the coordinated chloride ligand shows a drop from 
Pttpy to Pttpyeg followed by a slight increase as the length of the polyethyleneglycol 
ether bridging linker between Ru(II) and Pt(II) moieties is increased. This is an 
indication that the increase in the number of polyethyleneglycol ether units has a minor 
influence on the rate of substitution reactions (Table 7.2).  
 
DFT calculations show an increase in the global electrophilicity index, ω, of the complex 
when the Ru(tpy)2 moiety is attached to the Pttpyeg, an indication of the presence of π-
back donation. This remains constant as the chain length is increased. Therefore, the 
increase is due to the two terpyridine moieties attached to the Ru(II) and not an 
increase in the π-backbonding on the Pt(II) centre whose NBO charge remains 
constant. This is also true with respect to the other changes such as the chemical 
potential (μ) and hardness (η). General analysis of the DFT calculated data for the 
investigated heterometallic complexes are very similar, which indicates that the change 
in reactivity is not due to an electronic effect.36 
 
To understand the effect of Ru(tpy)2 moiety on the reactivity of the ethyleneglycol 
ether linked Ru(II)-Pt(II) complexes, the reactivity of the Pttpyeg (from Chapter 5) and 
RuPtdteg are compared. From the second order rate constants, it is noticeable that the 
reactivity increases slightly from Pttpyeg (257 ± 5 M-1 s-1) to RuPtdteg (288 ± 3 M-1 s-1). 
A similar increase is observed for the other heterometallic complexes when compared 
to their corresponding mono nuclear complexes having the same size of the 
polyethyleneglycol ether unit. One of the factors responsible for this slight increase in 
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the reactivity is the overall increase in the charge of the molecule on attaching Ru(tpy)2 
moiety to the mono nuclear Pt(II) complexes.  
 
The other factor influencing the reactivity of these heterometallic complexes is the 
steric hindrance imposed by the geometry adopted by the capped Ru(tpy)2 moiety as 
depicted in Figure 7.6. DFT calculated optimized geometries show that there is no 
extended π-electronic communication between the terpyridine ligand systems at the 
two metal centres. Also, the π-extended molecular orbital in each terpyridine ligand 
system in RuPtdteg are mutually orthogonal at the Ru(II) metal centre. Thus, this 
geometry breaks the flow of delocalized electron density across the entire 
heterometallic system but introduces steric hindrance on one side of the Pttpy moiety. 









Figure 7.6 Aerial view showing the steric disposition of the pendant group on the 4’-position 
of the chelate ligand (tpy) bonded to the Pt(II) metal centre obtained from DFT 
calculations. 
 
The DFT calculated optimized structures shown in Figure 7.2 and Figure S7.1 show that 
the polyethylenglycol ether bridging linkers are twisted such that the coordination 
sphere of the capped Ru(tpy)2 moieties effectively ‘shadows’ the Pt(II) centre from one 
of the directions of the approach of the nucleophile. When the chain length is increased, 
both the twisting as well as the distance between the two metal centres carrying the 
terpyridine ligands also increases. For example, the Ru(tpy)2 moiety in RuPtdteg 
shows a greater degree of aerial steric overlapping on the Pt(II) metal centre by the 
capped terpyridine system (a distance of 13 Å) while those in RuPtdttteg, the distance 
between the Pt(II) metal centre and the capped terpyridine ligand is 19 Å (Figure 7.6). 
Thus, it is evident that the length of the linker influences the degree of steric 
disposition.32 When the chain length is short, the steric influence to the axially incoming 
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nucleophile is greater and decreases proportionally as the chain length of the linker 
increases. This should result in gradual increase in reactivity from RuPtdteg to 
RuPtdttteg as observed.  
 
Furthermore, the two metal centres form a V-shape structure of angle δ.32,37 As 
reported by Jaganyi et al.,32 this geometry enhances the entrapment of the incoming 
nucleophiles, thereby increasing the successful collision frequencies between the 
nucleophiles and the reactive Pt(II) centre, leading to a greater number of nucleophile-
metal encounter pairs possessing greater energy than the required activation energy.32 
DFT calculations show that the depth of the cage increases with increase in the length 
of the linker as angle, δ decreases. The deeper the depth, the greater the successful 
collisions and hence, the reactivity.32 This elucidation, along with the steric influence 
affirms the observed slight increase in the reactivity with the increase in the 
polyethyleneglycol ether units. Thus, the increase in the rate of substitution reactions 
of the heterometallic complexes investigated in this work is mainly due to the 
structural architecture of the system which entraps the nucleophile. Furthermore, for 
heterometallic complexes bridged by non-aromatic flexible spaces, apart from their 
weak electronic transitions due to the rotational isomers and larger reorganizational 
energies, changes in electronic effect due to the changes in the length of the linker are 
difficult to investigation as they are spectroscopically almost indistinguishable.38 When 
compared the results of in this study with what has been obtained for the 
heterometallic Ru(II)-Pt(II) complexes in Chapter 3 (with a rigid aromatic linker) and 
Chapter 4 (with semi-rigid aromatic linker), one notices that the presence of a non-
aromatic flexible linker decreases the metal-metal interactions and the electronic 
effects39  due to the Ru(II) metal centre on the overall reactivity of the complex.   
 
Substitution reactions of the complexes show clear dependence on the steric hindrance 
of the incoming nucleophiles which is typical for square planar Pt(II) complexes.40 The 
sterically hindered nucleophiles, TMTU and DMTU show much slower reactivity than 
that of TU. Due to the high electrostatic force induced by high polarizability of the 
anionic Iˉ on the positively charge metal centre,32 the reactivity of Iˉ is comparable to 
TU. 
 
The activation parameters obtained for the substitution reactions support an 
associative mode of mechanism. The large and negative entropy of activation ( S ) 
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support along with the small enthalpy of activation ( H ) support an associative 
mode of substitution as reported for square planar Pt(II) complexes.22,26,32,35a,b,41  
 
7.4 Conclusions 
DFT calculated data shows electronic change from Pttpy to Pttpyeg as reported before. 
But after the introduction of the Ru(tpy)2 moiety, no significant electronic change is 
observed as the length of the linker is increased. The substitution reactivity of the 
heterometallic Ru(II)-Pt(II) dinuclear complexes investigated in this study are 
geometrically controlled. The increase in the length of the polyethyleneglycol ether 
linker decreases the steric hindrance imposed on the Pt(II) centre by the Ru(tpy)2 
moiety resulting in increased reactivity. This is further driven by the entrapment effect 
of the nucleophile due to the V-shape geometry adopted by the heterometallic 
complexes. It can be concluded that, presence of Ru(tpy)2 moiety influences the 
structural geometry of the complex system which in turn controls the reactivity of the 
Pt(II) centre. Unlike the work reported in Chapter 3 and Chapter 4, it is noticeable that 
the electronic transitions between Ru(II) and Pt(II) is insignificant in the presence of a 
non-aromatic flexible linker.39 In all cases the reactivity of the complexes are sensitive 
to the steric nature of the incoming nucleophiles which decreases with increase in the 
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7.6 Supporting Information 
A summary of wavelengths at which the kinetic studies were performed, plots of the 
dependence of kobs against concentration of the nucleophiles and plots from 
temperature dependence studies along with tables of kinetic data, graphs of exemplary 
mass spectra and the representative spectra for 1H NMR and 195Pt NMR work reported 
in this study are given as electronic supporting information (ESI). 
   
Table S7.1 Summary of the wavelengths (nm) used to study the substitution reactions of the 
complexes with thiourea nucleophile 
Complex Nu Wavelength (λ), nm 
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Table S7.2  Geometry optimised structures of the platinum complexes investigated and 
distribution of the electron density on the platinum complexes investigated. The 
blue area indicates the most electropositive areas and the orange region indicates 








































Figure S7.1 DFT calculated minimum energy structures, frontier molecular orbitals (HOMO and LUMO) of the complexes showing the V-shape geometry. 
Calculations were performed at B3LYP/LanL2DZ level of theory in all the systems. 




Table S7.3 Summary of DFT calculated data for the heterometallic RuPttpy complexes 
investigated. Included is the data obtained for the DFT calculated Pttpy complex 
for comparisons. 
Complex  Pttpy Ru(tpy)2 RuPtdteg RuPtdtdeg RuPtdtteg RuPtdttteg 
Bond Length/ 
(Å) 
      
Pt1/―Cl 2.443  2.440 2.442 2.443 2.443 
Pt―N1trans 1.961  1.961 1.961 1.961 1.960 
4’C―O1   1.373 1.370 1.368 1.368 
Length of the 
linkekr 
  2.958 5.616 7.5586 
 
9.967 
Ru···Pt   11.475 13.962 16.599 19.589 
O1-O2    3.653 2.9331 3.0501 
O2-O3    2.2.962 3.0859 3.0302 
O3-O4     2.9452 3.7652 
O4-O5      2.9877 
Ru-Ntrans  2.009 2.014 2.018 2.014 2.014 
Bond angles/ (o)       
N1PtN2   80.87 80.40 80.86 80.88 
N2PtN3   80.77 81.03 80.73 80.73 
N1PtCl   99.2 99.61 99.39 99.09 
N2PtCl   178.73 176.98 179.65 179.98 
N3PtCl   99.05 99.00 99.01 98.28 
N1PtN3   161.63 161.38 161.59 161.62 
N4RuN5  78.90 78.60 78.80 78.59 78.56 
N5RuN6  78.90 78.70 78.37 78.74 78.76 
N4RuN6  157.80 157.30 157.16 157.32 157.32 
N5RuN8  179.995 179.30 179.56 179.77 179.86 
N7RuN8   78.95 79.02 78.96 79.00 
N8RuN9   78.98 78.88 78.98 78.94 
N7RuN9   157.93 157.89 157.94 157.94 
Ru-Ntrans  2.009 2.014 2.018 2.014 2.014 
Dihed- Cl   2.126 0.304 0.677 0.869 
NBO charges       
Pt 0.604  0.595 0.594 0.592 0.592 
Ru  0.309 0.307 0.307 0.307 0.307 
N1(trans) -0.453  -0.469 -0.470 -0.470 -0.471 
O1   -0.568 -0.561 -0.558 -0.564 
O2   -0.572 -0.646 -0.653 -0.657 
O3    -0.571 -0.652 -0.655 
O4     -0.571 -0.651 
O5      -0.575 
C 4’ -0.134  0.406 0.408 0.408 0.409 
C 4’ to Ru  -0.156 0.388 0.389 0.390 0.390 
Cl -0.502  -0.503 -0.504 -0.505 -0.505 
N1   -0.492 -0.493 -0.492 -0.493 
N2   -0.469 -0.470 -0.471 -0.471 
N3   -0.493 -0.493 -0.493 -0.493 
N4  -4.21 -0.420 -0.420 -0.420 -0.419 
 
Chapter 7   
29 
 
………Continuation of Table S7.3         
N5  -4.10 -0.427 -0.429 -0.429 -0.428 
N6  -4.21 -0.420 -0.419 -0.419 -0.420 
N7  -4.21 -0.421 -0.421 -0.421 -0.421 
N8  -4.10 -0.410 -0.409 -0.410 -0.409 
N9  -4.21 -0.421 -0.421 -0.421 -0.421 
EHOMO/eV -7.04 -6.28 -6.28 -6.25 -6.24 -6.25 
ELUMO/eV -3.35 -2.87 -3.34 -3.29 -3.28 -3.27 
∆E/ eV 3.69 3.41 2.94 2.96 2.96 2.98 




Table S7.4  Average observed rate constants, kobs, s-1, for the displacement of the chloride 
ligand in RuPtdteg with the nucleophiles, at T =  298 K, I = 0.02 M LiCF3SO3, 
adjusted with LiCl. 
TU DMTU TMTU Iˉ 
Conc., M kobs., s-1 Conc., M kobs., s-1 Conc., M kobs., s-1 Conc., M kobs., s-1 
0.0001 0.02645 0.0001 0.01049 0.0001 0.00325 0.0001 0.02351 
0.0002 0.06005 0.0002 0.01921 0.0002 0.00677 0.0002 0.0530 
0.0003 0.08845 0.0003 0.0293 0.0003 0.0105 0.0003 0.08209 
0.0004 0.1140 0.0004 0.03851 0.0004 0.01340 0.0004 0.11434 




Table S7.5  Average observed rate constants, kobs, s-1, for the displacement of the chloride 
ligand in RuPtdtdeg with the nucleophiles, at T =  298 K, I = 0.02 M LiCF3SO3, 
adjusted with LiCl. 
TU DMTU TMTU Iˉ 
Conc., M kobs., s-1 Conc., M kobs., s-1 Conc., M kobs., s-1 Conc., M kobs., s-1 
0.0001 0.02364 0.0001 0.01294 0.0001 0.00403 0.0001 0.0194 
0.0002 0.05582 0.0002 0.0239 0.0002 0.009 0.0002 0.03995 
0.0003 0.08845 0.0003 0.03605 0.0003 0.01375 0.0003 0.05937 
0.0004 0.11821 0.0004 0.04349 0.0004 0.01703 0.0004 0.0784 
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Table S7.6  Average observed rate constants, kobs, s-1, for the displacement of the chloride 
ligand in RuPtdtteg with the nucleophiles, at T =  298 K, I = 0.02 M LiCF3SO3, 
adjusted with LiCl. 
TU DMTU TMTU Iˉ 
Conc., M kobs., s-1 Conc., M kobs., s-1 Conc., M kobs., s-1 Conc., M kobs., s-1 
0.0001 0.02785 0.0001 0.01503 0.0001 0.00317 0.0001 0.02092 
0.0002 0.05957 0.0002 0.03313 0.0002 0.0064 0.0002 0.04301 
0.0003 0.08592 0.0003 0.05378 0.0003 0.0102 0.0003 0.06445 
0.0004 0.1273 0.0004 0.07055 0.0004 0.01268 0.0004 0.08215 
0.0005 0.1564 0.0005 0.08798 0.0005 0.01569 0.0005 0.1012 
  
 
Table S7.7  Average observed rate constants, kobs, s-1, for the displacement of the chloride 
ligand in RuPtdttteg with the nucleophiles, at T =  298 K, I = 0.02 M LiCF3SO3, 
adjusted with LiCl. 
TU DMTU TMTU Iˉ 
Conc., M kobs., s-1 Conc., M kobs., s-1 Conc., M kobs., s-1 Conc., M kobs., s-1 
0.0001 0.02855 0.0001 0.00992 0.0001 0.00383 0.0001 0.02129 
0.0002 0.06756  0.0002 0.02193 0.0002 0.00856 0.0002 0.04449 
0.0003 0.09465  0.0003 0.03241 0.0003 0.01093 0.0003 0.06845 
0.0004 0.13498 0.0004 0.04224 0.0004 0.01487 0.0004 0.09023 




Table S7.8  Temperature dependence of k2 M-1s-1, for the displacement of the chloride ligand 
in RuPtdteg by the nucleophiles at 30-fold excess over [RuPtdteg], at T =  298 K, I = 
0.02 M LiCF3SO3, adjusted with LiCl. 
TU DMTU TMTU Iˉ 
1/T, K-1 ln(k2/T) 1/T, K-1 ln(k2/T) 1/T, K-1 ln(k2/T) 1/T, K-1 ln(k2/T) 
0.00347 -0.29331 0.00347 -1.5313 0.00347 -2.58986 0.00347 -0.655 
0.00341 -0.16154 0.00341 -1.3484 0.00341 -2.3264 0.00341 -0.4338 
0.00335 -0.01119 0.00335 -1.1160 0.00335 -2.14416 0.00335 -0.23417 
0.0033 0.17209 0.0033 -0.8985 0.0033 -1.98934 0.0033 -0.04125 
0.00325 0.37532 0.00325 -0.6576 0.00325 -1.70274 0.00325 0.28088 
      0.00319 0.52478 
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Table S7.9  Temperature dependence of k2 M-1s-1, for the displacement of the chloride ligand 
in RuPtdtdeg by the nucleophiles at 30-fold excess over [RuPtdtdeg], at T =  298 K, 
I = 0.02 M LiCF3SO3, adjusted with LiCl. 
TU DMTU TMTU Iˉ 
1/T, K-1 ln(k2/T) 1/T, K-1 ln(k2/T) 1/T, K-1 ln(k2/T) 1/T, K-1 ln(k2/T) 
0.00347 -0.3421 0.00347 -1.47737 0.00347 -2.3850 0.00347 -0.9502 
0.00341 -0.1550 0.00341 -1.23105 0.00341 -2.0790 0.00341 -0.6341 
0.00335 -0.0112 0.00335 -0.90872 0.00335 -1.8726 0.00335 -0.4098 
0.0033 0.1619 0.0033 -0.64428 0.0033 -1.6194 0.0033 -0.1539 




Table S7.10  Temperature dependence of k2 M-1s-1, for the displacement of the chloride ligand 
in RuPtdtteg by the nucleophiles at 30-fold excess over [RuPtdtteg], at T =  298 K, I 
= 0.02 M LiCF3SO3, adjusted with LiCl. 
TU DMTU TMTU Iˉ 
1/T, K-1 ln(k2/T) 1/T, K-1 ln(k2/T) 1/T, K-1 ln(k2/T) 1/T, K-1 ln(k2/T) 
0.00347 -0.6281 0.00347 -0.85037 0.00347 -2.62875 0.00347 -0.74192 
0.00341 -0.38894 0.00341 -0.68516 0.00341 -2.3944 0.00341 -0.50056 
0.00335 -0.06947 0.00335 -0.50869 0.00335 -2.17168 0.00335 -0.32769 
0.0033 0.1418 0.0033 -0.36284 0.0033 -1.95529 0.0033 -0.07531 




Table S7.11  Temperature dependence of k2 M-1s-1, for the displacement of the chloride ligand 
in RuPtdttteg by the nucleophiles at 30-fold excess over [RuPtdttteg], at T =  298 
K, I = 0.02 M LiCF3SO3, adjusted with LiCl. 
Tu DMTu TMTu Iˉ 
1/T, K-1 ln(k2/T) 1/T, K-1 ln(k2/T) 1/T, K-1 ln(k2/T) 1/T, K-1 ln(k2/T) 
0.00347 -0.34161 0.00347 -1.34703 0.00347 -2.50826 0.00347 -0.99346 
0.00341 -0.09007 0.00341 -1.15574 0.00341 -2.23338 0.00341 -0.59206 
0.00335 0.05659 0.00335 -1.01523 0.00335 -2.10202 0.00335 -0.26749 
0.0033 0.26719 0.0033 -0.84209 0.0033 -1.88251 0.0033 0.18369 
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Figure S7.2 Dependence of the pseudo first-order rate constants (kobs) on the concentrations 
of the nucleophiles for the chloride substitution from RuPtdteg (2.0 x 10-5 M) in 
methanol solution (I = 0.02 M) at 298 K. 
  






















Figure S7.3 Eyring plots obtained for RuPtdteg with the nucleophiles for the forward 
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Figure S7.4 Dependence of the pseudo first-order rate constants (kobs) on the concentrations 
of the nucleophiles for the chloride substitution from RuPtdtteg (2.0 x 10-5 M) in 
methanol solution (I = 0.02 M) at 298 K. 
























Figure S7.5 Eyring plots obtained for RuPtdtteg with the nucleophiles for the forward 
reactions over the temperature range 15-35 °C in methanol solution (I = 0.02 M). 
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Figure S7.6 Dependence of the pseudo first-order rate constants (kobs) on the concentrations 
of the nucleophiles for the chloride substitution from RuPtdttteg (2.0 x 10-5 M) in 
methanol solution (I = 0.02 M) at 298 K. 
 
























Figure S7.7 Eyring plots obtained for RuPtdttteg with the nucleophiles for the forward 
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Figure S7.12 Low resolution ESI mass spectrum of Ru(tpy)dtdeg. 

















































































Figure S7.14  Low resolution ESI mass spectrum of Ru(tpy)dtteg. 
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Figure S7.17 Low resolution ESI mass spectrum of Ru(tpy)dttteg. 
 




















































































Figure S7.19  Low resolution ESI mass spectrum of RuPtdteg. 





Figure S7.20 Low resolution ESI mass spectrum of RuPtdtdeg. 
 




Figure S7.21 Low resolution ESI mass spectrum of RuPtdtteg. 
 




Figure S7.22 Low resolution ESI mass spectrum of RuPtdttteg. 
 




Figure S7.23 Exemplary elemental analysis spectrum for RuPtdtteg. 





Equal amounts of RuCl3· 3H20 (~150 mg) and tpy were refluxed in absolute EtOH (125 
mL) for 3 hours. The resulting reaction mixture was cooled to room temperature and the 
precipitate was filtered, washed with cold absolute EtOH (5 mL) followed by copious 
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Summary and Future Prospects 
8.1 Summary 
The main aim of this project was to investigate the thermodynamic and kinetic 
properties of heterometallic Ru(II)-Pt(II) complexes with N-donor chelate ligands that 
exhibit anticancer activity, with the focus on how the electronic and steric properties of 
a biologically active Ru(II) fragment influences the substitution reactivity of a Pt(II) 
metal centre. This was done by studying the rates of substitution as a function of 
concentration and temperature under pseudo first-order conditions.  Knowledge on 
substitution kinetics is a vital aspect for the design of effective and improved 
antitumour drugs since it provides the basis for the rational mechanisms of 
interactions. Therefore, the rationale of this study was to provide meaningful 
information on the design and development of effective anticancer drugs, with reduced 
toxicity and improved uptake.   
 
The structures of complexes enabled a systematic investigation into how the different 
linkers influence the reactivity of the momo- di and heteronuclear complexes as well as 
how the different metal centers (Ru(II) and Co(II)) influence the reactivity of the Pt(II) 
metal centre. A series of neutral biologically relevant thiourea nucleophiles (TU, MTU, 
DMTU and TMTU) along with some ionic nucleaophiles (I⁻ and SCN⁻) were used for the 
substitution reactions. The results and the discussions are reported in Chapter 3 to 
Chapter 7 of this Thesis. The structures of the complexes studied (Figures 8.1, 8.2, 8.3, 
8.4 and 8.5) are reported in the chapter summary for clarity.  
 
Chapter1 presented an introduction to the development of the platinum and 
ruthenium anticancer complexes. The clinical success of cisplatin, its mechanism of 
actions, its cellular resistance and the development of other platinum based anticancer 
drugs along with the current focus on the development of platinum drugs. This chapter 
also summarizes the theory on ligand substitution reactivity of Pt(II) complexes 
focusing on relevant and current research work on the subject. The second part of this 
chapter presents a short summary of development of anticancer ruthenium complexes 
with an insight into the biological features of ruthenium that make its complexes as 




photodynamic therapy, DNA binding including postulated mechanism of action of 
ruthenium anticancer agents and the substitution reactions. The last part of this 
chapter focuses on a short summary of some of the heterometallic Ru(II)-Pt(II) 
complexes reported and their biological activities.  
 
Chapter 2 presented an introduction to the substitution reactions of Pt(II) complexes 
and the relevant kinetic theory including the techniques employed in investigating the 
ligand substitution reactions. It also reviewed on the factors influencing the ligand 
substitution reactions and links these to current mechanistic investigations reported 
into the ligand substitution reactions of Pt(II) complexes. 
 
In Chapter 3, the substitution kinetics of heterometallic Ru(II)-Pt(II) complexes linked 
by tppz (where tppz = tetra-2-pyridyl-1,4-pyrazine) ligands is reported. In this study it 
was found that incorporation of Ru(tppz) increases the reactivity of Pt(II) metal centre 
in [Pt(tpy)Cl]Cl (Pttpy) (where tpy = 2,2’:6’,2”-terpyridine) and is ascribed to the 
increased π-back donation from the tppz ligand which increases the electrophilicity of 
the metal centre,  overall charge and the global electrophilicity index of the complex. 
Additionally, it also increases the metal-metal interactions and electronic transitions 
within the complex. The increase in the number of tppz ligands further stabilises the 
anti-bonding lowest unoccupied molecular orbital (LUMO) (π*). Presence of two Ru(II) 
metal centres in [ClPtRu2(tppz)3PtCl](PF6)6 (PtRuRuPt) further enhances intermetallic 
communication within the complex.  
 
An interesting aspect of this work is the considerable decrease in the rate of 
substitution reactions by changing the metal centre from Ru(II) to a Co(II). The rate of 
substitution decreased by a factor of four due to the weaker π-back donation of 
electron density in [(tpy)Co(tppz)PtCl](PF6)3 (CoPt) complex. UV/visible 
spectrophotometric analysis along with the density functional theory (DFT) 
calculations indicate that (Pt(dπ)→tppz(π*)) electronic transitions are weaker for CoPt 
which is an indication of weak π-backbonding from the Pt(II) d orbitals to the tppz 
ligand. Based on the facts it was concluded that the Ru(II) is better at accepting the 
electron density than Co(II). Furthermore, the reactivity of the complexes is also driven 
by the increase in the global electrophilicity index of the complexes.  
 
1H NMR and 195Pt NMR spectroscopic techniques were used to demonstrate the 




NMR study it was shown that second step observed was due to the degradation of the 
coordinated ligand from the Pt(II) metal centre forming Pt(TU)4 which was achieved in 
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Figure 8.1  Structure of complexes reported in Chapter 3. 
 
The rates of substitution of a series of heterometallic Ru(II)-Pt(II) complexes of cis 
geometry with a semi-rigid linker (qpy =  4’-pyridyl-2,2’:6’,2”-terpyridine) are reported 
in Chapter 4. The reactivity increases from the mononuclear, cis-
[Pt(en)(py)H2O](CF3SO3)2, Pt1 to heterometallic cis-[(tpy)Ru(qpy)Pt(en)H2O](CF3SO3)4, 
Pt2 and cis-[H2Ol(en)Pt(qpy)Ru(qpy)Pt(en)H2O](CF3SO3)6, Pt3 (where en = 1,2-
ethylenediamine, py = pyridine). Substitution reactions proceeded via a single step. 
195Pt NMR spectroscopic analysis of Pt3Cl with TU showed simultaneous substitution 
of the aqua ligands in Pt3 with no dechelation. This reaffirms that the cis geometry at 
the Pt(II) centre confers stability which precludes labilization of the Ru(qpy) linker.  
 
Apart from the increased overall charge and the electrophilicity, the octahedrally 
coordinated Ru(II) moiety lowers the LUMO energy of the complexes thereby 
enhancing the transfer of electrons from the highest occupied molecular orbital 
(HOMO) the empty LUMO energy level of the ligand systems. Furthermore, presence of 
Ru(II) moiety increases the metal-metal coupling and electronic transitions within the 
complex. The effect of increasing or decreasing the electron density of the Pt(II) centre 






The reactivity of Pt2 and Pt3 are not of much difference. The Ru(II) metal centre 
prevents the flow of electron density through the three metal centres since the two qpy 

















































Figure 8.2  Structure of complexes reported in Chapter 4. 
 
The substitution kinetics of Pt(II) terpyridine (Pttpy) complexes possessing 
polyethylene glyoxy pendant unit attached trans to the leaving group of Pttpy is 
reported in Chapter 5. The polyethylene glycoxy pendant unit acts as a σ-donor 
towards the Pt(II) centre, thereby decreasing the reactivity compared to the parent 
Pttpy molecule. The σ-donation due to the pendant unit and the and π-electronic 
contribution due to O1 was found to be effective only up to one unit of the ethylene 
glycoxy pendant, beyond which there is no significant electronic effect on the Pt(II) 
metal centre.  
 
The reactivity is retarded from Pttpy to Pt(II)-4’-(ethylene glycoxy)-2,2':6',2''-
terpyridine (Pttpyeg). This is attributed to both steric and electronic effects caused by 
the appended ethylene glycoxy pendant. However, the slight increase in substitution 
reactivity from Pttpyeg to Pt(II)-4’-(tetraethyleneglycoxy)-2,2':6',2''-terpyridine 
(Pttpytteg) was controlled mainly by steric effects which decrease as the angle of 
inclination of the appended ethylene glycoxy pendant decreases relative to the Pt(II) 
plane. The complexes are sensitive to steric size of the incoming nucleophiles as 



















































Figure 8.3  Structure of complexes reported in Chapter 5. 
 
In Chapter 6, the work from Chapter 5 is extended to investigate the substitution 
reactivity of dinuclear Pt(II) complexes bridged with polyehtyleneglycol ether of the 
type [ClPt(tpy)- O(CH2CH2O)n(tpy)PtCl]Cl2 where n = 1 (Ptdteg), 2 (Ptdtdeg), 3 
(Ptdtteg), 4 (Ptdttteg). A linker free complex, ClPt(tpy)-(tpy)PtCl]Cl2, (Ptdt) was also 
investigated.  
 
The lability of the dinuclear polyethyleneglycol ether linked complexes differs 
significantly from the corresponding linker free dinuclear complex, Ptdt and the 
monomeric complex, Pttpy. The difference in reactivity was accounted for in terms of 
the electronic as well as steric effects. Introduction of the linker decreases the 
electrophilicity of the platinum centre as well as the overall electrophilicity of the 
whole complex. The ethyleneglycol ether units donate electrons to the Pt(II) centre 
including the lone pair of electrons on the O1 oxygen atoms. The reactivity of the 
glycolether linked complexes decrease with increase in the distance between the Pt···Pt 
metal centres. This decrease in reactivity is also accounted for the increase in the steric 
hindrance at the Pt(II) centres by the terpyridine ligands due to the geometry imposed 
by the linker.  
 
The results from this study clearly show that the nature of the bridging ligand uniquely 
influences the rate of substitution reactions. The complexes showed coordination 

































































Figure 8.4  Structure of complexes reported in Chapter 6. 
 
In Chapter 7, the work reported in Chapter 5 and Chapter 6 is extended to investigate 
the substitution reactivity of heterometallic Ru(II)-Pt(II) complexes bridged by 
polyethyleneglycol ether units viz; [(tpy)Ru(tpy)-O(CH2CH2O)n-(tpy)PtCl] (where tpy = 
2,2':6',2''-terpyridine and n = 1 (RuPtdteg), 2 (RuPtdtdeg), 3 (RuPtdtteg) and 4 
(RuPtdttteg)). The measured rate constants show that the increase in the length of the 
polyethyleneglycol ether linker increases the entrapment effect of the nucleophiles due 
to the V-shape geometry of the complexes. The reactivity is also influenced by the steric 
hindrance imposed by the Ru(tpy)2 moiety at the reactive Pt(II) metal centre. The 
electronic transitions between Ru(II) and Pt(II) is insignificant in the presence of a non-
aromatic polyethyleneglycol ether linker. Density functional theory (DFT) calculated 
data for the complexes show that the rate of substitution reactions of the 

















































































Figure 8.5  Structure of complexes reported in Chapter 7. 
 
In the work reported in Chapters 3 to Chapter 7, large and negative entropy of 
activation and the positive enthalpy of activation support an associative mode of 
activation. In all cases the reactivity of the complexes is sensitive to the steric nature of 
the incoming nucleophiles which decreases with increase in the size of the nucleophile.  
 
8.2 Work Completed but Not Included in This Thesis 
The work reported in this thesis can be extended further to investigate new analogues 
of heterometallic Ru(II)-Pt(II) systems. As an extension of the current study, the two 
heterometallic Ru(II)-Pt(II) complexes1 bridged by diethtyleneglycol ether units viz; 
[ClPt(tpy)-O(CH2CH2O)2(tpy)Ru(tpy)O(CH2CH2O)2(tpy)PtCl], Ru(Ptdeg)2 and 
[ClPt(tpy)-O(CH2CH2O)2(tpy)Ru(tpy)-O(CH2CH2O)2(tpy)Ru(tpy)O(CH2CH2O)2(tpy)PtCl], 
(RuPt)2(deg)3  (Figure 8.6) were synthesized and characterized. Their substitution 
kinetics has also been investigated as chloro complexes with thiourea and Iˉ 







































































Figure 8.6 Structure of the two heterometallic complexes; Ru(Ptdeg)2 and (RuPt)2(deg)3 
investigated. Complexes, Pttpydeg and RuPtdeg are already reported in this thesis 
and Pttpy reported from literature are included for comparisions. 
 
This is an extension of the work on the heterometallic complexes with the flexible 
linkers reported in this Thesis. The main aim of this work is to understand the effect on 
the substitution kinetics when the number of metal centres and the diethyleneglycol 
ether linkers are increased.  The complexes were selected due to their comparable 
cytotoxic activity to cisplatin. The heterometallic complex Ru(Ptdeg)2 inhibit cell 
growth of A2780cis cells for 50% at a concentration of 20 μM.1 The complex 
(RuPt)2(deg)3 was reported to show moderate cytotoxicity against A2780cis and 
A2780R cells-lines.1 Since the complexes are able to bind with DNA, they may play an 
important role in medicinal chemistry and molecular biology. The heterometallic 
complexes mentioned are potentially bifunctional, where Ru(II) bridging ligand 





The substitution kinetics of the complexes were fast and were followed on stopped-
flow reaction analyzer via a single step. The kinetics data obtained are given in Table 
8.1. The substitution reactions gave single exponential fits following the rate law, kobs = 
k2[Nu]. The activation parameters, enthalpy of activation and entropy of activation well 
support an associative mode of mechanism. The manuscript for this work is under 
preparation.  
 
Table 8.1 Summary of second-order rate constants, k2 and activation parameters, with the 
corresponding standard deviations for the substitution of the chloro ligands by a 
series of thiourea nucleophiles and iodide ion at I = 0.02 M LiCF3SO3, adjusted 
with LiCl. Data for Pttpydeg and RuPtdtdeg are taken from Chapter 5 and Chapter 
6 and data for Pttpy2 are included for comparison. 
Complex Nu k1/M-1s-1 SΔ / JK-1 mol-1 HΔ / kJ mol-1 
Pttpy TU   1494 ± 10    -88 ± 5      29 ± 2 
 DMTU     448 ± 10    -73 ± 4     36  ± 1  
 TMTU        82 ± 4    -91 ± 8     35  ± 2  
 Iˉ      243 ± 4    -42 ± 11     47  ± 3  
Pttpydeg TU       265 ± 1     -66 ± 5       40 ± 1  
 DMTU        83 ± 0.8    -54 ± 9       46 ± 3 
 TMTU         23 ± 0.5    -83 ± 7       41 ± 2 
 Iˉ        91 ± 2    -44 ± 9        48 ± 3 
RuPtdtdeg TU      298 ± 5 -112 ± 3       25 ± 1 
 DMTU      114 ± 2    -69 ± 0.7       41 ± 0.2 
 TMTU        44 ± 0.9    -90 ± 4       37 ± 1 
 Iˉ     192 ± 3    -80 ± 5       36 ± 2 
Ru(Ptdeg)2 TU      306 ± 3     -93 ± 3       31 ±1 
 DMTU       96 ± 0.4  -114 ± 1       28 ± 0.4 
 TMTU        30 ± 0.8    -36 ± 6       54 ± 2 
 Iˉ    252 ± 2 -113 ± 4       26 ±1 
(RuPt)2(deg)3 TU     166 ± 2    -47 ± 7       46 ± 2 
 DMTU       45 ± 0.4    -43 ±9       50 ± 3 
 TMTU        17 ± 0.6     -20 ± 6       60 ± 2 







Another interesting series of heterometallic Ru(II)-Pt(II) complexes synthesized during 


















































Figure 8.7 Structure of complexes synthesized and characterized. 
 
Kinetics of ClRu was followed in aqua form at pH = 2, T = 298 K, I = 0.02 M HCF3SO3, 
adjusted with LiCF3SO3 with TU and DMTU (data obtained is not presented here). 
Investigations on substitution kinetics of the other complexes are under progress. The 
complexes are chosen to study their substitution kinetics in order to understand how 
the substitution reactivity at the Ru(II) metal differs from that of the Pt(II) metal centre. 
The effect of the diethyleneglycol ether linker on the Pt(II) centre is reported in this 
thesis. The design of the complexes in this set of complexes however, would allow to 
understand the influence of the diethyleneglycol ether linker on the Ru(II) metal centre. 
Furthermore, the work would also investigate how the substitution behaviour at the 
Ru(II) metal centre is affected when a Pt(II) metal centre is attached to the Ru(II) 
molecule.  
 
8.3 Future Prospects 
It would be interesting to investigate the biological activity of the novel complexes 
reported in this thesis. Moreover, further study should be done probably by using DNA 
substrates to mimic the interactions of platinum complexes with DNA. Most of the 
complexes investigated in this study are expected to interact with DNA in a different 
way compared to the known mechanisms of cisplatin. Ongoing studies1,3 have shown 






Another approach in the extension of this work is to use other bioactive metals such as 
gold(III),4 iron(II) or iron (III) in place of Pt(II) and Ru(II). Research has shown that 
gold complexes show high anticancer activity.5 Furthermore, it would also be 
interesting to understand how the substitution reactivity of the Pt(II) centres is 
effected by the use of alkydiamine linkers instead of polyethyleneglycol ether bridges. 
Alkydiamine linked Pt(II) complexes such as BBR3464 were reported as potential 
anticancer agents.6 Other flexible linkers containing different atoms such as sulphur 
and nitrogen can also be used.7 
 
It would be interesting to study the substitution kinetics of the complexes presented in 
Chapter 4 by changing the ligand system around the Pt(II) metal centre from 
ethylenediamine (en) to cis and trans platin analogues.1 Tethering of Ru(II) moiety to 
known drugs may undergo different modes of actions than cisplatin which may 
produce interesting results. This might also improve the anticancer activity of the 
complexes. Another different strategy that can be employed is to reverse the 
coordination sites of the metals with qpy linker, i.e. Pt(II) coordinating to the tridentate 
terpyridine part and Ru(II) coordinating to the monodentate fourth pyridine.1 This 
could produce interesting polynuclear heterometallic Ru(II)-Pt(II) complexes which 
can resemble the Keppler type molecule.1,8  
 
In short, research on heterometallic antitumour drugs is an area of interest. 
Substitution kinetics of such complexes is novel and therefore full of prospects. Clinical 
investigations of heterometallic anticancer drugs are under process. There is room for 
further development of effective heterometallic Ru(II)-Pt(II) anticancer drugs with 
more promising cytotoxicity. However, more research needs to be done to further 
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